Expression and regulation of neuron-specific enolase by Twyman, Richard M.
 warwick.ac.uk/lib-publications  
 
 
 
 
 
 
A Thesis Submitted for the Degree of PhD at the University of Warwick 
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/109286 
 
Copyright and reuse:                     
This thesis is made available online and is protected by original copyright.  
Please scroll down to view the document itself.  
Please refer to the repository record for this item for information to help you to cite it. 
Our policy information is available from the repository home page.  
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Expression and Regulation of Neuron-Specific Enolase
R IC H A R D  M A R T IN  TW Y M A N  (B.Sc. H ons.)
Thesis submitted for the degree of 
Doctor of Philosophy
MRC Animal Molecular Genetics Group 
Department o f Biological Sciences 
University of W arwick 
Coventry 
C V 4 7AL
November 1995
Title Page i
Table of Contents in Brief ii
Table of Chapter Contents in Full iii
List of Tables and Figures x
Acknowledgements xv
Declaration xvi
Summary xvii
Abbreviations xviii
Section l  - Introduction
• Chapter 1 2
The Molecular Biology of Enolase in Mammals and Birds
• Chapter 2 32
The Molecular Basis of Neuron-Specific Gene Expression
in the Mammalian Nervous System
• Aims 69
Section II - Materials and Methods
• Chapter 3 71
Materials
• Chapter 4 78
Methods
Section III - Results and Discussion
• Experimental Overview 105
• Chapter 5 106
Ex vivo analysis of the rat NSE 5’ flanking region:
development of an experimental system
• Chapter 6 158
Cell type-specific and inducible expression of the rat
NSE gene ex vivo
• Chapter 7 239
Analysis of the of the NSE promoter in vivo using
transgenic mice
• Chapter 8 304
Preliminary studies of protein-DNA interaction in
the NSE 5’ flanking region
• Chapter 9 321
Discussion, conclusions and future work
Section IV - Bibliography 353
Table o f Contents
(in Brief)
ii
Table o f Chapter Contents
(in Full)
Chapter 1 - The Molecular Biology o f  Enolase in Mammals and Birds
1.1 There is more than one gene encoding enolase in mammals and birds
1.2 Early studies of the mammalian enolases
1.3 Expression and ontogeny of a-enolase (nonneuronal enolase)
1.4 Expression and ontogeny of p-enolase (muscle-specific enolase)
1.4.1 Cell-type specificity
1.4.2 Developmental regulation in vivo and ex vivo
1.5 Expression and ontogeny of y-enolase (neuron-specific enolase)
1.5.1 Cell-type specificity
1.5.2 Developmental regulation in vivo
1.5.3 Developmental regulation and induction ex vivo
1.6 Mammalian and avian enolases - structure, function and evolution
1.7 The molecular basis of enolase gene regulation
1.7.1 The human NNE gene
1.7.2 The Peking duck aENO/xCRY gene
1.7.3 The rat, mouse and human MSE genes
1.7.4 The rat and human NSE genes
1.7.5 Posttranscriptional regulation of enolase
1.8 Concluding comments
Chapter 2 - The Molecular Basis o f  Neuron-Specific Gene Expression in 
the Mammalian Nervous System
2.1 Gene expression in the mammalian nervous system.
2.2 Strategies for studying gene regulation.
2.3 Mechanisms of neuron-specific gene expression
2.3.1 Neuron-specific gene expression conferred by a basal promoter
2.3.2 Promiscuous transcription repressed by a neuron-specific negative 
modulator
2.3.3 Minimal nonspecific basal transcription activated by a neuron- 
specific positive modulator
2.3.4 Gene expression in subsets of neurons involving combinatorial 
controls superimposed upon a more promiscuous mechanism
2.4 Other conserved features of neuron-specific genes
2.4.1 A neuronal consensus with unknown function
2.4.2 The SNN motif
2.4.3 The neuronal identifier (ID) sequence
2.4.4 The peptide hormone downstream octamer
2.4.5 Purine-rich sequence elements
2.5 Neuronal gene table
2.6 Transcription factors in the mammalian nervous system - 
approaches to isolation and identification of function.
iii
2.7 Transcription factors in the mammalian nervous system - 
regulation of neuronal genes
2.7.1 Regulation of neuronal genes by immediate early gene products
2.7.2 Putative regulatory factors containing a POU domain
2.7.3 Factors containing an HLH domain
2.7.4 Factors containing an Sry-like box
2.8 Transcription factor table
2.9 Neuron-specific gene expression in the mammalian nervous 
system - concluding comments
Chapter 3 - Materials
3.1 Equipment
3.1.1 Centrifuges
3.1.2 Microscopes and photography
3.1.3 Incubators and ovens
3.1.4 Electrophoresis apparatus
3.1.5 Cell culture equipment
3.1.6 Miscellaneous equipment
3.2 Reagents
3.2.1 General Chemicals and Solvents
3.2.2 Reagents for specific applications
3.2.3 Radioisotopes
3.2.4 Bacteriological media and fine chemicals
3.2.5 Cell culture media and fine chemicals
3.3 Enzymes
3.4 Kits
3.5 Antisera
3.6 Plasmids
3.6.1 Commercially available plasmids
3.6.2 Recombinant plasmids obtained as gifts
3.7 Bacterial strains
Chapter 4 - Methods
4.1 Routine procedures
4.1.1 Routine preparation of plasmid DNA
4.1.2 Routine subcloning
4.1.2.1 Diagnostic and preparative use of restriction endonucleases.
4.1.2.2 Filling recessed 3' ends with the Klenow fragment of E. coli 
DNA polymerase I
4.1.2.3 Removing overhanging 3' ends with T4 DNA polymerase
4.1.2.4 Removing 5' terminal phosphate groups with calf 
intestinal alkaline phosphatase
4.1.2.5 Ligation
4.1.2.6 Transformation of competent E. coli cells with 
plasmid vectors
tv
4.1.3 Gels for resolving nucleic acids
4.1.3.1 Nondenaturing agarose gels for diagnostic applications
4.1.3.2 Low melting point agarose gels for preparative applications
4.1.3.3 Denaturing polyacrylamide gels for high resolution 
electrophoresis
4.1.4 Isolating DNA from agarose gels
4.1.5 dsDNA sequencing
4.1.6 Isotopic and nonisotopic labelling of nucleic acids
4.1.6.1 Nick translation
4.1.6.2 Labelling 3' termini by end-filling
4.1.6.3 Generation of hapten-labelled antisense RNA probes by in 
vitro transcription
4.1.7 Filter hybridisation
4.1.7.1 Analysis of genomic DNA by Southern hybridisation
4.1.7.2 Extraction of cellular RNA
4.1.7.3 Northern hybridisation
4.1.8 Immunoblotting
4.1.8.1 Preparation and electrophoresis of protein extracts
4.1.8.2 Analysis of proteins following electrophoresis
4.1.8.3 Transfer of proteins to nitrocellulose membrane
4.1.8.4 Analysis of proteins following transfer
4.1.8.5 Immunological detection of proteins
4.2 Cell culture techniques
4.2.1 Routine maintenance o f cell lines
4.2.2 Storing cell lines
4.2.3 Differentiation of PC12 cells using nerve growth factor
4.2.4 Differentiation of EC cells using retinoic acid
4.2.5 Transfection of eukaryotic cells - General strategy
4.2.6 Transfection using DEAE-dextran
4.2.7 Transfection using calcium phosphate
4.2.8 Transfection using liposome formulations
4.2.9 Preparation of cell lysates
4.2.10 Soluble p-galactosidase assay
4.2.11 CAT assay
4.3 Immunological techniques
4.3.1 Preparation of cultured cells for immunocytochemical staining
4.3.2 Preparation of mouse embryos and adult tissue for 
immunohistological staining
4.3.3 Sectioning of mouse tissue
4.3.4 Immunological staining - General strategy
4.3.5 Immunocytochemical staining of cells
4.3.6 Immunohistochemical staining of tissue sections
4.4 In situ hybridisation techniques
4.4.1 In situ hybridisation - General strategy
4.4.2 Preparation of embryos
4.4.3 Wholemount in situ hybridisation to mouse embryos
4.4.4 Posthybridisation washes
4.4.5 Signal detection
V
4.5 Transgenic mice
4.5.1 Preparation of transgene DNA
4.5.2 Generation of transgenic mice
4.5.3 Identification of transgenic embryos
4.5.3.1 Preparation of genomic DNA.
4.5.3.2 PCR test to identify transgenic embryos
4.5.3.3 Southern analysis of transgenic embryos
4.5.4 Staining whole mouse embryos for (I-galactosidase activity
4.6 Gel retardation assay
4.6.1 Preparation of protein extracts from cell lines, embryos and adult 
organs
4.6.2 Preparation of probes for the gel restardation assay
4.6.3 DNA - protein interaction in vitro
4.6.4 Gels for the gel retardation assay
Experimental overview
Chapter 5  - Ex vivo analysis o f  the rat NSE gene 5 ’ flanking region: 
development o f  an experimental system
5.1 Chapter summary
5.2 Choice of cell lines
5.2.1 Initial considerations
5.2.2 Analysis of cell lines
5.2.3 Endogenous NSE gene expression in Ltk- and PC12 cells
5.2.4 Endogenous NSE gene expression in U-138 MG and U-373 MG 
cells
5.2.5 NSE gene expression in neuroblastoma cells
5.2.6 Endogenous NSE gene expression in HeLa cells
5.2.7 NSE gene expression in P19 EC cells and their neuronal 
derivatives
5.2.8 NSE gene expression in PC12 cells and their neuronal 
derivatives
5.3 Strategy for the generation of deletion constructs
5.3.1 Starting material
5.3.2 Sequence and numeration of the rat NSE 5' flanking region
5.3.3 Subcloning strategy
5.3.4 Verification of constructs
5.4 Optimisation of transfection parameters
5.4.1 Optimisation of transfection of Ltk- cells
5.4.1.1 Optimisation of transfection of Ltk- cells using DEAE- 
dextran
5.4.1.2 Optimisation of transfection of Ltk- cells using calcium 
phosphate
5.4.1.3 Optimisation of liposome-mediated transfection of Ltk- cells
5.4.2 Optimisation of transfection of PC 12 cells
5.4.2.1 Attempts to transfect PC12 (Geneva) cells
5.4.2.2 Optimisation of liposome-mediated transfection of 
PC 12 (Sheffield) cells
vi
5.4.3 Optimisation of transfection of U-138 MG and U-373 MG 
cells using calcium phosphate
5.4.4 Optimisation of transfection of Neuro-2A cells
5.4.5 Optimisation of transfection of NB4-1A3 cells
5.4.6 Transfection of HeLa cells using calcium phosphate
5.4.7 Optimisation of liposome-mediated transfection of P19 EC cells
5.5 Processing data from cotransfection experiments
5.5.1 Correcting and normalising the primary data
Chapter 6  - Cell type-specific and inducible expression o f  the rat NSE 
gene ex  vivo
6.1 Chapter summary
6.2 Methodology and data presentation
6.3 Transfection with initial NSE-cat constructs
6.3.1 Transfection of Ltk- cells
6.3.2 Transfection of U138-MG cells
6.3.3 Conclusions from first series transfections
6.4 Transfection with full series of NSE-cat constructs
6.4.1 Transfection of Ltk- cells
6.4.2 Transfection of Neuro-2A cells
6.4.3 Transfection of NB4-1A3 cells
6.4.4 Transfection of HeLa cells
6.4.5 Conclusions from the full series transfections
6.5 NSE gene regulation during ex vivo neuronal differentiation
6.5.1 Transfection of PC 12 cells
6.5.1.1 Transfection of undifferentiated PC12 cells
6.5.1.2 Transfection of NGF-treated PC12 cells
6.5.2 Transfection of P19 EC cells
6.5.2.1 Transfection of P19 stem cells
6.5.2.2 Transfection of P19 neurons
6.5.3 Conclusions from transfection studies involving ex vivo neuronal 
differenti ation
6.6 Cotransfection of NSE-cat constructs with cSox2 and cSox3 expression 
vectors
6.7 Conclusions from the Sox factor cotransfection experiments
Chapter 7 - Analysis o f  the NSE promoter in vivo using transgenic mice
7.1 Chapter summary
7.2 Expression of endogenous NSE during mouse development
7.2.1 Biochemical analysis of endogenous NSE gene expression 
during mouse development
7.2.2 In situ detection of endogenous NSE gene products during 
mouse development
7.2.3 Expression of endogenous NSE mRNA - in situ 
hybridisation analysis
v i i
7.2.3.1 Construction of the transcription vector
7.2.3.2 In vitro transcription of antisense and sense RNA 
probes
7.2.3.3 Wholemount in situ hybridisation to mouse embryos
7.2.4 Expression of endogenous NSE protein - in situ
immunohistochemical analysis
7.2.4.1 Expression of endogenous NSE protein at E9.5
7.2.4.2 Expression of endogenous NSE protein at E10.5
7.2.4.3 Expression of endogenous NSE protein at E l 1.5
7.2.4.4 Expression of endogenous NSE protein at E12.5
7.2.4.5 Expression of endogenous NSE protein at E13.5
7.2.4.6 Expression of endogenous NSE protein at E14.5
7.3 Generation of NSE-lacZ transgenic embryos
7.3.1 Construction of transgenes
7.3.2 Generation of transgenic embryos
7.3.3 Identification of transgenic embryos
7.3.4 Analysis of MSE-driven reporter expression in transgenic 
embryos
7.3.5 Expression of transgene TGNSE1800
7.3.6 Comparison of transgene and endogenous gene expression
7.3.7 Conclusions from the transgenic studies
Chapter 8  - Preliminary studies o f protein-DNA interaction in the NSE 5 ' 
flanking region
8.1 Chapter summary
8.2 Summary of transfection data and choice of regions for in vitro analysis
8.3 Preliminary analysis of region A by gel retardation assay
8.4 Further analysis of binding complexes on region A in nonneuronal cells
8.5 Preparation for analysis of the proximal 120 bp of the NSE 5’ flanking 
region
8.6 Conclusions from in vitro studies of the NSE gene
Chapter 9  - Discussion, conclusions and future work
9.1 Chapter summary
9.2 Ex vivo analysis of gene regulation - suitability of the approach and 
criticism of the way systems were chosen, tested and applied.
9.2.1 Suitability of transient transfection analysis for the study of 
gene regulation
9.2.2 Establishment of endogenous NSE gene expression in cell lines
9.2.3 Justification of combined northern and western analysis of gene 
expression
9.2.4 Comparison to previous investigations of NSE gene expression in 
cell lines
9.2.5 Strategy for the generation of deletion constructs
9.2.6 Transfection strategy and data handling
9.3 Transfection experiments
viii
9.3.1 Preliminary attempts to isolate neuron-specific elements in the 
NSE 5 'flanking region
9.3.2 Further analysis of NSE gene regulation in neuronal lines
9.3.3 Further analysis of NSE gene regulation in nonneuronal lines
9.3.4 NSE gene regulation during neuronal differentiation and in the 
presence of cSox2 and cSox3 factors
9.3.5 The role of distal regulatory elements and intron 1
9.3.6 How useful are neuronal cell lines?
9.4 Expression and regulation of NSE in vivo
9.4.1 Endogenous expression of NSE
9.4.2 Expression of (3-galactosidase under control of the NSE promoter
9.4.3 How reliable are transgenic mice for the study of neuronal 
gene expression?
9.5 Protein-DNA associations in the NSE 5' flanking sequence
IX
List o f Tables and Figures
• Table 1.1 Nomenclature of the mammalian and avian enolases
• Table 1.2 Origin of the known mammalian and avian enolase sequences
• Table 1.3 Comparison of the primary amino acid sequences of each enolase isoprotein 
deduced from rat (r), mouse (m) and human (h) cDNA clones
• Table 1.4 Characteristics of the 5’ putative regulatory region of the human NNE gene
• Table 1.5 Characteristics of the 5' putative reguatory region of the duck aENOMCRY gene
• Table 1.6 Characteristics of the putative reguatory regions of the human and rat MSE genes
• Table 1.7 Characteristics of the putative regulatory regions of the human and rat NSE genes
• Table 2.1 Advantages and disadvantages of the cell line and transgenic approaches to the 
analysis of gene regulation
• Figure 2.1 Principle mechanisms of neuron-specific gene expression
• Table 2.2 Comparing the sequences of some of the known neural restrictive silencer 
elements
• Figure 2.2 Catecholamine synthesis in the mammalian nervous system
• Table 2.3 Comparing the flanking regions of neuron-specific genes containing a conserved 
motif with the core consensus sequences CCAGG and GA.. CTG
• Figure 2.3 SNN motifs in neuronal genes
The neuronal gene table (section 2.5) and transcription factor table (section 2.8) are
independent sections and are not also given table numbers.
Table 3.1 Composition of cell culture reagents made in the department
Table 3.2 Strains of bacteria used in this project with their genotypes and applications.
Table 4.1 Controls used to verify ligation reactions
Table 4.2 Maintenance media for the cell lines used in this project
Table 4.3 Liposome formulations used in this project and their manufacturers
Table 4.4 Optimal conditions for liposome-mediated transfections
Figure 5.1 Reference curve for the determination of protein concentrations
Figure 5.2 Western blot to show specificity of anti-human NSE antiserum for NSE of rat
and mouse origin
Figure 5.3 Alignment of the rat and mouse NSE 3' untranslated regions
Figure 5.4 Southern blot showing detection of NSE 3' UTR in mouse genomic DNA
Figure 5.5 Northern, western and immunocytochemical analysis of Ltk- and PC12 (Geneva)
cells
Figure 5.6 Northern, western and immunocytochemical analysis of U-138 MG and U-373 
MG cells
Figure 5.7 Northern, western and immunocytochemical analysis of Neuro-2A and NB4-1A3 
cells
Figure 5.8 Northern and western analysis of NSE gene expression in neuroblastoma cells as 
confluence increases
Figure 5.9 Northern and western analysis of HeLa cells
Figure 5.10 Neuronal differentiation of P19 EC cells
Figure 5.11 Northern and western analysis of differentiating P19 EC cells
Figure 5.12 Northern and western analysis of differentiating PC 12 (Geneva) cells
Figure 5.13 Northern and western analysis of differentiating PC 12 (Sheffield) cells
Figure 5.14 Sequence of the rat NSE gene 5' flanking region
Figure 5.15 Plasmid map of pNSElacZ
X
Figure 5.16 Plasmid map of pCAT-Basic
Figure 5.17 Linear MAPPLOT of the sequenced portion of the rat NSE 5' flanking region 
Figure 5.18 Cloning strategy for the first series of NSE-cat constructs 
Figure 5.19 Cloning strategy for the highly truncated second series of NSE-cat constructs 
Figure 5.20 The effect of transfection duration upon the transfection efficiency of Ltk- cells 
transfected using DEAE-dextran
Figure 5.21 Optimisation of DEAE-dextran-mediated transfection of Ltk- cells by varying 
the dose of DEAE-dextran
Figure 5.22 Optimisation of DEAE-dextran-mediated transfection of Ltk- cells by varying 
the amount of DNA
Figure 5.23 Optimisation of calcium phosphate-mediated transfection of Ltk- cells by 
varying the amount of DNA
Figure 5.24 Optimisation of liposome-mediated transfection of Ltk- cells by varying the 
dose and type of liposome
Figure 5.25 Optimisation of LipofectAMINE-mediated transfection of Ltk- cells by varying 
the amount of DNA
Figure 5.26 Optimisation of LipofectAMINE-mediated transfection of PC12 (Sheffield) 
cells by varying the dose of liposome
Figure 5.27 Optimisation of liposome-mediated transfection of PC12 (Sheffield) cells by 
varying the amount of DNA
Figure 5.28 Optimisation of calcium phosphate-mediated transfection of U-138 MG and LI- 
373 MG cells by varying the pH of the BES-buffered saline
Figure 5.29 Optimisation of calcium phosphate-mediated transfection of U-138 MG and U- 
373 MG cells by varying the amount of DNA
Figure 5.30 Optimisation of calcium phosphate-mediated transfection of Neuro-2A cells by 
varying the amount of DNA
Figure 5.31 Optimisation of liposome-mediated transfection of NB4-1A3 cells by varying 
the dose and type of liposome
Figure 5.32 Optimisation of LipofectAMINE-mediated transfection of NB4-1A3 cells by 
varying the amount of DNA
Figure 5.33 Optimisation of LipofectAMINE-mediated transfection of P19 cells by varying 
the dose of liposome
Figure 5.34 Optimisation of LipofectAMINE-mediated transfection of P19 cells by varying 
the amount of DNA
Table 5.1 Calculation of Molar Equivalence Constants
Figure 6.1 A glossary to explain the data presentation used in Chapter 6
Figure 6.2 Table and histogram showing data from the first transfection of Ltk- cells with
the initial series of NSE-cat constructs
Figure 6.3 Table and histogram showing data from the second transfection of Ltk- cells with 
the initial series of NSE-cat constructs
Figure 6.4 Table and histogram showing data from the third transfection of Ltk- cells with 
the initial series of NSE-cat constructs
Figure 6.5 Table and histogram showing combined data from the transfection of Ltk- cells 
with the initial series of NSE-cat constructs
Figure 6.6 Representative CAT assay from the Ltk- series of transfections using the initial 
series of NSE-cat constructs
Figure 6.7 Table and histogram showing data from the first transfection of U-138 
MG cells with the initial series of NSE-cat constructs
Figure 6.8 Table and histogram showing data from the second transfection of U-138 MG 
cells with the initial series of NSE-cat constructs
Figure 6.9 Table and histogram showing data from the third transfection of U-138 
MG cells with the initial series of NSE-cat constructs
Figure 6.10 Table and histogram showing combined data from the transfection of U-138 
MG cells with the initial series of NSE-cat constructs
Figure 6.11 Representative CAT assay from the U-138 MG series of transfections using the 
initial series of NSE-cat constructs
XI
• Figure 6.12 Comparison of transfection data from permissive U-138 MG and nonpermissive 
Ltk- cells
• Figure 6.13 Table and histogram showing data from the first transfection of Ltk- cells with 
the full series of NSE-cat constructs
• Figure 6.14 Table and histogram showing data from the second transfection of Ltk- cells 
with the full series of NSE-cat constructs
• Figure 6.15 Table and histogram showing data from the third transfection of Ltk- cells with 
the full series of NSE-cat constructs
• Figure 6.16 Table and histogram showing combined data from the transfection of Ltk- cells 
with the full series of NSE-cat constructs
• Figure 6.17 Representative CAT assay from the Ltk- series of transfections using the full 
series of NSE-cat constructs
• Figure 6.18 Table and histogram showing data from the first transfection of Neuro-2A cells
• Figure 6.19 Table and histogram showing data from the first transfection of Neuro-2A cells 
with the full series of NSE-cat constructs
• Figure 6.20 Table and histogram showing data from the second transfection of Neuro-2A 
cells with the full series of NSE-cat constructs
• Figure 6.21 Table and histogram showing data from the third transfection of Neuro-2A cells 
with the full series of NSE-cat constructs
• Figure 6.22 Table and histogram showing combined data from the transfection of Neuro-2A 
cells with the full series of NSE-cat constructs
• Figure 6.23 CAT assay from the initial Neuro-2A transfection experiment
• Figure 6.24 Representative CAT assay from the Neuro-2A series of transfections using the 
full series of NSE-cat constructs
• Figure 6.25 Table and histogram showing data from the first transfection of NB4-1A3 cells 
with the full series of NSE-cat constructs
• Figure 6.26 Table and histogram showing data from the second transfection of NB4-1A3 
cells with the full series of NSE-cat constructs
• Figure 6.27 Table and histogram showing combined data from the transfection of NB4-1A3 
cells with the full series of NSE-cat constructs
• Figure 6.28 Representative CAT assay from the NB4-1A3 series of transfections using the 
full series of NSE-cat constructs
• Figure 6.29 Table and histogram showing data from the first transfection of HeLa cells with 
the full series of NSE-cat constructs
• Figure 6.30 Table and histogram showing data from the second transfection of HeLa cells 
with the full series of NSE-cat constructs
• Figure 6.31 Table and histogram showing data from the third transfection of HeLa cells 
with the full series of NSE-cat constructs
•  Figure 6.32 Table and histogram showing combined data from the transfection of HeLa 
cells with the full series of NSE-cat constructs
• Figure 6.33 Representative CAT assay from the HeLa series of transfections using the full 
series of NSE-cat constructs
• Figure 6.34 Table and histogram showing data from the first transfection of undifferentiated 
PC 12 cells with the full series of NSE-cat constructs
•  Figure 6.35 Table and histogram showing data from the second transfection of 
undifferentiated PC 12 cells with the full series of NSE-cat constructs
• Figure 6.36 Table and histogram showing combined data from the transfection of 
undifferentiated PC12 cells with the full series of NSE-cat constructs
•  Figure 6.37 Representative CAT assay from the undifferentiated PC 12 series of 
transfections using the full series of NSE-cat constructs
• Figure 6.38 Table and histogram showing data from the first transfection of NGF-treated 
PC 12 cells with the full series of NSE-cat constructs
•  Figure 6.39 Table and histogram showing data from the second transfection of NGF-treated 
PC 12 cells with the full series of NSE-cat constructs
•  Figure 6.40 Table and histogram showing combined data from the transfection of NGF- 
treated PC12 cells with the full series of NSE-cat constructs
• Figure 6.41 Representative CAT assay from the NGF-treated PC12 series of transfections 
using the full series of NSE-cat constructs
Xll
• Figure 6.42 Table and histogram showing data from the first transfection of undifferentiated 
P19 EC cells with the full series of NSE-cat constructs
• Figure 6.43 Table and histogram showing data from the second transfection of 
undifferentiated P19 EC cells with the full series of NSE-cat constructs
• Figure 6.44 Table and histogram showing combined data from the transfection of 
undifferentiated P19 EC cells with the full series of NSE-cat constructs
• Figure 6.45 Representative CAT assay from the undifferentiated P19 EC cell series of 
transfections using the full series of NSE-cat constructs
•  Figure 6.46 Table and histogram showing data from the first transfection of P19 neurons 
with the full series of NSE-cat constructs
• Figure 6.47 Table and histogram showing data from the second transfection of P19 neurons 
with the full series of NSE-cat constructs
• Figure 6.48 Table and histogram showing combined data from the transfection of P19 
neurons with the full series of NSE-cat constructs
• Figure 6.49 Representative CAT assay from the P19 neuron series of transfections using the 
full series of NSE-cat constructs
• Figure 6.50 Table and histogram showing data from the first transfection of NB4-1A3 cells 
with pNSE1800CAT, CAT control vectors and Sox expression vectors
• Figure 6.51 Table and histogram showing data from the second transfection of NB4-1 A3 
cells with pNSE1800CAT, CAT control vectors and Sox expression vectors
• Figure 6.52 Table and histogram showing combined data from the transfection of NB4-1A3 
cells with pNSE1800CAT, CAT control vectors and Sox expression vectors
• Figure 6.53 Representative CAT assay from the transfection of NB4-1A3 cells with 
pNSE1800CAT, CAT control vectors and Sox expression vectors
Figure 7.1 Biochemical analysis of NSE gene expression during mouse development 
Figure 7.2 pBluescriptIIKS + , the source plasmid used to construct pNSEprobel 
Figure 7.3 Strategy for the generation of antisense RNA probes for the in situ detection of 
NSE mRNA and sense RNA probes for negative control hybridisations 
Figure 7.4 Confirmation of digoxigenin-UTP-labelled RNA probe synthesis 
Figure 7.5 In situ hybridisation to (a) E8.5 and (b) E9.5 mouse embryos using a 
digoxigenin-UTP-labelled antisense RNA probe complementary to the NSE 3' untranslated 
region
Figure 7.6 Mouse rostral neural tube at E14.5 (a) immunologically stained for NSE protein,
detected using an FITC-conjugated secondary antiserum and (b) negative control
Figure 7.7 Expression of NSE protein in mouse embryos at E9.5
Figure 7.8 Expression of NSE protein in mouse embryos at E10.5
Figure 7.9 Expression of NSE protein in mouse embryos at El 1.5
Figure 7.10 Expression of NSE protein in mouse embryos at E12.5
Figure 7.11 Expression of NSE protein in mouse embryos at E13.5 (brain sections)
Figure 7.12 Expression of NSE protein in mouse embryos at E13.5 (brainstem and rostral
neural tube sections)
Figure 7.13 Expression of NSE protein in mouse embryos at E14.5 (alar brain sections)
Figure 7.14 Expression of NSE protein in mouse embryos at E14.5 (basal brain sections and
peripheral organs)
Figure 7.15 Expression of NSE protein in mouse embryos at E14.5 (rostral neural tube 
sections )
Figure 7.16 Generation of NSE-lacZ transgenes 
Figure 7.17 PCR test to identify transgenic embryos
Figure 7.18 Spatial expression of transgene TGNSE1800 in (a) embryo 1A3 and (b) embryo 
2B1
Figure 7.19 Transverse sections of (a) midbrain and (b) medulla from embryo 1A3 
immunologically stained for P-galactosidase protein
Figure 7.20 Transverse sections through (a) eye and (b) pituitary gland from embryo 1A3 
immunologically stained for P-galactosidase protein
xiii
• Figure 8.1 Summary of the results of transfection experiments involving the most truncated 
NSE-cat constructs
• Figure 8.2 Preliminary analysis of DNA-protein interaction in region A of the NSE 5' 
flanking region using extracts of Ltk- and PC 12 cells
• Figure 8.3 Attempts to optimise protein-DNA binding activity using region A of the NSE 5' 
flanking region and extracts of PC 12 cells
• Figure 8.4 Further attempts to optimise protein-DNA binding activity using region A of the 
NSE 5' flanking region and extracts of PC 12 cells
• Figure 8.5 Preliminary analysis of DNA-protein interaction in region A of the NSE 5’ 
flanking region using extracts of Neuro-2A and HeLa cells
• Figure 8.6 Competition analysis to determine the specificity of three binding complexes on 
region A of the NSE 5' flanking sequence using extracts of (a) Ltk- cells and (b) HeLa cells
• Figure 8.7 Further competition analysis to determine the specificity of three binding 
complexes on region A of the NSE 5 ' flanking sequence using extracts of (a) Ltk- cells and 
(b) HeLa cells
XIV
Acknowledgements
I wish to thank all members of the department, both past and present who, by 
generously volunteering their time, advice, practical assistance and laptop 
computers, have helped me to complete this thesis. Particularly, I would like 
to thank Liz Jones for experimental guidance, lively discussions, and a 
seemingly limitless supply of encouragement and enthusiasm through good 
times and bad.
I acknowledge Sonja Forss-Petter and Patria Danielson for their magnanimous 
gifts of plasmids pNSElacZ and pcD169, without which this project would not 
have been possible. Thanks also to David Stott for supplying materials and 
technical expertise and for munificently generating transgenic mice at very 
short notice. The financial support of the BBSRC (formerly SERC) and Glaxo 
is gratefully acknowledged.
This thesis is dedicated to my parents, Peter Richard Twyman and Irene Rose 
Twyman, whose love and support over the years has taken many forms but has 
never wavered. It is also dedicated to my wife and best friend, Vicki Twyman, 
a constant source of motivation and inspiration. Finally, it is dedicated to my 
baby daughter, Emily Anne Twyman, who is, without doubt, my best result 
yet..........
xv
Declaration
I hereby declare that the work contained within this thesis was carried out 
exclusively by myself, with the notable exception that transgenic mice were 
generated by Dr David Stott. All information sources are acknowledged.
None of the data contained herein have been submitted in full or in part for any 
other degree. However, where indicated, some sections have been published 
or submitted for publication.
xvi
Summary
Neuron-specific enolase (NSE) is an isoform of the glycolytic enzyme enolase 
which is expressed specifically in neurons and neuroendocrine cells in the 
mammalian nervous system. Its onset of expression coincides with neuronal 
differentiation and it has therefore become established as a marker of mature, 
postmitotic neurons (Zomzely-Neurath, 1983). The molecular basis of neuron- 
specific gene expression is still poorly understood (Twyman and Jones, 1995b) 
and the panneuronal NSE gene thus represents an excellent model for the 
investigation of mechanisms responsible for neuronal gene regulation.
Recently, the proximal 1.8 kbp of 5' flanking sequence from the rat NSE gene 
was shown to confer neuron-specific and panneuronal expression upon a 
heterologous gene in transgenic mice (Forss-Petter et al. , 1990). This 
suggested that the sequence probably contained neuron-specific cis-acting 
elements which could be investigated using a deletion-reporter strategy in 
cultured cells and transgenic mice. The 1.8 kbp flanking sequence has also 
been shown to respond to NGF and retinoic acid in parallel with the 
endogenous gene (Alouani et al., 1993).
In this project, the 1.8 kbp 5' flanking sequence was dissected, and various 
truncated derivatives were compared to the full length construct in cultured 
cells of neuronal and nonneuronal origin. It was shown that 255 bp of 5' 
flanking sequence was capable of conferring full cell type-specific regulation 
upon a heterologous gene, indicating the presence of neuronal c/s-acting 
elements within 255 bp of the transcriptional start site. Further transfection 
experiments, concentrating on this short proximal fragment, showed that 
elements responsible for neuron-specific gene expression were present in this 
region and in vitro analysis identified at least one specific DNA-protein 
interaction. Preliminary analysis of NSE gene regulation was also carried out 
in transgenic mice. These experiments, taken together with previous studies, 
showed that the level of transgene expression was variable and subject to both 
position and gene dosage effects. It was concluded that further analysis should 
be carried out in transgenic lines, preferably utilising flanking boundary 
elements which would protect the NSE transgenes from the position effects (to 
which they were highly susceptible). The impact of the transfection and 
transgenic experiments was discussed with respect to the published literature 
and ideas for future experiments were suggested.
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Abbreviations
The abbreviations used in this thesis are listed below in alphabetical order. 
Generally, where an unestablished abbreviation first occurs in the text, it is 
supported by the unabbreviated term in parentheses. Several classes of 
abbreviation have been omitted from the list below for the sake of brevity. 
These include: a) SI units; b) chemical formulae; c) names of cell lines, strains 
of animals, plants and bacteria; d) accepted gene or phenotype designations, 
names of plasmids and transgenes, and names of transcription factors; e) 
abbreviations relating to products, manufacturers and their addresses and f) 
restriction endonucleases. Where necessary, the abbreviations listed below 
may be supported by some explanatory text.
A - adenine (base) or adenosine (nucleoside)
AADC - aromatic amino acid decarboxylase 
AC A - Actual CAT Activity (see section 5.5)
ACh - Acetylcholine
b, bp - base, base pair
BBS - BES-buffered saline
BDNF - brain-derived neurotrophic factor
BES - A,A-fcf's-[2-hydroxyethyl]-2-aminoethanesulphonic acid
BETA - brain enriched transcriptional activator
bHLH - basic helix-loop-helix motif
BSA - bovine serum albumin
BSF - brain-specific factor
bZIP - basic leucine zipper motif
C - cytosine (base) or cytidine (nucleoside)
cAMP - cyclic AMP (adenosine 5’-monophosphate)
CAT - chloramphenicol acetyltransferase 
cDNA - complementary DNA 
ch - chicken
CIAP - calf intestinal alkaline phosphatase
CNS - central nervous system
CoA - coenzyme A
CRE - cAMP response element
CTF - CAAT-binding transcription factor
dATP - 2 ’-deoxyadenosine 5’-triphosphate
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dbcAMP - dibutyryl cyclic adenosine 5’-monophosphate
DBH - dopamine p-hydroxylase
dCTP - 2’-deoxycytidine 5’-triphosphate
DEAE-dextran - diethylaminoethyl dextran
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dGTP - 2’-deoxyguanidine triphosphate
DIG - digoxigenin
DMEM - Dulbecco’s modified Eagle’s medium
DMSO - dimethylsulphoxide
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DNase - 2’-deoxyribonuclease
dNTP - Any 2’-deoxynucleoside 5’-triphosphate
DOTAP - N-[l-(2,3-dioleyloxy)propyl]-7V,N,A-trimethylammonium chloride 
DTT - dithiothreitol
dTTP - 2’-deoxythymidine 5’-triphosphate
E (followed by number) - embryonic day
EC - embryonal carcinoma
EDTA - ethylenediaminetetraacetic acid
EGF - epidermal growth factor
ES cells - embryonic stem cells
et al. - et alia, and others
FBS - Foetal bovine serum
FCS - Foetal calf serum
FITC - fluorescein isothiocyanate
G - guanine (base) or guanidine (nucleoside)
GABA - y-aminobutyric acid
GAL - unit p-galactosidase activity (see section 5.5)
GAP - growth associated protein
GCG - Genetics Computer Group
GRE - glucocorticosteroid response element
h - human
HIF - hypoxia-inducible factor
HIV - human immunodeficiency virus
HLH - helix-loop-helix
HMG - high mobility group
hrs - hours
HS - horse serum
HSV - herpes simplex virus
xix
ID - identifier (neuronal identifier element)
IEG - immediate early gene 
kb, kbp - kilobase, kilobase pair 
kDa - kiloDaltons 
Krox - Kruppel-like box 
LB - Luria broth 
m - mouse
MASH - mammalian achaete-scute homologue 
MEC - molar equivalence constant (see section 5.5)
MEM - minimal essential medium
min - minimal
mins - minutes
mRNA - messenger RNA
MSE - muscle-specific enolase
MTF - metal-responsive transcription factor
NAA - nonessential amino acids
NF - nuclear factor
NF-H heavy neurofillament
NF-L light neurofillament
NF-M mid-range neurofillament
NGF - nerve growth factor p
NNE - nonneuronal enolase
NRS(B)F - neural restrictive silencer (binding) factor
NRSE - neural restrictive silencer element
NS - neuron-specific
NSE - neuron-specific enolase
NTET - a washing solution containing salt (i.e. NaCl), Tris, EDTA and Tween 
20
Oct - octamer
OD - optical density
OMP - olfactory marker protein
ONPG - o-nitrophenyl-p-D-galactopyranoside
p - phosphate (denotes single phosphate group, hence CpG, Gppp etc.)
P (followed by number) - postnatal day 
PAGE - polyacrylamide gel electrophoresis 
PBS - phosphate buffered saline 
PBST - PBS containing Tween 20 
PCR - polymerase chain reaction
xx
PEP - phosphoeno/pyruvate
2-PGA - 2-phosphoglycerate
PMSF - phenylmethylsulphonylfluoride
PNMT - phenylethanolamine N-methyltransferase
PNS - peripheral nervous system
POU - conserved DNA-binding domain originally found in Pit-1, Oct-1 and 
Oct-2, and Unc-86 transcription factors 
PPT - preprotachykinin 
R - any puRine 
r - rat
RACE - rapid amplification of cDNA ends 
RARE - retinoic acid response element 
RCA - Relative CAT Activity (see section 5.5)
RNA - ribonucleic acid 
RNase - ribonuclease 
RSV - Rous sarcoma virus 
S - G or C (three bondS)
SCIP - suppressed cAMP inducible POU 
scRNA - small cellular RNA
SDS - sodium dodecylsulphate (also known as sodium lauryl sulphate) 
secs - seconds
sem - standard error of the mean
SNN - SNN motif (neuronal motif found in synapsin, neurofilament and NGF 
receptor gene 5’ flanking regions)
Sox - Sry-like box*
SSC - Standard saline citrate buffer
STE - a solution containing salt (i.e. NaCl), Tris and EDTA used during 
plasmid preparations 
SV40 - simian virus 40 
T - thymine (base) or thymidine (nucleoside)
T3, T4, T7 - tailed phages
TAR - 7ra«s-activator region (of the HIV genome)
TAT - Trans-activator gene
* Nomenclature for Sox genes and their products: In this thesis, both chicken and mouse Sox genes are 
discussed. The accepted nomenclature for the mouse genes is Sox-2. Sox-3 etc., and for their products, 
Sox-2, Sox-3 etc., whilst for the chicken genes the nomenclature is cSox2, cSox3 etc., and for the products 
cSox2. cSox3 etc. Where the Sox genes or their products are discussed in a generic sense, the mouse 
nomenclature is used.
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Introduction: Chapter 1
Chapter 1 - The Molecular Biology o f  Enolase in M ammals and  Birds
A project involving neuron-specific enolase would be incomplete without an 
introduction placing the study in the context of enolase research as a whole. The aim 
of this first introductory chapter is to provide a review of enolase molecular biology in 
mammals and birds, two branches of the phylogenetic tree where the existence of 
neuron-specific enolase is undisputed, and as such, this chapter has been submitted in 
modified form for publication (Twyman and Jones, 1995a).
1.1 There is more than one gene encoding enolase in mammals and birds
The dimeric metalloenzyme enolase is a critical component of glucose metabolism, 
catalysing the reversible dehydration of 2-phosphoglycerate (2-PGA) to 
phosphoenolpyruvate (PEP). As an intrinsic part of this ubiquitous metabolic 
pathway, enolase is probably found in all living cells and it has certainly been isolated 
from a wide variety of natural sources (Wold, 1971; Brewer, 1981). In eukaryotes, 
enolase is often found as multiple, distinct isoforms, a property it shares with many 
other enzymes. Such isozymic heterogeneity reflects the existence of a small, 
conserved family of enolase genes, the members of which are regulated 
independently in many species (Twyman and Jones, 1995c). In mammals and birds, 
there are (at least) three enolase genes whose products combine as homodimers and 
heterodimers to generate five isoenzymes. The levels of the three subunits vary 
according to tissue and developmental stage, indicating that the genes encoding them 
are spatially and temporally regulated. Experiments using various cell lines have also 
shown that certain agents and growth conditions can modulate the levels of the 
enolase subunits in cultured cells. Although the specificity, ontogeny and inducibility 
of enolase gene expression have been studied intensely for over twenty years, it is 
only recently, with the advent of modem molecular biology techniques, that the 
mechanisms of gene regulation have been investigated at the molecular level.
1.2 Early studies of the mammalian enolases
Enolase isoenzymes were first studied specifically in mammals as a continuation of 
investigations into the general heterogeneity of mammalian glycolytic enzymes (Rider 
and Taylor, 1974). Earlier studies had shown that several other such enzymes were 
represented by distinct and tissue-specific isoforms (Penhoet et al., 1966; Criss, 1971;
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Sato et al., 1972), and it was proposed that such diversity had evolved to allow 
glycolysis to subserve different functions in different tissues as has been demonstrated 
for certain plants (Miemyk and Dennis, 1982). In comparative studies carried out in 
the early 1970s, enolases were isolated from a variety of sources in nature and found 
to be biochemically and kinetically similar (Cardenas and Wold, 1971; Ruth et al., 
1970), however, samples taken from mammals and other animals were all derived 
from muscle, thus the tissue-specificity of enolase isoenzymes within each species 
was not investigated. Electrophoretic evidence for the existence of enolase 
isoenzymes in human skin (Halprin and Fukui, 1968) and erythrocytes (Bartels and 
Vogel, 1971) had been presented. Enolase had also been isolated from bovine brain 
(Wood, 1964), human erythrocytes (Witt and Witz, 1970), and porcine kidney (Oh 
and Brewer, 1973) without comparative studies being carried out.
Mammalian enolase isoenzyme diversity was first comprehensively investigated in 
the rat (Rider and Taylor, 1974; 1975a). These studies showed that three 
biochemically distinct enolase isoenzymes could be resolved, which, although 
kinetically indistinguishable, differed in their ontogeny, distribution and 
immunological properties. Isoenzyme 1 was found in extracts of all of the tissues 
examined except adult skeletal muscle, and was also the only form of enolase found in 
the embryo. Conversely, isoenzyme 3 was absent from the embryo and was the only 
form of enolase found in adult skeletal muscle. Reciprocal immunological cross­
reaction between isoenzymes 1 and 3 did not occur, suggesting they contained distinct 
polypeptides. Heart extracts contained both isoenzymes 1 and 3 along with a third 
form, isoenzyme 2, which demonstrated biochemical properties intermediate between 
the other enolases. Isoenzyme 2 was also present (together with isoenzyme 1) in 
developing skeletal muscle but isoenzyme 3 completely replaced these embryonic 
forms by postnatal day 30. Although isoenzymes 1 and 3 were shown to be 
immunologically distinct, antisera raised against each of them cross-reacted to 
isoenzyme 2, suggesting that this intermediate isoform shared antigenic determinants 
with both of them. From these initial results, the authors concluded that two discrete 
enolase polypeptides were encoded by the rat genome, one of which (a-enolase, now 
called nonneuronal enolase, NNE) was expressed nearly ubiquitously, the other (P- 
enolase, now called muscle-specific enolase, MSE) was restricted to skeletal muscle 
and heart. In most tissues, the native enolase dimer was composed of two a  or NNE 
subunits (isoenzyme 1, aa-enolase) whilst in adult muscle, the dimer was composed 
of two P or MSE subunits (isoenzyme 3, PP-enolase). The authors further suggested 
that, during muscle development, a rapid switch from NNE to MSE synthesis 
occurred resulting in transient expression of the heterodimer (isoenzyme 2, aP-
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enolase) whilst conversely, NNE and MSE subunits were coexpressed in the heart, 
resulting in the constitutive presence of all three isoenzymes (Rider and Taylor,
1974).
Evidence of enolase heterogeneity in mammalian brain tissue (Kamel and 
Schwartzfischer, 1975; Pearce et al., 1976; Chen and Giblett, 1976) prompted a 
careful re-examination of the enolase isoenzyme profile in rat brain (Rider and Taylor, 
1975b; Fletcher et al., 1976). A component representing 30% of total enolase activity 
was discovered which remained uninhibited by antisera raised against either the NNE 
or MSE subunits. Careful electrophoretic and chromatographic separation of brain 
extracts identified three peaks of enolase activity, one of which corresponded to 
isoenzyme 1, the others being novel and brain-specific. One of the new enolases, 
isoenzyme 5, was almost totally resistant to inactivation by antisera raised against 
NNE and MSE subunits and the authors concluded that this isoenzyme represented a 
homodimer of novel subunits, which they termed y-enolase (now known as neuron- 
specific enolase, NSE). Because isoenzyme 5 eluted at a characteristic acidic pH, it 
was also called acidic brain enolase in the early literature. The remaining form of 
enolase, isoenzyme 4, was inhibited by antisera raised against the NNE and NSE 
subunits and demonstrated biochemical properties intermediate between isoenzymes 1 
and 5. It was therefore concluded that this hybrid brain enolase was a heterodimer 
composed of NNE and NSE subunits. At about the same time as the NSE subunit of 
enolase was discovered, E. Bock and J. Dissing showed that a bovine neuronal 
antigen known as 14-3-2 protein, which had been isolated some years before (Moore 
and McGregor, 1965; Moore and Perez, 1966), possessed enolase activity (Bock and 
Dissing, 1975). Studies of homologous molecules in other mammals soon showed 
that rat 14-3-2 protein was identical to rat enolase isoenzyme 5 (yy-enolase)
(Marangos et al., 1976; 1977; Bock et al., 1978). The conclusion from these early 
studies was that the rat genome encoded three distinct enolase subunits which could 
combine as homodimers and heterodimers to form the observed isoenzymes. A guide 
to enolase nomenclature is provided in Table 1.1.
1.3 Expression and ontogeny of a-enolase (nonneuronal enolase)
In mammals, a-enolase is known as nonneuronal enolase (NNE) because early studies 
of its expression in the nervous system indicated (falsely, as it turned out) that it was 
excluded from the neuronal cell lineage (Schmechel et al., 1978). It is clear that there 
is a full switchover from NNE to MSE expression in developing skeletal muscle
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L o cu s A lte r n a t iv e  
lo c u s  n a m e s
G e n e  P r o d u c t  
(S u b u n it  n a m e )
D im e r I U P A C
n u m b e r
O th e r  n a m es
EN02 NSE, yENO y-enolase, 
neuron-specific 
enolase (NSE)
yy-enolase enolase 5 neuron-specific 
enolase, (NSE), acidic 
brain enolase 
[neuron-specific 
protein, 14-3-2 
protein]
ay-enolase enolase 4 hybrid brain enolase
ENOl NNE, a  ENO, 
aENOACRY
a-enolase, 
embryonic enolase, 
nonneuronal enolase 
(NNE)
aa-enolase enolase 1 nonneuronal enolase 
(NNE),
embryonic enolase, 
liver enolase
aP-enolase enolase 2
EN03 MSE, PENO P-enolase, 
muscle specific 
enolase (MSE)
PP-enolase enolase 3 muscle-specific 
enolase (MSE)
Py-enolase enolase 6
Table 1.1: Nomenclature of the mammalian and avian enolases. The cytogenetic nomenclature for all 
enolase gene loci is being brought into line with the human system (used in column 1 of the table), 
hence the rodent loci are named Enol, Eno2 and Eno3 and the chick loci are named ENOl, EN02 and 
EN03 according to species convention. The duck ENOl locus is also termed aENO/iCRY because the 
gene encodes a bifunctional protein (see text). Use of the conventional cytogenetic and biochemical 
nomenclature leads to confusion because the gene products (enolases 1-3) and the various dimers they 
form (enolases 1-6) do not always correspond. Most authors thus avoid convention in favour of a 
simpler nomenclature based on the acronyms for nonneuronal enolase, muscle-specific enolase and 
neuron-specific enolase. These can be used to refer to the genes and their products and the same name 
is routinely used to describe both the enolase subunit and the homodimer it forms. If it is necessary to 
specify dimeric structure, the apy system shown in column 4 can be used. For NSE, the alternative 
names shown in square brackets were those used before its enolase activity had been determined. Py- 
enolase is not found in vivo because the corresponding subunits are never coexpressed. However, such 
an isoenzyme can be prepared in vitro, using a method described in Shimizu el al., 1983.
which is controlled at the level of transcription, and that a similar switch from NNE to 
NSE expression may occur during the differentiation of at least some classes of 
neuron; these studies are discussed under the headings of the relevant tissue-specific 
enolases. There have been few studies of mammalian NNE expression outside the 
contexts of neurogenesis and myogenesis. The NNE gene is expressed in the majority 
of proliferating human cell lines, although mRNA levels are low in quiescent 
lymphoblasts (Giallongo el al., 1986). In these cells, and others, NNE gene 
expression can be induced by mitogenic stimulation, and a peak of NNE mRNA 
accumulation occurs about 24 hours after treatment (Giallongo et al., 1986). 
Previously, it had been reported that cDNA clones corresponding to five mRNAs 
induced by the mitogenic stimulation of quiescent rat fibroblasts represented five 
glycolytic enzymes including enolase (Matrisian et al., 1985). These data suggested 
that activation of glycolysis may herald re-entry into the cell cycle (Rubin and Fodge, 
1974) and it is therefore interesting to note that expression of the Saccharomyces
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cerevisiae enolase genes is also regulated globally by the growth status of the cells 
(see Twyman and Jones, 1995c). Unlike S. cerevisiae ENOl, human NNE is not 
inducible by heat shock, at least at the level where other human heat shock proteins 
can be easily detected (Giallongo et al., 1986).
In birds, NNE is expressed in a spatial and temporal pattern broadly similar to 
mammalian NNE. However, in certain species, high levels of the protein accumulate 
specifically in the lens, a property not displayed by the mammalian homologues. The 
components of lenses which enable them to transmit and refract light are highly 
abundant soluble proteins termed crystallins. Although these proteins perform a very 
specialised function, it has been shown that many are in fact common, housekeeping 
enzymes which are expressed to extraordinary high levels in a lens-specific manner 
(reviewed by Wistow and Piatigorsky,1987; 1988). The initial suggestion that 
enolase might be among these enzymes came from partial sequences of turtle and 
lamprey x-crystallin and when the complete amino acid sequence of Peking duck x- 
crystallin was deduced from a full length cDNA clone, it demonstrated 92.5% identity 
to human NNE (Wistow et al., 1988). The authors then provided convincing evidence 
to show that both the glycolytic enzyme and the lens crystallin were encoded by a 
single gene, a ENO/xCRY (Wistow et al., 1988). Northern analysis showed that the 
transcripts encoding each protein were identical and that levels of the common aENO/ 
xCRYmessage were 25 times higher in lens than in liver, indicating that regulation 
occurred at the level of transcription (Wistow et al., 1988). clENO/xCRY mRNA 
accumulated in the duck lens between E l2 and E l4, and levels were higher in the 
epithelial cells than the fibre cells (Kim et al., 1991). Although there was no evidence 
to suggest any differences between the tertiary structures of the two proteins, x- 
crystallin has been shown to exist as a 48 kDa monomer with little enolase activity 
(Stapel and de Jong, 1983; Williams et al., 1985; Rudner et al., 1988), whilst NNE in 
mammals, in common with eukaryotic enolases generally, has been shown to be 
dimeric (Rider and Taylor, 1974). Immunohistological studies of lens x-crystallin in 
turtles revealed a background staining in all tissues, persumably representing NNE 
expression; it is not known whether the difference in staining intensity was 
completely attributable to differing protein levels or perhaps reflected some antigenic 
discrimination between the proteins. Although x-crystallin has been detected in many 
lower vertebrates and in ducks, it appears to be absent in chickens (Stapel and de 
Jong, 1983). The levels o f chicken NNE have been investigated during development 
at both the protein and mRNA levels (Tanaka et al., 1985a; 1985b; 1995) and in 
neither case does lens accumulate significantly more gene product than liver. 
Furthermore, gel filtration analysis showed that all the chicken lens NNE existed as an
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enzymatically active dimer and not as a monomer (Tanaka et al., 1995). An 
interesting question raised by the above studies is why, in at least some birds and 
other lower vertebrates, should enolase have been recruited as a lens crystallin? It is 
unlikely that its catalytic properties would be valued in the lens, as the variety of 
independently recruited enzymes making up the crystallin population indicates a 
programme of neutral selection (Wistow et al., 1990). It has been suggested that, as 
enzymes (including enolase) are often found in high concentrations to enhance 
substrate processing (Srivastava and Bernhard, 1986), they may have become pre­
adapted to high protein environment found in the lens and therefore suitable for 
recruitment (Wistow et al., 1988).
1.4 Expression and ontogeny of P-enolase (muscle-specific enolase)
1.4.1 Cell-type specificity
As described above, the early studies of rat enolase showed that expression of P- 
enolase (muscle-specific enolase, MSE) was restricted to skeletal muscle and heart 
(Rider and Taylor, 1974). In the former, almost all enolase activity was due to the pp- 
enolase isoenzyme whilst in the latter, where the NNE and MSE subunits were 
coexpressed, the ap-enolase heterodimer was shown to predominate. In adult rat, 
mouse and human skeletal muscle, immunohistochemical and in situ hybridisation 
studies have shown that MSE is preferentially expressed in fast twitch (type II) 
muscle fibres (Ibi et al., 1983; Kato et al., 1985; Keller et al., 1992) whilst residual 
NNE is evenly distributed between fast and slow twitch fibres (Keller et al., 1992). 
Studies in rat and mouse (Fletcher et al., 1978; Kato et al., 1985) showed that 
moderate levels of MSE were also found in cartilagenous tissue (again with the 
heterodimer predominating) and low levels of the protein could be detected in organs 
such as stomach and bladder which contain smooth muscle. Insignificant levels of 
MSE were found in other tissues.
In a number of mammals, the level of MSE protein in adult skeletal muscle has been 
shown to depend upon the functional state of the muscle and its innervation (Kato et 
al., 1985; Matsushita et al., 1986; 1991; Satoh et al., 1991; Keller et al., 1992a).
Thus, MSE levels have been shown to decline following denervation, and this reflects 
a general decrease in the levels of enolase and other glycolytic enzymes (Prewitt and 
Salafsky, 1970; Shackelford and Lebherz, 1981). A moderate increase in NNE 
protein expression also accompanies denervation, and this may help to explain the
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foetal enolase isoenzyme profiles observed in some neuromuscular disorders 
(Edwards et al., 1982).
1.4.2 Developmental regulation in vivo and ex vivo
In rats, only the postnatal ontogeny of MSE has been considered in any detail (Rider 
and Taylor, 1974; Kato et al., 1985; Sakimura et al., 1989). By studying the relative 
amounts of the three muscle isoenzymes, a clear difference between heart and skeletal 
muscle ontogeny was demonstrated (Rider and Taylor, 1974; 1975a). In the heart, 
MSE was first detected postnatally and its contribution to total enolase activity rose 
from nothing to 30% by postnatal day 80. The profile o f the three isoenzymes 
conformed to a best fit binomial distribution based on the abundance of the NNE and 
MSE subunits, indicating that the subunits were coexpressed, the isoenzymes being 
generated by random dimerisation. In contrast, MSE was already detectable in foetal 
skeletal muscle, where it contributed 20-40% of total enolase activity. The prevalence 
of MSE increased until postnatal day 30 when none of the NNE subunit could be 
detected. During this switchover, the profile of the three isoenzymes failed to fit a 
best fit binomial distribution, revealing a deficiency for the heterodimer. These data 
suggested that a rapid switch from NNE to MSE expression occurred during 
development and that the heterodimer formed only during the transient stage when 
both subunits were expressed.
In the mouse, isoenzyme analysis showed that postnatal accumulation of MSE protein 
was similar to the profile observed in rats (Fletcher et al., 1978). The mouse studies 
have been more informative, however, because the investigators have considered 
earlier stages of development and have looked at the relative levels of MSE and NNE 
gene expression at both the protein and mRNA levels. Fletcher and colleagues found 
that MSE protein was already expressed in skeletal muscle, heart and tongue of the 
earliest stage mouse embryos they examined (E l3) although in hind limb skeletal 
muscle, significant accumulation of the MSE protein did not occur until El 7. 
Northern analysis showed that MSE mRNA could not be detected prior to El 5 in 
hindlimb skeletal muscle (Barbieri et al., 1990; Lucas et al., 1992). The study by 
Lucas and colleagues showed that from E l7, MSE became the predominant message; 
the accumulation was shown to be biphasic, the first steep rise occurring prenatally, 
and coinciding with the formation of secondary myofibres, the second beginning at 
P5, and coinciding with their definitive specialisation. The levels of NNE mRNA 
decreased over the entire developmental period studied, but the greatest decrease
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occurred postnatally. Quantitative western analysis carried out in parallel showed that 
the transition from NNE to MSE in the mouse was controlled primarily at the level of 
transcription. The biphasic accumulation of MSE mRNA was shown to match that of 
another muscle-specific protein, a-skeletal actin, and the second phase of MSE 
mRNA accumulation coincided with the accretion of fast type IIB myosin heavy 
chain transcripts. No correlation between the increase in MSE message and the 
decline of NNE message could be detected, indicating that the two processes, whilst 
physiologically related, were regulated independently.
In vivo experiments, showing the onset of MSE gene expression in the hindlimb buds 
to be coincident with the formation of secondary myofibres, suggested that the gene 
could be used as a marker of late myogenesis. However, analysis of myoblast 
differentiation ex vivo indicated that gene expression commenced at a much earlier 
stage. As a model for myogenesis, Lamande et al., (1989) investigated the 
modulation of NNE and MSE mRNAs in premyogenic C3H10T'/2 cells and their 
myogenic derivatives and also in permissive and inducible C2.7 myoblasts. The MSE 
message was already detectable in both proliferating and quiescent myoblasts and 
accumulated further during terminal differentiation. The ratio of MSE to NNE mRNA 
increased about threefold and a recent study has shown that the increase in the 
abundance of MSE mRNA was due to upregulation of transcription and not to an 
increase in RNA stability (Lamande et al., 1995). Other muscle-specific messages, 
such as the mRNA for a-skeletal actin, were not detected in myoblasts (Lamande et 
al., 1989). C3H10T‘/2 cells can be induced to differentiate into myoblasts or other cell 
types (e.g. adipocytes) by different chemical treatments. MSE was absent from 
undifferentiated C3H10T‘/2 cells, but present in myogenic derivatives generated by 
treatment with hypomethylation agents or transfection with MyoDI cDNA. Taking 
the results from the in vivo and ex vivo experiments together, it was suggested that 
MSE could be expressed in particular subsets of myoblasts, specifically the adult 
myoblasts (also called satellite cells) which accumulate during late foetal 
development and give rise to secondary myofibres, but not in embryonic myoblasts 
which give rise to primary myofibres (Barbieri et al., 1990). It is possible to 
discriminate between the two types of myoblast in culture on the basis of their 
response to various differentiating agents and their accumulation of myosin isoforms. 
This theory was therefore tested by assaying cultured embryonic and foetal myoblasts 
for the MSE message; this has been done in mouse (Barbieri et al., 1990) and human 
cells (Peterson et al., 1992). In the case of the mouse, MSE message was detected in 
foetal but not embryonic myoblasts as expected. Furthermore, when the myoblasts 
were differentiated in vitro, the expression of MSE mRNA in the secondary myotubes
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was tenfold higher than that observed in the primary myotubes. In humans, 
undifferentiated embryonic and foetal myoblasts showed levels of MSE expression 
similar to the murine myoblasts, however, upon differentiation, both primary and 
secondary myotubes accumulated comparable levels of the MSE transcript. The 
authors argued that the apparent discrepancy between these results was attributable to 
differences in the developmental stage from which the embryonic myoblasts were 
obtained (Peterson et al., 1992), the mouse embryonic myoblasts being derived from 
an earlier stage than the human cells. However, the more sensitive in situ 
hybridisation technique has been used to investigate MSE expression during very 
early myogenesis (Keller et al., 1992a) and this analysis showed that a more limited 
accumulation of the message occurred in primary myofibres, starting as early as E7.8. 
MSE mRNA was first detected in the cardiac tube, the earliest myogenic structure to 
form, and expression of the transcript was also observed in the myotomes of rostral 
somites from E8.75. By El 1.5, most developing skeletal muscles expressed 
detectable levels of MSE mRNA and MSE protein, but there was still no detectable 
expression in the limb buds. MSE transcripts were shown to start accumulating in the 
forelimb buds at E12.5, and in the hindlimb buds at E13.5, much earlier than results 
from previous northern analyses had suggested (Barbieri et al., 1990; Lucas et al.,
1992). These experiments showed that the ontogeny of MSE was triphasic, the first 
(embryonic) stage marked by accumulation of the message and protein in primary 
myofibres at levels detectable by in situ hybridisation and in situ immunohistological 
assay but not by biochemical analysis, the second stage marked by a more pronounced 
accumulation in secondary (foetal) myofibres at levels detectable by northern and 
western procedures and the third (postnatal) stage marked by rapid replacement o f 
embryonic enolase isoenzymes with MSE, coincident with final differentiation of the 
myofibres.
1.5 Expression and ontogeny of y-enolase (neuron-specific enolase)
y-enolase is known as neuron-specific enolase (NSE) because its expression is largely 
restricted to neuronal and neuroendocrine cells (Marangos et al., 1979). Of the three 
mammalian enolases, NSE has accumulated the most literature, a) because of its use 
as a neuronal marker, based on the early studies of 14-3-2 protein (also known as 
neuron-specific protein)-, b) because it has found many clinical applications, 
specifically in the diagnosis of various tumours and diseases/injuries of the nervous 
system, and c) because it provides an insight into the mechanism of neuron-specific 
gene expression (Twyman and Jones, 1995b; see Chapter 2). Whilst this chapter
10
Introduction: Chapter I
concentrates on the characteristics of NSE gene expression and regulation, the clinical 
uses of the enolases are outside its scope, however the interested reader can refer to 
several excellent reviews on the subject for further information (Marangos et al., 
1982; Zomzely-Neurath, 1983; Marangos and Schmechel, 1987).
1.5.1 Cell-type specificity
The first studies of NSE expression involved isoenzyme resolution and 
immunological analysis o f crude tissue extracts. These investigations showed that 
NSE was abundant in mammalian brain (accounting for about 1.5% of soluble 
protein) but that it was also expressed, albeit at much lower levels, in all manner of 
peripheral tissues (Marangos et al., 1975; Hullin et al., 1980; Kato et al., 1982; 
Jorgensen and Centervall, 1982; Haimoto et al., 1985). In many glandular tissues the 
moderate levels of NSE protein were thought to reflect its expression in 
neuroendocrine cells, whilst the low amounts of NSE observed in nonneuronal tissue 
such as liver and muscle were attributed to innervation of these organs. In the brain, 
most NSE was found as the yy-enolase homodimer although the heterodimer 
accounted for about 30% o f enolase activity (Fletcher et al., 1978; Lucas et al., 1988); 
in peripheral tissues, the heterodimer was predominant. Regional studies of the brain 
showed grey matter to be enriched for NSE whilst white matter contained mostly 
NNE (Marangos et al., 1979; Zaiko and Burbaeva, 1986). Generally, levels of NSE 
protein were found to be higher in the central nervous system compared to the 
peripheral nervous system and neuroendocrine tissue, whilst the levels of NNE were 
similar in each. In some peripheral tissues, the presence of NSE was thought to 
reflect not innervation, but perhaps a genuine level of nonneuronal NSE expression. 
For instance, a significant amount of NSE was detected in platelets, which are neither 
innervated nor derived from the neurectoderm (Marangos et al., 1980).
Whilst the analysis of bulk tissue extracts allowed the investigator to compare the 
abundance of the enolase subunits and the relative proportions of different 
isoenzymes, the use of this type of experiment was somewhat limited by its poor 
resolution. In the nervous system, which characteristically contains numerous cell 
types in a common tissue, the detection of NSE and NNE in situ was a more 
informative approach because such a strategy could discriminate between these 
disparate cell types. Such experiments showed that NSE was found only in the 
neurons of the nervous system, not in the glial cells or the vascular epithelial cells 
which instead expressed NNE. NSE was localised to neurons in the brain, spinal
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cord, ganglia and retina (Pickel et al., 1976; Schmechel et al., 1978a; Marangos et al.,
1979) . It was also localised to neuroendocrine cells of peripheral glandular tissue 
such as pinealocytes, adrenal chromaffin cells, Islets o f Langerhans cells of the 
pancreas and parafollicular cells of the thyroid gland (Schmechel et al., 1978b).
Early investigations also provided evidence that NNE was not expressed in neurons 
(Schmechel et al., 1978a; Marangos et al., 1979; Ghandour et al., 1981; Vinores et 
al., 1984) thus the two enolase subunits were regarded as discrete markers of the two 
cell lineages within the nervous system, and hence their names.
Unfortunately, further investigations soon showed that the neuronal/nonneuronal 
enolase dichotomy described by Marangos and Schmechel was not so clear cut as was 
at first suggested. Various immunological studies provided evidence for the 
expression of NNE in at least some classes of neuron: for example, cerebellar 
stellate/basket cells were shown to contain both NNE and NSE subunits, although the 
hybrid ay-enolase isoenzyme could not be detected in this assay (Schmechel et al.,
1980) , and single cell resolution radioimmunoassay and immunocytochemical 
staining showed that Purkinje cells contained all three brain isoenzymes (Kato et al.,
1981) . A consistent problem with many of these early experiments was that 
preparations of antisera were often quite crude, making it difficult to detect 
nonabundant isoenzymes. Perhaps the most convincing evidence against the mutually 
exclusive expression of NSE and NNE came from the prevalence of the hybrid ay- 
enolase in the brain and other nervous tissue. Biochemical studies have argued 
strongly against the formation of artefactual heterodimers in vitro as a consequence of 
extraction techniques (Keller et al., 1981; Shimizu et al., 1983) indicating that the ay- 
enolase must form in vivo, thus requiring a moderate number of cells to express both 
subunits. More recent analysis of NSE and NNE mRNA expression in the brain by in 
situ hybridisation has shown that most neurons do express both genes (Schmechel et 
al., 1987; Watanabe et al., 1990; 1993; Katagiri et al., 1993; Keller et al., 1994), 
whilst glial and other nonneuronal cells may express the NNE message but never the 
NSE message. Within the neuronal lineage, it is apparent that the relative amounts of 
the two gene products vary considerably depending upon cell type (Frikke et al.,
1987; Katagiri et al., 1993; Keller et al., 1994); this is similar to the heterogeneity of 
MSE and NNE gene expression in differentiating myoblasts (Barbieri et al., 1990; 
Peterson et al., 1992). In the most recent study, Keller and colleagues reported that 
many neurons, e.g. those of the hippocampus and lateral vestibular nucleus, appeared 
to contain similar amounts of each transcript. However, in some cases, e.g. neurons 
of the peripeduncular nucleus, high levels of NSE message were observed whilst NNE 
mRNA was undetectable. In these particular neuronal cells, therefore, it is possible
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that a complete switchover from NNE to NSE gene expression may occur, akin to the 
switch from NNE to MSE in skeletal muscle. Furthermore, neurons of the solitary 
nucleus appeared to demonstrate opposite properties to those above, accumulating 
high levels of the NNE message, greatly in excess of the observed NSE mRNA. A 
number of investigators have studied enolase gene expression in Purkinje cells of the 
cerebellar cortex and the conclusions of these studies have varied, some authors 
reporting that such cells are immunopositive for NSE (Langley et al., 1980; 
Schmechel et al., 1980; Kato et al., 1981) whilst others have reported that the same 
cells are immunonegative (Vinores et al., 1984) or immunopositive only during a 
particular stage of development (Whitehead et al., 1982). In an investigation 
involving both immunocytochemical staining and in situ hybridisation (Watanabe et 
al., 1990), NSE immunoreactivity was observed in rat Purkinje cells from postnatal 
day 3. There was a striking increase in the level of detectable protein from P3 to P9 
and this was reflected by a similar increase in the level o f NSE mRNA, indicating that 
regulation of the NSE gene in these cells occurred at the level of transcription. From 
P9 onwards, the number of NSE immunopositive Purkinje cell bodies decreased and 
none were observed in adult brain, however, NSE immunopositive Purkinje axons 
were still detectable in adult rats. Conversely, the NSE mRNA was still present in 
Purkinje cell bodies from P9 to adulthood. The expression of NNE mRNA in 
Purkinje cells has also been documented (Katagiri et al., 1991).
Two reports have indicated that oligodendrocytes lack detectable NNE (Langley and 
Ghandour, 1981; Ghandour et al., 1981) and may therefore not express enolase at all. 
Although these data conflict with the earliest immunohistochemical investigations 
(Schmechel et al., 1978a; 1980), recent in situ hybridisation studies have also 
provided evidence for the absence of NNE expression in white matter cells of the 
brain. The authors suggested that oligodendrocytes, which synthesise large amounts 
of lipid and fatty acids, may have dispensed with glycolysis and use an alternative 
oxidation pathway (Ghandour et al., 1981) although this remains to be demonstrated.
1.5.2 Developmental regulation in vivo
Prior to the discovery of its enolase activity, the ontogeny of 14-3-2 protein (neuron- 
specific protein) was studied extensively in order to help determine its (at the time 
unknown) biological function. Although these investigations (reviewed by Moore,
1975) failed to determine a biological role for the protein, they concluded that the 
onset of expression coincided with neuronal differentiation in vivo. The discovery of
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the NSE subunit in the rat prompted renewed investigation of the ontogeny of this 
protein (Fletcher et al., 1976): the yy-enolase isoenzyme was shown to be absent from 
the foetus, first becoming detectable at postnatal day 10. The heterodimer ay-enolase 
was, however, already detectable in the foetus, indicating the earlier onset of NSE 
expression. Isoenzyme and immunological analysis, and biochemical studies of 
mRNA expression demonstrated a biphasic accumulation of NSE in the rat. By 
immunohistochemical staining, NSE protein was first detected at embryonic day 13, 
increasing to approximately 100-fold its initial concentration by P0 (Marangos et al.,
1980). By northern analysis, a similar pattern of NSE mRNA expression was 
revealed, although using this less sensitive technique, the NSE message was first 
detectable at E l6, increasing threefold by P0. There followed a plateau, where no 
significant change in NSE gene expression occurred, then a subsequent rise in protein 
and mRNA levels lasting until P30 where gene expression remained at the same 
maximum level into adulthood (Fletcher et al., 1976; Forss-Petter et al., 1986; Di 
Liergo et al., 1991). During this time, the levels of NNE mRNA and NNE protein 
remained steady (Marangos et al., 1980; Di Liergo et al., 1991). The parallel 
expression of mRNA and protein for each subunit indicated that the genes encoding 
them were regulated primarily at the level of transcription. In the mouse, 
immunological analysis of bulk tissue extracts has shown that NSE protein could first 
be detected at E 15 (Fletcher et al., 1978). More sensitive immunohistochemical 
assays carried out by Forss-Petter and coworkers (Forss-Petter et al., 1990) and during 
the course of this project (see Chapter 7) have demonstrated the presence of 
immunoreactive neurons in the ventral hom of the rostral neural tube as early as 
E l0.5; it has also been claimed that NSE is present in the neuronal-glial precursor 
cells of embryos which contain no differentiated neurons at all (De Vitry et al., 1980; 
Schubert et al., 1985). Generally, experiments such as those described above have 
shown that in both mammalian and avian embryos, the levels of NSE protein are low 
pre- and perinatally, most accumulation occurring postnatally, whilst the levels of 
NNE protein are high in the embryo and remain so throughout development 
(Zomzely-Neurath and Keller 1977; Zomzely-Neurath, 1983; Marangos et al., 1980; 
Secchi et al., 1980; Ledig et al., 1982; 1985; Maxwell et al., 1982; Kato et al., 1985; 
Lucas et al., 1988; Gross et al., 1990). The ontogeny of NSE is thus characterised by 
an increase in the NSE:NNE ratio, a developmental process which is more rapid in 
brain areas which develop quickly, such as the brainstem, compared to those which 
develop more slowly, such as the cerebral cortex (Marangos et al., 1980; Zomzely- 
Neurath and Keller, 1977; Zomzely-Neurath and Walker, 1980).
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In the developing nervous system, NSE mRNA and NSE protein could not be detected 
in the proliferative zones, which were immunopositive for NNE. NSE gene 
expression begins in postmitotic, postmigratory neurons, probably at the time when 
synaptic associations are made (Schmechel et al., 1980). Because NNE gene 
expression in neuronal cells was not established until recently, the authors of this 
report concluded that a switchover from NNE to NSE gene expression occurred during 
neuronal differentiation, similar to the switch from NNE to MSE gene expression 
during myogenesis. As discussed above, recent data from in situ hybridisation studies 
has indicated that a complete switchover may occur in only a few neuronal cell types 
whilst the differentiation o f most is characterised by the onset of NSE expression 
without significant effects upon the expression of NNE. Notwithstanding these 
results, NSE remains a useful marker of neuronal differentiation and 
neuronal/neuroendocrine cells generally. NSE has therefore been used to determine 
the innervation and neuronal architecture of various developing and adult peripheral 
tissues and organs including the chick eye (Zwaan et al., 1994), human and rodent gut 
(Bishop et al., 1982; Frykberg et al., 1985), cutaneous Merkel cells (Gu et al., 1981), 
muscles (Hachisuka et al., 1984), mammalian respiratory tract (Sheppard et al., 1982), 
Leydig cells of the testis (Angelova et al., 1991) and avian and rodent organs of Corti 
in the developing inner ear (Whitehead et al., 1982; Whilton and Sobkowicz, 1988; 
Altschuler et al., 1985). It has also been used as an investigative tool in human 
development (Parsons et al., 1981; Shinohara et al., 1986)
1.5.3 Developmental regulation and induction ex vivo
Studies of NSE ontogeny using primary cultures of neurons dissociated from 
embryonic or foetal nervous tissue have generally supported the results from in vivo 
experiments where the levels of NSE reflected the extent of neuronal differentiation 
(Secchi et al., 1980; Bock et al., 1980; Schmechel et al., 1980; Ledig et al., 1982; 
1985; Jirikowski et al., 1983; Weyhenmeyer and Bright, 1983; Di Liergo et al., 1991). 
Thus, the amount of gene product has usually been shown to increase with time in 
culture, concomitant with the extent of differentiation as judged by neurite outgrowth 
and other physiological characteristics. However, Bock et al. (1980) found that NSE 
could be detected only in trace amounts after culturing neurons for seven days whilst 
Secchi et al. (1980) found that NSE was already expressed in undifferentiated 
embryonic rat neurons after five days in culture. Primary cultures of neurons from 
foetal mouse spinal cord, dorsal root ganglia and brain have all been shown to be 
immunopositive for NSE (Schmechel et al., 1980). Although such studies are broadly
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in agreement, the different investigators have found varying levels of the protein or 
mRNA in primary neuronal cell cultures. Such discrepancies probably reflect 
differences in the cell type, location and developmental stage from which the cells 
were isolated and the levels of differentiation they attained in culture; this is similar to 
the enolase heterogeneity observed in cultured myoblasts (Barbieri et al., 1990; 
Peterson et al., 1992).
NSE expression has also been investigated in established cell lines. Immunological 
and isoenzyme profile analysis in various clonal cell lines has shown that NSE levels 
are low in proliferating neuroblastoma cells (contributing less than 3% of the total 
enolase activity) but higher in neuronal cell lines (contributing 10% of the total 
enolase activity, similar to levels in foetal brain) consistent with the relatively more 
differentiated phenotype of the neuronal cells (Zomzely-Neurath and Keller, 1977; 
Marangos et al., 1978). In confirmation, the levels of NSE mRNA in various 
proliferating neuroblastoma cell lines are very low compared to primary cultures of rat 
neurons (Sakimura et al., 1995). A number of investigators have shown that the 
levels of NSE protein and NSE mRNA in various neuroblastoma cell lines increase in 
response to differentiating agents (Marangos et al., 1978; Legault-Demare et al.,
1982; Komblatt et al., 1983; Zeltzer et al, 1986; Cervello et al., 1993; Matranga et al.,
1993) whilst the levels of NNE protein and NNE mRNA remain more or less constant 
(Komblatt et al., 1983; Matranga et al., 1993). NSE expression can be induced by a 
number of chemical agents (dimethyl sulphoxide, retinoic acid, dibutyryl cyclic AMP 
(db-cAMP) and certain growth factors have been investigated) and by imposing 
growth conditions including serum withdrawal and increasing cell density. The 
inductive effects of these agents and conditions vary in potency, but the accumulation 
of NSE once again appears to correlate to the extent of physiological differentiation 
(as assessed by neurite outgrowth) and arrest of cell division, both of which mirror the 
maturation of neurons in vivo. Different reports of NSE induction have not always 
been in agreement, for example treatment of a neuroblastoma cell line with dbcAMP 
generated a twofold increase in NSE protein expression according to Marangos et al. 
(1978) whilst Matranga et al. (1993) showed that the same treatment generated a 
twentyfold increase in the levels of NSE mRNA. Such discrepancies might be 
attributable to different growth conditions, and the confluence of the cells when 
harvested would be a critical parameter in such studies. Furthermore, different agents 
promote the differentiation of human neuroblastoma cell lines into mixed populations 
of cells including neurons, Schwaan cells and melanocytes (Tsokos et al., 1987). 
Slight differences in the treatments administered to proliferating neuroblastoma cells 
could therefore generate different mixtures of cells which would express varying
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amounts of the induced genes (Matranga et al., 1993). Density-dependent induction 
of NSE gene expression has been demonstrated (Legault-Demare et al., 1980; Zeltzer 
et al., 1986; Matranga et al., 1993); the levels of NSE protein were reported to 
increase 20-25-fold during the slowing down of growth (Legault-Demare et al., 1980) 
although no quantifiable data concerning the cell densities was provided in this report. 
The levels of NSE mRNA were shown to increase approximately eightfold given an 
eightfold increase in cell density (Matranga et al., 1993) whilst the levels of mRNA 
for NNE remained constant. Induction of NSE gene expression by nerve growth factor 
has been reported for the pheochromocytoma cell line PC 12 (Vinores et al., 1981).
PC 12 cells are derived from (neuroendocrine) adrenal chromaffin cells, but they are 
stimulated by nerve growth factor (NGF) to differentiate in vitro towards a neuronal 
phenotype as judged by neurite outgrowth and other criteria (Green and Tischler,
1976). Vinores and colleagues showed that as little as lng/ml NGF could induce the 
maximal increase in NSE gene expression, a response which could not be elicited by 
insulin, growth hormone or epidermal growth factor (EGF), although the latter did 
cause a moderate induction of the gene. The developmental studies in vivo and ex 
vivo as well as the inductive studies using clonal cell lines have all provided evidence 
supporting the role of NSE as a marker of neuronal differentiation. Additionally, NSE 
can be used as a model for the analysis of inductive events caused by various 
chemical stimuli and growth conditions.
1.6 Mammalian and avian enolases - structure, function and evolution
In the preceding sections, the discovery of the mammalian enolases, and their 
expression and ontogeny have been discussed . A large body of evidence has 
established that the three subunits are encoded by three dispersed single-copy genes: 
this includes data from genomic Southern analysis, comparison of cDNA sequences 
and the mapping of each cytogenetic locus to separate chromosomes in man, rat and 
mouse (Khan et al., 1974; Grzeschik, 1974; Van Cong et al., 1977; Cook and 
Hamerton, 1979; Law and Kao, 1982; Craig et al., 1989; Feo et al., 1990a; Mitchell et 
al., 1991; Goran Levan, pers. comm.); there is also a NNE pseudogene in the human 
genome (Feo et al., 1990b). When enolase isoenzyme heterogeneity in the rat was 
first discovered, the authors asked why different subunits, with indistinguishable 
kinetic properties, should coexist (Rider and Taylor, 1974; Fletcher et al., 1976). This 
question has remained pertinent, given the specific and independent regulation of the 
enolase genes as described above.
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In recent years, a large number of enolase sequences has been published (see Table 
1.2) and this has facilitated comparisons between the three isoproteins to reveal 
differences in structure which may in turn provide some clues about their individual 
functional roles. The number of independently verified clones has virtually excluded
E n o la se S p e c ie s S e q u e n c e R e fe r e n c e s C o m m e n ts
a  (NNE) rat cDNA Sakimura el al., 1985a
mouse cDNA Kaghad et al., 1990
human cDNA
genomic
cDNA
Giallongo et al., 1986 
Giallongo et al., 1990 
Verma and Kurl, 1990 Lung enolase (1)
duck cDNA
genomic
Wistow et al., 1988 
Kim et al., 1991
a-enolase/t-crystallin (2)
chick cDNA Tanaka et al., 1995
P (MSE) rat cDNA
genomic
Ohshima et al., 1989 
Sakimura et al., 1990
mouse cDNA
genomic
Lamancte et al., 1989
Unpublished (3)
human cDNA
genomic
Call et al., 1990 
Peshavaria et al. ,1989 
Peshavaria and Day, 1991
rabbit protein Chin, 1990
chick protein
cDNA
Russel et al., 1986 
Tanaka et al., 1995
y (NSE) rat cDNA
cDNA
genomic
Sakimura et al., 1985b 
Forss-Petter et al., 1986 
Sakimura et al., 1987
mouse cDNA Kaghad etal., 1990
human cDNA/protein
cDNA
cDNA
cDNA
genomic
McAleese et al., 1988 
Day etal., 1987 
Van Obberghen et al., 1988; 
Oliva etal., 1989 
Oliva et al. ,1991
3' UTR only
Table 1.2: Origin of the known mammalian and avian enolase sequences. (1) Verma and Kurl (1990) 
have reported the sequence of a cDNA encoding enolase which they isolated from a human lung 
library. The lung enolase is most similar to NNE (Giallongo et al., 1986) but not identical; most 
remarkably, the deduced amino acid sequence is 458 residues in length, 25 residues longer than all the 
other reported mammalian sequences. (2) The duck a-enolase gene encodes a bifunctional protein also 
known as r-crystallin (see section 1.3). (3) The mouse MSE gene sequence (N. Lamandi, S. Brosset,
A. Keller, M. Lucas, and M. Lazar) is unpublished in the literature but is available from the databases 
under accession number X61600.
the problem of sequencing errors and it is therefore possible to compare the sequences 
of each subunit from mouse, rat and man without such errors confounding the 
observed variatioa Each polypeptide is 433 amino acid residues in length and perfect 
alignment between all nine sequences is possible; this allows both paralogous (within 
species between unlike subunits) and orthologous (across species between like 
subunits) comparisons to be made in all possible pairwise combinations (see Table
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1.3). It is also possible to align each mammalian sequence with that of S. cerevisiae 
enolase 1 (Holland et al., 1981), allowing any substitutions found between subunits to 
be assessed with respect to the secondary and tertiary structure predicted for the yeast 
protein (Lebidoa and Stec, 1988; Lebidoa et al., 1989; Stec and Lebidoa, 1990).
Species/
enolase
rNNE rNSE rMSE mNNE mNSE mMSE hNNE hNSE hMSE
rNNE 100 82.5
P
82.5
P
96 o . 82.5 83 82 84
rNSE 100 83 p 83 98,5., 84 84 iM S A ,■ 83.5
rMSE 100 82.5 81.5
o
82.5 82 97 o
mNNE 100 83 p 84 p ¡jgggg 83.5 83
mNSE 100 84 p 83 ■ 82.5
mMSE 100 83 82 9 7 S
o '  ■
hNNE 100 83 p 83 p
hNSE 100 83.5
P
hMSE 100
Table 1.3: Comparison of the primary amino acid sequences of each enolase isoprotein deduced from 
rat (r), mouse (m) and human (h) cDNA clones. Figures represent percent identity over entire amino 
acid sequences excluding the initiator methionine (432 amino acids). Paralogous comparisons (p) are 
highlighted in light grey. Orthologous comparisons (o) are highlighted in dark grey. Where multiple 
cDNA sequences exist, the following are used: human NSE - Oliva et al., 1990; rat NSE - Sakimura et 
al., 1985a. The lung enolase isolated by Verma and Kurl (1990) is ignored in this table.
The results of such comparisons show that there is greater identity between like 
subunits across species, than there is between unlike subunits within species. This 
underscores biochemical and immunological evidence which has shown that, between 
species, like isoenzymes have similar pi values and like subunits are immunologically 
cross-reactive (Cardenas and Wold, 1971; Moore, 1975; Rider and Taylor, 1974; 
1975a; Clark-Rosenberg and Marangos, 1980; Jackson et al., 1985; reviewed in 
Twyman and Jones, 1995c). Comparisons with the secondary structure predicted 
from crystallised yeast enolase showed that the major paralogous substitutions 
occurred at sites equivalent to yeast enolase 1 a-helices B, C, D, I and J which are 
presented on the surface of the protein and are not predicted to take part in substrate or 
cofactor binding (Day et al., 1993); the eight (3-strands which make up the active site 
o f the enzyme are invariant between the human subunits (Peshavaria et al., 1989).
The kinetic similarity of the mammalian enolase isoenzymes is therefore thought to
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arise from the invariant core structure of the polypeptides, whilst functional 
differences are thought to arise from surface properties which reflect interaction with 
other cellular components. Enolases throughout nature are well-known for secondary 
functions which are unrelated to catalysis: in the bacterium Clostridium difficile, 
enolase is thought to act as a toxin whilst in the yeast S. cerevisiae, enolase 1 is a heat 
shock protein (Green et al., 1993; Iida and Yahara, 1985); the role of a-enolase in 
certain birds and reptiles has already been discussed (Wistow et al., 1988).
Compared to NNE, the expression of the tissue-specific enolases MSE and NSE is 
highly regulated and secondary functions are likely to reflect adaptations to specific 
intracellular environments. Hence, it has been shown that NSE is more resistant to 
chloride ion inactivation than NNE, and this might reflect an adaptation to the high 
intracellular chloride ion concentration of electrophysiologically active neurons 
(Marangos et al., 1978). Both NSE and MSE have been shown to be more 
thermotolerant than NNE although the physiological relevance of this is not clear 
(Marangos et al., 1978; Tanaka et al., 1985a). NSE has been shown to undergo slow 
component axonal transport and to be associated both with other enzymes and the 
membrane at the synaptic terminal (Brady and Lasek, 1981; Batke et al., 1988; Lim et 
al., 1983); such interactions would certainly require modifications to the surface 
structure of the protein. NSE has also been shown to act as a neuronal survival factor 
(Takei et al., 1991); these and other observations provide some suggestions as to why 
three enolase isogenes have evolved and have come to be expressed in the manner 
discussed above, however, there is still much to learn about the roles of these proteins.
As well as providing data for functional autonomy amongst the enolases, sequence 
comparisons can provide some information about the evolution of the enolase gene 
family. Paralogous comparisons in man, rat and mouse show that the divergence 
between isoproteins is approximately 17% in all pairwise combinations, suggesting 
that all three genes were created during a single evolutionary event (Day et al., 1993). 
The existence of an ancestral enolase gene is confirmed by the identical intron/exon 
architecture within the nine coding regions, with boundaries occurring at homologous 
positions in each sequence. Orthologous comparisons demonstrate that the burst 
event must have occurred before man/rodent speciation and the level of sequence 
identity observed between the limited bird enolase sequences and those of mammals 
indicate that it predated the divergence of birds and mammals (about 200 M yr ago); 
bird enolase genes also share the same intron/exon boundaries as their mammalian 
counterparts. Several authors have deduced that the event occurred approximately 
300 M yr ago (Segil et al., 1984; Clark-Rosenberg and Marangos, 1980). This 
timescale would indicate that three enolases should exist in most tetrapods, although
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the specialisation seen in present day mammals and birds might not have arisen in all 
branches of the phylogenetic tree (see Twyman and Jones, 1995c). Orthologous 
comparisons also show how quickly each subunit is evolving: during man/rat 
speciation, only 8 amino acid substitutions occurred in the NSE subunit, 13 in the 
MSE subunit and 26 in the NNE subunit (Day et al., 1993); once again, the majority 
of these substitutions occurred on the surface of the protein. These data show that in 
mammals, NNE is evolving most quickly whilst the two tissue-specific subunits are 
evolving slowly, probably due to additional constraints on surface residues imposed 
by their probable secondary functions.
1.7 The molecular basis of enolase gene regulation
1.7.1 The human NNE  gene
S ite s  o f  in ter e st C h a r a c te r  o f  h u m a n  NNE g e n e
Basal Transcription No TATA box
GC rich, CpG:GpC ratio 0.95
Upstream promoter No CCAAT boxes 
5x CACCC (UPE) motifs
Consensus binding sites API, AP2, AP3, AP4, AP5, ATF, CREB, C2, 
CTF/NF1, E2AE-CP, E2F, E4TF1, EF.C, 
HIF-1, MLTF/USF, Oct-1, PEA2 and Spl (3x).
Other consensus motifs Viral core sequence GTGGAAAG
Other features of interest Paired direct repeats: GGTGAAATCAC, 
GGCAGGAGG, CGGAGCCCCG and 
CCCCTTTCC
Inverted repeat with the half sequence 
TGAATTTAAT
Table 1.4: Characteristics of the 5' putative reguatory region of the human NNE gene.
Very little is known about the regulation of mammalian NNE because no functional 
analysis has been carried out. About 2 kbp of the human NNE gene 5' flanking region 
has been sequenced and analysed for putative regulatory motifs (Giallongo et al.,
1990), and some characteristics of the gene are shown in Table 1.4. It has recently 
been reported that low blood oxygen tension (hypoxia) induces the expression the 
human glycolytic enzymes aldolase A, phosphoglycerate kinase 1 and pyruvate kinase 
M (Semenza et al., 1994). A trans-acting factor termed hypoxia inducible factor 1 
(HIF-1) has been identified which binds upstream of all three genes and transient 
transfection assays, in which each o f these putative HIF-1 binding sites was used to 
drive a reporter gene, showed that the motif was sufficient in each case to confer
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hypoxia-inducible reporter expression. HIF-1 binding sites are present upstream of 
other human glycolytic genes including those for phosphofructokinase L and 
nonneuronal enolase. Although the HIF-1 site in the NNE gene has not been tested by 
transfection analysis, synthetic oligonucleotides corresponding to the HIF-1 binding 
site of all five human genes, and the mouse gene for lactate dehydrogenase A, have 
been shown to bind HIF-1 in crude nuclear extracts and affinity purified preparations 
(Semenza et a l, 1994). These results strongly suggest that NNE may also be 
regulated by HIF-1.
1.7.2 The Peking duck aE N O /xC R Y gene
The duck aENO/xCRY gene has been cloned and about 1 kbp of its 5' flanking region 
has been sequenced and analysed for putative regulatory elements (Kim et al., 1991; 
see Table 1.5). The authors noted that three of the potential binding sites upstream of 
aENO/xCRY had been implicated in the lens-specific expression of other crystallins: 
An NF-kB like motif found upstream of the murine clA-CRY gene was shown to be 
critical for lens-specific expression in transfection experiments and to bind a zinc 
finger transcription factor known as aA-CRYBPl (Nakamura et al., 1990); octamer- 
like motifs present upstream of the chicken P Bl-CRY  gene and the mouse y F-CRY 
gene have also been shown to be important for lens-specific expression in transfection 
studies (Lok et al., 1989; Roth et al., 1991); finally, GC-rich motifs, including a 
putative Sp-1 site, have been shown to be important for the transcription of the 
chicken 81-CRY gene (Das and Piatigorsky, 1986; 1988). However, transfection 
studies, in which about 800 bp of the aENO/xCR Y 5' sequence was used to drive 
reporter gene expression in cultured liver, lens and fibroblast cells, showed no 
preferential gene expression in lens (Kim et al., 1991). There is also evidence to 
suggest that the duck aENO/xCRY gene may be a candidate for regulation by c-myc 
(Warwar et al., 1992). A comparison between the human NNE and duck aENO/xCRY 
5' flanking regions showed that although the sequences differed significantly, two 
regions of homology could be identified (Kim et al., 1991). The first, a sequence 
about 40 bp in length was located close to the start of transcription in both flanking 
regions; in the duck, this sequence appeared just once whilst in humans, another 
similar element was found about 350 bp upstream from the first. A second region of 
homology was found between positions -155 and -189 in the duck promoter and 
between positions -718 and -750 in the human promoter. In each case, the sequences 
demonstrated about 90% identity, however, their functional significance has not been 
tested.
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S ite s  o f  in ter e st C h a r a c te r  o f  a ENO/xCRV  g en e
Basal Transcription TATA box
Upstream promoter 3X CCAAT boxes
Putative lens-specific motifs NF-kB, Oct-1, and Spl
Other features of interest Several GC-rich areas
AT-rich region between -488/-605
Many repeats of ATTT motif
Two regions of homology with human NNE 5'
flanking region
Table 1.5: Characteristics of the 5' putative reguatory region of the duck aENO/xCRY gene. The 
relevance of the lens-specific motifs is discussed in the text.
Transgenic mice carrying the entire 13 kbp aENO/xCRY gene plus 3 kbp of 5'
Hanking region and 4 kbp of 3' flanking region have been generated to investigate 
how evolving lenses deal with sudden increases in the concentration of novel proteins 
and whether this affects their refractive properties (Kim and Wistow, 1993).
However, the mice expressed duck txENO/xCRYin the same manner as endogenous 
NNE with no obvious accumulation of the message in the lens, suggesting that the cis- 
acting elements responsible for lens-specific control in the duck were either 
nonfunctional in the mouse or located outside the region covered by the transgene.
The fact that t-crystallin is not a prevalent lens crystallin in mammals supports the 
former explanation. Although lens preferred expression of the transgene did not 
occur, a sudden increase in protein concentration within the lens was evident simply 
due to the effects of gene dosage. Transgenic lenses were, however, still transparent 
and remained so well into old age, thus showing that the lens demonstrates 
considerable flexibility with respect to acceptable levels of intracellular protein and 
that the stepped increases in protein concentration which occur as enzymes are 
recruited during evolution are probably well-tolerated.
1.7.3 The rat, mouse and human M SE  genes
Through studies of mRNA and protein expression, it has become well established that 
regulation of the enolase genes occurs primarily at the level of transcription. It is very 
likely that, in the case of MSE, such regulation involves the helix-loop-helix family of 
myogenic regulatory proteins. Evidence to support this statement is plentiful: in the 
embryo, MSE transcripts are first detected just after the early HLH regulators are 
expressed (Keller et al„ 1992a); undifferentiated C3H10T‘/2 cells transfected with 
cDNAs corresponding to each member of the MyoDl family differentiate into
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myoblasts expressing high levels of the MSE transcript, demonstrating that MSE gene 
expression accompanies myogenic determination whichever factor is responsible 
(Lamande et al., 1989; Keller et al., 1992b); and a survey of putative transcription 
factor binding sites in the 5' flanking region and introns of the human, rat and mouse 
MSE genes has revealed numerous myogenic binding motifs, including MyoDl- 
binding consensus sequences (Sakimura et al., 1990; Peshavaria and Day, 1991; 
Keller et al., 1992b; see Table 1.6). Comparitive analysis of the human and rat MSE 
5' flanking regions has shown that the muscle-specific c/'s-acting elements occur at 
homologous positions suggesting a regulatory mechanism conserved across species 
(Giallongo et al., 1993).
S ites  o f  in t e r e s t H u m a n  M SE  g e n e R a t M SE  g e n e
Basal Transcription Canonical TATA box 
Single transcriptional start 
CpG:GpC ratio 0.54
Cannonical TATA box 
Single transcriptional start 
CpG:GpC ratio 0.47
Upstream promoter No CCAAT boxes No CCAAT boxes
Myogenic motifs Within 800 bp of transcriptional 
start site: 2 binding sites for MyoD 
family proteins, M-CAT, CCArGG 
box
Within 1.8 kbp of transcriptional 
start site: 10 binding sites for MyoD 
family proteins, CCArGG box
Other features of interest Direct repeat CTGTCCCAGC 
Alternatively spliced 5’ exon 
Muscle-specific methylation
Probably alternatively spliced 5’ 
exon
Table 1.6: Characteristics of the putative reguatory region of the human and rat MSE genes. The 
CC(AT-rich)GG-box is also present in actin gene promoters (Gustafson and Redes, 1989; Ng et al.,
1989). The M-CAT element has been shown to be responsible for the muscle-specific activation of the 
troponin T gene (Mar and Ordahl, 1990). The muscle-specific methylation site in the human MSE 
gene is a CpG dinucleotide which is fully methylated in sperm and brain but unmethylted in muscle 
(Peshavaria and Day, 1993).
Although MSE expression may be controlled by the myogenic HLH family of 
regulatory proteins following differentiation, it is unlikely that the same factors 
regulate the gene in proliferating myoblasts. HLH family proteins are present in 
myoblasts, but they have been shown to be inactive as transcription factors for 
muscle-specific genes in these cells (Vaidya et al., 1989). Consistent with this theory 
is the high level of MSE expression in mutant C2C12 myoblasts in which expression 
of the entire MyoDl family of regulators has been abolished (Peterson et al., 1992). 
These data indicate that MSE is regulated by an alternative pathway in 
undifferentiated cells, and a recent investigation of the human MSE 5’ flanking region 
using a deletion-transfection strategy has identified a 79 bp myoblast-specific 
enhancer element approximately 500 bp upstream of the start of transcription (Taylor 
et al., 1995). As well as reducing reporter gene expression in cultured myoblasts,
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deletion of this element resulted in elevated transcription of the A/S£-luciferase 
construct in fibroblasts, suggesting that it also acts as a silencer in nonmyogenic cells. 
Gel retardation assays showed that protein(s) present in myoblast nuclear extract 
bound specifically to the 3’ region of the enhancer, which contains an ets motif. 
However, transfection experiments indiciated that the ets motif alone was insufficient 
for myoblast-specific gene expression, indicating that other sequences within the 
enhancer were also required. The MSE enhancer shows homology to the myoblast- 
specific enhancer found upstream of the desmin gene (Li and Paulin, 1993) suggesting 
that myoblast gene expression might be coordinately regulated.
1.7.4 The rat and human NSE  genes
Whilst mechanisms of muscle-specific gene expression are relatively well-understood, 
the basis of gene expression in neurons is less clear (Twyman and Jones, 1995b; see 
Chapter 2). In both cases, cX-acting elements and trans-acting factors are known to 
participate, but in the case of neuronal gene expression, much less is known about 
these participants. NSE represents a good model for the study of neuronal gene 
expression because it is tightly regulated and panneuronal, whilst many other neuronal 
genes are also expressed outside the nervous system or are restricted to particular 
subsets of neuronal cell types (Twyman and Jones, 1995b; see Chapter 2). Both the 
human and rat NSE genes have been cloned (Sakimura et al., 1987; Oliva et al., 1990) 
and extensive 5’ flanking material has been sequenced in each case. A search for ex­
acting elements has revealed a number of neuronal motifs and other elements which 
may be involved in the induction of the NSE gene by various differentiating agents 
(see Table 1.7). A comparison of the human and rat 5' flanking regions demonstrated 
70% identity over about 1 kbp of sequence and many of the abovementioned ex­
acting elements are conserved in both species, suggesting that the regulatory 
mechanisms may be shared (Oliva et al., 1991).
Of the three mammalian enolase genes, functional analysis of the NSE gene has been 
most thorough. The studies can be divided into three groups: those involving 
transgenic mice, those based upon transduction using recombinant herpesvirus 
vectors, and those based upon deletion-transfection analysis.
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S ites  o f  in te r e s t H u m a n  N S E  g e n e R a t NSE  g e n e
Basal Transcription Nonconsensus TATA 
(CCTATAGG) 
CpG:GpC ratio 0.54
Nonconsensus TATA 
(TCTATAGG) 
CpGiGpC ratio 0.6
Upstream promoter No CCAAT boxes No CCAAT boxes 
5x CACCC (UPE) motifs
Neuronal motifs CCAGG..CTG motif 2x in 5’ 
region
CCAGG..CTG motif 3x in 5’ region 
and lx in intron 1.
Neuronal ID element in 3’ region 
Peptide hormone octamer
Relevant response elements RARE, C/EBP, GRE, MTF-1, 
Octamer
Other features of interest 327nt Alu element at approx, 
position -800
Seven classes of repeated sequences 
of unknown function
Table 1.7: Characteristics of the putative regulatory regions of the human and rat NSE genes. Three 
elements known to be associated with neuronal gene expression are observed. A neuronal ID element 
is found 3' to the final exon of the rat NSE gene (Sutcliffe et at., 1982; McKinnon et at., 1986). An 
octameric motif, GCCCAGCC, which is present in several genes encoding peptide hormones 
(Habemer et at., 1989) and is required for the specific expression of the gastrin gene in neuroblastoma 
cells (Thiel et al., 1987) is found just downstream of the rat NSE TATA-like box, homologous to its 
position in other genes. This is particularly interesting because NSE is also expressed in the 
neuroendocrine system, however, in the human NSE gene, the central adenosine residue is replaced by 
a guanidine residue and it is not clear if this modified sequence would be functional. Both NSE gene 
5’ flanking regions contains several copies o f a bipartite consensus motif CCAGG(AT-rich)CTG, 
which is present in the regulatory regions o f many other neuronal genes (Twyman and Jones, 1995b; 
see Chapter 2). A fourth such element in the first intron of the rat NSE gene may be responsible for 
elevated neuron-specific gene expression (Sakimura et al., 1995). Ex vivo, NSE is induced by various 
agents and growth conditions (see text). Response elements specific for some of those agents (e.g. 
retinoic acid) are found in the 5' flanking region of the rat gene.
Transgenic mice, carrying 1.8 kbp of the rat NSE 5’ flanking region (including the 
first noncoding exon but not the first intron) fused to Escherichia coli lacZ, expressed 
the transgene almost specifically in the nervous system (Forss-Petter et al., 1990). Of 
seven transgenic lines, the two which expressed the transgene most strongly were 
chosen for more extensive analysis and in each case, northern blots also showed that a 
number of aberrant lacZ transcripts were present in testis although no p-galactosidase 
activity could be detected. There was, however, transient p-galactosidase expression 
in the (nonneuronal) pigmented layer of the retina during development. Expression of 
the transgene was compared to endogenous NSE using immunohistochemical 
techniques, and as expected, NSE and p-galactosidase expression were both found 
only in neuronal cells of the brain, spinal cord and retina. Both the transgene and 
endogenous gene were expressed at different levels in distinct neuronal populations: 
for instance, stellate/basket cells were shown to express the transgene and endogenous 
gene at a relatively low level, in agreement with earlier immunohistological studies 
(Schmechel et al., 1980). The transgenic lines which expressed the transgene weakly
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were also analysed and in these cases, both the level and extent of reporter gene 
activity were less, thus p-galactosidase activity could not be detected in all classes of 
neuron. During development, there was parallel onset of reporter gene and 
endogenous gene expression, however, whilst endogenous mRNA accumulated in 
postnatal mice, the reporter transcript remained at embryonic levels. These results 
showed that the 1.8 kbp regulatory element contained all the c/s-acting information 
required for correct spatial and early temporal regulation of the NSE gene but that 
additional elements, probably lying outside the region analysed, were responsible for 
the high level of gene expression in postnatal mice. The NSE 5' flanking region was 
also used in a recent study to drive the human BCL-2 gene in transgenic mice 
(Martinou et al., 1994). Although this study was concerned with the overexpression 
of BCL-2 protein and its effects on naturally occurring cell death in the developing 
nervous system, and not particularly with the specificity and efficiency of the NSE 
promoter, it also served to demonstrate that AKE-driven transgenes could vary in their 
modes of expression, with different transgenic mice showing onset of NSE-BCL-2 at 
different stages (the earliest being at E l3, much later than shown in the original study 
by Forss-Petter and coworkers). Martinou et al. also reported the presence of NSE- 
BCL-2 transcripts in uterus, kidney, testis and heart, but not in vagina or liver, 
however, no human BCL-2 protein could be detected by immunohistochemical 
methods in any of these ectopic sites, suggesting that the transcripts were aberrant or 
unstable. Full expression of reporter genes driven by the NSE promoter was therefore 
found to be almost completely neuron-specific in two independent studies, however, 
transcription of the construct was somewhat leaky, leading to the observed ectopic 
transcription in various nonneuronal tissues.
Similar or identical expression cassettes have been subcloned into herpesvirus vectors 
for the purpose of transducing genes into cultured cells and into the central nervous 
system of live animals (Andersen et al., 1992; 1993; Roemer et al., 1995). In the first 
such experiment, the NSE-lacZ fusion gene (Forss-Petter et al., 1990) was inserted 
into the tk locus of the wild-type HSV-I genome. Transduction of neuronal and 
nonneuronal cells in culture showed that P-galactosidase activity was neuron-specific, 
although no expression was detected in PC 12 cells which do express endogenous 
NSE. Infection of live rats by injection of the recombinant virus into the right frontal 
lobe resulted in extended expression of the reporter gene in neurons, however, the 
numbers of transduced, expressing cells were limited and the authors concluded that 
although the NSE promoter was highly specific, it was not particularly efficient and 
was therefore not an ideal system for therapeutic use. Some p-galactosidase activity 
was also detected in immune cells, a phenomenon which the authors attributed to
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phagocytosis of other transduced cells (Andersen et al., 1993) and not to ectopic 
expression. In a more recent study, the 1.8 kbp NSE 5' regulatory sequence was fused 
to the firefly luciferase gene and inserted into an intergenic site in the genome of a 
replication deficient HSV-I (Roemer et al., 1995). In this investigation, the reporter 
gene was expressed constitutively in all transduced cell lines, including PC 12 and the 
nonneuronal line BHK. It is not clear why the cell-type specificity of the NSE 
promoter was lost in this series of experiments, but it could reflect a number of 
technical differences such as site of insertion or the use of a replication defective 
rather than a replication competent vector; several foreign promoters have been 
reported to be regulated in an unusual manner in the context of the herpesvirus 
genome and the position of integration has previously been shown to affect promoter 
activity (Roemer et al., 1995 and references therein).
Although transgenic mice carrying an NSE-lacZ reporter construct were shown to 
express the transgene exclusively in neuronal cells (Forss-Petter et al., 1990), 
undifferentiated ES cells stably transfected with the same expression cassette 
unexpectedly diplayed P-galactosidase activity (Alouani et al., 1993). Further 
analysis showed that NSE mRNA was also present in undifferentiated ES cells, 
morulae and blastocysts, however the endogenous NSE protein could not be detected. 
These data suggested that factors resposible for the neuron-specific transcriptional 
regulation of NSE were already present in the very early embryo, however, these 
factors were presumably lost later on in development as RNA analysis experiments 
have shown that the NSE transcript cannot be detected in more advanced rat and 
mouse embryos until the biphasic accumulation associated with neurogenesis occurs 
(Forss-Petter et al., 1986; Zeitoun et al., 1983; Yoshida et al., 1983). Consistent with 
this theory was the transient drop in both P-galactosidase activity and NSE mRNA 
levels accompanying the initiation of neuronal differentiation in the stably transfected 
cells (Alouani et al., 1993). However, in long term culture, the levels increased once 
again and were positively regulated by attachment factors such as laminin and 
treatment with nerve growth factor (NGF). These data indicated that ES cells could 
provide an important model for the investigation of neuronal differentiation and the 
regulation of the genes involved in this process. The parallel behaviour of 
endogenous NSE and integrated lacZ also demonstrated that the 1.8 kbp NSE 
regulatory element was likely to contain not only the cw-acting elements responsible 
for spatial and temporal regulation of the gene, but also response elements for 
induction by NGF and other agents.
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Deletion-transfection analysis is a very direct approach to identifying c/i-acting 
elements responsible for gene regulation (Twyman and Jones, 1995b; see Chapter 2). 
Very recently, Sakimura and colleagues have reported an extensive study of rat NSE 
gene regulation based upon such a deletion-transfection strategy using primary 
cultured rat neurons, neurobastoma cell lines, PC 12 cells, glial cells and nonneuronal 
HeLa cells (Sakimura et al., 1995). A 4.5 kbp segment of the 5' flanking region 
(including the first exon and the proximal half of intron 1) was investigated by 
generating numerous stepwise and internal deletions, inversions and rearrangements 
and fusing the products to the cat reporter gene. Comparisons of normalised reporter 
activities in neurons showed that deletion to the Sac I site corresponding to the start of 
the 1.8 kbp regulatory element used in previous studies caused only a slight reduction 
in reporter activity, whilst external deletion to a proximal Xho I site just 250 bp 
upstream o f the transcriptional start site only reduced reporter expression to 70% of its 
maximum value. However, removal of the proximal half of the first intron reduced 
CAT activity by at least twentyfold, regardless of the presence or absence of 5' 
flanking sequences; similar results were obtained for NGF treated PC 12 cells. These 
results indicated that cw-acting elements present in the proximal half of the first intron 
were crucial for high level gene expression in neurons and PC 12 cells, thus it is 
interesting to note that transgenic mice lacking the intron are still capable of 
expressing a reporter gene driven by the NSE 5' flanking sequence in a neuron- 
specific manner (Forss-Petter et al., 1990). When the short Xho I external deletion 
construct lacking intron 1 was transfected into nonneuronal cells, low but significant 
CAT activity, about fiftyfold less than the level seen in neurons, was observed. 
Addition o f intron 1 and 2.7 kbp of 5' flanking sequence separately and in 
combination made little difference to the levels of CAT activity, indicating that 
elements in the intron and 5' flanking region were neuron-specific and not constitutive 
enhancers of gene expression. It is possible that the 5' flanking region of the NSE 
gene contains spatial and temporal controls whilst the intron contains strong neuronal 
enhancers; this might explain why transgenic mice carrying the NSE-lacZ transgene 
express (J-galactosidase correctly, but are unable to match the high levels of 
endogenous gene expression in adult animals.
1.7.5 Posttrancriptional regulation of enolase
In certain eukaryotes, it is apparent that enolase gene expression is regulated in a 
complex manner, often at the levels of transcription, RNA processing, protein 
synthesis and beyond (Twyman and Jones, 1995c). It has been reported that chicken
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NNE is phosphorylated in Rous Sarcoma Virus (RSV) transformed chick fibroblast 
cells (Cooper et al., 1983) and further in vitro experiments have shown that chicken 
NNE and rabbit MSE, but not chicken MSE are phosphorylated on the same tryptic 
peptide fragment by RSV tyrosine kinase (Cooper et al., 1984). Recent sequence data 
has shown that a tyrosine residue at position 44 in the chicken NNE sequence and in 
the equivalent position in all mammalian enolases is replaced by histidine in chicken 
MSE (Tanaka et al., 1995), however, no kinetic differences between phosphorylated 
and nonphosphorylated chicken NNE have been observed and the significance of this 
obscure posttranslational modification, if any, remains to be determined (Eigenbrodt 
et al., 1983).
In mammals, there is evidence that both MSE and NSE genes are regulated 
posttranscriptionally although transcription appears to be the most important level of 
control. Orthologous comparisons of cDNA sequences has shown that the 5' and 3' 
untranslated regions (UTRs) of the genes are highly conserved. This is particularly 
striking in the case of NSE because, in common with many other neuronal genes, the 
3' UTR is very long (approximately 1 kbp) yet there is still over 70% identity between 
rat, mouse and human sequences. It is apparent that the long NSE 3' UTR came into 
existence by an evolutionary insertion event, as there is a long sequence of 
consecutive adenosine residues approximately 150 bp from the 3' end of the coding 
region, a position homologous to the polyadenylation sites of the yeast ENOl and 
EN02 and the mammalian NNE genes (Day et al., 1987). There are also numerous 
tandem repeats of the sequence ATTT about 400 bp from the 3' end of the coding 
region (Day et al., 1987), which have been shown to influence mRNA stability in 
other genes (Shaw and Kamen, 1986). A further repetitive motif, CCACCG, is found 
in the short NSE 5' UTR although its significance is unknown. Posttranscriptional 
negative regulation of NSE has been proposed on the basis of evidence showing that 
the message accumulates faster than the encoded protein during neuronal 
differentiation both in vivo and ex vivo (Forss-Petter et al., 1986; Di Liergo et al., 
1990). The differential expression of NSE protein and NSE mRNA in Purkinje cells 
(Watanabe et al., 1990) and the recent demonstration that NSE mRNA but not NSE 
protein accumulates in murine ES cells and preimplantation embryos (Alouani et al.,
1993) provides further support. Finally, in two studies of AOT-transgenic mice, 
transcripts were found in both neuronal and nonneuronal tissue, whilst reporter 
protein was found only in neuronal tissue (Forss-Petter et al., 1990; Martinou et al.,
1994) .
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Heterogeneity at the 5' end of human MSE mRNA provided the first evidence for 
posttranscriptional regulation of the MSE gene (Peshavaria and Day, 1991). RACE 
cloning confirmed that the MSE gene gives rise to two alternatively spliced products 
by differential utilisation of two splice donor sites and one splice acceptor site within 
exon 1 (Giallongo et al., 1993). The two mRNAs differed from each other in the 
presence or absence of a 42 base leader sequence and alternatively spliced MSE 
messages of similar structure have been found in mouse (S. Ventura, unpublished) 
and, based upon cDNA sequence comparisons, probably also exist in rat (Ohshima et 
al., 1989; Giallongo et al., 1993). Although each splice product encodes the same 
protein, the secondary structures predicted from the primary sequence data suggested 
that differential translational controls may be operative, as has been described for 
other eukaryotic genes (Alberts et al., 1994). Although the role of alternatively 
spliced MSE transcripts is not known, their cross-species conservation argues for an 
important regulatory function.
1.8 Concluding comments
In this Chapter, we have discussed the expression, ontogeny and regulation of the 
three enolases in mammals and birds, with particular emphasis on recent 
investigations into the molecular basis o f enolase gene regulation. The present study, 
which examines regulation of the rat neuron-specific enolase gene, will hopefully 
contribute to the growing literature on this important subject.
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C hapter 2  -  The M o lecu la r  B asis o f  N eu ron -S pecific  Gene E xpression  in the  
M am m alian  N erv o u s  S ystem
As discussed in the previous chapter, one of the major reasons for studying neuron- 
specific enolase is to find out more about neuron-specific gene regulation in general, a 
subject which is still poorly understood (Mandel and McKinnon, 1993). The purpose 
of this second introductory chapter is therefore to summarize the current litereature 
embracing the molecular basis of neuronal gene expression in the mammalian nervous 
system and as such, it has been published as a review (Twyman and Jones, 1995b).
2.1 Gene expression in the mammalian nervous system.
The development of a multicellular organism from a fertilised egg involves the 
progressive and hierarchical restriction of gene expression in time and space. 
Eventually, each differentiated cell comes to express a characteristic set of gene 
products, conferring upon it specific biochemical and physiological properties which 
can be termed its phenotype. In mammals, many genes are expressed only in the 
nervous system and a great number of these are restricted to the neuronal cell lineage. 
The gene encoding neuron-specific enolase is an example of a panneuronal gene, a 
gene expressed in all cells of neuronal origin. Panneuronal genes encode proteins 
which are responsible for those characteristics general to all neuronal cell types (e.g. 
electrophysiologically excitable membranes, exit from the cell cycle, neurite 
outgrowth and formation of synaptic junctions). Other neuronal genes may be 
described as subneuronal because they are expressed in a subset of neuronal cell types 
and encode proteins which are responsible for the individual characteristics of 
particular subpopulations of cells (e.g. neurotransmitter phenotype).
The mammalian nervous system originates from two major embryonic tissues. The 
central nervous system (CNS) is derived from the neural tube whilst the majority of 
the peripheral nervous system (PNS) is derived from the neural crest, the remainder 
originating from placodes of ectodermal origin. Within the adult nervous system, 
there is an incredible variety of cell types, the origins of which are considered in two 
excellent reviews concentrating on the CNS and PNS lineages respectively 
(Anderson, 1989; McKay, 1989). In the last few years, much attention has been 
directed towards the function and regulation of genes involved in the developing 
nervous system, specifically to those genes responsible for the determination of cell 
fates (reviewed by Lemke, 1993). Other groups have aimed to explain the effects of
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neurotrophic factors, a family of polypeptides whose members exert development- 
related effects upon neurons (see Barde, 1991); of these, the best characterised is 
nerve growth factor (NGF) (Levi-Montalclini, 1987). Neurotrophic factors are 
thought to exert their effects by stimulating the expression of early response or 
immediate early genes (Sheng and Greenberg, 1990), a class of genes encoding 
transcription factors which directly or indirectly regulate the expression o f the 
terminal or late response genes in the nervous system, those responsible for neuronal 
phenotype. Although such studies have already provided much information 
concerning the genetic control of neural development, it is apparent that there is still a 
'missing step’ between the early stages of neurogenesis and the maintenance of the 
neuronal phenotype in the mature animal. At present, investigators are attacking this 
problem from both ends, i.e. by studying the regulation of neuron-specific genes and 
the downstream targets of neurogenic genes and immediate early genes. The present 
study o f neuron-specific enolase gene regulation contributes to the former.
2.2 Strategies for studying gene regulation.
Most genes are regulated at the level of transcription, primarily by interaction between 
diffusible trans-acting factors and cx-acting DNA elements located near to the 
transcribed region of the gene (reviewed by Maniatis et al., 1987). Generally, the ex­
acting elements consist of a core basal promoter, which is absolutely required for 
minimal gene expression, and any number of additional upstream regulatory elements 
which modulate that expression either constitutively (i.e. in all environments) or 
confer upon the gene its spatial, temporal and inducible specificity. It is desirable to 
identify particular functional elements within this upstream region as such elements 
often represent sites where tram-acting factors bind to the DNA.
Genes may be studied as intact units, in which case a suitable assay must be available 
to detect and measure the gene product. In such cases, the gene is usually studied in a 
surrogate environment, e.g. a transgenic mouse containing an integrated human gene. 
It is usually more convenient, however, to study gene regulation indirectly by fusing 
the putative control elements of the gene under investigation to a reporter gene, a 
heterologous gene whose product can be assayed easily and quantitatively. Common 
reporter genes used in animal studies include those encoding the enzymes p- 
galactosidase (P-gal), chloramphenicol acetyltransferase (CAT) and luciferase (luc). 
The advantage of using reporter constructs, rather than intact genes, is that assays can
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easily be carried out in cell lines or in vivo where the endogenous gene is also 
expressed.
A general strategy for the analysis of gene regulation is to identify important cis- 
acting elements in the flanking region of a given gene by deleting, rearranging, 
substituting or otherwise modifying specific regions of the putative regulatory 
sequence and comparing the performance of the modified and unmodified constructs. 
Preliminary results may be obtained by simple stepwise deletions but these may need 
to be refined and reinforced by observing the effects of internal deletions, linker 
scanning mutations and finally, specific point mutations. There are two major 
approaches to the analysis of gene regulation: a cell line approach, involving the 
transfection of reporter constructs into a variety of permissive and nonpermissive cell 
lines, and a transgenic approach, involving the analysis of gene expression in vivo. 
Each has its advantages and disadvantages (see Table 2.1). Gene expression may also 
be analysed in vitro using protein extracts from cell lines and organs; in vitro 
transcription assays may succeed where the transfection approach has failed (e.g. 
Schwartz et a l, 1994). Usually, the in vitro approach is used to identify protein 
binding sites, e.g. by using gel retardation and footprinting assays.
Cell line approach.
Advantages: Easy technique with rapid results.
Many constructs can be studied during a single experiment.
Can study specific inductive responses and irarw-activation/repression.
Disadvantages: No indication of temporal or spatial regulation.
Often limited by properties of available cell lines; sometimes difficult to identify 
cell lines with appropriate properties.
Established cell lines may not accurately represent conditions in vivo.
Introduction of too much DNA may titrate out available transcription factors. 
Transfected DNA does not respond to endogenous c/s-acting factors such as distant 
enhancers, chromatin effects, replication timing and methylation.
Transgenic approach:
Advantages: Spatial and temporal gene regulation can be observed, often at single cell 
resolution.
Transgenes respond to true in vivo conditions.
Usually only a limited number of copies integrated so that transcription factors will 
not be titrated out.
Disadvantages: Technique more difficult and time-consuming, making it less easy to study many 
constructs at once.
Integrated gene may be subjected to unfavourable position effects.
Table 2.1: Advantages and disadvantages of the cell line and transgenic approaches to the analysis of 
gene regulation.
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Introduction: Chapter 2
2.3 Mechanisms of neuron-specific gene expression
For many eukaryotic cells, the c/.v-acting elements responsible for cell type specific gene 
transcription have been identified and well-characterised. For instance, the molecular 
basis of muscle-specific gene regulation is now understood in detail (reviewed by 
Buckingham, 1994). Although neuron-specific gene regulation has been under study for 
the last ten years, its molecular basis remains largely unclear. Many neuronal genes 
possess a GC-rich, housekeeping type promoter although just as many have typical 
TATA box-containing class II promoters or intermediate type promoters; in each case, 
transcription may be initiated at single or multiple start sites. A number of motifs have 
been identified which appear to be important for the cell type specific expression of small 
groups of neuronal genes, but no panneuronal mechanism of gene control has emerged.
It is possible that both the promoter and regulatory element heterogeneity reflect the 
variety of distinct neuronal cell types in the nervous system, which, in addition to a 
ubiquitous control mechanism, would require distinct developmental programmes.
Recent studies indicate that neuronal gene expression can be achieved by three principle 
mechanisms (Figures 2.1a-2.1c) which may operate alone or in combination. In each 
case, the c/s-acting elements responsible for cell-type specificity may be supported by 
further elements which act constitutively. Genes expressed in specific neuronal 
subpopulations (rather than panneuronal ly) are often regulated by modular elements 
which act to restrict expression driven by a more promiscuous underlying programme 
(Figure 2.Id). In the following sections, these four mechanisms are examined in detail 
with examples taken from the recent literature. There is then a brief discussion of some 
putative regulatory motifs which are common to several neuronal genes and finally a gene 
table which summarises the studies of neuron-specific gene expression to date.
2.3.1 Neuron-specific gene expression conferred by a basal promoter
The analysis of a number of neuronal genes has shown that the functional cell type- 
specific regulatory elements lie very close to the transcriptional start site meaning that 
most of the 5' flanking region can be deleted without affecting the specificity of gene 
expression. The smallest functional regulatory element is often less than 300 bp in 
length, which suggests either that the basal transcriptional apparatus may be preferentially 
active in neuronal cells (as shown in Figure 2.1a) or that neuronal control elements are 
located very close to the basal promoter (as shown in Figures 2.1b and 2.1c).
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The existence of a neuron-specific basal promoter has been proved beyond doubt in the 
case of the mouse peripherin gene which encodes a panneuronal but PNS-preferred 
neuronal intermediate filament protein. The 5' flanking region was dissected by Desmaris 
et al. (1992) who showed that as little as 98 bp of sequence upstream from the 
transcriptional start site was sufficient for cell-type specific reporter gene activity 
following transfection. Minute analysis of this region by DNase footprinting identified 
three protected fragments: PERI, PER2 and PER3. Targeted mutation of these regions 
showed that PERI, which overlapped the TATA box, was required for cell-type specific 
expression whilst PER2 and PER3 were required for general, constitutive upregulation. 
The neuron-specific element PERI probably interacts with the basal transcription 
apparatus as deletion experiments have shown that it cannot be removed without the loss 
of expression in all cells-, this is the essential point of Fig 2.1a. Two possible 
mechanisms of core promoter specificity have been reported: Tamura et al. (1990) have 
shown that different forms of the basal transcription factor TFIID exist in extracts of 
brain and liver, and that these factors differentially support expression of the myelin basic 
protein gene. Thus, neuronal specificity could be brought about by the existence or 
activity of a basal transcription factor only in neuronal cells. Secondly, Wefald et al. 
(1990) have shown that the context of the TATA box may influence the way in which 
ubiquitous transcription factors interact with tissue-specific factors located elsewhere in 
the gene and this is another possible explanation for cell type-specific expression of 
peripherin.
Neuron-specific core promoters are also thought to control transcription of the rat 
GAP-43, synapsin I and calmodulin II-encoding genes as well as the mouse gene 
encoding synapsin II. However, although cell type-specific expression has been observed 
for short reporter constructs in all cases, the proximal regulatory sequences have not been 
studied by footprinting and might conceivably contain independant enhancers or silencers 
upstream of a nonspecific promoter, as shown in Figures 2.1b and 2.1c. GAP-43 encodes 
a panneuronal axonal growth-associated protein (neuromodulin, B-50) which is expressed 
preferentially in immature and regenerating neurons. Dissection of the 5' flanking region 
(Nedivi et al., 1992) revealed a neuron specific promoter extending 386 bp upstream of 
the transcriptional start site. Interestingly, this core sequence was flanked by two unusual 
DNA elements; one, a short sequence of alternating purines and pyrimidines with the 
potential to form left-handed Z-DNA (Rich et al., 1984) and the other, a long polypurine 
sequence with the potential to form triple stranded H-DNA by Hoogsteen base pairing
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(Htun and Dahlberg, 1989). In transfection experiments, deletion o f either of these 
unusual elements resulted in the severe repression of transcription, but if both were 
present, there were no adverse effects. It is therefore possible that GAP-43 gene 
expression is mediated by countermodulation, involving interaction between the 
elements.
Synapsins are membrane-associated phosphoproteins localised in the presynaptic termini 
throughout the nervous system. There are four synapsin proteins, (la and lb, Ila and lib) 
which are produced by alternative splicing of the two synapsin genes. Neuron-specific 
core promoters are thought to be present in the rat synapsin I and mouse synapsin II genes 
(Saurwald et al., 1990; Chin et al., 1994; Howland el al., 1991) but not in the human 
synapsin I gene (G. Thiel et al., 1991). All the promoters appear to be of the 
housekeeping type, with no canonical TATA box, and there is only one transcriptional 
start site for each of the genes. The 5' flanking region of the rat synapsin I gene was 
dissected by Saurwald et al. ( 1990) who found that 225 bp of upstream sequence and 105 
bp downstream from the transcriptional start site was sufficient to drive cell type-specific 
expression in transfection experiments. Thiel et al. (1991) showed, however, that the 
human synapsin I gene was driven by a nonspecific basal promoter, which extended 115 
bp upstream of the transcriptional start site, and one or more neuron-specific enhancer 
elements located further upstream but within 422 bp of the start. The 5' region o f the rat 
synapsin II gene was analysed by Chin et al. ( 1994) and was shown to comprise a neuron- 
specific promoter extending 153 bp upstream of the transcriptional start site and a number 
of neuron-specific positive and negative elements located further upstream. The synapsin 
genes therefore demonstrate that gene regulation is often more complex than shown in 
Fig 2 .1, and may involve a combination of alternative mechanisms.
2.3.2 Promiscuous transcription repressed by a neuron-specific negative modulator
A neuron-specific negative modulator would function in nonneuronal cells and would 
confer cell type-specificity upon a nonspecific basal promoter. By sequential deletion, it 
should be possible to remove the modulator and allow the expression of a reporter 
minigene in a wider variety of cell types; these are the essential features of Fig 2.1b. 
Should such an element function in an orientation and position independent fashion, and 
be capable of conferring neuronal specificity upon a heterologous promoter, it would then 
constitute a silencer (Brand et al., 1985).
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The first gene discovered to be regulated by a neuron-specific negative element was the 
rat Nall gene encoding the type II sodium channel (Nall). Sodium channels are 
transmembrane-gated ion channels which confer upon neurons and other cells the 
property of electrical excitability. The type II sodium channel is one of four such proteins 
differentially expressed in neurons and it belongs to a large protein family, other 
members of which are expressed in muscles and glia (for a review, see Mandel, 1992).
Of the neuronal sodium channel genes, the type II gene is the best candidate for the study 
of neuron-specific gene regulation because it is the only gene expressed strongly and 
panneuronally in the adult nervous system. A reporter gene, driven by 1051 bp of Nall 5' 
flanking sequence was generated by Maue et al. (1990). In transfection experiments, this 
construct was expressed in cells of neuronal origin but neither in excitable nor 
nonexcitable cells of nonneuronal origin. Stepwise 5' deletions identified a number of 
negative regulatory elements, the strongest of which was located between 983 and 1051 
bp upstream of the transcriptional start site; when this region was deleted, a ninefold 
upregulation of reporter expression in nonneuronal cells was observed. The functional 
element (then called repressor element 1, RE1) was identified by footprinting as a 28 bp 
motif with the sequence ATTGGGTTTCAGAACCACGGACAGCACC (Kraner et al., 1992). 
This element fulfilled all the properties of a silencer and was later renamed the neuronal 
restrictive silencer element (NRSE) (Mori et al., 1992). Kraner and colleagues also 
performed gel retardation assays and identified a protein present only in nonneuronal cell 
extracts which bound specifically to the NRSE.
The regulation of the rat neuron-specific SCGIO gene was studied by transfection (Mori 
et al., 1990) and in transgenic mice (Wuenschell et al., 1990). SCG10 is another axonal 
growth-associated protein which is homologous to the ubiquitously expressed protein 
strathmin but unrelated to GAP-43 (for a review, see Okazaki et al., 1993). 500 bp of the 
5' flanking sequence was shown to confer no cell type-specificity either in cell lines or in 
vivo, although a number of constitutive enhancer elements were identified. However, a 
construct containing 4 kbp of upstream sequence was neuron-specific. Further 
characterisation of this upstream region (Mori et al., 1992) revealed an element which 
was very similar in sequence and function to the Nall silencer, and bound a similar sized 
protein, which was termed the neural-restrictive silencer [binding] factor (NRSBF, 
NRSF).
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The discovery of similar functional civ-acting elements in two neuron-specific but 
otherwise unrelated genes prompted a search for conserved elements in other neuronal 
promoters, some of which are shown in Table 2.2. Homologous elements have now been 
identified in 18 neuronal genes demonstrating a mean identity of 93% to the consensus 
(Schoenherr and Anderson, 1995). In addition to the Nall and SCG10 NRSEs, two 
further elements - those in the synapsin 1 (Saurwauld el al., 1990; G. Thiel et al., 1991; 
1994; L. Li et al., 1993) and Na,K-ATPase subunit genes (Pathak et al., 1994) - have 
been shown to be functional. Analyses of the putative NRSEs upstream of the human 
and rat synapsin 1 genes (Saurwald et al., 1990; G. Thiel et al., 1991) at first failed to 
demonstrate their neuron-specific silencer activities. L. Li et al. (1993) reported that the 
putative silencer element located in the human synapsin I promoter was indeed functional 
and that deletion of the element caused an upregulation of synapsin I-reporter expression 
in nonneuronal cell lines, however, statistical analysis of the results suggested that the 
observed upregulation was not significant. G. Thiel and colleagues have shown that the 
NRSE in the human synapsin I promoter overlaps a binding site for the positive 
transcriptional activator K.rox-24 (G. Thiel et al., 1994). They have shown that the
R a t B D N F TTCAGCACCTTGGACAGAGCCa 
I  I I I I I  I I I I I  I  I I  g  
TGATGGTGGAGCCTGTTTAGGc
Human D BH gGTCAG. . CGCTGGACAGCTCCtcg
R a t N a l l c a t  TTCAGCACCACGGAGAGTGCCtCtgct
R a t S C G 1 0 g g  t  TTCAGAACCACGGACAGCACCagag t
Human s y n a p s  i n  I ggaTTTAGTACCGCGGACAGAGCCttcgc
R a t  s y n a p s in  I agcTTCAGCACCGCGGACAGTGCCttcgc
C o n s e n s u s . . . TTYAGNACCRCGGASAGNRCC_____
Table 2.2: Comparing the sequences of some of the known neural restrictive silencer elements (adapted 
from Fig 4 in Mori et al., 1992). In the human DBH element, maximum alignment has been achieved by 
inserting gaps (represented by stops). Base pair complementarity is shown between the two contiguous 
sequences present in the BDNF promoter. Nomenclature for ambiguous nucleotides: R = G or A (puRine), 
Y = C or T (pYrimidine), S = G or C (three bonds), N = any Nucleotide.
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NRSF can prevent transactivation of synapsin I reporter constructs by Krox-24 in vitro 
and propose that interaction between Krox-24 and the NRSF mght therefore play a 
pivotal role in the regulation of this gene.
A cDNA encoding the NRSF has recently been isolated from a HeLa kgtl 1 library using 
a probe comprising three tandem repeats of the N al I NSRE (Schoenherr and Anderson,
1995). A partial cDNA was isolated which encoded a novel protein containing eight zinc 
finger motifs. NRSF mRNA was absent from neuronal cell lines, including PC 12 cells, 
but present in glia and fibroblast cells. In situ hybridisation to mouse embryos showed 
that NRSF transcripts could be detected in the proliferative ependymal layer of the neural 
tube, but not in the mantle zone which is rich in postmitotic neuronal cell bodies. The 
expression domains of SCG10 and NRSF mRNA in the neural tube were mutually 
exclusive and complementary. Northern and RNase protection analysis showed that, 
excluding the nervous system, expression of NRSF mRNA was nearly ubiquitous 
throughout the mouse embryo, supporting the role o f NRSF as a widespread inhibitor of 
neuronal gene expression in nonneuronal tissue.
Although only four of the NRSEs have been shown to be functional as neuronal silencers, 
those from six other genes bind specifically to recombinant NRSF in vitro (Schoenherr 
and Anderson, unpublished observations). Similar elements have also been observed in 
the flanking regions of several nonneuronal genes, although they demonstrate only 84% 
identity to the consensus NRSE compared to 93% for those in neuronal genes. NRSF 
activity has also been reported in neuronal as well as nonneruonal tissue (Thiel et al.,
1994) although this conflicts with earlier reports (Mori et al., 1992; Kraner et al., 1992). 
The BDNF gene locus contains two NRSEs, inverted with respect to each other, between 
two brain-specific promoters (Timmusk et al., 1992). A homologous element has also 
been identified in the 5' flanking region of the human dopamine p-hydroxylase (DBH) 
gene which has been shown to possess a relatively promiscuous basal promoter (Ishiguro 
et al., 1993). If functional, however, the silencer must work in concert with a cAMP 
responsive neuron-specific enhancer which was shown by Ishiguro et al. to be essential 
for cell type specific expression. The equivalent region in the rat DBH promoter does not 
contain a silencer element (Shaskus et al., 1992). Putative neuron-specific negative 
modulators have been identified upstream of genes encoding other neuronal proteins 
including synaptophysin (Bargou and Leube, 1991) but these have not been further 
characterised and it is not known if they correspond to the NRSE consensus.
41
Introduction: Chapter 2
2.3.3 Minimal nonspecific basal transcription activated by a neuron-specific positive 
modulator
A neuron-specific positive modulator would function in neuronal cells and would 
upregulate transcription from a constitutive minimal promoter. By sequential deletion, it 
should be possible to remove such an element and return the expression of a reporter 
minigene to a minimal level in all cell types; these are the essential features of Fig 2.1c. 
Should such an element function in a position and orientation independent fashion and be 
capable of conferring neuronal-specificity upon a heterologous basal promoter, it would 
then constitute an enhancer (see Maniatis et al., 1987).
As positive regulation is a common feature of eukaryotic gene function, it is not 
surprising that a number of neuron-specific genes should possess binding sites for 
specific transcriptional activators. In some cases, however, such elements have been 
difficult to isolate. A number of filament proteins are expressed specifically in neuronal 
cells including the intermediate neuronal filament proteins NF-H (heavy chain), NF-M 
(mid range chain) and NF-L (light chain). Early reporter-transfection studies, using 
considerable lengths of 5' and 3' flanking DNA from various neurofilament genes, 
identified a number of constitutive positive and negative regulatory elements but failed to 
isolate elements required for cell type-specificity. Thus, reporter constructs were found to 
be expressed with equal efficiency in neuronal and nonneuronal cell lines alike (Julien et 
al., 1987; Monteiro and Cleveland, 1989; Nakahira et al., 1990; Pleasure et al., 1990; 
Schneidman at al., 1992; Zopf et al., 1990). This was also found to be true for the a- 
intemexin gene, which encodes another neuron-specific intermediate filament protein 
(Ching and Liem, 1991). Evidence from transgenic mouse experiments showed, 
however, that reporter transgenes driven by relatively short regions of 5' and 3' flanking 
sequence were properly regulated, indicating that all the required m-acting elements 
were present near to the transcriptional start site (Byrne and Ruddle; 1989; Julien et al., 
1988;1990; Beaudet et al., 1992; Lee et al., 1992; Reeben et al., 1993; Yazdanbakhsh et 
al., 1993). This discrepancy was attributed to the artificial nature of the transfection 
assay (see Table 2.1) but deletion analysis in transgenic mice also failed to identify 
specific functional control elements. In conflicting reports, Yazdanbakhsh et al. (1993) 
claimed to have identified a neuron-specific positive element in the flanking region of the 
human NF-L gene, located between 190 and 300 bp upstream of the transcriptional start 
site whilst Beaudet et al. (1992) claimed that 300 bp of upstream sequence was
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insufficient to confer neuronal-specificity upon a reporter transgene but that 4.6 kbp of 
downstream information, combined with the minimal promoter, could confer cell type 
specificity in transfection experiments. To overcome the limitations of the transfection 
assay, Schwartz et al. (1994) have analysed the regulation of the mouse NF-H gene by in 
vitro transcription using protein extracts from brain and liver. They found that a minimal 
promoter extending 65 bp upstream of the transcriptional start site was capable o f 
sponsoring relatively strong reporter expression using extracts from both tissues but that a 
region located between 65 and 115 bp upstream of the start site was responsible for brain- 
specific enhancement of transcription. Within this region, a sequence displaying perfect 
dyad symmetry was shown to be essential: GGGGAGGAGG N )5 CCTCCTCCCC.
Interestingly, deletion experiments showed that only the pyrimidine-rich repeat was 
essential and that the complementary, purine-rich element could be mutated or deleted 
without effect. Identical or highly conserved elements have been found near to the 
transcriptional start sites in all three human and murine neurofilament genes suggesting a 
common overall mechanism of spatial regulation, however, as the genes are differentially 
regulated during development (Julien et al., 1986) further controls may be superimposed 
upon this general regime. In the human and murine NF-L genes, the enhancer is found 
downstream of the transcriptional start site, supporting the conclusions of Beaudet et al.
(1992). The NF enhancer has not been found in the flanking regions of any other genes 
and is presumed to be unique to this closely related gene family.
Cell-specific transcription of the rat tyrosine hydroxylase gene has also been traced to a 
neuron-specific enhancer. Transfection analysis in PC8b cells located the enhancer just 
upstream of the transcriptional start site (Yoon et al., 1992). The 77/ enhancer comprises 
an AP-1 binding motif (TGATTCA) with an overlapping 20 bp element displaying 
imperfect dyad symmetry. This element has an E-box core, which features in other 
tissue-specific enhancers such as the exocrine specific Pan element and the 
immunoglobulin light chain enhancer kE2 (Nelson et al., 1990; Murre et al., 1989). 
Mutational analysis carried out by Yoon et al. has shown that both the E-box motif and 
the AP-1 binding site are required for enhancer function and that their spatial relationship 
is also important, indicating a close interaction between them. More recently, Wong et 
al. (1994) have shown that the AP-1/ E-box dyad motif is both insufficient and 
nonessential for neuron-specific expression of rat TH reporter constructs in PC 12 cells. 
Instead, a functional enhancer sequence was located 500 bp upstream of the 
transcriptional start site.
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2.3.4 Gene expression in subsets of neurons involving combinatorial controls 
superimposed upon a more promiscuous mechanism
Many neuron-specific genes have been analysed in transgenic mice but these studies are 
usually limited to showing that a particular length of flanking DNA is capable of 
conferring correct spatial and temporal expression. Relatively few genes have been 
dissected in a rigorous manner, to identify elements responsible for spatiotemporal 
control, but those encoding enzymes of the catecholamine synthesis pathway are an 
exception. The genes involved in neurotransmitter synthesis and function are prime 
examples of subneuronal-specific genes. The transmitter phenotype of a particular 
neuron depends upon the combination of enzymes made in the cell (for example, the 
pathway to catecholamine synthesis is shown in Figure 2.2) and neurons which synthesise 
particular neurotransmitters are located in characteristic parts of the nervous system. One 
would expect that the enzymes involved in neurotransmitter synthesis, activity and 
degradation would be synthesised in specific overlapping spatial domains, and this would 
be reflected in the promoters of the corresponding genes.
Tyrosine
U TYROSINE HYDROXYLASE (Til)
L-DOPA
U AROMATIC AMINO AICD DECARBOXYLASE (AADC) 
Dopamine
U DOPAMINE P-1IYDROXYLASE (DB11)
Noradrenaline
U PHENYLETIIANOLAM1NE /V-METIIYLTRANSFERASE (PNMT) 
Adrenaline
Figure 2.2. Catecholamine synthesis in the mammalian nervous system. The pathway is shown to the left 
with the enzymes to the right.
Hoyle and colleagues have recently investigated the regulation of the human DBH gene in 
transgenic mice using a nested set of 5' deletions (Hoyle et al., 1994). Endogenous DBH 
expression is restricted to noradrenergic neurons (i.e. most sympathetic and 
parasympathetic neurons) and adrenal chromaffin cells whilst transgenic mice carrying
5.8 kbp of the human DBH  5' flanking region express the reporter-transgene in those cells 
where endogenous DBH mRNA is detected but also in ectopic tissues such as the dorsal 
root ganglia and dopaminergic and noncatecholaminergic neurons of the brain. Transient 
ectopic expression is also observed during development in the spinal cord and facial
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mesenchyme (Mercer et al., 1991; Kapur et al., 1991; Hoyle et al., 1994). The ectopic 
expression was thought to be due to the absence of negative modulators located outside 
the limited regulatory DNA flanking the reporter gene. Deletion of 5' flanking sequence 
to 1.1 kbp upstream of the transcriptional start site allowed further ectopic expression in 
the hypothalamus, septum and olfactory bulb, however neither this expression, nor the 
ectopic expression observed for the 5.8 kbp 5' sequence, was observed if 1.5 kbp of 
flanking DNA was present. Hoyle et al. therefore suggested that the region between 1.1 
and 1.5 kbp upstream of the transcriptional start site was responsible for restricting the 
pattern of expression conferred by the more promiscuous 1.1 kbp sequence but that 
further elements, located between 1.5 and 5.8 kbp upstream were able to allow expression 
in other cells and that these permissive elements were repressed by sequences elsewhere. 
Finally, deletion of the 5' flanking sequence to within 600 bp of the transcriptional start 
site abolished reporter gene expression altogether suggesting the presence of an essential 
positive element between -600 and -1100 bp. Transfection analysis using the same 
promoter (Ishiguro et al., 1993) identified a functional NRSE 500 bp upstream of the 
transcriptional start site and an essential cAMP responsive element (CRE) less that 300 
bp from the transcriptional start site. The loss of expression in transgenic mice could not 
be due to the removal of either of these elements and might be caused by unfavourable 
position effects.
Because all cells expressing DBH should also express 77/, Hoyle et al. put forward the 
idea that the ectopic expression from the DBH minigene might correspond to the 
endogenous expression of 77/. This would further suggest that the genes involved in 
catecholamine synthesis could be regulated according to a common paradigm with extra 
levels of restriction imposed upon those genes encoding downstream enzymes. Although 
this was an attractive proposal, comparison of promiscuous DBH reporter expression with 
endogenous 77/ mRNA showed that some populations of cells expressed the DBH- 
reporter message but not 77/, and that the domains of expression of the two genes did not 
match. Furthermore, Shaskus et al. (1992) has compared the proximal flanking regions 
of the rat DBH and 77/ genes and although two conserved regions were found, deletion 
analysis showed that neither were required for cell type-specific expression and that the 
conserved region was not present in the human 77/ promoter.
A striking example of subneuronal-specific gene regulation imposed upon an underlying 
panneuronal mechanism comes from study of the Purkinje cell protein 2 (Pcp-2) gene 
(Vandaele et al., 1991). Pcp-2 is expressed specifically in cerebellar Purkinje cells and
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retinal bipolar neurons, and transgenic mice carrying 4 kbp of 5' flanking sequence 
express the reporter gene faithfully in the Purkinje cells (Oberdick et al., 1990). 
Vandaele et al. showed that a transgene driven by only 400 bp of the flanking sequence 
was expressed in a multitude of neuronal cell types whilst a transgene driven by 3.5 kbp 
was expressed in the same manner as the endogenous gene. This showed that negative 
elements, located between -400 and -3500 bp, were responsible for the restriction of 
expression to certain subneuronal cell types and that this restriction had been imposed 
upon a more promiscuous (but still neuron-specific) core region.
2.4 Other conserved features of neuron-specific genes
The studies outlined above have identified a number of cii-acting motifs which appear to 
confer neuronal cell type specificity; these include the neuronal restrictive silencer 
element orNRSE (Mori et al., 1992) and the neurofilament enhancer (Schwartz et al., 
1994). A number of further motifs, described below, have been found to be conserved 
between otherwise unrelated neuronal genes, however, their functional significance is less 
clear.
2.4.1 A neuronal consensus with unknown function
Maue et al. (1990) first noted a conserved sequence with the core motif CCAGG within 
the flanking regions of four neuronal genes: the rat type II sodium channel and peripherin 
genes, the mouse NF-L gene and the Drosophila dopamine decarboxylase gene. The 
sequence has been found to be required but not sufficient for CNS expression in 
Drosophila (Scholnick et al., 1986) and was termed element 1, however, in the sodium 
channel gene, its deletion was shown to have no effect (Maue et al., 1990). Later, the list 
of neuronal genes carrying the consensus sequence within their flanking sequences was 
expanded by Vandaele et al. (1991). Some genes were shown to possess multiple copies 
of the sequence either dispersed or arranged in tandem. For instance, the rat neuron- 
specific enolase gene contains four such sequences, three located upstream of the 
transcriptional start site (Vandaele et al., 1991) and one located within the first intron 
(Sakimura et al., 1995). Homologous elements are also present upstream of the mouse 
synapsin II gene (Chin et al., 1994), the rat GAP-43 gene (Nedivi et al., 1992), the mouse 
OMP gene (Kudrycki et al., 1993) and the rat P P T gene (Quinn and McAlister, 1993); all
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the known sequences are aligned for comparison in Table 2.3. In those cases where the 
sequence has
S e q u e n c e S p e c ie s /G e n e P o s it io n
AGTGTTTGCCCCAQQ G C A T ...................................... . . GGGCTG Rat DBH ( -1 3 6 /-1 11)
CCAGG AGAT Rat GAP-43 (-279/-286J
G C T . . GAGCCAGG A ............................................... GCTGGCTO R a t Gotfa (-2S2 /-232)
G AACTgggtggggC C A G G A A ............................................ GAAGGCTG Mouse OMP (-61 /-86 )
AGCTT. . G . . CCAGG AGAGCCTG Rat Satt (-1050 /-1026)
A . C T T . GTGACCAGG A G A T ...................................... GGA.GCTG Rat Nall (-60 /-34 )
AG C.............GGCCAGG C T ............................................ GGAGCC.G Mouse NF-L (-184 /-161)
. G CT. . GGGCCCAGG GCAGAAAAGT................... Human NF-M (502 /5 4 3 )
............................ CCAGG T T C C C A T ............................ GCGGCCTG
GAG AGAGGCTC Rat NSE (-995/-986J
AG CT. . GGGGCCAGG G A A A ...................................... ASATCCTG Rat NSE (-823 /-771 )
CCAGG AGGCCAA............................ AGATGCTG Rat NSE (-662 /-641 )
A . C T T . GTGACCAGG AGAT G O A . GCTG Rat NSE (372 /378 )
CCAGG AGATCAA............................ AGACGCTG Human NSE (-7Ö 3/-782)
AGGTcaGAGACCAGG AGAAAAGTATAGGAGAG Mouse Pcp-2 (-285 /-210 )
acacacaatGGACCAGG AAGAAGAAAAGGGAGAG GGAGGCTC
G C T T . AGGCCAGG Rat peripherin (-404 /-393 )
AG C. . . . AACCAGG ...................................... AGAG GOAGGGTO * Rat peripherin (-167 /-151 )
G G G A .. . G O A . GCTG Rat peripherin (-77 /-64 )
TGTGCCtGG ......................................... G A . AGAAGCTG Rat PPT (-761 /-741 )
AGCTT. . . . CCAGG C A ............................................ A G A . GCTG Rat SCGIO (-226 /-204 )
AACCAGG AG Mouse synapsin II (-1 3 0 /-1 3 9  opp)
A . C T T . . GGCCAGG ACGCCTAACCGTGCGA. C G A . CCTG Drosophila Ddc (-6 1 /-9 6  opp)
AGCTTGNGVCCAGG A G -R IC H R G A in) s c t g CONSENSUS
Table 2.3: Comparing the flanking regions of various neuron-specific genes containing a conserved motif 
with the consensus sequence shown on the bottom row of the table. Sequences are shown with gaps 
(indicated by stops) or condensed sequence (subscript lower case letters) introduced for maximum 
alignment. The core sequences CCAGG and GA.. CTG are emphasised in bold. The GAAAAG motif, 
which appears in three of the genes, is underlined. In the right hand column of the table, numbers indicate 
the positions, within the respective genes, where the sequences occur. In the mouse Pcp-2 and human NF- 
M genes, the consensus occurs twice and the two sequences are contiguous. In the other genes where the 
consensus is present as multiple copies, each sequence occurs at a distinct position as indicated. The 
sequence usually appears on the sense strand, except where opposite orientation is indicated (opp). The 
asterisk indicates that the peripherin sequence has been condensed to show maximum alignment; the 
correct sequence of the distal element is GGAaGgGGTG. Adapted from Fig 4 in Vandaele et at., 1991; 
original consensus described for type II Na+ channel gene, peripherin, NF-L and Drosophila Ddc by Maue 
et al., 1990.
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been manipulated in mammalian genes, it has proved both insufficient and nonessential to 
confer neuronal specificity upon a reporter construct. Its existence in the promoters of so 
many neuronal genes is therefore a mystery, but the observed conservation with the 
essential Drosophila element 1 would suggest an important function. Quinn and 
McAlister (1993) have shown that the neuronal element in the rat PPT gene binds a 
protein of approximately 40 kDa in brain extracts but not in extracts of various cell lines 
(neuronal and nonneuronal). Remarkably, the protein binds to only one strand o f the 
element and binding is not competed by the duplex. The authors noted that there is some 
homology between the PPT neuronal element and single-stranded binding elements in 
other genes (adipsin, growth hormone) and the TAR region of HIV which interacts with 
the TAT protein at the RNA level. Molecular modelling has shown that the TAR region 
can form a stem loop structure, with the TAT protein interacting with a single-stranded 
portion of the stem. The neuronal consensus is included within this stem-loop structure 
and it is therefore possible that DNA secondary structures may be involved in the 
neuronal regulation of PPT and other genes containing the motif. However, as no studies 
have shown the neuronal element to be necessary for cell type-specific gene expression, 
its relevance remains to be determined.
2.4.2 The SNN motif
Another bipartite motif, identified by Saurwald et al. (1990), was termed the SNN motif 
because it is found in the rat and human Synapsin I promoters, the mouse N.F-M promoter 
(Lewis and Cowan, 1986) and the human NGF receptor gene promoter (Sehgal et al., 
1988). Although the SNN motif itself has not been functionally tested, a cAMP response 
element, shown to be essential for transcription overlaps the motif in both synapsin I 
promoters and the upstream moeity forms a consensus Krox-24 binding site which may 
be required for proper gene regulation in the synapsin and neurofillament promoters. The 
kown SNN motifs are shown in Figure 2.3.
2.4.3 The neuronal identifier (ID) sequence
In the early 1980s, Sutcliffe et al. identified two small cellular RNA (scRNA) molecules, 
called BC1 and BC2 respectively, which were expressed specifically in the rat brain and
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peripheral nervous system by RNA polymerase III (Sutcliffe et al., 1982; 1984). A 
middle repetitive DNA element dispersed throughout the rat genome was found to
S equence S p ecies/gene P osition
C C T T C G C C C C C G C  -  N ,fi - CGGGCTGAC 
C C T T C G C C C C C G C  - N37 -  CGCGCTQAC 
GGTTCGCCCCCGC - N „  - CGCGCTGCC 
CCTTTGCCTCTGC - N47 -  CGGGCTGGC
Rat synapsin I -212 
Human synapsin I -213 
Mouse neurofilament -130 
Human NGF receptor -117
CSTTYGCCYCYGC -N 36 . < 7 -  CGSGCTGNC C on sensu s
Figure 2.3: SNN motifs in neuronal genes (adapted from Sauerwald el at., 1990). Underline shows 
position fo overlap with cAMP response element in synapsin promoters. Double underline shows Krox 24 
binding sites. Positions relative to transcriptional start site. Nomenclature for ambiguous nucleotides: R = 
G or A (puRine), Y = C or T (pYrimidine), S = G or C (three bonds), N = any Nucleotide
hybridise to these scRNA molecules and it was later discovered that the sequences were 
preferentially located near to or within postnatally expressed neuronal and 
neuroendocrine genes (Milner et al., 1984), e.g. there is an ID element 3' to the final exon 
of the rat NSE gene (Sakimura et al., 1987). A model was proposed in which neuron- 
specific polymerase III transcription of the ID element would produce the scRNAs and at 
the same time generate an open chromatin domain which could be exploited by RNA 
polymerase II (Sutcliffe et al., 1984). Although this model has not been experimentally 
proven, such a mechanism would have to work in concert with the gene-specific 
transcriptional regulation described in the preceding sections. The 75 bp ID element has 
been shown to work as a c/.v-acting positive modulator of neuronal gene expression in 
transfection experiments (McKinnon et al., 1986).
2.4.4 The peptide hormone downstream octamer
An octamer motif with the sequence 5' GCCCAGCC 3’ was reported to confer cell-type 
specificity upon the human gastrin gene when transfected into neuroblastoma cells (Thiell 
et al., 1987). Unlike many of the functional c/'.v-acting elements discussed in this Chapter, 
the peptide hormone gene octamer is always located between the TATA box and the 
transcriptional start site. Homologous motifs are found in similar positions in the genes
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for other peptide hormones including cholecystokinin, gastrin-releasing hormone, 
neuropeptide Y, thyrotropin-releasing hormone, vasoactive intestinal peptide and 
vasopressin (Habener et al., 1989) and in at least one case, the sequence has been shown 
to direct reporter gene expression to certain populations of neurons (Habener et al., 1989). 
It is interesting to note that an identical element is found between the TATA-like box and 
the first exon in the rat NSE gene (Sakimura et al., 1987).
2.4.5 Purine-rich sequence elements
A 22 bp purine-rich repetitive element with the consensus sequence 
GAGAGGGGAGAGGRGRGAGRRG was identified upstream of the rat gene for 
GABAa receptor 5 and was shown to bind a brain-specific protein factor termed BSF-1 
(Motejlek et al., 1994). Analysis of the sequences of other promoters showed that 
homologous elements were located upstream of other neuronal genes including three 
further GABAa receptor subunit genes, Pcp-2, and several neurofilament genes. These 
purine-rich elements within the human neurofilament gene promoters had previously 
been identified as binding sites for a ubiquitous protein factor, PAL (Elder et al., 1992a; 
1992b). An element showing limited homology was also found within the astrocyte- 
specific GFAP (glial fibrillary acidic protein) gene. Overall, these elements demonstrated 
50-60% identity to the B site found in the immunoglobulin k3 light chain enhancer (Sen 
and Baltimore, 1986) which is recognised by a brain-specific transcription factor termed 
BETA (Komere/ al., 1989). Purine rich elements with little homology to the above have 
been identified in the promoters for rat GAP-43 (Nedevi et al., 1992), human synapsin I 
(Saurwauld et al., 1990) and in the first intron of rat NSE (Sakimura et al., 1995). None 
of these sequences have been shown to demonstrate protein-binding activity although in 
both GAP-43 and NSE, these elements lie close to other unusual DNA structures which 
may cooperate with them to regulate gene expression.
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Introduction: Chapter 2
2.6 Transcription factors in the mammalian nervous system - approaches to 
isolation and identification of function.
Although the expression of many neuronal genes has been studied, relatively little is 
known about the transcription factors which regulate them. This lack of knowledge 
reflects the major approaches used to identify such factors, approaches which exploit their 
structural or functional similarity to those expressed outside the nervous system or in 
other animals, rather than their participation in the regulation of specific genes. For 
example, a large family of neuronal POU domain-containing factors has been identified 
using the popular approach of homology-based PCR amplification, where degenerate 
primers are synthesised to match the most highly conserved sequences of a given DNA- 
binding domain and used to isolate novel factors of the same family (He et al., 1988).
An alternative approach exploits known transcription factor binding sites and traps novel 
proteins which bind to them. The brain-specific DNA binding proteins BETA and BSF1 
have been isolated in this manner (Komer et al., 1989; Motejlek et al., 1994). Both these 
methods are limited by their inability to identify downstream genes although, in the latter 
case, consensus binding sites may be sought in appropriate genes and candidates 
containing such sites may be analysed for binding activity. The homology search 
approach has the major advantage that genes encoding novel putative transcription factors 
may be isolated and cloned, thereby allowing domains of expression to be determined by 
in situ hybridisation and downstream candidate genes with overlapping expression 
patterns may then be sought. Perhaps the greatest disadvantage of the homology search 
approach is that only novel factors belonging to well-characterised families can be 
isolated. The opposite approach involves the characterisation of putative transcription 
factors based on their ability to bind c/.v-acting elements which have been shown to be 
involved in neuronal gene expression. This strategy was used to identify the NRSBF 
(Mori et al., 1992) and has the advantage that natural downstream target genes are 
already known. However, most such factors are only poorly characterised because it is 
more difficult to move from this stage to then isolate the corresponding gene. An 
interesting and novel way to isolate putative neuronal transcription factors was reported 
by Mullen et al. (1992). These investigators raised a battery of monoclonal antibodies 
against brain cell nuclei in an attempt to isolate neuronal nuclear proteins. One such 
antibody recognised a neuron-specific and almost panneuronal nuclear protein, named 
NeuN, which bound to DNA in vitro. Once an interesting protein has been identified, 
this approach becomes very powerful, allowing purification and in situ localisation of the 
protein, and isolation of cDNA sequences from an expression library.
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2.7 Transcription factors in the mammalian nervous system - regulation of neuronal 
genes
2.7.1 Regulation of neuronal genes by immediate early gene products
A number of neuronal genes have been shown to be regulated at the transcriptional level 
by the products of the cellular immediate early genes (Sheng and Greenberg, 1990). The 
immediate early genes (IEGs) encode transcription factors which are expressed promptly 
and transiently following certain extracellular stimuli (e.g. electrical polarisation or the 
presence of growth factors). Most of the IEG products are not specific to neuronal cells 
and mediate their effects in other tissues as well as the nervous system, however, such 
factors may provide an important constitutive regulatory function or may co-operate with 
tissue-specific factors to mediate specific regulatory controls. The Krox-24 factor 
(Lemaire et al., 1988), also known as NGFI-A (Milbrandt, 1987) and zif268/egr-l 
(Christy et al., 1988) has been shown to transactivate at least one neuronal gene, synapsin 
I, probably in concert with the NRSBF which binds an adjacent silencer element (G.
Thiel et al., 1994). The binding site for Krox-24 (Christy and Nathans, 1989; Lemaire et 
al., 1990; Cao et al., 1990) has been found upstream of a number of other neuronal genes 
including those of the neurofilament family, synapsin II, synaptophysin and 
synaptobrevin II (Archer et al., 1990; Ozcelik et al., 1990; Sudhof et al., 1990). At least 
one IEG product, NGFI-C, is restricted to neuronal cells, mostly those of the cortex, 
dorsal root and superior cervical ganglia and sciatic nerve.
2.7.2 Putative regulatory factors containing a POU domain
At present, most of the transcription factors which have been identified in the mammalian 
nervous system belong to the POU-domain class of helix-tum-helix proteins, so called 
because they share a consensus domain common to the mammalian transcription factors 
Pit-1, Oct-l/Oct-2 and the Caenorhabditis elegans protein unc 86 (Herr et al., 1988; for 
reviews, see Robertson, 1988; Ruvkin and Finney, 1991; Schöler, 1991; Rosenfeld, 1991; 
Wegner et al., 1993). In C. elegans and Drosophila melanogaster, POU-domain proteins 
have been shown to play a pivotal role in the control of neuronal cell fate during 
development (Campos-Ortega and Jan, 1991; Finney et al., 1988). Given the premise
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that such factors could play an equally important role during mammalian development,
He and colleagues carried out a homology-based PCR search for novel POU factors in the 
mammalian brain (He et al., 1989). Four new factors were identified, named Bm-1, Bm- 
2, Bm-3 and Tst-1 (see also Hara et al., 1992). The Bm factors were brain specific and 
restricted to discrete populations of cells, supporting the notion that they might influence 
neuronal cell fate and regulate discrete sets of neuronal genes. Tst-1 (which is also 
known as Oct-6 and SCIP (suppressed cAMP inducible POU)) was expressed in both 
brain and testis. Since that early report, a number of additional nervous system-specific 
POU domain proteins have been identified and characterised (see section 2.8).
Although the differential and overlapping distribution of these POU domain proteins 
suggested an important regulatory role in the nervous system, proof that such factors 
directly interact with neuronal genes has been slow in coming. Tst-1/SCIP has been 
shown to downregulate the glial gene P0 (which encodes protein zero, the major protein 
component of myelin) in Schwann cells transiently cotransfected with Tst-l/SCIP cDNA 
(He et al., 1991; Monuki et al., 1993), whilst Yang et al. (1994) have recently shown that 
the same factor is able to activate the gene for the acetylcholine receptor a3 in neuronal 
cells, even in the absence of its characteristic binding site. This more recent study 
suggests that the factor mediates its effect by binding to other proteins and not necessarily 
by binding to the upstream promoter. Kemp et al. (1990) have shown that the replication 
deficiency of Herpes Simplex Virus type I in neuronal cells can be traced to octamer 
motifs located upstream of the viral immediate early genes. In their study, the octamer 
motif upstream of the IE3 gene was shown to bind a repressor protein present only in 
neuronal cell lines; the nature of the repressor is unknown but any one of the neuronal 
POU domain proteins could well fill this role. Oct-2 is a POU gene expressed both in the 
nervous system and in B-cells. The gene encodes numerous splice variants (Writh et al., 
1990) two of which (Oct-2.4 and 2.5) are expressed preferentially in neuronal cells 
(Lillycrop and Latchman, 1992). Recently, Dawson et al. (1994) have shown that the 
tyrosine hydroxylase gene can be repressed in a cell-specific manner by neuronal 
isoforms of Oct-2 and that the cw-acting element responsible for this repression is the 
heptamer component of adjacent heptamer-octamer motifs located in the proximal TH 
promoter. Most recently, the Brn factors Brn-3a, Brn-3b and Bm3c have been shown to 
differentially regulate at least two neuronal genes, and domain swap experiments have 
been carried out to determine the regions of each protein required for the specificity of 
regulation (Milton et al., 1995; Budhram-Mahadeo et al., 1995).
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More direct proof of neuronal POU protein function comes not from mammals, but from 
Drosophila. The D. melanogaster gene Ddc encodes the enzyme L-dopa decarboxylase, 
which is required for catecholamine synthesis (see Fig. 2.2). A POU domain 
transcription factor termed Cfl -a, which is homologous to the C. elegans factor unc 86, 
binds upstream of the Ddc transcriptional start site and has been implicated as a mediator 
of dopaminergic/serotonergic neuronal differentiation (Johnson and Hirch, 1990). In C. 
elegans, unc 86 also functions to specify dopaminergic and serotonergic neuronal 
differentiation during development. Treacy et al. (1991) have identified a Drosophila 
POU protein which lacks a DNA-binding domain but can form heterodimers with Cfl-a 
and hence repress Ddc. The suggestion is that this factor, named I-POU, may be 
expressed in nondopaminergic neurons and may repress Ddc through the formation of 
inactive heterodimers although this has yet to be proven experimentally.
2.7.3 Factors containing an HLH domain
An additional class of neuronal transcription factors has been isolated from mammalian 
brain due to homology with the Drosophila achaete-scute complex, a group ofproneural 
genes so-called because they confer upon cells the potential to become neurons (Glysen 
and Dambly-Chaudiere, 1988). Two cDNAs were isolated, termed Mash-1 and Mash-2 
(for murine achaete-scute homologue) and whilst Mash-2 was expressed only in the 
trophectoderm, the Mash-1 product was shown to be restricted to neuronal precursors 
(Johnson et al., 1990; Guillemot and Joyner, 1993) suggesting that the role in neuronal 
development was also preserved. Accordingly, homozygous Mash-1 knockout mice 
showed normal development of the central nervous system but defects in the sympathetic, 
parasympathetic and enteric ganglia, and death of neuronal progenitor cells in the 
olfactory epithelium (Guillemot et a l, 1993). Neurogenic genes act later than the 
proneural genes and their expression contributes to the decision of whether or not a 
competent proneual cell becomes a neuron. The Drosophila homeobox gene Prospero 
and its mammalian homologue Prox-1 are expressed specifically in newborn postmitotic 
neurons and may act as transcription factors controlling genes involved in the early 
processes of neuronal differentiation (Oliver et al., 1993). A number of additional HLH 
family transcription factors have been identified in the mammalian nervous system, some 
of which are restricted to the nervous system whilst others are also expressed elsewhere 
(see Section 2.8). Perhaps the most interesting of these is NeuroD (Lee et al., 1995), a 
bHLH protein which is expressed during the terminal differentiation of a subset of central
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and peripheral neurons and which, when expressed ectopically, can cause the premature 
differentiation of neuronal precursors.
2.7.4 Factors containing an Sry-like box
The Sry-like box is a sequence-specific DNA-binding motif first identified in the human 
sex determining gene SRY. A number of autosomal genes containing similar motifs have 
recently been identified which are developmentally regulated (Laudet et al., 1993) and 
these genes have been named the SRY-like box or Sox genes. Several chicken 
(Uwanogho et al., 1995) and mouse (R. Lovell-Badge, unpublished observations; P. 
Koopman, unpublished observations) Sox genes have recently been identified whose 
expression patterns suggest a role in nervous system development. Sox-2 and Sox-3 are 
expressed in the proliferative neural epithelium, like the proneural gene Mash-I. The 
deposition of postmitotic neurons in the mantle layer of the nervous system is marked by 
downregulation of Sox-2 and Sox-3 and the onset of Sox-11 expression. Sox-11 is absent 
from the proliferative layer. Like the proneural and neurogenic HLH factors, therefore, 
the Sox proteins may also play a role in the progressive determination of neuronal cell 
fate, a process which necessarily involves the regulation of numerous downstream genes.
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Introduction: Chapter 2
2.9 Neuron-specific gene expression in the mammalian nervous system - concluding 
comments
Gene expression in the mammalian nervous system has been shown to follow the same 
basic rules that govern those genes expressed in all other tissues, i.e. mechanisms 
involving the interaction between specific c/.v-acting elements and diffusible trans-acting 
factors. With a number of notable exceptions, neuronal expression appears to be 
regulated primarily by positive c/.v-acting elements which, by binding transcriptional 
activators, allow high level gene expression specifically in neuronal cells. This paradigm 
is common to eukaryotic genes generally, with negative regulation playing an important 
role in the tissue-specific expression of only a few genes. Although neuronal gene 
expression per se is mediated principally by positive interactions, the expression of genes 
in restricted subsets of neuronal cells appears to be controlled essentially by negative 
interactions. For example, the studies of Ishiguro et al. (1993) and Shaskus et al. (1992) 
have shown that the human and rat dopamine (3-hydroxylase genes require a cAMP 
response element as an essential enhancer of gene activity, however, to achieve the 
correct subneuronal expression pattern, a number of negative modules are required 
further upstream to progressively restrict the expression domain (Hoyle et al., 1994). It 
has been suggested that the disproportionate frequency of negative regulatory 
mechanisms in the mammalian nervous system may reflect the unusually large number of 
distinct cellular phenotypes which exist and interact within what is commonly regarded a 
single tissue (Mandel and McKinnon, 1993). Thus the importance of negative 
modulation may have increased in order to potentiate the maximum number of modes of 
interaction for a limited number of transcription factors (Mandel and McKinnon, 1993). 
This is supported by experiments which have shown the same transcription factor can act 
as both a positive and negative modulator of gene expression (e.g. Tst-1, compare 
Monuki et al., 1993 and Yang et al., 1994) and that minor modifications to c/.v-acting 
elements located in a gene promoter can convert them from enhancers to suppressers of 
gene activity (e.g. see Bessis et al., 1993).
Although a relatively small number of mammalian neuronal genes have been cloned and 
characterised (there are estimated to be 3 x 10^ brain specific genes in the rat genome 
(Milner et al., 1984)), a number of encouraging similarities are now emerging. It is very 
likely that, in such a complex tissue as the mammalian nervous system, the number of 
c/.v-acting elements and /ram-acting factors which regulate its intricate development, 
interaction and adaptation to the environment is much larger than the selection that has
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been identified thus far. It remains for further studies to shed more light upon this most 
intricate and elaborate biological phenomenon.
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Aims
The two introductory chapters have placed the study of neuron-specific enolase in the 
context of neuronal gene regulation as a field of research. Particularly, the last sections of 
Chapter 1 discussed the recent molecular studies of neuron-specific enolase gene 
regulation, and indicated the limits of those studies and work which could be carried out 
to further them. The major aims of this project were therefore as follows:
• To develop a system for the analysis of NSE gene regulation in cell lines.
• To identify cw-acting elements responsible for cell type-specific expression of NSE ex 
vivo, using a deletion-transfection strategy.
• To investigate NSE regulation in the context of neuronal differentiation, using the 
deletion-transfection strategy and established ex vivo models such as EC cells and the 
PC 12 cell line.
• To investigate NSE regulation in vivo by generating transgenic mice carrying parts of 
the NSE 5’ flanking region linked to lacZ.
• To use information from both in vivo and ex vivo experiments to delineate gel 
retardation assays to characterise binding activity on the NSE 5’ flanking region.
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Chapter 3 - Materials
3.1 Equipment
3.1.1 Centrifuges
For routine laboratory procedures involving small sample volumes in Eppendorf 
microfuge tubes, an MSE MicroCentaur was used at 13 000 x g. Where protocols 
especially recommended cooling, a temperature-controlled IEC Centra MP4R fitted 
with a microfuge rotor was used as above. Larger samples were centrifuged in 20ml 
Sterilin universal tubes using an MSE Mistral 2000 or IEC Centra MP4R fitted with a 
swing bucket rotor. An MSE Mistral 2000 dedicated for cell culture applications was 
used for pelleting cells during routine cell culture procedures. For greater volume 
applications such as large scale plasmid preparations, a Beckman J2-21 M/E 
centrifuge, fitted with a JS 13.1 or JA 14 rotor as appropriate, was used. Caesium 
chloride equilibrium gradient centrifugation was carried out using a Beckman L8- 
70M ultracentrifuge fitted with a Vti-50 rotor. For double centrifugations, a Vti-65 
rotor was used for the second step.
3.1.2 Microscopes and photography
Embryo dissections were carried out using a Zeiss Stemi SV6 dissecting microscope. 
This instrument was also used for the photography of wholemount embryos subjected 
to P-galactosidase staining, in situ hybridisation or wholemount 
immunohistochemical staining. Embryos were photographed on a white tile 
background with incident light from a Schott KL 1500 electronic fibre optic source 
using an Olympus SLR OM10 camera and Kodak Ektachrome 160T colour slide film. 
Cultured cells were observed using a Wild M40 inverted phase microscope. Cells and 
tissue sections stained with fluorescent antibodies were observed using a Nikon 
Optiphot epifluorescence microscope and photographed using a Nikon FX-35A 
camera with Kodak Ektachrome 160T colour slide film.
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3.1.3 Incubators and ovens
For hybridisation reactions, membranes were dried in a Gallenkamp 80°C oven and 
hybridised and washed in a Hybaid minioven. A Gallenkamp size 1 incubator at 37°C 
was used for the static incubation of agar plates, whilst a New Brunswick Scientific 
G25 incubator/shaker at 37°C, 250 rpm was used for growing bacterial cultures. A 
variable temperature Gallenkamp size 1 incubator was used for in situ hybridisation 
protocols and various other incubations. Cultured eukaryotic cells were maintained in 
a Heraeus C 02 incubator at 37°C, 5% C 02, whilst following calcium phosphate 
transfection, cells were moved to a Flow C 02 incubator 220 at 35°C, 3% C 02. Low 
temperature reactions were carried out in Sadia Airofreeze refrigerators and similar 
instruments were used for storage of reagents and samples at 4°C and -20°C. For 
ultralow temperature storage, a Kelvinator 100 series -70°C freezer was used. For 
sterilisation, a Gallenkamp 180°C OV-330 size 2 oven was used for glassware, and a 
Victor UV plate dryer was used for drying and sterilising fresh agar plates.
3.1.4 Electrophoresis apparatus
Agarose gels for routine preparative and analytical procedures were run in Horizon 58 
horizontal gel tanks (Gibco BRL). Agarose gels for Southern and northern analysis 
were run in Horizon 11.14 horizontal gel tank (Gibco BRL). Gels were photographed 
using IS03000 black and white Polaroid film. Denaturing polyacrylamide gels for 
resolving nucleic acids (e.g. sequencing gels) were run on a Raven vertical slab gel 
tank. Nondenaturing gels for electrophoretic mobility shift assays were run on a 
VI 5.17 vertical gel tank (Gibco BRL), fitted with a cyclical buffer pump. SDS 
polyacrylamide gels for resolving proteins were run using a Mini-Protean II system 
(Bio-Rad). Gels for resolving nucleic acids were run using an LKB 2197 power 
source. A Bio-Rad model 200 power source was used in conjunction with the Mini- 
Protean II system. Gels were dried using a Bio-Rad 583 Slab gel dryer and 
autoradiography was carried out using Fuji X-ray film in cassettes supplied by X-ray 
Accessories Ltd., Bushey, UK.
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3.1.5 Cell culture equipment
Cell culture experiments were carried out in a Gelaire BSB4 containment cabinet. A 
Bibby rechargeable automatic pipetter was used for aseptic transfer of cells and 
media.
3.1.6 Miscellaneous equipment
Waterbaths were supplied by Grant Instruments, Cambridge, UK. Microwave ovens 
were supplied by Phillips, Germany. Heating blocks were supplied by Jennings 
Laboratory Supplies, Bridgeford, UK. Geiger counters were supplied by Mini- 
Instruments Ltd., Essex, UK. The vacuum dryer, model EF-03, was supplied by 
Edwards High Vacuum Ltd., Crawley, UK. Heated stirrers were supplied by A. 
Gallenkamp & Co. and Vortex machines by Fisons. Rotating platforms and mixers 
were supplied by Luckham Ltd., Burgess Hill, UK. The cryostat used in this project 
was a Reichert-Jung Frigocut model 2700. PCRs were carried out on Hybaid Omn-E 
thermal cyclers. DNA and RNA concentrations were determined using a Pharmacia 
Ultraspec III UV/visible spectrophotometer.
3.2 Reagents
3.2.1 General chemicals and solvents
Chemicals and solvents used to make common laboratory solutions were usually 
supplied by Analar BDH or Fisons depending upon availability. Deionised 
formamide was supplied by Fluka. The detergents Triton X-100 and Tween 20 were 
supplied by Sigma Chemical Co., St. Louis, USA. For general applications, distilled 
water was made in the laboratory using a Purite Labwater system and solutions were 
autoclaved for 20 minutes at 15 psi in a Rosamon electric autoclave. Solutions which 
could not be autoclaved were made up in sterile redistilled water purified centrally by 
the department. For RNase-free work, solutions were made up in sterile redistilled 
water and treated with DEPC according to Sambrook et al. (1989). Tris-containing 
solutions for RNase-free work, which cannot be treated with DEPC, were made up in 
DEPC-treated, autoclaved water using dedicated Tris-base crystals and baked 
glassware.
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3.2.2 Reagents for specific applications
Agarose and low melting point agarose were supplied by Gibco BRL. Acrylamide 
was supplied by Fisons and W.v-acrylamide by Kodak. Tris-buffered phenol was 
supplied by Fisons. The following reagents, used in several applications, were 
supplied by Sigma Chemical Co., St. Louis, USA: unlabelled nucleotide 
triphosphates, gel loading dyes (bromophenol blue, xylene cyanol FF), ethidium 
bromide, dithiothreitol (DTT), p-mercaptoethanol, guanidine isothiocyanate, protease 
inhibitors (aprotinin, bestatin, leupeptin, PMSF), sodium azide, paraformaldehyde 
powder and bovine serum albumin. The suppliers of other reagents intended for use 
in specific methods are indicated in the appropriate section of the methods chapter.
3.2.3 Radioisotopes
a-32P-dGTP and a -35S-dATP were supplied by Amersham International with specific 
activities of 3000 and 1000 Ci mmol'1 respectively. D-threo-[l, 2-14C]- 
chloramphenicol was supplied by ICN Radiochemicals with a specific activity of 98 
Ci mmol'1
3.2.4 Bacteriological media and fine chemicals
Materials for bacterial growth media were supplied by Difco laboratories (Michigan, 
USA) and Oxoid Ltd. (England). Antibiotics were supplied by Sigma Chemical Co., 
St. Louis, USA. Petri dishes were supplied by Falcon.
3.2.5 Cell culture media and fine chemicals
DMEM (Dulbeccos Modified Eagles Medium) and L-glutamine, 
penicillin/streptomycin, Versene and trypsin stock solutions were made in the 
department (see Table 3.1). Ham's F10 medium, RPMI 1640 medium and OptiMEM 
serum reduced medium were obtained from Gibco BRL. FBS (Foetal Bovine Serum), 
myoclone FCS (Foetal Calf Serum), Horse Serum and lOOx MEM (Minimal Essential 
Medium) were also obtained from Gibco BRL. Tissue culture grade plastic ware was
74
Materials and M ethods: Chapter 3
obtained from Nunc and Costar. Rat tail collagen and poly-L-lysine for attaching 
neuronal type cells were obtained from Sigma Chemical Co., St. Louis, USA. The 
mitogenic inhibitors uridine, cytosine arabinoside and 5'-fluoro-2'-deoxyuridine, and 
the differentiation inducing agents NGF-p (nerve growth factor P) and all-tram' 
retinoic acid were also obtained from Sigma Chemical Co., St. Louis, USA. For 
transfection, DEAE-dextran was obtained from Pharmacia BioProcesses, Uppsala, 
Sweden; BES (A(Ar-A/s[2-hydroxyethyl]-2-aminoethanesulphonic acid) was obtained 
from Sigma Chemical Co., St. Louis, USA; TransfectACE, Lipofectin and 
LipofectAMINE were obtained from Gibco BRL; Transfectam and Tfx-50 were 
obtained from Promega and DOTAP was obtained from Boehringer Mannheim. 
Assays for p-galactosidase and CAT (chloramphenicol acetyltransferase) were carried 
out using acetyl coenzyme A, ONPG (o-nitrophenyl-P-galactopyranoside ) and P- 
glactosidase obtained from Sigma Chemical Co., St. Louis, USA. 200 x 200 mm 
TLC (thin layer chromatography) plates for CAT assays were obtained from Merck, 
Darmstadt, Germany.
Reagent (Manufacturer) Stock composition Used
L-Glutamine (Flow) 200mA/ in water 1/100
Penicillin/Streptomycin (Sigma) 10 000 U ml'1 penicillin,
0.1 g ml'1 streptomycin in PBS
1/1000
Trypsin (Difco) 0.25% w/v in TBS (pH 7.7) 
+ 0.1% w/v phenol red
neat
Versene (Analar) 0.02% w/v EDTA in PBS (pH 7.2) 
+ 0.1% w/v phenol red
neat
Table 3.1: Composition of cell culture reagents made in the department. Abbreviations: PBS - 
Phosphate Buffered Saline; TBS - Tris Buffered Saline; EDTA - ethylenediaminetetraacetic acid; U 
units; w/v - weight solute per volume solvent.
3.3 Enzymes
All enzymes and buffers (excluding those obtained as part of kits) were supplied by 
Gibco BRL except Bsa 1 and Hph 1 restriction endonucleases and p-agarase 1 which 
were supplied by New England Biolabs, and calf intestinal alkaline phosphatase, 
DNase I and proteinase K which were supplied by Boehringer Mannheim.
3.4 Kits
Geneclean II and Qiaex DNA preparation kits were supplied by Bio 101 Inc, La Jolla 
CA, USA and Qiagen, Chatsworth CA, USA respectively. The Sequenase version 2.0
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DNA sequencing kil was obtained from USB, Cleveland Ohio, USA. The DIG-RNA 
(T7/SP6) labelling kit and the DIG detection kit were obtained from Boehringer 
Mannheim, Mannheim, Germany.
3.5 Antisera
A polyclonal antiserum against human NSE (neuron-specific enolase) was obtained 
from INCstar Corporation, Stillwater MN, USA. Secondary goat anti-rabbit IgG 
FITC and horseradish peroxidase conjugated antibodies were obtained from Sigma 
Chemical Co., St. Louis, USA. Polyclonal anti-P-galactosidase antiserum was a kind 
gift from Mr Dylan Sweetman. Monoclonal anti-DIG antiserum was a kind gift from 
Mr S S Bhamra. Tissue-specific antisera 2G-9, Ep-A and 4G6 were kind gifts from 
Dr E A Jones (Jones and Woodland, 1987; Jones and Woodland, 1989; Jones et a!.,
1993).
3.6 Plasmids
3.6.1 Commercially available plasmids
The following commercially available plasmids were used during this project: 
pBluescriptUKS-, pBluescriptUSK- (Stratagene, La Jolla CA, USA) and pCAT- 
Control, pCAT-Basic, pSV-P-galactosidase (Promega Biotech, UK).
3.6.2 Recombinant plasmids obtained as gifts
pNSElacZ contains 1,8kb o f the rat NSE 5' flanking region upstream of the E. coli 
lacZ gene allowing expression of p-galactosidase under NSE promoter control (Forss- 
Petter et al., 1990). pcD169 contains the rat NSE cDNA including 5' and 3' 
untranslated regions and a small insert within the coding region, probably 
representing part of an unexcised intron (Forss-Petter et al., 1986). Both plasmids 
were kind gifts from Drs. Sonja Forss-Petter and Patria Danielson. pcD-cSox2 and 
pcD-cSox3 contain the cDNA sequences of the chick Sry-like box transcriptional 
regulators Sox2 and Sox3 respectively. These were kind gifts from Dr Maria Rex.
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3.7 Bacterial strains.
For cloning, four strains of Escherichia coli have been used in this project (see Table 
3.2). Strains DH5a, JM101 and MC1061 were used for general cloning purposes 
according to their availability and these were kind gifts from Dr S Burbidge. Strain 
HB101 was recommended by the suppliers of the pCAT series of vectors for cloning 
these plasmids and their derivatives. This strain was a kind gift from Dr D P Smith.
Strain Genotype Uses
DH5a supE44 A/tfcU169 (080 lacZ AM 15) hsaKM recAl endA\ 
gyrA96 thi\ relAX
General cloning
JM101 supE thi A(lac-proAB) [F' lraD36 proAB tael4 ZAM15] General cloning
HB101 F" /eu36 proA2 recA 13 thi\ ara 14 lacY\ galK2 xyl5 mil 1 rpsE20 
X' supE44 /isdS20r¡,mñ
Cloning pCAT 
vectors
MC1061 A(/acIPOZYA) X74 galU galK sir A General cloning
Table 3.2: Strains of bacteria used in this project with their genotypes and applications.
3.8 Eukaryotic cell lines
The mouse Ltk- line was a gift from Dr E A Jones. Mouse U-138 MG astrocytoma 
and U-373 MG glioblastoma lines were gifts from Dr A G Morris. HeLa cells were a 
gift from Mrs S Corden. The mouse P19 EC (embryonal carcinoma) line was a gift 
from Dr D Clements. Two PC12 lines have been used during this project. The first 
was a gift from Glaxo Institute for Molecular Biology, Geneva, Switzerland whilst the 
second was a gift from Dr P W Andrews; these are termed PC 12 (Geneva) and PC 12 
(Sheffield) in the text. Mouse Neuro-2A and NB4-1 A3 neuroblastoma lines were 
obtained from the American Type Culture Collection.
3.9 Animals
Mice for immunological and in situ hybridisation studies were strain TO. For 
transgenic studies, DNA fragments were microinjected into the pronuclei of one-cell 
stage C57B1/6 x CBA F2 embryos. All mice were supplied by Bantin and Kingsman 
Ltd., Hull, UK.
77
Materials and Methods: Chapter 4
Chapter 4 - Methods
4.1 Routine procedures
Most of the procedures in this section are either modified from those published in 
Molecular Cloning: a Laboratory Manual (Sambrook et al., 1989) or taken directly 
from manufacturers' instructions. I have therefore refrained from lengthy reiteration 
of readily available information and have restricted the material presented below to 
the description of deviations from the published protocols.
4.1.1 Routine preparation of plasmid DNA
Depending upon the amount of DNA required and its purpose, a number of different 
plasmid preparation methods were used.
For routine diagnostic procedures, plasmid DNA was prepared by the TELT method 
(D Stott, pers. comm.). The DNA obtained using this protocol was unsuitable for 
many applications due to the presence of impurities but it was of sufficient quality to 
be cleaved by the majority of restriction endonucleases. From small scale cultures 
(5ml), 1.5ml was removed to a fresh microcentrifuge tube and centrifuged at 13 000 x 
g  for 30 seconds. The supernatant was removed and the pellet of bacterial cells 
resuspended in lOOpl TELT (2.5A/LiCl, 50mA/Tris.Cl (pH 8.0), 63.5mMEDTA, 4% 
v/v Triton X-100). To this suspension was added 50pl Tris-buffered phenol and 50pl 
chloroform:isoamyl alcohol (24:1, v/v). The tube was vortexed for 30 seconds to 
facilitate thorough mixing of the aqueous and organic phases, and centrifuged as 
above for 5 minutes. The upper, aqueous layer was transferred to a fresh 
microcentrifuge tube and precipitated immediately with 2 volumes of ethanol. The 
tube was vortexed briefly, then centrifuged for 10 minutes as above. The supernatant 
was removed and the pellet, containing the plasmid DNA, was washed with 70% v/v 
ethanol, dried and resuspended in 40pl TE (pH 8.0) containing DNase-free RNaseA at 
a final concentration of 50pg ml-1. The DNA could then be used directly for digestion 
with restriction endonucleases, as the RNase worked during this subsequent reaction. 
The yield of plasmid DNA was enough for 5-6 restriction digests.
Where small quantities of plasmid DNA were required for further manipulation, the 
alkaline lysis method found in Sambrook et al. (1989), pp 1.25-1.28 was followed 
exactly, including the optional step in which the bacterial pellet is resuspended in 500
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pi STE (O.lAf NaCl, lOmA/Tris.Cl (pH 8.0), ImA/EDTA) to avoid enzyme inhibition 
by components of the bacterial cell walls. This protocol was based on original 
methods from Bimboim and Doly (1979) and Ish-Horowicz and Burke (1981). The 
alternative 'boiling method' for small scale plasmid preparation, also found in 
Sambrook et al. (1989), ppl.29-1.30 was tried as well, although it was found to be 
less satisfactory. This method was adapted from a procedure first published by 
Holmes and Quigley (1981).
Where large quantities of high quality plasmid DNA were required, the alkaline lysis 
method (Sambrook et al., 1989), pp 1.38-1.39 was used, followed by purification of 
supercoiled plasmid DNA by equilibrium centrifugation in a continuous 
CsCl/ethidium bromide gradient (Sambrook et al., 1989), pp 1.42-1.43. The impure 
DNA was centrifuged for 22 hours at 45 000 rpm in a fixed angle Vti50 rotor. The 
lower (supercoiled) band was removed with a wide bore syringe and the DNA 
purified by extraction with butan-l-ol, followed by extensive dialysis against several 
changes of 51 TE, followed by ethanol precipitation. Plasmid DNA for transfection of 
eukaryotic cells was put through two rounds of centrifugation as recommended 
(Sambrook et al., 1989). Following the first step described above, the supercoiled 
band was transferred to a fresh 6ml Beckman ultracentrifuge tube and topped up with 
1.55 g mk1 CsCl containing 600pg ml'1 ethidium bromide. The sample was then 
centrifuged for 6 hours at 65 000 rpm in a Vti65 fixed angle rotor. The (major) 
supercoiled band was then removed and purified as described above. The yield of 
plasmid DNA from this procedure was usually l-2mg, although it was reduced 
somewhat by a second centrifugation.
Where the presence of nicked circular DNA and small amounts of linear DNA did not 
present a problem, the nucleic acid pellet remaining at the final stage of the lysis 
procedure was resuspended in 2ml of water and the RNA selectively precipitated by 
adding 2.5ml 5Af LiCl. The mixture was incubated on ice for 15 minutes then 
centrifuged at 10000 rpm using a Beckman J2-21M/E centrifuge precooled to 4°C . 
The DNA (remaining in solution) was transferred to a fresh Corex tube and 
precipitated with 10ml of cold absolute ethanol; the tube was incubated at -20°C for 
10 minutes then centrifuged as above. The DNA pellet was redissolved in 400pl TE 
(pH 8.0) and transferred to a microcentrifuge tube. DNase free RNaseA was added to 
a final concentration of 50pg ml-1 and the tube was incubated at 37°C for 30 minutes. 
Residual protein was removed by extraction with phenol, then phenolxhloroform: 
isoamyl alcohol. Residual phenol was removed by extraction with chloroform:
79
M aterials and Methods: Chapter 4
isoamyl alcohol and the DNA precipitated with ethanol as described in (Sambrook et 
al., 1989). The yield of this method was 2-3mg DNA.
4.1.2 Routine subcloning
4.1.2.1 Diagnostic and preparative use of restriction endonucleases.
Restriction endonucleases were supplied by their manufacturers with the appropriate 
buffers and were used according to manufacturers' instructions. The progress of each 
reaction was assessed by agarose gel electrophoresis as described in section 4.1.3.1. 
Partial digests were assessed by taking samples from the reaction at various times 
until completion and comparing the reaction products to the uncut plasmid. For full 
digests, completion of the reaction was verified by ensuring the absence of uncut 
plasmid bands in each lane. DNA markers (lkb ladder, Gibco BRL) were always 
used as a reference. In the case of double digests, the route chosen to achieve the 
desired reaction depended upon the properties of the enzymes involved. If both 
enzymes worked with greater than 80% efficiency in the same buffer at the same 
temperature, the reactions were carried out concurrently. If both enzymes worked 
with greater than 80% efficiency in the same buffer, but the optimal temperature 
varied, the reactions were carried out consecutively with an intermediate heat 
inactivation step if necessary. If the enzymes could not work with greater than 80% 
efficiency in the same buffer, but one buffer could be converted into the other e.g. by 
increasing the salt concentration, the reactions were carried out consecutively with the 
necessary supplementation step and an intervening heat inactivation step if necessary. 
If the enzymes were totally incompatible, and no route could be found to combine 
them, the products of the first digest were purified using the Geneclean II kit 
according to the manufacturer's instructions and redissolved in the buffer appropriate 
for the subsequent reaction.
4.1.2.2 Filling recessed 3' ends with the Klenow fragment of E. coli DNA 
polymerase I
To facilitate the joining together of incompatible sticky ended DNA fragments, the 
recessed 3' ends of certain restriction digestion products were filled using the 5'->3' 
polymerase activity of the Klenow fragment of E. coli DNA polymerase I. The 
procedure followed was similar to that presented in Sambrook et al. (1989), appendix
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F2-F3, although the final concentration of each dNTP in the reaction was 1mA/, not 
0.5mA/ as suggested.
4.1.2.3 Removing overhanging 3' ends with T4 DNA polymerase
Recessed 5' termini cannot be filled in the same manner as recessed 3' termini because 
of the polarity of all DNA polymerases and their inability to initiate DNA synthesis 
de novo. To generate blunt ends from overhanging 3' termini the 3'=>5' exonuclease 
activity of bacteriophage T4 DNA polymerase was exploited. This enzyme is more 
suitable than the Klenow fragment for this particular application because it's 
exonuclease activity is 2-300 fold greater than that of the other enzyme. Whilst 
trimming overhanging 3' termini, the enzyme simultaneously fills in recessed 3' 
termini.. The Klenow fragment of DNA polymerase I was chosen when end-filling 
alone was required simply on the basis of its cost. The procedure followed was 
similar to that presented in Sambrook et al. (1989), appendix F4-F5, although the 
final concentration of each dNTP in the reaction was 0.1 mA/, not 2mA/ as suggested.
4.1.2.4 Removing 5'-terminal phosphate groups with calf intestinal alkaline 
phosphatase
The removal of 5'-terminal phosphate groups from linearised plasmids with 
compatible ends helps to limit intramolecular ligation. The method used was similar 
to that presented in Sambrook et al. (1989), pp 1.60-1.61, although the same amount 
of enzyme (1 unit per 2 pmoles 5'-terminal phosphate residues) was used for both 
protruding 5' termini and blunt or recessed 5' termini, resulting in a great excess of 
enzyme for the former reaction. Following restriction digestion, 1 Ox 
dephosphorylation buffer (supplied by the manufacturer) and enzyme were added 
directly to the reaction mixture with no intermediate phenol :chloroform extraction and 
ethanol precipitation step which is advised in the method of Sambrook and 
colleagues. A phenolxhloroform extraction step followed by ethanol precipitation 
was carried out after the reaction was complete in order to remove all traces of the 
enzyme. This was necessary because even small amounts of phosphatase activity in 
the subsequent ligation reaction could dramatically reduce its efficiency.
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4.1.2.5 Ligation
Ligations (involving cohesive and blunt-ended fragments) were carried out using 
bacteriophage T4 ligase according to the method of Sambrook et al. (1989), pp 1.68- 
1.70. Bacteriophage T4 ligase buffer was supplied by the manufacturer as a 5x 
concentrate and was used according to manufacturer's instructions. For the majority 
of ligations, a recombinant plasmid containing an insert of foreign DNA was 
generated. Under these circumstances, a threefold molar excess of insert over vector 
fragments was used in the reaction and the vector fragment was pretreated with CIAP 
to limit intramolecular ligation (see section 4.1.2.4). No condensing agents were used 
in blunt-ended ligation reactions, but the concentration o f vector fragments was 
increased from lOpg mb1 to lOOpg mH with a proportionate increase in the 
concentration of insert. The concentration of bacteriophage T4 DNA ligase used was 
50 Weiss units mb' (Weiss et al., 1968) for both cohesive and blunt-ended ligations. 
To verify the various stages of the subcloning procedure, several control ligations 
were carried out in parallel as shown in table 4.1. These controls were still carried out 
if subcloning was directional (i.e. the vector ends were incompatible) as they then 
gave some indication of the performance of the restriction endonuclease digestions.
Control Contents Purpose
A Dephosphorylated vector 
No insert
Tests for success of dephosphorylation
B Untreated vector 
No insert
Tests for integrity of vector sequence and 
indicates maximum transformation efficiency
C No vector 
Untreated insert
Tests for purity of insert
D No DNA Tests for purity of reaction components and 
integrity of bacteria
Table 4.1: Controls used to verify ligation reactions
4.1.2.6 Transformation of competent Escherichia co li cells with plasmid vectors
Competent Escherichia coli cells were prepared freshly for each transformation 
according to the method of Cohen et al. (1972). An additional step was included in 
which the cells were resuspended in cold 1 OOmM MgCl2 then pelleted at 2000 rpm 
prior to resuspension in cold 100mA/ CaCl2 as described in the published method. 
This step was reported to increase the transformation efficiency (C. Mason, pers. 
comm.). Transformation was carried out with 200pl competent cells using 
approximately 50ng DNA (from a ligation reaction or freshly diluted from plasmid 
stock) according to the method of Cohen et al (1972). All plasmids used in this study
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conferred ampicillin resistance upon their hosts and it was therefore unnecessary to 
allow the cells to recover following transformation. Transformed cells were plated on 
LB-agar supplemented with lOOpg ml-1 ampicillin, incubated at 37°C overnight and 
transferred to 4°C before satellite colonies were able to grow.
4.1.3 Gels for resolving nucleic acids
4.1.3.1 Nondenaturing agarose gels for diagnostic applications
For the separation of DNA fragments between lOObp and 12kbp for diagnostic 
applications, 0.2 volumes of Type III loading buffer (50% v/v glycerol, 0.25% w/v 
bromophenol blue, 0.25% w/v xylene cyanol FF) was added to each sample and they 
were loaded and run on 0.6 to 2.0% w/v agarose gels made in lx TBE buffer, 
supplemented with 0.2pg mb1 ethidium bromide (made up as a stock in lx TBE 
buffer). Gels were run at 80mA in lx TBE buffer supplemented with 0.5|ig mb' 
ethidium bromide. At the appropriate time, they were examined over a UV 
transilluminator and photographed using IS03000 black and white Polaroid film. The 
use of nondenaturing agarose gels for Southern and northern hybridisation analysis is 
described in section 4.1.7.
4.1.3.2 Low melting point agarose gels for preparative applications
For the isolation of DNA fragments generated by restriction endonuclease digests, 
samples were mixed with Type III loading buffer as described in the preceding section 
and run on 0.8-1.2% w/v low melting point agarose gels made in lx TBE buffer 
supplemented with 0.5pg mb1 ethidium bromide. Gels were run at a maximum of 
40mA in lx TBE buffer supplemented with 0.5pg mb1 ethidium bromide.
Appropriate bands were excised as a small gel slice using a fresh razor blade and 
transferred to a microcentrifuge tube. The DNA was then purified as described in 
section 4.1.4.
4.1.3.3 Denaturing polyacrylamide gels for high resolution electrophoresis.
Where it was necessary to resolve DNA fragments of similar length (e.g. sequencing 
reactions), 6% or 8% polyacrylamide gels (19:1 acrylamide:6;.v-acrylamide)
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containing 42% w/v urea in lx TBE were poured between 20 x 40cm glass plates 
according to the method described in Sambrook et al. (1989), pp 6.39-6.43. Samples 
in denaturing gel loading buffer (90% v/v deionised formamide, lOmMEDTA (pH 
8.0), 0.01% w/v bromophenol blue, 0.01% w/v xylene cyanol FF) were heated to 
100°C on a heating block for 5 minutes, loaded onto the gel and run at 38W in lx 
TBE. Gels with 35S-containing samples (e.g. sequencing gels) were fixed by 
immersion in 10% v/v ethanol, 10% v/v acetic acid for 15 minutes, transferred to 
Whatmann 3MM paper, dried under vacuum at 80°C and exposed to X-ray film in an 
autoradiograph cassette without an intensifying screen at room temperature. Gels 
with 32P-containing samples were left on the lower gel plate, wrapped in cling film 
and exposed to X-ray film in an autoradiograph cassette with an intensifying screen at 
-70°C.
Polyacrylamide gels for protein resolution and gel retardation assays are discussed in 
sections 4.1.8 and 4.6.4 respectively.
4.1.4 Isolating DNA from agarose gels
DNA fragments generated by restriction endonuclease digestion were excised from 
low melting point agarose gels as a small gel slice according to the method of 
Sambrook et al. (1989), pp 6.30-6.31. The fragment was then purified by one of three 
methods depending upon its subsequent use. For routine subcloning, fragments were 
purified using the Geneclean II kit (Bio 101 Inc.) according to manufacturer's 
instructions. For the purification of particularly small fragments, with which the 
Geneclean 11 system was unable to cope, the Qiaex Gel Extraction kit (Qiagen) was 
used according to manufacturer's instructions. For the purification of particularly 
large fragments, which tend to be sheared by the vortexing steps required in the above 
procedures, p-agarase I (New England Biolabs) was used according to manufacturer's 
instructions.
4.1.5 dsDNA sequencing
Double stranded DNA sequencing was carried out using the Sequenase kit version 2.0 
(Promega) according to the manufacturer's instructions. The protocol is based on the 
dideoxy chain terminator method first proposed by Sanger et al. (1977). 2pg of 
plasmid DNA (prepared using the CsCl equilibrium centrifugation method described
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in section 4.1.1) was dissolved in lOOpl water and denatured by adding 1 Ojj.1 2M 
NaOH, 2mMEDTA and incubating at 37°C for 30 minutes. The DNA was then 
precipitated with ethanol and resuspended in 1 Ojj.1 Sequenase lx react buffer prior to 
the sequencing reaction.
4.1.6 Isotopic and nonisotopic labelling of nucleic acids
4.1.6.1 Nick translation
Nick translation, to generate isotopically labelled DNA probes for filter hybridisation 
analysis, was carried out essentially as described in Sambrook et al. (1989), pp 10.8- 
10.9. This was based on methods originally presented by Maniaitis et al. (1975) and 
Rigby et al. (1977). The amounts of the various components of the nick translation 
mix varied between the method of Sambrook et al. and the one used during this 
project. The nick translation mix used in the present study comprised 50-100ng DNA 
in lx nick translation buffer (50mAf Tris.Cl (pH 7.5), 10mA/ M gS04, O.lmA/DTT, 50 
pg ml'1 bovine serum albumin), 0.75mA/dATP, 0.75mA/dCTP, 0.75mA/dTTP, lpl 
DNase 1 (105-fold dilution from 10U pH stock), 20U DNA polymerase I and 40pCi 
a 32P-dGTP in a total volume of 20pl. The reaction was incubated for 3 hours at 16°C 
and stopped by adding 80pl 0.3A/sodium acetate, ImA/EDTA. Labelled probe was 
separated from unincorporated nucleotides by chromatography through a small 
column of Sephadex G-50 (Sigma Chemical Co., St. Louis, USA). Aliquots of the 
probe were eluted from the column and those with the highest specific activity were 
denatured by floating on boiling water for 5 minutes, quenched on ice to prevent 
reannealing and added to the hybridisation stage of the appropriate reaction (see 
section 4.1.7).
4.1.6.2 Labelling 3' termini by end-filling
Probes for the electrophoretic mobility shift assay were prepared by end-filling small 
(50-200bp) DNA restriction fragments, with 5' overhangs, using a nucleotide mix 
containing a 32P-dGTP. The fragments used in this study were generated by 
restriction endonucleases which left unpaired cytidine residues in the template strand, 
therefore only one labelled nucleotide was required. The protocol is modified from 
Sambrook et al. (1989), pp 1052-1053. 50-100ng of DNA was labelled in a total 
reaction volume of 20pl. The reaction mixture comprised 50mMTris.Cl (pH 7.6),
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7mA/MgCl2, O.lmA/DTT, 0.1% v/v P-mercaptoethanol, 0.3mA/dATP, 0.3mA/ 
dCTP, 0.3mA/ dTTP, 0.5mg ml-' BSA, 20pCi a 32P-dGTP and 1-2 units of the 
Klenow fragment of DNA polymerase I. The reaction was incubated at room 
temperature for one hour, and stopped by adding 80gl TE and 3pg Escherichia coli 
tRNA (Sigma Chemical Co., St. Louis, USA). The mixture was extracted three times 
with phenol ¡chloroform then ammonium acetate was added to a final concentration of 
2.5A/ and the DNA was precipitated overnight with ethanol. The probe was 
recovered by centrifugation at 13 000 x g for 10 minutes at 4°C. It was washed with 
70% v/v ethanol, dried and resuspended in 100|il water.
4.1.6.3 Generation of hapten-labelled antisense RNA probes by in vitro 
transcription
The synthesis of RNA probes was facilitated by the use of vectors designed 
specifically for the in vitro transcription of inserted DNA. Such vectors generally 
contain a polylinker flanked by promoters specific for different bacteriophage RNA 
polymerases. The pBluescriptll transcription vectors, which were used in this project, 
contained promoters specific for bacteriophage T3 and bacteriophage T7 RNA 
polymerases. Linearisation of the recombinant plasmid by restriction endonuclease 
digestion within the insert allowed the synthesis of'run-off sense and antisense 
transcripts of defined length. The presence of digoxigenin-labelled UTP in the 
nucleotide mix allowed the synthesis of probes which could be detected using an 
enzyme-linked immunoassay (Holtke and Kessler, 1990). 2pg of plasmid DNA was 
linearised with the appropriate restriction endonuclease as described in section 4.1.2.1 
and the linear DNA was purified by phenolxhloroform extraction followed by ethanol 
precipitation. Sense and antisense probes were synthesised using the DIG RNA 
labelling kit (SP6/T7) (Boehringer Mannheim) according to the manufacturer's 
instructions, excepting that bacteriophage T3 RNA polymerase (Gibco BRL) was 
used, in the buffer supplied by the manufacturer, instead of bacteriophage SP6 RNA 
polymerase. Aliquots of probe were taken from the reaction prior to and following 
DNase treatment. The success of the reaction was assessed by running samples of 
DNA template, pre-DNase probe and post-DNase probe against DNA and RNA 
markers (DNA lkb ladder and RNA ladder, Gibco BRL) on a 2% w/v agarose gel 
made in lx  TBE supplemented with 0.2|ig ml-1 ethidium bromide. 0.2 volumes of 
Type III loading buffer (50% v/v glycerol, 0.25% w/v bromophenol blue, 0.25% w/v 
xylene cyanol FF) was added to each sample prior to loading and the gel was run in 
lx TBE supplemented with 0.5pg ml-1 ethidium bromide for 15 minutes at 100mA.
86
Materials and  M ethods: Chapter 4
The probe was precipitated with LiCl and ethanol according to manufacturer's 
instructions and stored at -20°C in 50pl DEPC-treated sterile distilled water 
containing 20 units RNase inhibitor.
4.1.7 Filter hybridisation
4.1.7.1 Analysis of genomic DNA by Southern hybridisation
Aliquots o f mouse genomic DNA (a gift from Dr David Stott) were digested with 
three common restriction endonucleases (£coR 1, Hind III and BamW 1) according to 
manufacturers' instructions, separated by agarose gel electrophoresis and transferred 
to a nylon membrane (Hybond N+, Amersham) under denaturing conditions as 
described by Sambrook et al. (1989) p 9.45. 20pg of genomic DNA was used per 
reaction. At completion, the entire contents of each reaction was mixed with 0.2 
volumes of Type III loading buffer and loaded onto a 0.6% w/v agarose gel made as 
described in section 4.1.3.1. Overnight electrophoresis was carried out at 10mA in lx 
TBE buffer supplemented with 0.5pg ml-1 ethidium bromide. As controls for the 
subsequent hybridisation reaction, defined quantities of plasmid DNA (lng, lOOpg 
and lOpg) containing the probe sequence were run alongside the genomic DNA.
DNA markers (lkb DNA ladder, Gibco BRL) were used as a reference. After 
electrophoresis, the gel was photographed as described in section 4.1.3.1 against a 
fluorescent ruler for future reference.
Following transfer, the nylon membrane was baked for 2 hours at 80°C then 
immediately cross-linked by placing face-down over a UV transilluminator for 2 
minutes. For the subsequent procedures, the membranes were placed in Hybaid C4 
glass tubes and were kept wet by constant rotation in a Hybaid mini-oven. 
Hybridisation reactions and washing steps were carried out according to the 
phosphate-buffer method of Church and Gilbert (1984). By using this method, 
prehybridisation was unnecessary and the washing stringency could controlled 
entirely by temperature. High stringency washes were carried out at 65°C for 15-20 
minutes. By varying the temperature between 40°C and 60°C, a range of low and 
moderate stringency conditions could be generated. Following the washing steps, 
membranes were removed from the Hybaid tubes, wrapped in cling-film whilst still 
wet and exposed to X-ray film in a cassette with intensifying screen at -70°C. If kept 
wet, membranes could be stripped and reused by washing for 10 minutes in 0.2M 
NaOH at room temperature and rinsing in distilled water.
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4.1.7.2 Extraction o f cellular RNa
Total RNA was extracted from cultured cells using 4M guanidine isothiocyanate 
according to the method of Chirgwin et al. (1979). The quality and yield of each 
extraction was deterrni°ed by IJV spectrophotomertry at 260 and 280nm.
4.1.7.3 Northern hybridisation
Northern hybridisation was carried out according to the method of Thomas et al. 
(1980) using nick trans*ated DNA corresponding to the 3' UTR of the rat NSE gene.
4.1.8 Immunoblotting
4.1.8.1 Preparation »nd e*ectrophoresis of protein extracts
Samples for protein electr°phoresis were prepared as described in Sambrook et al. 
(1989), pp 18.62-18-63 although leupeptin and bestatin protease inhibitors were added 
to the suspension buffer’ at flna* concentrations of 0.5pg mH and 40pg ml'1 
respectively, in additi°n t0 die aprotinin and PMSF mentioned in the published 
protocol. Sonication to s^ear chromosomal DNA was not performed and did not 
appear to affect subseduent stePs in the procedure. Proteins were separated by SDS- 
polyacrylamide gel electrophoresis using a discontinuous Tris-glycine buffer 
according to the meth°d described by Sambrook et al. (1989), pp 18.47-18.54. Lanes 
were equalised for total protein loading using the Bio-Rad protein assay system. 
Protein size markers vvere used as a reference and electrophoresis was carried out 
using the Mini-PRC>TEAN II gel system (Bio-Rad) according to manufacturer's 
instructions.
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4.1.8.2 Analysis of proteins following electrophoresis
Generally, two identical gels were run in parallel, allowing one to be used for 
immunoblotting and the other to be stained for total protein. Gels were stained with 
Coomassie Brilliant Blue R250 (Sigma Chemical Co., St. Louis, USA) according to 
the method of Sambrook et al. (1989), pi 8.55. Gels were photographed over a light 
box using an Olympus SLR OMIO camera and Kodak ISO 400 black and white film.
4.1.8.3 Transfer of proteins to nitrocellulose membrane
Proteins were transferred from the gel to a nitrocellulose membrane (Hybond C, 
Amersham) according to the method of Sambrook et al. (1989), pp 18.64-18.66. The 
transfer was carried out using a Trans-Blot tank (Bio-Rad Laboratories, Richmond 
CA, USA) for 3 hours at 60V (»200mA) with the tank immersed in ice.
4.1.8.4 Analysis o f proteins following transfer
Following transfer, nitrocellulose filters were stained with Ponceau S (Sigma 
Chemical Co., St. Louis, USA) according to the method of Sambrook et al. (1989), p 
18.67. Although the published protocol suggested that the solution should be 
discarded after use, recycled Ponceau S was found to be perfectly satisfactory.
4.1.8.5 Immunological detection of proteins
Immunological detection of proteins bound to nitrocellulose filters was carried out 
according to the method of Sambrook et al. (1989), pp 18.69-18.75. After blocking in 
5% w/v Marvel milk, 0.02% w/v sodium azide in PBS for two hours, the filter was 
sealed into a plastic bag with 1ml primary antiserum at manufacturers' recommended 
working dilution and incubated on a tilting platform under foil overnight. Once- or 
twice-used primary antiserum recovered from immunohistological staining 
procedures was also found to be perfectly adequate for immunoblot applications. 
Before incubation with the secondary, horseradish peroxidase-conjugated antiserum, 
the filter was washed several times in PBS then extensively in phosphate-free, azide- 
free saline (150mMNaCl, 50mA/Tris.Cl (pH 7.5)). The optimal working dilution for
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the secondary antiserum was determined empirically by titration. The filter was 
sealed into a second plastic bag and incubated on a tilting platform under foil for 2 
hours with 1 ml of the secondary antiserum at the optimal concentration in phosphate- 
free, azide-free saline without block. The filter was then washed extensively in 
phosphate-free, azide-free saline and stained with diaminobenzidine 
tetrahydrochloride (Sigma Chemical Co., St. Louis, USA) without metal ions as 
described by Sambrook et al. (1989), p 18.75. Filters were photographed over a light 
box whilst still wet, using an Olympus SLR OM 10 camera and Kodak Gold colour 
film.
4.2 Cell culture techniques
4.2.1 Routine maintenance of cell lines
Cells were maintained in T75 Costar tissue-culture grade flasks in a 37°C humidified 
incubator with 5% C 0 2. Cultures were split when subconfluent, the harshness of the 
split ranging from 1:5 to 1:20 depending upon the cell line and experimental 
requirements. The media used to maintain each cell line are shown in table 4.2. To 
facilitate attachment of the PC 12 cells, flasks were coated with rat tail collagen 
according to the method of Green et al. (1987). All cell lines were split using trypsin 
and Versene. Briefly, the medium was removed from a flask by aspiration and 
replaced with 5m! Versene, prewarmed to 37°C. The Versene was left in contact with 
the cells for five minutes to chelate divalent cations, specifically calcium and 
magnesium. The Versene was then removed by aspiration and replaced with 5ml 
0.25% w/v trypsin, also prewarmed to 37°C. The trypsin was left in contact with the 
cells for up to 5 minutes and then the cells were removed from the surface of the flask 
by gentle agitation. 10ml complete medium, prewarmed to 37°C, was then added to 
the flask and the cell suspension collected into a 20ml Sterilin tube. The cells were 
pelleted by a 3 minute centrifugation at 1000 rpm and resuspended in 10ml fresh 
medium. 0.5ml - 2ml of the suspension was used to reseed a fresh flask containing 
15ml medium prewarmed to 37°C. Cells which tended to clump together, such as the 
PC 12 (Geneva) and P19 cells, were removed from the plastic surface using a Costar 
cell scraper and a small volume of medium. The cells were then collected into a 20ml 
Sterilin tube and monodispersed by pipetting up and down a number of times.
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Cell line Maintenance Medium
Ltk- DMEM + 10% FBS
HeLa DMEM + 10% FBS
U138MG DMEM + 10% FBS
U373MG DMEM + 10% FBS
Neuro 2A DMEM + 10% FBS, 1%NAA
NB4-1A3 Ham's F10 + 12.5% HS, 2.5% FBS
PC 12 (Geneva) RPM11650 + 10% HS, 5% FCS
PCD (Sheffield) DMEM + 10% FBS
PI9 (stem cells) DMEM + 10% FBS
NTERA-2 (stem cells) DMEM + 10% FBS
Table 4.2 - Maintenance media required for cell lines used in the present study. All media were also 
supplemented with 2mM L-glutamine and 10 U ml"'/0.1 mg ml'1 penicillin/streplomycin. 
Abbreviations: DMEM - Dulbecco's Modified Eagle's Medium, FBS - Foetal Bovine Serum, NAA - 
Nonessential Amino Acids, FIS - Horse Serum, FCS - Myoclone Foetal Calf Serum.
4.2.2 Storing cell lines
For long term storage, cells were dissociated and pelleted as described in the 
preceding section. They were then dispersed in 10ml fresh medium, in order to dilute 
out the trypsin and ensure that all clumps were separated, and pelleted once again.
The cells were then dispersed in 5ml freezing mix (90% v/v serum, 10% v/v DMSO) 
and divided into 1 ml aliquots in freezing vials. The serum in the freezing mix was 
made up to reflect the requirements of the proliferating cells, thus for Ltk- cells a 
mixture containing 90% v/v foetal bovine serum and 10% v/v DMSO was used whilst 
for PC 12 (Geneva) cells, a mixture containing 60% v/v horse serum, 30% v/v 
myoclone foetal calf serum and 10% v/v DMSO was used. The cells were 
immediately transferred to a storage box at -70°C and left overnight. They were then 
stored indefinitely under liquid nitrogen.
4.2.3 Differentiation of PC12 cells using nerve growth factor
PC 12 cells were induced to differentiate with NGF-P from mouse submaxillary gland 
(Sigma, St. Louis MO, USA). PC 12 (Geneva) cells were differentiated with complete 
medium supplemented with 50ng mb1 NGF according to the method of Green et al.
(1987). PC 12 (Sheffield) cells were differentiated according to the same method but 
using 1 OOng mb1 NGF (R Gibson, pres. comm.). Differentiated cells for transfection 
were seeded at a density of 5 x 105 into collagen-coated Nunc 35mm plates.
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4.2.4 Differentiation of EC cells using retinoic acid
P19 mouse EC cells were induced to differentiate with retinoic acid according to the 
method of Rudnicki and McBurney (1987). Differentiated neuronal cells were 
selected by supplementing the growth medium with 5 pg mH cytosine arabinoside 48 
hours after retinoic acid treatment was discontinued, thus inhibiting the growth of 
proliferative cells (Rudnicki and McBurney, 1987).
4.2.5 Transfection of eukaryotic cells - general strategy
Transfections were carried out in triplicate using Nunc 35mm 6-well plates. Each 
experiment was performed at least twice (lipofections) or three times (other 
transfection methods). Two independent preparations of each construct were tested 
(plasmids were prepared using the double caesium chloride equilibrium centrifugation 
method described in section 4.1.1). In pilot experiments designed to optimise 
transfection efficiency, cells were transfected with pSV-P-galactosidase, a plasmid 
which contains the E. coli lacZ gene under the control of the SV40 early promoter, 
and transfection efficiency was determined by soluble P-glactosidase assay. To 
analyse transcriptional regulation of the rat NSE gene, constructs containing parts of 
the NSE 5' flanking region joined to the E. coli cat gene were transfected into a 
variety of neuronal and nonneruonal cell lines and the transcriptional activity of each 
construct was determined by CAT assay. As internal controls, pCAT-Control, a 
plasmid which contains the E. coli cat gene under the control of the SV40 early 
promoter, and pCAT-Basic, a plasmid which contains the E. coli cat gene but lacks a 
eukaryotic promoter, were transfected into parallel cultures as standards to compare 
promoter function. Each construct was cotransfected with an equal amount (by mass) 
of pSV-P-galactosidase to control for transfection efficiency across all constructs.
The cotransfection control plasmid allowed the data from CAT assays to be 
normalised for transfection efficiency as shown in section 5.5.1.
4.2.6 Transfection using DEAE-dextran
DEAE-dextran mediated transfection was used successfully for Ltk- cells but was 
found unsatisfactory for other cell types. The method used was that of Selden (1987) 
and after careful optimisation, 2|ig DNA and 200pg DEAE-dextran (added as a 1 Omg
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ml'1 solution i" TBS) made up in 1.5ml OptiMEM serum-reduced medium were used 
per 35mm well- Transfection was carried out at 50-60% confluence with a duration 4 
hours followed hy 2 minute 10% v/v DMSO/PBS shock at room temperature. 
Chloroquine treatment’ which has been reported to increase transfection efficiency 
(Luthman and Magnusson, 1983) was not attempted.
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4.2.7 Transfect'011 usi"g calcium phosphate
Transfection by ca'c‘urn phosphate was carried out according to the modified 
procedure o f C ^en 3,1(1 Okayama (1987; 1988) as described in Sambrook et al. 
(1989), ppl6.39-16.40 Several batches of 2x BES-buffered saline were prepared and 
tested for transfectlon efficiency using mouse Ltk- cells. The optimal buffer was 
stored and used 38 3 reference for the preparation of further buffer stocks. 
Coprecipitates vVere PrePared in 1ml volumes which were divided equally between 
triplicate wells- The optimal amount of DNA used per transfection was carefully 
optimised for e"ch individual cell line.
4.2.8 T ran sfec t'0"  “sing liposome formulations
Several différé"1 lip°sorne formulations have been used to transfect cells during this 
project (seeTable 4-3). Liposome-mediated transfection was carried out in the first 
instance according to the manufacturers' general guidelines and then carefully 
optimised for e"ch cell line by modulation of the transfection parameters according to 
the manufactures' instructions. The choice of liposome formulation itself appeared to 
be critical for the efficient transfection of some cell lines and a number of different 
products were compared wherever possible. The critical parameters for liposome 
mediated transfect*on were transfection duration, concentration of lipid, concentration 
of DNA and the presence or absence of serum in the transfection medium. Table 4.4 
shows the optirr>um parameters for the cell lines used in this project.
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Liposome formulation Manufacturer
DOTAP Boehringer Mannheim
Lipofectin Gibco BRL
LipofectAMINE Gibco BRL
Tfx-50 Promega
TransfectACE Gibco BRL
Transfectam Promega
Table 4.3: Liposome formulations used during this project and their manufacturers
Cell line Lipid / amount (pi) DNA (pg) Duration (hrs) Medium
Ltk- LipofectAMINE 5 2 5-8 OptiMEM
NB4-1A3 LipofectAMINE 5 1.5 5 OptiMEM
HeLa LipofectAMINE 6 2 8-10 OptiMEM
P19 (stem cells) LipofectAMINE 10 2 4 OptiMEM
PC 12 (-NGF) LipofectAMINE 6-10 2 5 OptiMEM
Table 4.4: Optimal conditions for liposome-mediated transfection of a number of cell lines. Amounts 
for lipid and DNA are totals per 35mm well with 1ml medium. LipofectAMINE is supplied at 2mg 
ml"*. OptiMEM is serum reduced medium developed for transfection (Gibco BRL). PCI2 cells 
require collagen coated flasks for attachment (see section 4.2.1).
4.2.9 Preparation of cell lysates
Transfected cells were scraped into microfuge tubes using a Costar disposable 
scraper, pelleted by 30 second pulse centrifugation and resuspended in 100pl 0.25M 
Tris.Cl (pH 7.5). The cells were lysed by three freeze-thaw cycles, and the debris 
pelleted by centrifugation at 13 000 x g  for 10 minutes. 30pl of the cleared lysate was 
transferred to a fresh microfuge tube and assayed for p-galactosidase activity as 
described in section 4.2.10 whilst 50pl of the remaining lysate was transferred to a 
second fresh microfuge tube and assayed for CAT activity as described in section 
4.2.11.
4.2.10 Soluble p-galactosidasc assay
Assays for p-galactosidase activity in mammalian cell extracts were carried out 
exactly as described in Sambrook el al. (1989), pp 16.66-16.67.
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4.2.11 CAT assay
CAT activity was assayed by thin layer chromatography, essentially as described by 
Gorman et al. (1982) although there were minor differences between the method used 
in this project and the published protocol. The CAT reaction mixture comprised 50pl 
cell lysate, 5pl 25pCi m l'1 D-threo-[l, 2-14C]-chloramphenicol, 5pl 66mg ml'1 acetyl 
coenzyme A and 40pl sterile redistilled water. Reactions were carried out for 1 hour 
at 37°C. Following chromatography, the plates were dried and exposed to X-ray film 
in an autoradiograph cassette without intensifier screen at room temperature. 
Quantification was carried out by wrapping TLC plates in cling film and exposing 
them to a phosphorimager screen (Molecular Dynamics) for 4 hours. Phosphorimager 
analysis was facilitated by using the ImageQuant programme (Molecular Dynamics) 
according to manufacturer's instructions.
4.3 Immunological techniques
4.3.1 Preparation of cultured cells for immunocytochcmical staining
Adherent cells were grown on high grade microscope coverslips (Chance Proper Ltd., 
Warley, UK) according to the method of Harlow and Lane (1988). Coverslips were 
sterilised by dipping in 70% v/v ethanol and flaming, then they were aseptically 
transferred to petri dishes under a flow hood. Cells were seeded into the petri dishes 
at a density of 105 ml'1, transferred to a humidified incubator at 37°C, 5% C 02 and 
allowed to attach to the coverslips for 24 hours. For nonadherent or partially adherent 
cells such as PC 12 cells, the coverslips were treated with poly-L-lysine and sterilised 
by overnight exposure to UV light under a flow hood prior to seeding. Cells were 
fixed by rinsing the coverslips in PBS and incubating in 4% w/v paraformaldehyde 
(pH 8.0) in PBS for 10 minutes at room temperature. The cells were then washed 
twice with PBS and permeabilised by dipping into 0.2% v/v Triton X-100 in PBS for 
2 minutes. Prior to staining with antibodies, the coverslips were washed in PBS, 3x 5 
minutes.
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4.3.2 Preparation of mouse embryos and adult tissue for immunohistological 
staining
Pregnant female mice were sacrificed by cervical dislocation and embryos were 
dissected into cold PBS. After rinsing, litters were transferred to 20ml Sterilin tubes 
and fixed in 4% w/v paraformaldehyde/PBS (pH 8.0) on ice. The fixation time was 
varied from 30 minutes to 12 hours according to the size of the specimens and 
embryos more advanced than E12.5 were pierced to facilitate penetration of the 
fixative. After fixation, litters were transferred to fresh 20ml Sterilin tubes and 
equilibrated first in 5% then 15% w/v sucrose/PBS on ice. Meanwhile, a solution of 
7% gelatin, 300 Bloom (Sigma Chemical Co., St. Louis, USA.) in 15% w/v 
sucrose/PBS was prepared by boiling in a microwave oven and cooling to 37°C in a 
waterbath. The embryos were transferred to fresh 20ml Sterilin tubes containing 
10ml gelatin solution at 37°C and incubated for 30 minutes. They were then 
transferred to plastic moulds, oriented and embedded in gelatin overnight at 4°C. The 
blocks were trimmed into trapezoid shapes to emphasise orientation and frozen by 
immersion in isopentane over liquid nitrogen. They were stored in Sterilin tubes at 
-70°C prior to sectioning. Adult tissues were dissected, cut into blocks approximately 
5mm3 if necessary and prepared in the same manner as embryos.
4.3.3 Sectioning of mouse tissue
Blocks stored at -70°C were transferred to the cryostat cabinet at -20°C, mounted onto 
the chuck using Tissue-Tek O.C.T. compound (Miles Inc.) and trimmed. Sections 
were cut at 10pm and collected onto gelatin-subbed slides stored at room temperature. 
10-20 sections were collected onto each slide. They were briefly air dried and used 
immediately for immunohistological staining.
4.3.4 Immunological staining - general strategy
Specimens subjected to immunological staining for specific proteins were also 
subjected to control reactions in order to verify the results. As a negative control, 
specimens were incubated in blocking agent whilst the experimental specimens were 
exposed to the primary antiserum. Both the experimental and control specimens were 
then exposed to the secondary antiserum. This strategy controlled for nonspecific
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binding of the secondary antiserum and autofluorescence. As a positive control, a 
number o f antisera known to bind to specific tissues were used. Control specimens 
were incubated with these antisera whilst the experimental specimens were exposed to 
their primary antiserum. Both the experimental and control specimens were then 
exposed to the secondary antiserum. This strategy controlled for failure of primary or 
secondary binding and allowed nonambiguous identification of specific cell types.
4.3.5 Immunocytochemical staining of cells
Cell staining was carried out according to the method o f Harlow and Lane (1988), pp 
392-393. Coverslips were transferred to a damp chamber lined with water repelling 
film (Nescofilm) and blocked with 3% w/v BSA/PBS. Primary antisera were used at 
manufacturers' recommended working dilutions and coverslips were incubated in the 
foil-wrapped chamber for 3 hours. The coverslips were then rinsed in three changes 
of 100ml PBS containing 1% v/v Triton X-100, blotted on a tissue to remove excess 
liquid and incubated with the secondary, FITC-conjugated antiserum. The optimal 
working dilution for the secondary antiserum was determined empirically by titration 
and incubation was carried out as above. The cells were washed and dried as above 
then mounted on clean glass slides with 50% v/v glycerol/PBS. No anti-quenching 
additives were used as the stained sections were observed and photographed 
immediately, as described in section 3.1.2.
4.3.6 Immunohistochemical staining of tissue sections
Sections were blocked and stained according to the method of Hogan et al. (1986), pp 
243-4. Primary antisera were used at the manufacturers' recommended working 
dilutions, 250pl per slide. Incubation was carried out for 1 hour in a foil-wrapped 
damp chamber on a tilting platform. Slides were then transferred to a rack which was 
placed in a staining jar containing a small magnetic stirrer and washed for 5 minutes 
each in three changes of 400ml PBS. The optimal concentration of the secondary, 
FITC-conjugated antiserum was determined empirically by titration. Tissue paper 
was used to dry as much of the slides as possible without disturbing the sections and 
the secondary antisera were added, 250pl per slide. Incubation was carried out for 30 
minutes as above. The slides were washed and dried as above and the sections were 
mounted in 50% v/v glycerol/PBS. No anti-quenching additives were used in the
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mountant and the stained sections were observed and photographed immediately, as 
described in section 3.1.2.
4.4 In  situ  hybridisation techniques
4.4.1 In situ  hybridisation - General strategy
Analysis of NSE expression at the mRNA level during mouse development was 
facilitated by the use of antisense RNA probes corresponding to a distal portion of the 
rat NSE 3' UTR. The UTRs of the three mammalian enolase genes are highly 
divergent, allowing isogene-specific probes to be generated (see section 1.6), 
however, there is strong orthologous conservation of the UTRs between species 
allowing heterologous probes to be used with success. NSE mRNA expression was 
studied by wholemount in situ hybridisation using digoxigenin-UTP-labelled 
antisense RNA probes synthesised as described in section 4.1.6.3. Sense probes 
generated from the same construct were used as controls for non-specific 
hybridisation. Further controls, where no probe was included in the hybridisation 
step, were used to detect nonspecific binding of the antibody or accumulation of 
colouring reagents.
4.4.2 Preparation of embryos
Wholemount in situ hybridisation was carried out according to the procedure 
described in the following sections. This was optimised by Dr D Stott from standard 
in situ hybridisation protocols (Wilkinson, 1992). Embryos were dissected into cold 
PBS and the extraembryonic membranes were removed with fine forceps. The 
embryos were transferred to 20ml Sterilin tubes and fixed on ice in 4% w/v 
paraformaldehyde/ PBS (pH 8.0) overnight. All following steps were carried out in 
microcentrifuge tubes at room temperature for 5 minutes using 1 ml of solution and 
gentle end over end rotation, unless stated otherwise. Following fixation, the embryos 
were washed twice in PBS, refixed in 4% w/v paraformaldehyde/PBS (pH 8.0) at 4°C 
for 20 minutes, washed twice in PBST (1% v/v Tween 20/PBS) and then incubated 
with proteinase K (20 pg mP1 in PBST). The duration of proteinase K treatment 
depended upon the size of the specimen: embryos at E9 or earlier were incubated for 3 
minutes, those at E9.5-El0.5 for 5 minutes. The embryos were then rinsed briefly in 
PBST, washed in PBST then postfixed for 10 minutes in 4% w/v
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paraformaldehyde/PBS (pH 8.0). After a brief rinse in distilled water, the embryos 
were treated for 10 minutes with 0.1 M  triethanolamine (pH 8.0) (Analar BDH) 
containing 2.5 pi mb1 acetic anhydride (Analar BDH), to reduce background staining. 
The embryos were transferred to glass vials, washed twice in PBST and were then 
ready for hybridisation. If storage of the embryos was required, they were transferred 
to glass vials containing 50% v/v ethanol after the first fixation and wash step. They 
were then equilibrated in several changes of 70% v/v ethanol and stored at 4°C in the 
dark. Stored embryos were stable for at least three months and were rehydrated by 
incubating in 50% v/v ethanol, 30% v/v ethanol/PBS followed by two washes in 
PBST before further processing.
4.4.3 Wholemount in situ  hybridisation to mouse embryos
The following steps were carried out at 50°C in a waterbath without rotation. The 
embryos were equilibrated for 1 hour in hybridisation solution without blocking 
agents (50% v/v deionised formamide, 5x SSC, 20mAf Tris.Cl (pH 8.0), 5mA/EDTA, 
0.1% v/v Tween 20). The hybridisation solution was removed and replaced with 
fresh, plus an equal volume of hybridisation solution with blocking agents (50% v/v 
deionised formamide, 5x SSC, 20mMTris.Cl (pH 8.0), 5mA/EDTA, 0.1% v/v Tween 
20, 0.2% w/v polyvynilpyrrolidone, 0.2% w/v Ficoll type 400, 2mg mb1 heparin, 2mg 
mb' yeast RNA; all blocking agents obtained from Sigma Chemical Co., St. Louis, 
USA.) and prehybridisation was carried out for at least 2-6 hours. The probe was 
added to the hybridisation mix to a final concentration of 0.1 pg mb' and 
hybridisation was carried out overnight.
4.4.4 Posthybridisation washes
Following hybridisation, the embryos were washed at 50°C for 20 minutes in 50% v/v 
deionised formamide, 2x SSC, then at 37°C for 3x 10 minutes in NTET (0.5A/NaCl, 
lOmAf Tris.Cl (pH 7.5), 5mA/EDTA, 0.1% v/v Tween 20). The embryos were then 
treated with RNase for 30 minutes at 37°C (final concentrations 20pg mb1 RNase A, 
100U mb' RNase T1 in NTET) and washed again in NTET for 10 minutes. The 
embryos were then washed in 50% v/v deionised formamide, 2x SSC, 50°C for 1 
hour; 2x SSC, 0.1% v/v Tween 20, 50°C for 1 hour and 0.2x SSC, 0.1% v/v Tween 
20, 50°C for 1 hour. They were then equilibrated with PBST.
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4.4.5 Signal detection
Signal detection was carried out using the DIG detection kit (Boehringer Mannheim, 
Mannheim, Germany) according to manufacturer's instructions. Briefly, nonspecific 
binding sites were blocked by incubating the embryos with 1ml 0.5% w/v Boeringher 
blocking compound in PBST for 1 hour at room temperature. 0.5pl of Boehringer 
antidigoxigenin antiserum was then added (final concentration 1:2000 dilution from 
stock) and the reaction was incubated overnight at 4°C. The next day, the embryos 
were washed in PBST at room temperature, 6x 1 hour. The colour reaction was then 
set up by washing the embryos twice, for 5 minutes each time, in 1ml colour buffer 
(O.lA/Tris.Cl (pH 9.5), 50mMMgCl2, O.lAfNaCl, 0.1% v/v Tween 20, 5mM  
levamisole (Sigma Chemical Co., St. Louis, USA)) and then adding 4.5pl nitroblue 
tetrazolium and 3.5pl X-phosphate (5-bomo-4-chloro-3-indolyl 
phosphate) from the kit. The reaction was left to colour for 24 hours, then the 
embryos were cleared in Murray's reagent (50% v/v benzyl alcohol/benzyl benzoate) 
and photographed as described in section 3.1.2.
4.5 Transgenic mice
4.5.1 Preparation of transgene DNA
Transgene DNA was prepared according to the method of Hogan et al. (1986) without 
prokaryotic vector sequences, which have been shown to inhibit the expression of 
integrated genes (e.g. see Chada et al., 1985). Plasmid DNA was prepared by 
caesium chloride equilibrium centrifugation as described in section 4.1.1 and the 
transgene excised by digestion with restriction endonucleases as described in section 
4.1.2.1. The restriction fragments were separated by agarose gel electrophoresis as 
described in section 4.1.3.2 and the desired band isolated using P-agarase 1 as 
described in section 4.1.4. The washed DNA pellet was resuspended at a 
concentration of lpg ml'1 in SmA/Tris.Cl (pH 7.4), O.lmMEDTA.
4.5.2 Generation of transgenic mice
Transgenic mice were generated by pronuclear injection according to the method of 
Hogan et al. (1986). Vasectomisation of stud males, superovulation of donor females,
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embryo retrieval, pronuclear microinjection and embryo transfer were carried out by 
Dr D Stott.
4.5.3 Identification of transgenic embryos
4.5.3.1 Preparation of genomic DNA.
Genomic DNA was isolated from tail tips or extraembryonic membranes according to 
the method of Gendon-Maguire and Gridley (1993). The tissue was dissected into 
cold PBS, transferred to a clean microfuge tube and pelleted by brief centrifugation at 
13 000 x g. The supernatant was removed and the tissue digested overnight at 55°C 
with proteinase K. The proteinase K incubation mixture comprised lOmAf Tris.Cl 
(pH 7.5), ImA/EDTA, 1% w/v SDS and 200 pg ml'1 proteinase K (Boehringer 
Mannheim, Mannheim, Germany). The digested tissue was extracted once with 
phenolxhloroform and the aqueous phase, containing the DNA, was transferred to a 
fresh microfuge tube.
4.5.3.2 PCR test to identify transgenic embryos
The presence of transgene sequences was established by PCR using lOOng each of 
primers LC1 and LC2 which anneal to the lacZ coding region (Stott el al., 1993). 
Three control reactions were performed alongside each experiment, one using DNA 
from a known lacZ transgenic mouse, one using DNA from a known wild type mouse 
and one using no DNA at all, to control for contamination. The primers and control 
DNAs were a gift from Miss H Taylor.
4.S.3.3 Southern analysis of transgenic embryos
Following PCR analysis, embryo genomic DNA was investigated by Southern 
analysis to estimate transgene copy number and check for any rearrangements. 
Southern analysis was carried out as described in section 4.1.7.1. 20pl genomic 
DNA, was prepared as described in section 4.5.3.1 by digestion with BamH 1, which 
cuts within the lacZ gene. The DNA was transferred to a nylon membrane and 
hybridised with a nick translated probe containing the lacZ sequence. The results 
were analysed by autoradiography as described in section 4.1.7.1.
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4.5.4 Staining whole mouse embryos for f)-galactosidase activity
For wholemount [i-galactosidase staining, embryos were prepared and stained 
according to the method of Bonnerot and Nicholas (1993); they were then equilibrated 
in absolute methanol and stored at -20°C. As a positive control for the staining 
reaction, salivary glands were dissected from transgenic homozygous ULZ:307 
Drosophila and incubated alongside the mouse embryos (dissections carried out by J. 
Drummond). P[GAL4] enhancer trap lines tend to strongly express ectopic (J- 
galactisidasc in the salivary glands due to a poorly understood intrinsic effect of the 
insert, possibly relating to properties of the polytene chromosomes (M. Allen, pers. 
comm.) Generally, a blue colour developed in the salivary glands within one minute. 
F.mbryos were first photographed uncleared, then after clearing in Murray's reagent 
(50% v/v benzyl alcohol, 50% v/v benzyl benzoate). Mouse embryos stained for [1- 
galactosidase activity were suitable for cryostat sectioning and were prepared by 
equilibration in methanol (to remove the clearing agent) followed by incubation in a 
series of methanol/water mixtures with a decreasing proportion of methanol, followed 
by equilibration sucrose, embedding in gelatin and freezing in isopentane over liquid 
nitrogen as described in section 4.3.2. The sections were restained for (i-galactosidase 
activity according to the method of Bonnerot and Nicholas (1993) prior to observation 
and photography.
4.6 Gel retardation assay.
4.6.1 Preparation of protein extracts from cell lines, embryos and adult organs.
Attached cells were removed from culture vials in a small volume of cold PBS using 
Costar disposable plastic scrapers. Embryos and adult organs were dissected into cold 
PBS and cut into small blocks of approximately 5mm3 if necessary. Protein extracts 
were prepared from the above material according to the method of Dent and 
I.atchman (1993).
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4.6.2 Preparation of probes for the gel retardation assay
Probes were prepared by end-filling as described in section 4.1.6.2. 1 pi of 
redissolved probe was used for each assay.
4.6.3 DNA - protein interaction lit vitro.
Binding reactions were carried out in a total volume of 15pl. The components were 
mixed on ice and were added in the following order: water, 5x gel retardation assay 
buffer, nonspecific competitor, specific competitor (if appropriate), protein extract. 
Generally, the components were allowed to equilibrate at 37°C for 10 minutes. The 
probe was then added and the reaction incubated at 37°C for a further 10 minutes. 
Different reaction temperatures and incubation times were also tried for individual 
assays, where appropriate, as described in Chapter 8.
4.6.4 Gels for the gel retardation assay
After incubation, the components of the gel retardation assay reaction were placed on 
ice. They were then transferred to the cold room and loaded onto a 6% nondenaturing 
polyacrylamide gel, which had been prerun at 200V, 4°C for 30 minutes. Type III 
loading buffer (see section 1.4.3.1), diluted with an equal volume of water, was 
loaded into the first lane as a reference. The gel was run at 500V for 2 minutes then at 
200V, 4°C for 2-3 hours in lx TAE buffer which was recirculated using a cyclical 
pump. After electrophoresis, the upper glass plate was removed and the gel was fixed 
by immersion in 10% v/v ethanol, 10% v/v acetic acid for 15 minutes. It was then 
transferred to Whatmann 3MM paper, dried under vacuum at 80°C and exposed to X- 
ray film in an autoradiograph cassette with an intensifying screen at -70°C.
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Experim ental Overview
Studies of gene regulation which involve the identification of specific sequence 
elements and protein factors required for particular modes of expression are often 
grouped under the phrase promoter analysis, despite the loose use of the term 
promoter in this context. Promoter analysis may be approached from three directions: 
firstly, by the in vivo route, which requires the generation of transgenic animals; 
secondly, by the ex vivo route, which requires the transfection of suitable cultured 
cells; and finally, by the in vitro route, for which binding activities are sought in 
purified cell extracts. Generally, the in vivo and ex vivo approaches are used to 
establish the position of specific regions of regulatory information, whilst the in vitro 
approach is used to characterise protein binding activities following the location of 
such regulatory elements. Exceptionally, in vivo and ex vivo analysis may fail to 
identify the position of relevant c/s-acting elements and an in vitro transcription assay 
may be preferred (see Schwartz <?/ al., 1994).
The in vivo and ex vivo approaches to promoter analysis have relative advantages and 
disadvantages (see Table 2.1) and for this reason, studies of neuronal gene regulation 
based upon one or the other alone have sometimes been inconclusive (see section 2.2). 
It was therefore desirable to investigate the regulation of NSE using both transgenic 
animals and cell lines, allowing the advantages of both strategies to be exploited 
(Chapters 6 and 7). Before such analysis could take place, however, it was necessary 
to establish the nature of endogenous NSE gene expression in each of the systems 
used. This preliminary work was essential because no firm conclusions could be 
drawn from experiments involving the analysis of reporter genes driven by specific 
regions of the rat NSE 5' flanking region, without using the expression of the 
endogenous (wild type) gene as a reference (Chapters 5 and 7). Finally, the results 
from in vivo and ex vivo analysis of the NSE 5' flanking region were used to plan in 
vitro experiments to characterise protein binding activities (Chapter 8).
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Chapter 5 - Ex vivo analysis o f  the rat NSE gene S 'flank ing  region: 
development o f  an experimental system .
5.1 Chapter summary
For ex vivo analysis of NSE gene regulation, four preliminary factors had to be 
considered before experiments began. Firstly, it was necessary to consider which cell 
lines would be most informative for the study. Previous investigators of neuronal 
gene regulation have often used a range of cell lines, usually including at least one of 
neuronal and one of nonneuronal origin. The most important aspect of this choice is 
that cell lines should be available which either do or do not express the gene under 
investigation. Secondly, it was necessary to consider the manner in which the 5' 
flanking region should be dissected. Once again, previous studies of neuronal gene 
expression offer plenty of examples of how such analysis should be undertaken: for 
some studies, simple external deletions were sufficient. Others required internal 
deletions, linker-scanning mutations and point mutations. Thirdly, an essential 
preliminary step was to optimise the parameters for transient transfection. Experience 
has shown that different cell lines vary widely in their ability to take up DNA, and the 
most efficient transfection method had to established in each case. Finally, it was 
important to determine how the results from the transfection experiments would be 
analysed and used to draw conclusions for further investigation. The purpose of this 
first results chapter is to describe these preliminary experiments and set the scene for 
the ex vivo analysis proper, which is discussed in Chapter 6.
5.2 Choice of cell lines
5.2.1 Initial considerations
The choice of cell lines for transfection was based upon the ability of each cell type to 
express NSE mRNA and NSE protein. Cells which expressed the endogenous gene 
were said to be permissive whilst those lacking this property were termed
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nonpermissive. Before discussing the cells lines in detail, it is worth considering how 
endogenous gene expression was established and which methods of detection were 
used.
To establish the expression of NSE protein, protein extracts were resolved by SDS- 
polyacrylamide gel electrophoresis, electroblotted onto a nitrocellulose membrane and 
exposed to a polyclonal antiserum raised against human NSE. Because the protein 
extracts used in this study originated from either murine or rat sources (or cell lines 
originally derived therefrom), it was essential to ascertain whether or not the 
antiserum would cross-react with the mouse and rat NSE proteins and therefore be 
useful as a detection tool. Previous studies have indicated that antigenic determinants 
on the surface of the NSE protein are highly conserved throughout mammals and birds 
(Clarke-Rosenberg and Marangos, 1980) and probably other vertebrates (Jackson et 
al., 1985) therefore cross-reactivity of the antiserum was anticipated. It has also been 
reported that NSE is an abundant protein in adult mouse, rat, human and monkey 
brains, accounting for 1-2% o f total soluble protein. This preliminary investigation 
therefore also served to establish the optimal amounts of total protein required to 
detect NSE.
The concentration of protein in extracts of various cells, adult organs and embryos 
was determined using the Bio-Rad protein assay according to manufacturers 
instructions. The assay was calibrated using bovine serum albumin as shown in 
Figure 5.1. Next, mouse brain protein and PC 12 cell protein (of rat origin) were 
loaded in the following amounts: lOpg, lpg, lOOng, lOng, lng, resolved and 
subjected to western analysis as described in section 4.1.8. The results of this analysis 
are shown in Figure 5.2. In both mouse brain and PC 12 extracts, single bands were 
observed which comigrated with the 45kDa ovalbumin marker, corresponding to the 
expected size of the NSE monomer (Rider and Taylor, 1975b). This showed that the 
antiserum raised against human NSE was indeed capable of detecting both the mouse 
and rat isoproteins. Also in both cases, NSE protein could be detected in as little as 
lOOng total protein. As the limits of detection in the western procedure lie between 1-
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5ng specific protein (Maniatis et al., 1989), this result suggested than in mouse brain 
and PC 12 cells, NSE accounts for approximately 1% of total soluble protein.
To establish the expression of NSE mRNA, total RNA was resolved by 
electrophoresis, transferred to a nylon membrane and hybridised to a probe 
corresponding to part of the long 3' untranslated region of the rat NSE gene. Whilst 
the coding regions of the three enolase genes are highly conserved and virtually 
useless as specific probes in cross-species hybridisation studies, the untranslated 
regions enjoy the status of isogene-specificity and probes corresponding to such 
regions can discriminate between the three isogenes even across species barriers.
These differences form the basis of a major strategy which has been used for the 
isolation and cloning of enolase sequences, and for the detection of specific sequences 
in filter and in situ hybridisation experiments (see Sakimura et al., 1995 for an 
example of UTR hybridisation in northern analysis and Keller et al., 1994 for an 
example in in situ hybridisation analysis). Because many of the RNA samples used in 
the present study were of murine origin, it was essential to establish whether or not the 
rat NSE 3' untranslated region could hybridise with the mouse NSE sequence. 
Alignment using the BESTFIT subroutine of the GCG database showed a high degree 
of conservation between the mouse and rat 3’ untranslated regions, although a number 
of large gaps were evident in the middle of the rat sequence (Figure 5.3). Convenient 
restriction endonuclease sites within the rat NSE 3’ UTR allowed a 300 bp Nco I - 
Sma I fragment to be excised and labelled as a probe. This probe was tested by 
hybridisation to mouse genomic DNA as shown in Figure 5.4. Single hybridising 
bands were observed in each lane, corresponding to the single copy of the mouse NSE 
gene. This experiment showed that despite some gaps, the rat NSE 3' UTR could 
indeed be used to identify the murine NSE sequence in hybridisation studies and was 
used for all subsequent analysis.
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Figure 5.1: Bovine serum albumin (BSA) reference curve for the determination of protein 
concentrations. Different known concentrations of BSA ([BSA], shown on x-axis) were used to 
calibrate the Bio-Rad protein assay, each preparation producing a certain optical density at 595nm 
(ODmj , shown on y-axis) when the assay was carried out according to manufacturer’s instructions. By 
plotting O D Wj values against [BSA], a straight line graph was generated. This represented a linear 
range over which known values on one axis could be used to predict the unknown values on the other, 
using the universal equation for a straight line,y = mx + c. Protein concentrations were therefore 
calculated using the equation [protein] = O D /0 .0 3 2 , which is a simple substitution and rearrangement 
of the above, where x = [protein], y  = O D 1M, m = 0 .0 3 2  (a constant determined in this experiment 
representing the gradient of the straight line) and c = 0 (c is the intercept and the line passes through 
the origin).
Fig 5.2: Western blot titration to show the sensitivity of polyclonal anti-human NSE antiserum forNSE 
from mouse brain and PC12 cells (of rat origin). Bound antibody was detected using horseradish 
peroxidase-conjugated goat anti-rabbit IgG secondary antiserum and bands were revealed by staining 
with diaminobenzidine tetrahydrochloride without metal ion enhancement. Lanes 1-5 contain total 
mouse brain protein in lng, lOng, lOOng, lpg and lOpg amounts respectively. Lanes 6-10 contain 
total protein from proliferating PC12 cells in lng, lOng, lOOng, lpg and lOpg amounts respectively.
A single band is detected in each lane with a size of approximately 45kDa. This corresponds to the 
expected size of the NSE monomer. Extra bands observed in lanes 5 and 10 probably reflect 
overloading of the gel. The 45kDa protein marker was ovalbumin.
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Fig 5.3 (above and opposite page): Alignment of the rat (r) and mouse (m) NSE 3' UTRs. Numbers 
refer to the positions within each respective cDNA sequence (Sakimura el at., 1985a; Kaghad et at., 
1990) and bear no significance to the numbering system used to describe the rat NSE 5’ flanking 
sequence throughout this thesis. An internal A-rich region, which is thought to represent the site of an 
obsolete poladenylation sequence (Day el at., 1993), is shown in bold italic. A conserved element, 
characterised by numerous repeats of the motif ATTT(Day el at., 1993) is shown in bold underlined. 
These motifs are discussed in section 1.7.5. In the rat sequence, the positions of restriction 
endonucelase sites for Nco I and Sma I are identified by double underlining with the endonuclease 
identified in the right hand margin. These sites are the boundaries of the segment used as a probe for 
hybridisation experiments.
Figure 5.4: Southern blot showing mouse genomic DNA, digested with three common restriction 
endonucleases and probed with a Sma I - Nco I fragment of the rat NSE 3’ untranslated region.
Lanes 1, 2 and 3 loaded with plasmid pcD169, containing the rat NSE cDNA (Forss-Petter et at. , 
1986) in lOpg, lOOpg and lng amounts respectively, as positive controls for hybridisation. Lane 4 
was empty. Other lanes loaded with 20pg genomic DNA, lane 5 - digested with BamH I; lane 6 - 
digested with EcoR I; Lane 7 - digested with Hind III. Blot was hybridised overnight, washed at a 
final stringency equivalent to 0.4x SSC at 55°C and exposed overnight. Markers are Gibco BRL lkb 
DNA ladder.
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5.2.2 Analysis of cell lines
In previous ex vivo studies of gene regulation, the investigators have tended to use 
permissive and nonpermissive cells to distinguish between positive and negative 
aspects of cell type-specific regulation. Thus the deletion of a positive cell type- 
specific regulatory element would generate a fall in reporter gene activity specifically 
in the permissive cell line, whilst the removal of a negative cell type-specific element 
would cause a rise in reporter gene activity in the nonpermissive cells. Neuron- 
specific gene regulation can be achieved by positive or negative regulation, as 
discussed in Chapter 2. It was therefore desirable to study NSE gene regulation in 
both permissive and nonpermissive backgrounds.
The choice of cell lines for this project is discussed in the following sections. In each 
case, endogenous expression of NSE mRNA and NSE protein was established by 
northern and western analysis using RNA and protein from mouse brain and liver as 
positive and negative controls, respectively. For those cells where the expression of 
NSE was confirmed by western analysis, immunocytochemical staining was used to 
investigate intracellular localisation of the protein.
5.2.3 Endogenous N SE  gene expression in Ltk- and PCI2 cells
For the preliminary studies of NSE gene regulation, PC 12 (Geneva) and Ltk- cells 
were chosen as candidate neuronal and nonneuronal lines. The expression of NSE 
mRNA and NSE protein has been reported previously in undifferentiated and NGF- 
treated PC 12 cells (Vinores et al., 1981; Sakimura et al., 1995) and this cell line was 
recently used for analysis of NSE gene regulation (Sakimura et al., 1995). NSE gene 
expression in Ltk- cells has not been reported, and it was important to establish the 
nonpermissive status of these cells. For RNA analysis, total RNA (lOpg per lane) 
was resolved by electrophoresis and subjected to northern hybridisation as described 
in section 4.1.7.3. Figure 5.5a shows the results of this analysis. In the brain and
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PC 12 cell lanes, a single intense hybridising band could be seen comigrating with the 
2.37 kb marker, corresponding to the expected size of the mouse and rat NSE 
messages. A second, weakly hybridising band, which was estimated to be 
approximately 600 b in length, could also be observed in the same lanes. The nature 
of this band was unknown: it was unlikely to be an unrelated transcript because in this 
experiment and those presented later in the chapter, its specificity and intensity 
mirrored those of the major band. Furthermore, Southern analysis carried out at the 
same stringency revealed only a single hybridising sequence in the mouse genome 
(Figure 5.4). Some heterogeneity in the transcriptional start site of the NSE gene 
generates transcripts with a range of sizes, but all such products have been reported to 
be over 2 kb in length. It was very unlikely that the 600 b band represented a novel 
alternative splice product as this would surely have been identified by other authors 
(Sakimura et al., 1985b; Forss-Petter et al., 1986). The weak band may correspond to 
a more stable degradation product, as a smeared ‘tail’ of such products can be seen 
running ahead of the major band. Neither the major NSE band, nor the minor band 
was observed in the liver or Ltk- cell lanes. For protein analysis, total protein (5pg 
per lane) was resolved by electrophoresis and subjected to immunoblotting as 
described in section 4.1.8. The results of this experiment are shown in Figure 5.5b.
In the brain and PC 12 cell lanes, a single band was detected which was slightly 
retarded with respect to the 45kDa ovalbumin marker. The position of this band 
corresponded to the expected size of the NSE monomer (47kDa). It is clear from these 
experiments that the PC12 (Geneva) cell line expresses levels of NSE mRNA and 
NSE protein which are comparable to or greater than those found in adult brain. This 
may reflect the large population of glial cells in the whole brain, which dilute the 
MS’A'-expressing neuronal cells. NSE mRNA and NSE protein were undetectable in 
the Ltk- cell line, confirming its proposed role as a nonpermissive system for the 
analysis of NSE gene regulation. In situ detection of NSE protein in PC12 cells was 
carried out as described in section 4.3.5. The results are shown in Figure 5.5c and 
demonstrate that the protein is dispersed throughout the cytoplasm.
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Figure 5.6: Northern, western and immunocytochemical analysis of U138MG glioma and U373MG 
astrocytoma cells, a) Northern analysis using the Sma I - Nco I fragment of the rat NSE 3’ UTR as a 
probe - lanes loaded equally for total RNA, lOpg per lane: I - U373MG, 2 - U138MG, 3 - mouse liver, 
4 - mouse brain. Markers are Gibco BRL RNA ladder, b) Western analysis using anti-human NSE, 
detected with horseradish peroxidase-conjugated goat anti-rabbit IgG and revealed by staining with 
diaminobenzidine tetrahydrochloride without metal ion enhancement - lanes loaded equally for total 
protein, 5pg per lane: 1 - mouse brain, 2 - UI38MG, 3 - U373MG, 4 - mouse liver. 45kDa marker is 
ovalbumin, c) Immunocytochemical analysis of (i) UI38MG and (ii) U373MG cells using anti-human 
NSE, detected with FITC-conjugated goat anti-rabbit IgG, x40 under epifluorescence microscopy. 
Staining observed throughout cell bodies of both cell types, but only limited staining was observed for 
the glioma line U138MG.
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5.2.5 A'SE gene expression in neuroblastoma cells
Following the preliminary transfection studies described in the first part of the next 
chapter, two neuroblastoma cell lines, Neuro-2A and NB4-1 A3, were obtained.
Whilst the glioma cell lines described in the preceding section proved satisfactory as 
permissive cells, it was preferable to study NSE gene regulation in a truly neuronal 
background for the following reason: as endogenous glial cells do not express NSE, 
the expression observed in cell lines of glial origin must reflect some aspect of the 
genetic change which accompanies growth transformation and it is therefore possible 
that NSE gene expression in such cell lines is mediated by an unusual or aberrant 
pathway; dissection of the 5’ flanking sequence in such a background might not, 
therefore, reveal the mechanism of gene regulation which occurs normally.
Previous studies have shown that proliferating neuroblastoma cells express NSE at 
very low levels, and that in some cases, the mRNA and protein may be barely 
detectable (Zomzely-Neurath, 1983; Sakimura et al. , 1995). However, if cells are 
allowed to become confluent, the slowing down of growth induces NSE gene 
expression and levels of the gene product rise (see section 1.5.3 and references 
therein). It was important to establish the characteristics of NSE gene expression in 
proliferating and confluent neuroblastoma cells because this crowding factor would 
also influence the behaviour of reporter constructs containing fragments of the NSE 5’ 
flanking region. Generally, in the transfection experiments described in this and the 
following Chapters, transfection was carried out using semi-confluent proliferating 
cells and posttransfection cells were collected 48 hrs later when fully confluent. In the 
first instance, total RNA and protein was isolated from proliferating Neuro-2A and 
NB4-1 A3 cells and subjected to northern, western and immunocytochemical analysis 
as described in section 5.2.3. As reported previously for other neuroblastoma lines, 
the levels of NSE mRNA and NSE protein were almost undetectable by biochemical 
means although staining was observed in the perikarya and neurites of isolated cells of 
both types subjected to immunocytochemical analysis. These results are shown in 
Figures 5.7a-c. Total RNA and protein was then isolated from proliferating Neuro-2A
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cells seeded at 105 cells ml'1 after 0, 1, 2 and 3 days in culture (by day 3, the cells were 
fully confluent). The results, shown in in Figures 5.8a and 5.8b, showed that the 
levels of mRNA and protein increased with time in culture, and that the upregulation 
correlated to the confluence of the cells. Fully confluent cells expressed NSE mRNA 
and NSE protein at similar levels to those observed in adult brain, suggesting that 
posttransfection cells represented an excellent permissive system for the analysis of 
NSE gene regulation. The 600 b RNA band observed in the brain control lane (as 
discussed in section 5.2.3) was also evident in the Neuro-2A cell lanes, and its 
intensity increased in parallel with the major NSE mRNA band. This observation in 
particular suggested that the 600 b RNA band was not an independent transcript, but a 
degradation product of the full length NSE message. Western analysis suggested that 
NSE protein accumulation lagged behind that of the transcript, as the intensity of the 
NSE protein signal by day 2 in culture did not match that in adult brain (Figure 5.8b, 
lane 5) whereas the NSE message had already accumulated to such levels (Figure 5.8a, 
lane 5); evidence for posttranscriptional downregulation of the NSE gene has already 
been discussed (see section 1.7.5).
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Figure 5.7: Northern, western and immunocytochemical analysis of Neuro-2A and NB4-1A3 
neuroblastoma cells, a) Northern analysis using the Sma I - Nco I fragment of the rat NSE 3’ UTR as a 
probe - lanes loaded equally for total RNA, lOpg per lane: 1 - NB4-1A3 cells, 2 - Neuro-2A cells, 3 - 
mouse liver, 4 - mouse brain. Markers are Gibco BRL RNA ladder, b) Western analysis using anti­
human NSE, detected with horseradish peroxidase-conjugated goat anti-rabbit IgG and revealed by 
staining with diaminobenzidine tetrahydrochloride without metal ion enhancement - lanes loaded 
equally for total protein, 5pg per lane: 1 - NB4-1A3 cells, 2 - Neuro-2A cells, 3 - mouse liver, 4 - 
mouse brain. 45kDa marker is ovalbumin, c) Immunocytochemical analysis of (i) Neuro-2A cells and 
(ii) NB4-1A3 cells using anti-human NSE, detected with FITC-conjugated goat anti-rabbit IgG, x40 
under epifluorescence microscopy. Staining observed throughout cell bodies and neurites of both cell 
types.
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Figure 5.8: Northern and western analysis of NSE gene expression in cultured Neuro-2A cells, a) 
Northern analysis using the Sma I - Nco I fragment of the rat NSE 3’ UTR as a probe - lanes loaded 
equally for total RNA, 10pg per lane: 1 - mouse liver, 2 - mouse brain, 3-6 - Neuro-2A cells after 0, 1, 
2 and 3 days in culture. Markers are Gibco BRL RNA ladder, b) Western analysis using anti-human 
NSE, detected with horseradish peroxidase-conjugated goat anti-rabbit IgG and revealed by staining 
with diam¡nobenzidine tetrahydrochloride without metal ion enhancement - lanes loaded equally for 
total protein, 5pg per lane: 1 - mouse liver, 2 - mouse brain, 3-6 - Neuro-2A cells after 0, 1, 2 and 3 
days in culture. 45kDa marker is ovalbumin. Cells were 90% confluent after 2 days and fully 
confluent by three days.
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Figure 5.11: Northern and western analysis of differentiating P19 EC cells, a) Northern analysis using 
the Sma I - Nco I fragment of the nlNSE 3’ UTR as a probe - lanes loaded equally for total RNA, lOpg 
per lane: 1 - P19 stem cells, 2 - P19 neurons, 3 - mouse liver, 4 - mouse brain. Markers are Gibco BRL 
RNA ladder, b) Western analysis using anti-human NSE, detected with horseradish peroxidase- 
conjugated goat anti-rabbit IgG and revealed by staining with diaminobenzidine tetrahydrochloride 
without metal ion enhancement - lanes loaded equally for total protein, 5pg per lane: 1 - P I9 stem 
cells, 2 - P19 neurons, 3 - mouse liver, 4 - mouse brain. 45kDa marker is ovalbumin. P19 stem cells 
were proliferating cells equivalent to stage (a) in Figure 5.10. P19 neurons were fully differentiated, 
equivalent to stage (C) in Figure 5.10.
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5.2.81WSE gene expression in PC12 cells and their neuronal derivatives
PC 12 cells present a classic ex vivo model of neuronal differentiation. It is well 
established that these cells can differentiate into neurons when treated with low doses 
(lng ml'1) of nerve growth factor (Green et al., 1987), and other investigators have 
demonstrated that the induction of NSE gene expression accompanies this process 
(Vinores et al., 1981). Undifferentiated PC 12 cells have been shown to express NSE 
mRNA and NSE protein at relatively high levels (see sections 5.2.1 and 5.2.3) thus an 
investigation of NSE induction by NGF was made. Northern and western analysis 
were used to determine the levels of NSE gene products in both proliferating and 
differentiating PC 12 cells as described in section 5.2.3. However, under the 
conditions employed in this project, only a slight increase in NSE mRNA and NSE 
protein expression was observed in differentiated verses undifferentiated PC 12 cells. 
It is interesting to note that almost identical results were obtained from both PC 12 
clones used in this study as shown in Figures 5.12 (PC12 (Geneva)) and 5.13 (PC12 
(Sheffield)).
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Figure 5.12: Northern and western analysis of differentiating PC12 (Geneva) ceils, a) Northern 
analysis using the Sma I - Nco I fragment of the rat NSE 3’ UTR as a probe - lanes loaded equally for 
total RNA, 10|ig per lane: 1 - mouse brain, 2 - mouse liver, 3 - undifferentiated PC12 cells, 4 - 
differentiated PC 12 cells. Markers are Gibco BRL RNA ladder, b) Western analysis using anti-human 
NSE, detected with horseradish peroxidase-conjugated goat anti-rabbit IgG and revealed by staining 
with diaminobenzidine tetrahydrochloride without metal ion enhancement - lanes loaded equally for 
total protein, 5pg per lane. During immunoblotting, gel was placed upon the filter in the normal rather 
than inverted orientation. Consequently, the order o f lanes was reversed with respect to the northern 
blot: 1 - differentiated PC 12 cells, 2 - undifferentiated PC 12 cells, 3 - mouse liver, 4 - mouse brain. 
45kDa marker is ovalbumin.
a
NSE-
9 -
b
Figure 5.13: Northern and western analysis of differentiating PC12 (Sheffield) cells, a) Northern 
analysis using the Sma 1 - Nco I fragment of the rat NSE 3’ UTR as a probe - lanes loaded equally for 
total RNA, lOpg per lane: 1 - mouse brain, 2 - mouse liver, 3 - undifferentiated PC 12 cells, 4 - 
differentiated PC12 cells. Markers are Gibco BRL RNA ladder, b) Western analysis using anti-human 
NSE, detected with horseradish peroxidase-conjugated goat anti-rabbit IgG and revealed by staining 
with diaminobenzidine tetrahydrochloride without metal ion enhancement - lanes loaded equally for 
total protein, 5pg per lane: 1 - mouse brain, 2 - mouse liver, 3 - undifferentiated PC 12 cells, 4 - 
differentiated PC 12 cells. 45kDa marker is ovalbumin.
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5.3 Strategy for the generation of deletion constructs
5.3.1 Starting material
At the time this project was initiated, the only published information concerning the 
regulation of NSE was that of Forss-Petter et al. (1990). As discussed in section 1.7.4, 
these researchers found that a 1.8 kbp fragment of the rat NSE 5' flanking region, up to 
and including the first (noncoding) exon but not the first intron, was sufficient to 
direct the expression of a reporter transgene in the same manner as that of endogenous 
NSE in transgenic mouse embryos, but was unable to support postnatal accumulation 
of the reporter message, a feature characteristic of the endogenous NSE gene in both 
rats and mice.
The major aims of this project were to investigate the mechanisms of cell type- 
specific and inducible expression of the rat NSE gene. As the 1.8 kbp regulatory 
sequence described by Forss-Petter and coworkers appeared to be sufficient to confer 
the developmental stage- and cell type-specific properties of NSE upon a heterologous 
reporter gene, it was chosen as the starting point for the study. The 1.8 kbp regulatory 
element is referred to as the complete NSE regulatory sequence in this thesis because 
of its properties in transgenic mice, although the more recent study by Sakimura and 
colleagues suggests that additional regulatory material, both upstream and 
downstream of the complete NSE regulatory sequence, may be involved in the 
expression of this gene (Sakimura et al., 1995). No information was initially available 
concerning the molecular basis of MS7i-induct ion by the various agents and growth 
conditions described in section 1.5.3, however, a recent investigation has shown that 
the complete NSE regulatory sequence is able to respond to retinoic acid, nerve 
growth factor and attachment factor treatments in a manner similar to the endogenous 
NSE gene when stably transfected into ES cells (Alouani et al., 1993; see section 
1.7.4). The complete NSE regulatory sequence was therefore a prudent starting point 
for the study of both cell type-specific and inducible regulatory elements.
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5.3.2 Sequence and numeration of the rat NSE  5' flanking region
The rat NSE 5' flanking region has been independently cloned and partially sequenced 
by two groups (Sakimura et ah, 1987; Forss-Petter el al., 1990). The published 
sequence data from Sakimura and colleagues extends 1157 bp upstream from the start 
of the first intron and has been submitted to the GenBank database under the 
accession number M22565. The published sequence data from Forss-Petter and 
colleagues extends 354 bp upstream from the start of the first intron and has not been 
submitted. The two sequences are in excellent agreement over the area available for 
comparison, differing at only two positions as shown in Figure 5.14.
Although the sequences are all but identical, the two groups have presented evidence 
for different major transcriptional start sites and their numbering systems have been 
based upon this data (Sakimura et al., 1987; Forss-Petter et al., 1990; Sakimura et al.,
1995). To avoid confusion, only one o f the numbering systems has been used in this 
thesis and the one originally employed by Forss-Petter and colleagues was chosen. 
This choice was made on the basis that the material used in this project was the same 
as that used by these investigators in their earlier study (Forss-Petter et al., 1990) and 
also because position +1 refers to the start of transcription corresponding to the first 
nucleotide found in three independent cDNA clones (Sakimura et al., 1985b; Forss- 
Petter et al., 1986) as well as a prominent site identified by primer extension analysis 
(Forss-Petter et al., 1990).
5.3.3 Subcloning strategy
Plasmid pNSElacZ, which contains the complete NSE regulatory sequence linked to 
the E. coli lacZ gene and the SV40 polyadenylation sequence, was the source of all 
material used in this study (Figure 5.15). Although it would have been possible to 
manipulate this vector to generate suitable deletion constructs for transfection
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-1 1 0 2  AG
-1 1 0 0  TAAAGGTGAT GGCAGGAAGG CAGCCCCCGG AGGCAAAGGC TGGGCACGCG H ph  1
-1 0 5 0  GGAGGAGAGG CCAGAGTCAG AGGCTGCGGG TATCTCAGAT ATGAAGGAAA 
-1 0 0 0  GATGAGAGAG GCTCAGGAAG AGGTAAGAAA AGACACAAGA GACCAGAG.AA B a a  1
-9 5 0  GGGAGAAGAA TTAGAGAGGG AGGCAGAGGA CCGCTGTCTC TACAGACATA
-9 0 0  GCTGGTAGAG ACTGGGAGGA AGGGATGAAC CCTGAGCGCA TGAAGGGAAG
-8 5 0  GAGGTGGCTG GTGGTATATG GAGGATGTAG CTGGGGCCAG GGAAAAGATC
-8 0 0  CTGCACTGGG GATCTGAAGC TGGGGAGAAC AGGACACGGGG TGGAGAGGC D r  a  III
-7  50 GAAAGGAGGG CAGAGTGAAG CAGAGAGACT GAGGCCTGGGG ATGTGGGCA S t u  1
-7  00 TTCCGGTAGG GCACACAGTT CACTTGTCTT CTCTTTTTCCA GGAGGCCAA 
-6 5 0  AGATGCTGAC GTCAAGAACT CATAATACCC CAGTGGGGACC ACCGCATTC 
-6 0 0  ATAGCCCTGT TACAAGAAGT GGGAGATGTT CCTTTTTGTCC CAGACTGGA 
-5 5 0  AATCCATTAC ATCCCGAGGC TCAGGTTCTG TGGTGGTCATC TCTGTGTGC 
-5 0 0  CTTGTTCTGT GGGCCTACCT AAAGTCCTAA GCACAGCTCTC AAGCAGATC 
-4 5 0  CGAGGCGACT AAGATGCTAG TAGGGGTTGT CTGGAGAGAAG AGCCGAGGA
-4 0 0  GGTGGGCTGT GATGGATCAG TTCAGCTTTC AAATAAAAAGG CGTTTTTAT
=>
-3 5 0  ATTCTGTGTC GAGTTCGTGA ACCCCTGTGG TGGGCTTCTCC ATCTGTCTG
*  *
-3 0 0  GGTTAGTACC TGCCACTATA CTGGAATAAG GUGACGCCTGC TTCCCTCGA X h o  1 
-2 5 0  QTTGGCTGGA CAAGGTTATG AGCATCCGTG TACTTATGGGG TTGCCAGCT 
-2 0 0  TGGTCCTGGA TCGCCCGGGC CCTTCCCCCA CCCGTTCGGTT CCCCACCAC 
-1 5 0  CACCCGCGCT CGTACGTGCG TCTCCGCCTG CAGCTCTTGAC TCATCGGGG P s t  1
U
-1 0 0  rrrCCGGGTG ACATGCGCTC GCTCGGCTCT A T A GGC.GC.CGC CCCCTGCCC Sma 1 ,  N a r 1
u i  i  l  i
-SO ACCCCCCGCC CGCGCTGGGA GCCGCAGCCG CCGCCACTCCT GCTCTCTCT
1 I
+ 1 GCGCCGCCGC CGTCACCACC GCCACCGCCA CCGGCTGAGTC TGCAGTCCT
+51 C G A G g tg ag g .................
Figure 5.14: Sequence of the rat NSE 5' flanking region (data taken from Sakimura el al., 1987 and 
Forss-Petter el al., 1990). Double underlined motifs are restriction endonuclease sites (with the 
appropraite enzyme identified in the right hand margin) used in the present study to generate deletion 
constructs. The putative TATA box is shown in bold italic. Transcriptional start sites are shown with 
vertical arrows - double arrows refer to sites identified by both authors, single arrows to those sites 
detected only by Forss-Petter el al. The site at position -65 is position +1 in Sakimura el al. (1995). 
Asterisks refer to positions where sequence data do not agree - at position -269, Sakimura el al. 
reported A and Forss-Petter el al. G; The G at position -277 is absent from the sequence of Forss-Petter 
el al. Horizontal arrow indicates beginning of the sequence data from Forss-Petter el al. ( 1990). Intron 
I begins at position +55, shown by lower case letters.
131
Results: Chapter 5
Figure 5.15: Plasmid map o f pNSElacZ, a hybrid of three vectors (pSV-cat, pCHl 10 and pUC18) 
which contains the 1.8kb full NSE regulatory region (P) upstream of the E. coli lacZ gene (lacZ) and 
the SV40 polyadenylation site (polyA). The ampicillin resistance gene (Ampi) and various restriction 
endonuclease sites are also shown. This plasmid was the source of all NSE regulatory sequences used 
in this study and is redrawn from Forss-Petter el at. (1990), wherein details of its construction can also 
be found.
Figure 5.16: Plasmid map of pCAT-Basic, containing a promoterless E coli cat gene downstream of a 
multiple cloning site. This vector is used as a negative control in transfection experiments and as the 
source vector to construct recombinants in which cat is driven by exogenous regulatory elements. The 
map shows the ampicillin resistance gene (Amp1), the cat gene (CAT), the translational initiation site 
(AUG), the SV40 large T antigen region (SV40) and restriction endonuclease sites in the polylinker. 
Taken from Promega Protocols and Application Guide, second edition, 1991.
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analysis, the ungainly size of the plasmid («9 kbp), its hybrid nature and lack of 
unique restriction endonuclease sites made it an inconvenient subcloning system. 
Therefore, the complete NSE regulatory sequence was excised as a 1.8 kbp EcoR I - 
Hind III fragment, blunted by end-filling using the Klenow fragment of DNA 
polymerase I and inserted into the more suitable pCAT-Basic vector for subsequent 
analysis. The pCAT-Basic vector (Figure 5.16) contains a promoterless E. coli cat 
gene downstream of a poly linker and was developed specifically for transient 
transfection analysis. A major advantage of pCAT-Basic over pNSElacZ was the 
availability of its complete sequence, allowing a computer-generated restriction map 
to be obtained using the circular MAPPLOT subroutine of the GCG database. The 1.8 
kbp regulatory fragment was inserted into the (blunt) Xba I site in the pCAT-Basic 
poly linker to generate a recombinant vector named pNSEl 800CAT. As a byproduct 
of this subcloning strategy, a second recombinant was obtained with the 1.8 kbp 
regulatory region in the reverse orientation. This vector was named 
pNSEinv 1800CAT.
pNSE1800CAT represented a logical starting point for transfection analysis, as the 
regulatory information driving the reporter gene had been shown to confer correct 
spatial and temporal expression of lacZ in transgenic mice (Forss-Petter et al., 1990). 
Earlier investigation had also shown that 255 bp of the rat NSE 5’ flanking sequence 
was capable of driving in vitro transcription using HeLa cell extracts (Sakimura et al.,
1987) and the authors suggested that this fragment of the flanking sequence 
constituted the basal promoter of the gene. For preliminary analysis, therefore, the 
aim was to generate deletion constructs with 200-600 bp blocks of sequence removed 
in a stepwise fashion between positions -1800 and -255.
To choose suitable restriction endonuclease sites for the production of such constructs, 
a computer-generated restriction map of the sequenced portion of the rat NSE 5' 
flanking region was obtained using the linear MAPPLOT subroutine of the GCG 
database (Figure 5.17). Four candidate sites were identified: these were the Hph I site 
at -1084, the Bsa 1 site at -950, the Stu I site at -717 and the Xho I site at -255, the 
latter representing the minimal fragment investigated previously (Sakimura et al.,
134
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1987). In each case, recombinant vectors were generated by excising the appropriate 
fragments (of 1205 bp, 1072 bp, 839 bp, and 376 bp respectively) from pNSElacZ 
using one of the endonucleases named above in combination with Him1 III. Each 
fragment was then blunted and inserted into the Xba I site of pCAT-Basic.
Fortunately, the Hph I site was located only 10 bp downstream from the beginning of 
the published sequence, which allowed the removal of the entire unsequenced portion 
of the insert. This strategy permitted experiments to be carried out in which only the 
sequenced portion of the NSE flanking region was used to drive reporter expression. 
Comparison of this construct with that containing the complete NSE regulatory 
element showed whether the unsequenced portion of the flanking region was worthy 
of further study.
Due to the presence of an overlapping dam methylase site, the Stu 1 digest was 
unsuccessful. Unfortunately, the suitable alternative (a unique Dra III site at position 
-760), also failed to cleave. Control experiments showed that the enzyme was 
working efficiently and it was concluded that the Dra III site shown on the restriction 
map was there due to a discrepancy between the sequences of the independent clones 
(Sakimura et al., 1987; Forss-Petter et al., 1990) or a sequencing or clerical error. The 
remaining strategies were successful and the recombinant plasmids were named 
pNSE1200CAT, pNSElOOOCAT and pNSE300CAT respectively (Figure 5.18).
The first series of transfections showed that the smallest construct, pNSE300CAT, 
was still capable of cell type-specific reporter activity. Further deletion constructs 
were therefore required in which more of the NSE flanking sequence had been 
removed. Because of the small size of the inserts required, a different subcloning 
strategy was used. Vector pNSE1800CAT was used as the starting material and 
variable sized distal portions of the original insert were removed; the vector was then 
reclosed. The sites within the pCAT-Basic polylinker were found to be very 
convenient for this purpose. pNSE120CAT was generated by partial digestion with 
Pst 1, releasing an internal fragment from the Pst I site at position -119 in the insert to 
the Pst I site in the polylinker (upstream o f the Xba I site originally used to 
accommodate the larger insert) and the vector was then reclosed.
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6.5.3 Conclusions from transfection studies involving ex vivo neuronal 
differentiation
Transient transfection analysis of PC12 cells revealed remarkably little difference 
between undifferentiated and differentiated cells with respect to the regulation of 
NSE. In both cultures, cells transfected with the longest construct, pNSE1800CAT, 
yielded mean Relative CAT Activities of approximately 100%. Slightly greater 
CAT activity was observed for the NGF-treated cells. Cells transfected with 
pNSE120CAT and the more truncated construct pNSE95CAT demonstrated very 
low mean Relative CAT Activities (10% or less) and these results indicated that 
strong positive regulatory elements were located in the 5’ flanking sequence, 5’ to 
position -120 (the upstream boundary of pNSE120CAT). In the undifferentiated 
cells, a biphasic stepped decrease in reporter activity was observed. When the 5’ 
flanking region was truncated to 1000 bp, a twofold reduction in mean Relative 
CAT Activity was evident. There was no significant modulation following 
truncation to 255 bp, but a fivefold reduction occurred following truncation to 
120bp. These results indicated the presence of at least two positive regulatory 
elements in the 5‘ flanking region, one located between 1800 and 1000 bp upstream 
of the transcriptional start site and one located between 255 and 120 bp upstream of 
the transcriptional start site. In differentiated cells, there was no significant 
difference in levels of reporter activity when comparing cells transfected with 
pNSE1800CAT, pNSElOOOCAT and pNSE300CAT. However, truncation to 120 
bp resulted in a seven to tenfold reduction in reporter expression, indicating the 
presence of a very strong enhancer located between 255 and 120 bp upstream of the 
transcriptional start site. It is interesting to note that the same small region of the 
promoter was found to be important for regulation of NSE in the Ltk- and Neuro-2A 
cell lines. P19 stem cells demonstrated very low mean Relative CAT Activities 
(less than 5%) regardless of the construct transfected into them. However, P19 
neurons transfected with all constructs except the highly truncated pNSE65CAT 
demonstrated very high levels of reporter expression. The mean values fell within a 
range 90-170%, although this may have been underestimated due to poor 
transfection efficiency in one experiment as discussed above. There was a slight
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Transfected *  Untransfected Control
Figure 5.20: Graph to show effect of duration upon transfection efficiency. Cells were transfected 
using DEAE-dextran according to the method of Selden (1987). Control cells were not transfected, but 
were exposed to OptiMEM serum-free medium for the appropriate time.
Thus, although shortening the transfection time did increase transfection efficiency 
slightly above background, the results were not in the linear range of the [)- 
galactosidase assay and were therefore not useful.
Attempts were next made to optimise DEAE-dextran mediated transfection from first 
principles. Initially, 0.5pg DNA was used per 35mm well and the concentration of 
DEAE-dextran in the medium was varied through the range 0 - 200pg mb1. It was 
found that, using these parameters, transfection efficiency showed a linear response to 
increasing doses of the reagent up to an optimal value of 133pg ml'1 For values 
above this dose, there was a fall in transfection efficiency and at doses greater than 
166pg ml'1 significant cell death became apparent. These results are shown in Figure 
5.21. The concentration of DEAE-dextran was then held at its optimal level and the 
amount of DNA was varied between 0 and 5pg per 35mm well. It was observed that 
transfection efficiency demonstrated a linear relationship to increasing amounts of 
DNA up to 2pg per 35mm well. Higher doses appeared neither to increase nor 
decrease the efficiency of transfection although the highest dose of DNA caused a 
heavy precipitate to form in the medium which resulted in some cell death. These 
results are shown in Figure 5.22.
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-♦—  Transfected M  Untransfected Control |
Figure 5.21: Optimisation of DEAE-dextran transfection of Ltk- cells by varying the dose of DEAE- 
dextran in the medium. Other parameters: cells transfected at 50% confluence, 0.5 pg DNA used per 
35mm well, duration of transfection 4 hours followed by 2 minute 10% v/v DMSO/PBS shock. 
Untransfected cells were exposed to the same experimental conditions as the transfected cells with the 
exception that no DNA was included in the transfection mixture.
■+  T r » n « f » c t « d  — M —  U n t r « n » f e c t « d  C o n t r o l  |
A m o u n t  of D N A  u » * d  per 3 5 m m  well  ( p g )
Figure 5.22: Optimisation of DEAE-dextran transfection of Ltk- cells by varying the amount of DNA: 
Other parameters: cells transfected at 50% confluence, 133pg ml'1 DEAE-dextran used per 35mm 
well, duration of transfection 4 hours followed by 2 minute 10% v/v DMSO/PBS shock. Untransfected 
cells were exposed to the same experimental conditions as the transfected cells with the exception that 
no DEAE-dextran was included in the transfection mixture.
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5.4.1.2 Optimisation of transfection of Ltk- cells using calcium phosphate
When it became clear that other cell types used in this project, specifically the Neuro- 
2A neuroblastoma cell line and the U-l 38 MG and U-373 MG glioma lines, were 
refractory to DEAE-dextran-mediated transfection, it was decided to transfect Ltk- 
cells using calcium phosphate. As Ltk- cells were used as nonneuronal controls 
against each of these cell lines, it was convenient to carry out parallel transfections by 
the same method. Also, it was useful to compare the results of NSE-cat experiments 
from cells transfected by different methods to ensure that different transfection 
methods did not affect the results obtained.
Ltk- cells were transfected using BBS under conditions optimised for the U -l38 MG 
and U-373 MG lines as described in section 5.4.3. Initially, it was decided to hold all 
other parameters at the same values optimised for U-l 38 MG and U-373 MG and vary 
the amount of DNA used in the transfection between 0 - 25pg per triplicate. A low 
transfection efficiency was observed when using 5-1 Opg DNA per triplicate and then 
a linear increase in transfection efficiency was evident with increasing amounts of 
DNA up to a peak value of 25pg. The transfection efficiency was observed to drop if 
greater amounts of DNA were used. These data are shown in Figure 5.23.
5.4.1.3 Optimisation of liposome-mediated transfection of Ltk- cells
Liposome-mediated transfection of Ltk- cells was carried out to allow this cell line to 
be used as a nonneuronal control against cell lines which could only be transfected 
using this method (e.g. NB4-1 A3 and PC 12 (Sheffield) cells). Transfections were 
optimised according to manufacturers' recommendations starting with the following 
parameters: cells transfected at 80% confluence, duration of transfection 5 hours, 2pg 
DNA per 35mm well in OptiMEM serum reduced medium. Four different liposome 
formulations were tried and the results are shown in Figure 5.24. It was clearly found 
that LipofectAMINE was the superior reagent for liposome-mediated transfection of 
Ltk- cells and 5pi of the reagent per 35mm well was the optimal amount. It was also
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+■ ■ - T ra nsfe c ted  — Unt r ansf ect ed C on tr o ls
A m o u n t  of D N A  used per triplicate (y g )
Figure 5.23: Optimisation of calcium phosphate-mediated transfection of Ltk- cells by varying the 
amount of DNA: Other parameters: cells transfected at 70% confluence, duration of transfection 18 
hours. Untransfected cells were exposed to the same experimental conditions as the transfected cells 
with the exception that no CaClj was included in the transfection mixture.
Figure 5.24: Optimisation of liposome-mediated transfection of Ltk- cells by varying the amount of 
liposome. Other parameters: cells transfected at 80% confluence, duration of transfection 5 hour, 2pg 
DNA per 35mm dish. Because of the cost of liposome formulations, negative control lacking DNA but 
containing the same amount of each liposome as the experimental transfections were not carried out. 
The untransfected cells in this experiment were not treated with DNA or liposomes, but were exposed 
to serum-reduced medium for the same duration as the transfected cells
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noted that the highest doses of Lipofectin, TransfectACE and LipofectAMINE caused 
regional cell death, generating patches of lysed cells, often at the periphery of each 
dish. Next, the amount of DNA used per transfection was optimised, using the 
LipofectAMINE reagent at its optimal dose. Keeping the other parameters 
unchanged, the amount of DNA was varied between 0.5 and 3 pg per 35mm well. It 
was found that 2pg DNA per transfection was, in fact, the optimal amount. These 
results are shown in Figure 5.25.
| t ransfected B  Untransfected Control
Amount of DNA per 35mm well (pg)
Figure 5.25: Optimisation of LipofectAMlNE-mediated transfection of Ltk- cells by varying the 
amount of DNA. Other parameters: cells transfected at 80% confluence, duration of transfection 5 
hour, 5pl LipofectAMINE per 35mm dish. Untransfected cells were exposed to the same experimental 
conditions as the transfected cells with the exception that no LipofectAMINE was included in the 
transfection mixture.
144
Results: Chapter 5
5.4.2 Optimisation of transfection of PC12 cells
5.4.2.1 Attempts to transfect PC 12 (Geneva) cells
PC 12 (Geneva) cells were first transfected using the DEAE-dextran protocol 
optimised for Ltk- cells. This attempt to introduce DNA into the cells failed to 
generate detectable levels of p-galactosidase above the background of untransfected 
cells even after an 18 hour assay for p-galactosidase activity (data not shown). Whilst 
keeping the other parameters constant, attempts were made to optimise the 
transfection of these cells by varying the dose o f DEAE-dextran, the amount of DNA, 
the duration of transfection and the method of posttransfection shock. In all cases, no 
detectable levels of p-galactosidase activity were found. Transfection of PC 12 cells 
by this approach was then abandoned.
PC12 cells were next transfected using calcium phosphate coprecipitation. In the first 
instance, the parameters optimised for U-138 MG and U-373 MG glioma cell lines 
were used although the amount of DNA per triplicate was varied between 5 and 50pg. 
As before, no p-galactosidase activity above untransfected background was observed 
(data not shown). The duration of transfection was extended up to 24 hours, but this 
approach merely resulted in extensive cell death. In the case of difficult cell lines, it 
has been demonstrated that the pH of the BES buffered saline can play a critical role 
in the success of transfection. A series of alternative buffers, ranging from pH 6.95 to 
6.98 inclusive, were therefore prepared and tested with a range of DNA 
concentrations. Once again, no p-galactosidase activity was evident (data not shown) 
and transfection of PC 12 cells by this approach was also abandoned.
Next, a range of liposome formulations was investigated. The following products 
were used according to the manufacturers’ instructions but failed to yield any 
posttransfection P-galactosidase activity above background: Lipofectin, TransfectACE 
and Transfectam (data not shown). Two formulations, LipofectAMINE and Tfx-50, 
generated posttransfection p-galactosidase activities slightly above background, yet 
still not in the linear range of the soluble assay even after 18 hour incubations (results
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not shown). Also no CAT activity was evident in cells contransfected with pCAT- 
Control (results not shown). Following the failure of this approach, PC 12 (Geneva) 
cells were abandoned as an experimental system.
5.4.2.2 Optimisation of liposome-mediated transfection of PC 12 (Sheffield) cells
Having failed to transfect the PC 12 (Geneva) cells using all available means, a 
different solution to the problem was sought. It has been reported that PC 12 
subclones with different characteristics can be propagated by selection and 
modification of growth conditions (Green el al., 1987). For instance, it is easy to 
produce a clone of PC 12 cells which attach relatively well to plastic surfaces simply 
by discarding those cells which are less adherent (Twyman and Jones, unpublished 
observations) and presumably these cells differ according to their expression of 
various extracellular matrix proteins and cell adhesion molecules. Transfection of 
PC 12 cells by calcium phosphate and liposome methods had been reported elsewhere 
(e.g. Sakimura et al., 1995) and there was therefore no reason why these experiments 
should be so difficult to carry out unless there was a characteristic of the cells in our 
possession which made them refractory to DNA uptake. The PC 12 (Geneva) cells 
displayed many characteristics which would suggest transfection difficulty - they 
attached poorly, were rounded and grew as large aggregates, masking many of the 
cells from exogenously applied DNA. A different PC 12 line was therefore obtained, 
whose characteristics were more suitable. The PC 12 (Sheffield) cells grew as a 
monolayer, spread out in a fibroblastoid manner and attached well to plastic surfaces 
coated in collagen. The two PC 12 lines required drastically different growth 
conditions (see section 4.2.1.) which might partially explain their different 
characteristics. Transfections were optimised with LipofectAMINE according to 
manufacturers' recommendations starting with the following parameters: cells 
transfected at 70% confluence, duration of transfection 5 hours, 2pg DNA per 35mm 
well in OptiMEM serum reduced medium. It was found that 6-1 Opl of the reagent per 
35mm well gave the optimum transfection efficiency (Figure 5.26) and that 2pg of 
DNA per 35mm well was ideal (Figure 5.27).
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Figure 5.26: Optimisation of LipofectAMINE-mediated transfection of PC 12 (Sheffield) cells by 
varying the concentration of liposome. Other parameters: cells transfected at 70% confluence, duration 
of transfection 5 hours, 2pg DNA per 35mm dish. Because of the cost of liposome formulations, 
negative controls lacking DNA but containing the same amount of each liposome as the experimental 
transfections were not carried out. The untransfected cells in this experiment were not treated with 
DNA or liposomes, but were exposed to serum-reduced medium for the same duration as the 
transfected cells. The very large OD readings in this experiment are outside the linear range of the 
assay and occurred because the assay was left for 18 hours. The success of the transfection was 
unexpected, as reflected by the long assay time.
Figure 5.27: Optimisation of LipofectAMINE-mediated transfection of PC 12 (Sheffield) cells by 
varying the amount of DNA. Other parameters: cells transfected at 70% confluence, duration of 
transfection 5 hour, 6pl LipofectAMINE per 35mm dish. Untransfected cells were exposed to the same 
experimental conditions as the transfected cells with the exception that no LipofectAMINE was 
included in the transfection mixture. Duration of the soluble p-galactosidase assay was 2 hours as 
usual.
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It is notable that whilst 6-10pl of LipofectAMINE was optimal for PC 12 (Sheffield) 
cells but insufficient for the transfection of PC 12 (Geneva cells), 15pl of 
LipofectAMINE was the stated optimal amount for a PC 12 clone transfected by 
another group (Hawley-Nelson et al., 1994), whilst 15pl was toxic to both clones used 
in this project. This data supports our conclusions concerning the variability of PC 12 
cells and indicates that careful optimisation of transfection parameters must be carried 
out before such cells are used.
5.4.3 Optimisation of transfection of U-138 MG and U-373 MG cells using calcium 
phosphate
Attempts to transfect U-138 MG and U-373 MG glioma cells using DEAE-dextran 
failed although the same optimisation procedure was followed as for Ltk- cells. It was 
noted that doses of DEAE-dextran above 133mg mb1 medium were toxic for a 4 hour 
transfection (data not shown). Transfection using calcium phosphate was then 
attempted, following the recommendations of Sambrook et al. (1989) and using 20pg 
DNA per triplicate as a starting parameter. Several batches of BES buffered saline 
with pH ranging from 6.95-6.98 were then made and each of these solutions was tried 
in parallel transfections. The BBS at pH 6.96 was found to be optimal, although the 
superiority of this batch over the others was not particularly marked (Figure 5.28).
The amount of DNA per triplicate transfection was then optimised, using a range from 
5-30pg. It was found that 25pg DNA per triplicate was ideal for both cell lines 
(Figure 5.29).
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pH of BBS solution
— ♦ — -  U138MG Transfected
• -  U373MG Transfected
— -  U138MG Untransfected
Control
— • -  U373MG Untransfected
Control
Figure 5.28: Optimisation of calcium phosphate-mediated transfection of U-138 MG and U-373 MG 
cells by varying the pH of the BES buffered saline: Other parameters: cells transfected at 70% 
confluence, duration of transfection 18 hours, 20pg DNA per triplicate. Untransfected cells were 
exposed to the same experimental conditions as the transfected cells with the exception that no CaCl2 
was included in the transfection mixture.
-  U138MG Transfected
■ -  U373 Transfected
— * - -  U138MG Untransfected
Control
— • - -  U373MG Untransfected
Control
Amount of DNA per triplicate (pg)
Figure 5.29: Optimisation of calcium phosphate-mediated transfection of U-138 MG and U-373 MG 
cells by varying the amount of DNA: Other parameters: cells transfected at 70% confluence, duration 
of transfection 18 hours, BBS at pH 6.95. Untransfected cells were exposed to the same experimental 
conditions as the transfected cells with the exception that no CaCl2 was included in the transfection 
mixture.
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bacteria or fungi. It is possible that specific vector sequences in the NSE-cat 
constructs either interfered with the expression of the pSV-|i-galactosidase plasmid 
or generally reduced transcription in the cells, but it was thought unlikely that this 
should occur specifically in one cell type. Furthermore, the immunity of construct 
pNSE95CAT suggested that vector sequences were not responsible for the observed 
effects. Eventually, it was decided to carry out the experiments notwithstanding 
this phenomenon, and to increase the assay times accordingly. The results showed 
that P19 stem cells expressed all constructs at < 10% of the control levels. The 
highest level of reporter activity was demonstrated by pNSE95CAT in the first 
transfection, but as discussed above, this elevation of gene expression might reflect 
the peculiar transfection efficiency of this construct. Notwithstanding the high 
transfection efficiency of pNSE95CAT, the second transfection experiment showed 
the lowest Relative CAT Activities for this construct. Reduction of the NSE 5’ 
flanking region from 255 bp to 120 bp did not reveal a silencer element similar to 
that observed in Ltk- cells.
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5.4.5 Optimisation of transfection of NB4-1 A3 cells
Despite careful modulation of transfection parameters, NB4-1 A3 cells could not be 
transfected using either DEAE-dextran or calcium phosphate (data not shown). 
Liposome-mediated transfection was attempted using DOTAP, LipofectAMINE, 
Lipofectin and TransfectACE. Transfections were optimised according to 
manufacturers' recommendations starting with the following parameters: cells 
transfected at 50-60% confluence, duration of transfection 5 hours, 2pg DNA per 
35mm well in OptiMEM serum reduced medium; the results are shown in Figure 
5.31. As with the Ltk- cells, LipofectAMINE was found to be the superior reagent for 
liposome-mediated transfection and 5gtl of the reagent per 35mm well was found to be 
the ideal dose. The regional cell death, characterised by patches of lysed cells was not 
observed for NB4-1 A3 cells as it was for other cell lines. The amount of DNA used 
per transfection was then optimised, using the LipofectAMINE reagent at its optimal 
dose. Keeping the other parameters unchanged, the amount of DNA was varied 
between 0.5 and 3 pg per 35mm well and 1.5pg DNA per transfection was found to 
be the optimal amount. These results are shown in Figure 5.32.
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Figure 5.31: Optimisation of liposome-mediated transfection of NB4-1 A3 cells by varying the amount 
of liposome. Other parameters: cells transfected at 50% confluence, duration of transfection 5 hour, 2 
pg DNA per 35mm dish. Because of the cost of liposome formulations, negative controls lacking 
DNA but containing the same amount of each liposome as the experimental transfections were not 
carried out. The untransfected cells in this experiment were not treated with DNA or liposomes, but 
were exposed to serum-reduced medium for the same duration as the transfected cells
Figure 5.32: Optimisation of LipofectAMINE-mediated transfection of NB4-1 A3 cells by varying the 
amount of DNA. Other parameters: cells transfected at 50% confluence, duration of transfection 5 
hour, 5pl LipofectAMINE per 35mm dish. Untransfected cells were exposed to the same experimental 
conditions as the transfected cells with the exception that no LipofectAMINE was included in the 
transfection mixture.
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Construct RCA1 RCA2 xRCA12 semRCA12
Control 88.03 87.25 100.00 5.28
119.07 110.55
92.90 102.19
Basic -0.69 -1.08 0.00 0.37
N/A 1.10
0.69 -0.02
NSE 1800 122.46 157.71 116.73 10.68
129.86 102.59
106.01 81.75
NSE 1 (XX) 92.31 153.65 97.26 13.54
119.37 71.14
73.83 73.24
NSE3(X) 150.40 4.60 79.37 27.27
134.58 5.92
129.05 51.69
NSE120 1.98 11.89 10.50 3.34
3.87 13.84
7.05 24.37
NSE95 0.68 19.88 10.13 4.02
3.21 20.35
-0.06 16.74
NSE65 -1.72 -0.62 -1.19 0.21
-1.65 -1.09
-1.52 -0.52
Control Basic NSE 1800 NSE1000 NSE300 NSEI20 NSE95 
C o n s t r u c t
NSE65
Figure 6.40: Table and histogram showing combined data from the transfection of NGF-treated PC 12 
cells with the full series of NSE-cat deletion constructs. Abbreviations used in the table: RCA1 and 
RCA2 - Relative CAT Activities from the two individual experiments (as shown in Figures 6.38 and 
6.39); xRCA12 - combined mean Relative CAT Activity for each construct over two experiments 
(six transfections); semRCA12 - standard error of the combined mean Relative CAT Activities. A 
brief explanation of these terms can be found in Figure 6.1, a fuller explanation in section 5.5. The 
histogram shows combined mean relative CAT activity for each construct and illustrates the trend in 
reporter gene activity for reporter constructs containing stepwise deletions of the rat NSE 5’ flanking 
region. Error bars represent standard errors of the combined mean Relative CAT Activities.
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C o n s tr u c t N a m e  a n d  S iz e  o f  
s o u r c e  v e c to r
S iz e  o f  
in s e r t
S iz e  o f  
r e c o m b in a n t
M E C
pNSEI800CAT pCAT-Basic 4364 1799 6163 1
pNSEI200CAT pCAT-Basic 4364 1205 5569 l.l 1
pNSEIOOOCAT pCAT-Basic 4364 1072 5436 1.13
pNSE300CAT pCAT-Basic 4364 376 4740 1 .30
pNSE120CAT pCAT-Basic 4364 240 4604 1.34
pNSE95CAT pCAT-Basic 4364 216 4580 1.35
pNSE65CAT pCAT-Basic 4364 186 4550 1.35
pCAT-Control pCAT-Control 4752 - 4752 1.30
pCAT-Basic pCAT-Basic 4364 - 4364 1.41
Table 5.1: Calculated Molar Equivalence Constants (MECs) for the constructs used during this project. 
All sizes are in nucleotides.
To directly compare the performance of different constructs within an experiment, 
CAT activity was normalised for transfection efficiency and corrected for molar 
equivalence to yield a value termed the Actual CAT Activity (ACA). The ACA was 
calculated as shown below, where CAT = CAT activity, GAL = p-galactosidase 
activity and MEC = molar equivalence constant:
ACA = CAT Units CAT activity per Unit P-galactosidase activity
1000GAL.MEC
Generally, CAT activities fell within the range 1000 to 100 000, whereas p* 
galactosidase activities fell within the range 0.1 to 1.0. Each p-galactosidase activity 
was multiplied by 1000 so that ACA values could be written without the use of 
exponents. MEC was placed as a divisor in the above equation because for smaller 
constructs, a relatively greater molar quantity of plasmid was introduced into the cells, 
thus the CAT activity had to be reduced by the appropriate amount.
The calculation of ACA values allowed the performance of different constructs to be 
compared within each experiment (i.e. where transfections were carried out in 
parallel) but due to variations in experimental technique, and the need to vary assay 
times in different cell lines, meaningful comparison between experiments was not 
possible. To allow intraexperimental comparisons to be made, the ACA of each 
construct was expressed as a percentage of the ACA of the positive control vector, 
pCAT-Control, corrected for the background CAT activity of the negative control
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vector, pCAT-Basic and this value was termed the Relative CAT Activity (RCA). 
Because transfections were carried out in triplicate within each experiment, the RCA 
values for each construct were based on the mean ACAs of the control vectors. 
Obviously, a large variation in the ACA values of the control vectors themselves 
would render the RCA calculations meaningless and, as an arbitrary condition, a 
maximum standard error of 15% was permitted for the control vector ACAs. The 
RCA for each construct was therefore calculated as follows where ACA = Actual 
CAT Activity of the construct under investigation and xACA = mean Actual CAT 
Activity for the control vectors as shown in parenthesis. The RCA is a relative value 
and has no units:
RCA(construct) = . (ACA(construct) - xAC'AtpCAT-BasicH . x 100% 
{xACA(pCAT-Control) - xACA(pCAT-Basic)}
From each triplicate transfection, mean RCA values were calculated. Whilst 
presenting the results in this manner allowed direct comparisons between experiments 
using the same cell line, such comparisons between different cell lines were made 
with caution because the tacit assumption has to be made that the SV40 promoter, 
which drives the control plasmids, functions in a similar manner in all cells. If this 
were not so, differences noted and attributed to the function of the NSE promoter 
could in fact reflect differences in both the NSE promoter and SV40 early promoter. 
Having said this, however, the calculation of RCA values allows one to legitimately 
compare trends in activity as the NSE flanking region is reduced in different cell lines, 
because this reflects only upon the function of the NSE promoter, and not upon its 
relationship with the SV40 early promoter.
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Chapter 6 - Cell type-specific and inducible expression of the rat NSE gene 
ex vivo.
6.1 Chapter summary
The previous chapter showed how an ex vivo system for promoter analysis of the rat 
NSE gene was developed. The present chapter turns to the ex vivo analysis itself, 
showing how this system was put into practice. The initial experiments, involving 
one permissive and one nonpermissive cell line, and four deletion constructs, aimed 
to determine the position of cell type-specific regulatory elements in the upstream 
region of the NSE gene. The results showed, however, that even the shortest 
construct was capable of full cell type-specific reporter activity in the system chosen 
for analysis, and that it was necessary to truncate the flanking region further still to 
identify functional elements. Subsequent analysis was carried out in two permissive 
and two nonpermissive cell lines. The regulation of NSE was also investigated in 
the context of ex vivo neuronal differentiation, involving PC12 and P19 cell lines as 
described in sections 4.2.3 and 4.2.4. Finally, NSE expression was investigated in 
cells expressing cSox2 and cSox3 transcription factors, which are expressed in the 
developing nervous system at about the time of neuronal differentiation and whose 
pattern of expression has been shown to be complementary to that of NSE 
(Uwanogho et al., 1995; R. Lovell-Badge, unpublished observations).
6.2 Methodology and data presentation
As discussed in section 4.2.5, convention dictates that transient transfection studies 
are carried out at least three times, using two or more independently derived 
preparations of plasmid DNA. The rationale behind such a strategy is obvious: by 
carrying out each experiment a number of times, one increases the statistical 
reliability of the results; and by using more than one source of DNA, one can 
identify artefactual effects caused by specific plasmid preparations. During the 
project, transfections mediated by DEAE-dextran or calcium phosphate were 
routinely carried out nine times (three experiments in which each construct was 
transfected into triplicate parallel cultures). In the case of transfections mediated by 
liposomes, the constancy and repeatability of the method was greater and six 
transfections were sufficient (two triplicate experiments). Two preparations of each 
plasmid were made, both by double CsCl gradient centrifugation as described in 
section 4.1.1. To save time and minimise expense, the plasmids were tested for
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transfection efficiency and expression in only one cell line (Neuro-2A) and were 
found to give similar results (data not shown). Given the supposition that any 
preparation-specific properties of plasmid DNA would be manifest in all cell lines, 
this single test was judged to be a sufficient confirmation of the suitability of 
plasmids for use in transfection assays.
For each series of experiments, the raw and processed data are presented in tables, 
one per experiment, with histograms to illustrate the results graphically. A full 
explanation of the terms used in this chapter can be found in section 5.5, but a brief 
glossary is provided in Figure 6.1 for quick reference by the reader. Following the 
individual experiments, a combined table summarises the data over the whole 
experimental series and a histogram is shown to illustrate the overall trend of 
reporter construct activity in the particular cell line under investigation. There is 
also a representative CAT assay for each group of transfections to exemplify the 
calibre of the primary data.
6.3 Transfection with initial NSE-cat constructs
The first series of NSE-cat constructs, comprising pNSE1800CAT, pNSE1200CAT, 
pNSElOOOCAT and pNSE300CAT, was transfected into permissive U-138 MG 
glioma and nonpermissive Ltk- fibroblast cells, both of murine origin. As discussed 
in the previous chapter, the longest construct contained sufficient regulatory 
information to confer correct spatial and temporal properties upon the heterologous 
lacZ gene in transgenic mice (Forss-Petter et al., 1990), whilst the regulatory 
information in the shortest construct was, at the time the study was initiated, 
thought to comprise the minimal NSE promoter (Sakimura et al., 1987). These 
constructs were transfected into permissive and nonpermissive cells to investigate 
both positive and negative aspects of gene regulation.
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C o n s t r u c t
Figure 6.35: Table and histogram showing data from the second transfection of undifferentiated 
PC12 (Sheffield) cells with the full series of NSE-cat deletion constructs. Transfection was carried 
out using LipofectAMINE. Abbreviations used in table headings: CAT - CAT (chloramphenicol 
acetyltransferase) activity; GAL - (i-galactosidase activity; MEC - Molar Equivalence Constant;
ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control constructs; RCA - 
Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard error of the mean 
Relative CAT Activity. A brief explanation of these terms can be found in Figure 6.1, a fuller 
explanation in section 5.5. The histogram shows mean Relative CAT Activities for each construct 
with error bars representing standard errors.
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Glossary
(a) Abbreviations used in data  tables and histogram s - 
C onstruct - The plasmid transfected into the cells.
CA T - The C A T (chloramphenicol acetyltransferase) activity o f the posttransfection cells, reflecting the activity 
of the NSE-cat reporter construct transfected into them. These values were obtained by phosphorimaging and lie 
within the range 104-106.
GAL - The (J-galactosidase activity o f the posttransfection cells. A vector expressing lacZ  under the control of 
the SV40 early prom oter was cotransfected into all cultures to provide an internal control for transfection 
efficiency and cell number. These values were obtained by colourimetric assay and lie w ithin the range 0.1 - 
1.0; they were multiplied by 1000 so that they might be represented by integers.
M EC - The M olar Equivalence Constant: a dimensionless number introduced into the calculations to account for 
the molar ratio o f the various constructs introduced during transfection, the constructs being of unequal size but 
the mass of DNA introduced into the cells remaining the same.
ACA - The Actual CAT Activity, a measure o f CAT activity corrected for transfection efficiency and molar 
ratio of plasmid DNA. This allows direct comparisons between the performance of the various NSE-cat 
constructs within a single experiment. The Actual CAT Activity is calculated using the following equation:
ACA = CAT/(GAL x MEC).
xACA - Mean Actual CAT Activity. xACAs are calculated for the control constructs only (pCAT-Basic, pCAT- 
Control) and allow calculation o f the Relative CAT Activity (RCA).
RCA - Relative C A T Activity, the CAT activity o f  each construct expressed as a percentage of that of the 
positive control construct, pCAT-Control, corrected for the background level of the negative control construct, 
pCAT-Basic. The Relative CAT Activity, which is calculated using the following equation, allows comparisons 
between the performance of various NSE-cat constructs across experiments.
RCA = . ACA(construct) - xACAtpCAT-Basic)__. x 100%
xACA(pCAT-Control) - xACA(pCAT-Basic)
xRCA - Mean Relative CAT Activity. xRCAs are calculated for each construct from the individual RCAs and 
are the values shown on the histograms; for individual experiments, the means are from a sample of three whilst 
for the combined results the means are generally from a sample of six or nine. Note that, the xRCA of pCAT- 
Control is always 100% and that of pCAT-Basic is always 0% . These arbitrary values arise  from use of the 
above equation.
scmRCA - Standard error of the mean Relative CAT Activity, calculated for each construct and represented by 
error bars on the histograms.
(b) A bbreviation used in CAT assay figures - 
O  - Origin
C - Position o f chloramphenicol 
IA - Position o f 1-acetylchloramphenicol 
3A - Position o f  3-acetylchloramphenicol
Figure 6.1: A glossary to explain the data presentation style used throughout this chapter.
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Figure 6.34: Table and histogram showing data from the first transfection of undifferentiated PC12 
(Sheffield) cells with the full series of NSE-cat deletion constructs. Transfection was carried out 
using LipofectAMINE. Abbreviations used in table headings: CAT - CAT (chloramphenicol 
acetyltransferase) activity; GAL - p-galactosidase activity; MEC - Molar Equivalence Constant; 
ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control constructs; RCA - 
Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard error of the mean 
Relative CAT Activity. A brief explanation of these terms can be found in Figure 6.1, a fuller 
explanation in section 5.5. The histogram shows mean Relative CAT Activities for each construct 
with error bars representing standard errors.
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6.3.1 Transfection of Ltk- cells
Under the conditions described in section 5.4.1, Ltk- fibroblasts were transfected 
with the initial series of NSE-cat constructs and controls using DEAE-dextran.
Data from three individual experiments are presented in Figures 6.2-6.4, followed 
by combined results in Figure 6.5. A representative CAT assay is shown in Figure 
6.6. The results showed that constructs containing over 1 kbp of the NSE 5’ 
flanking sequence displayed a mean Relative CAT Activity of approximately 10- 
15%, whilst the most truncated construct, pNSE300CAT, displayed a mean Relative 
CAT Activity of approximately 20%. The individual values varied from 
transfection to transfection but were highly repeatable; this is demonstrated by the 
similar trends in Relative CAT Activity for each experiment and the generally low 
standard errors (i.e. less than 10% of the mean) for the combined results.
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previous experiments, the most truncated construct, pNSE65CAT, gave no 
expression above the background level of pCAT-Basic.
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Construct
Figure 6.4: Table and histogram showing data from the third transfection of Ltk- cells with the initial 
series of NSE-cal deletion constructs. Abbreviations used in table headings: CAT - CAT (chlor­
amphenicol acetyltransferase) activity; GAL - p-galactosidase activity; MEC - Molar Equivalence 
Constant; ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control constructs; 
RCA - Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard error of 
the mean Relative CAT Activity. A brief explanation of these terms can be found in Figure 6.1, a 
fuller explanation in section 5.5. The histogram shows mean Relative CAT Activities for each 
construct with error bars representing standard errors.
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6.3.2 Transfection of U-138 MG cells
Under the conditions described in section 5.4.3, U-138 MG glioma cells were 
transfected with the first series of NSE-cat constructs and controls using calcium 
phosphate. Data from three individual experiments are presented in Figures 6.7- 
6.9, followed by combined results in Figure 6.10. A representative CAT assay is 
shown in Figure 6.11. The results showed that all four constructs displayed mean 
Relative CAT Activities of approximately 100%-110%. The individual values 
varied from transfection to transfection but were in most cases repeatable; this was 
demonstrated by the similar trends in mean Relative CAT Activity for each 
experiment and the generally low standard errors (i.e. less than 10% of the mean) 
for the combined results. For the most truncated construct, pNSE300CAT, an 
uncharacteristically low mean Relative CAT Activity was observed for the third 
transfection experiment (Figure 6.8). Although this may have reflected a genuine 
fall in reporter activity caused by removal of the =700 bp separating the upstream 
boundaries of pNSE300CAT and pNSElOOOCAT, the absence of this trend in the 
previous transfection experiments and the high standard error (30% of the mean), 
indicated that at least one of the data points in this experiment was 
nonrepresentative. The third transfection experiment showed generally higher 
standard error values than the previous two in the series, perhaps reflecting an 
undetected problem with the cultured cells or the transfection process itself. It has 
been observed that calcium phosphate-mediated transfection can produce less 
repeatable results than other transfection methods, even using carefully controlled 
parameters (Kingston et al. , 1990). It was also notable that the standard error for 
the positive control vector, pCAT-Control, was greater than 15% of the mean. In 
section 5.5, the knock-on effect of highly variable control transfections upon the 
NSE-cat constructs was discussed and a maximum standard error value of 15% was 
allowed. As this limit was transcended, less confidence must be placed in the 
conclusions from this particular experiment.
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Construct CAT GAL MEC ACA xACA RCA xRCA semRCA
Control
294400 304 744.94
667.83
111.95
100.00 6.01240339 297 1.30 622.48 92.97
266264 322 636.08 95.08
Basic
10765 402 18.99 -0.57
0.00 0.4511462 287 1.41 28.32 22.67 0.88
9477 325 20.68 -0.31
NSE1800
202647 288
1.00
703.64 105.55
102.17 2.15215984 315 685.66 102.76
193564 295 656.15 98.19
NSE1200
221754 310
1.11
644.45 96.38
109.36 6.77238981 272 791.54 119.17
223563 269 748.73 112.54
NSE1000
232656 265 776.94 116.91
103.86 6.53116563 158 1.13 652.87 97.68
111372 152 648.42 96.99
199543 177 867.20 130.90
NSE300 212736 248 1.30 659.85 98.76 108.88 12.10
245527 308 613.20 91.53
Construct
Figure 6.7: Table and histogram showing data from the first transfection of U-138 MG cells with the 
initial series of NSE-cat deletion constructs. Abbreviations used in table headings: CAT - CAT 
(chloramphenicol acetyltransferase) activity; GAL - p-galactosidase activity; MEC - Molar 
Equivalence Constant; ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control 
constructs; RCA - Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard 
error of the mean Relative CAT Activity. A brief explanation of these terms can be found in Figure 
6.1, a fuller explanation in section 5.5. The histogram shows mean Relative CAT Activities for each 
construct with error bars representing standard errors.
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Construct
Figure 6.8: Table and histogram showing data from the second transfection of U-138 MG cells with 
the initial series of NSE-cal deletion constructs. Abbreviations used in table headings: CAT - CAT 
(chloramphenicol acetyltransferase) activity; GAL - P-galactosidase activity; MHC - Molar 
Equivalence Constant; ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control 
constructs; RCA - Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard 
error of the mean Relative CAT Activity. A brief explanation of these terms can be found in Figure 
6.1, a fuller explanation in section 5.5. The histogram shows mean Relative CAT Activities for each 
construct with error bars representing standard errors.
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Construct CAT GAL MEC ACA xACA RCA xRCA semRCA
Control
323422 178
1.30
1397.68
1451.78
96.25
100.00 2.09249763 132 1455.50 100.26
283157 145 1502.16 103.49
Basic
2154 109
1.41
14.02
8.55
0.38
0.00 0.201653 167 7.02 -0.11
1003 154 4.62 -0.27
NSE1800
308753 177 1744.37 120.27
125.62 7.22284372 168 1.00 1692.69 116.69
312267 154 2027.71 139.91
NSE1200
229452 154
1.11
1342.30 92.41
117.43 16.63287421 120 2157.82 148.92
216230 121 1609.93 110.%
NSE1000
263211 148
1.13
1573.85 108.46
127.74 14.48321953 126 2261.22 156.09
237293 122 1721.26 118.67
342839 156 1690.53 116.54
NSE300 295469 123 1.30 1847.84 127.44 120.89 8.45
289911 156 1429.54 98.46
Construct
Figure 6.9: Table and histogram showing data from the third transfection of U-138 MG cells with the 
initial series of NSE-cat deletion constructs. Abbreviations used in table headings: CAT - CAT 
(chloramphenicol acetyltransferase) activity; GAL - P-galactosidase activity; MEC - Molar 
Equivalence Constant; ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control 
constructs; RCA - Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard 
error of the mean Relative CAT Activity. A brief explanation of these terms can be found in Figure 
6.1, a fuller explanation in section 5.5. The histogram shows mean Relative CAT Activities for each 
construct with error bars representing standard errors.
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Construct RCA1 RCA2 RCA3 XRCA123 semRCA123
Control 111.95 99.83 96.25 100.00 4.88
92.97 72.96 100.26
95.08 127.21 103.49
Basic -0.57 0.06 0.38 0.00 0.14
0.88 -0.05 -0.11
-0.31 -0.01 -0.27
NSE18(X) 105.55 89.43 120.27 112.43 5.04
102.76 116.21 116.69
98.19 122.89 139.91
NSE12(X) 96.38 98.07 92.41 113.77 5.82
119.17 121.92 148.92
112.54 123.57 110.96
NSE 1 (XX) 116.91 113.96 108.46 114.72 9.04
97.68 153.66 156.09
96.99 70.09 118.67
NSE3(X) 130.90 81.43 116.54 104.63 8.37
98.76 60.74 127.44
91.53 135.89 98.46
Construct
Figure 6.10: Table and histogram showing combined data from the transfection of U-138 MG cells 
with the initial series of NSE-cat deletion constructs. Abbreviations used in the table: RCA1, RCA2, 
RCA3 - Relative CAT Activities from the three individual experiments (as shown in Figures 6.7- 
6.9); XRCA123 - combined mean Relative CAT Activity for each construct over three experiments 
(nine transfections); semRCA123 - standard error of the combined mean Relative CAT Activities. A 
brief explanation of these terms can be found in Figure 6.1, a fuller explanation in section 5.5. The 
histogram shows combined mean relative CAT activity for each construct and illustrates the trend in 
reporter gene activity for reporter constructs containing stepwise deletions of the rat NSE 5’ flanking 
region. Error bars represent standard errors of the combined mean Relative CAT Activities.
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Construct CAT GAL MEC ACA xACA RCA xRCA semRCA
Control
497552 188
1.30
2035.81
1670.69
122.50
100.00 11.26369121 192 1478.85 88.18
391275 201 1497.42 89.32
Basic
10023 187
1.41
38.01 -0.63
0.00 0.4114223 166 60.77 48.30 0.77
9561 147 46.13 -0.13
NSE1800
25723 172
1.00
149.55 6.24
5.96 0.4228912 188 153.79 6.50
18923 144 131.41 5.12
NSE1000
12840 122
1.13
93.14 2.76
3.23 0.8014377 101 125.97 4.79
10342 110 83.20 2.15
NSE300
14883 124
1.30
92.33 2.71
4.46 1.0919832 131 116.45 4.20
20121 101 153.24 6.47
NSE120
15932 131
1.34
90.76 2.62
2.64 0.5312900 126 76.40 1.73
16240 114 106.31 3.58
NSE95
13021 122
1.35
79.06 1.90
1.35 0.2812783 141 67.16 1.16
14515 167 64.38 0.99
10231 132 57.41 0.56
NSE65 9462 121 1.35 57.92 0.59 0.74 0.16
9101 103 65.45 1.06
Figure 6.29: Table and histogram showing data from the first transfection of HeLa cells with the full 
series of NSE-cat deletion constructs. Abbreviations used in table headings: CAT - CAT 
(chloramphenicol acetyltransferase) activity; GAL - p-galactosidase activity; MEC - Molar 
Equivalence Constant; ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control 
constructs; RCA - Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard 
error of the mean Relative CAT Activity. A brief explanation of these terms can be found in Figure 
6.1, a fuller explanation in section 5.5. The histogram shows mean Relative CAT Activities for each 
construct with error bars representing standard errors.
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6.4.4 Transfection of HeLa cells
HeLa cells were considered as a suitable nonpermissive cell line because of their 
use in previous studies of neuronal gene expression, including NSE (Sakimura et 
al., 1995). Under the conditions described in section 5.4.6, HeLa cells were 
transfected with the full series of NSE-cat constructs and controls using calcium 
phosphate. Data from three individual experiments are presented in Figures 6.29- 
6.31, followed by combined results in Figure 6.32. A representative CAT assay is 
shown in Figure 6.33. The results showed that all NSE-cat constructs were 
expressed at minimal levels compared to pCAT-Control. The Relative CAT 
Activities for pNSE1800CAT ranged from 3% to 10%, although in one case a RCA 
of 18% was recorded. This was likely to be nonrepresentative of the construct and 
generated a standard error of >50% for this construct in the second transfection. 
The Relative CAT Activities of the first series of constructs were greater than those 
of pNSE120CAT and pNSE95 CAT, but only by two- to threefold. The Relative 
CAT Activities of pNSE65CAT were around 0% in each experiment.
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6.3.3 Conclusions from first scries of transfections
The first series of transfections showed that the reporter constructs driven by NSE 
regulatory sequence were more active in permissive IJ-138 MG cells than 
nonpermissive I.tk- cells. With all four constructs, the levels of reporter activity in 
the permissive cell line matched or exceeded the activity o f the positive control 
construct, pCAT-Control, whilst in the nonpermissive cell line, the levels of 
reporter activity remained at 10-20% of the control level. The data from each 
transfection series are compared in Figure 6.12. The first major conclusion which 
could be drawn from this series of experiments was that the shortest of the 
constructs, pNSE300CAT, contained sufficient regulatory information to confer cell 
type-specificity upon the reporter gene. Secondly, the lack of significant 
modulation in the levels of reporter activity between this short construct and the 
more extensive ones in both permissive and nonpermissive cells indicated that, at 
least in these two cell lines, the regulatory information between 18(H) and 3(H) bp 
upstream of the first intron was not critical for cell type-specificity. These two 
factors indicated that the logical next step was to generate constructs containing 
further stepwise deletions in the 5’ regulatory region, as described in section 5.3.3. 
Endogenous NSE expression in Ltk- and U-138 MG cells was investigated by 
northern and western analysis as described in sections 5.2.3 and 5.2.4. These 
experiments showed that, whilst NSE mRNA and NSE protein could be easily 
detected in U-138 MG cells, the levels were undetectable in Ltk- cells. However, 
the transfections clearly showed that Ltk- cell RCA values for all four constructs 
were approximately 10% of those in U-138 MG cells. It is not clear why the level 
of reporter gene expression in nonpermissive Ltk- cells appears to be 
proportionately greater, compared to permissive U-138 MG cells, than the 
corresponding levels of endogenous gene expression. It is possible that sequences 
outside the 18(H) bp region studied in this project are required for specific 
downregulation of the gene in nonneuronal cells, thus allowing some reporter 
expression in transfected Ltk- cells. The increased activity of NSE-cat constructs in 
Ltk- cells might also reflect the artificial nature of the transfection system: with
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more regulatory DNA introduced into the cell than would ever normally exist in 
vivo, transcriptional repressors could be titrated out of the system and transcription 
could occur from the excess, unrepressed DNA; alternatively, low level 
transcription from the single copy gene in vivo could be amplified millions of times 
in transfected cells. A further possibility is that chromatin structure contributes to 
the silencing of NSE expression in nonneuronal tissue, and that because plasmids 
lack this epigenetic programming, some transcriptional leaking occurs. It has 
already been discussed in Chapter 5 that U-138 MG cells might represent a nonideal 
ex vivo model for the investigation of NSE gene expression because of their 
nonneuronal origin (see section 5.2.5). It was therefore desirable to investigate the 
expression of NSE-cat constructs in neuronal cell lines, as described in the 
following sections.
Figure 6.12: Comparison of transfection data from permissive U-138 MG cells and nonpermissive 
Ltk- cells. The values represented are combined mean Relative CAT Activities and standard errors 
from Figures 6.5 and 6.10.
120 -i
I U138MG
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U  8 0 -V>
6 0 -
= 4 0 -
20-
0
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174
Results: Chapter 6
The first series of NSE-cat constructs, as described in section 6.3, plus the second 
series, comprising the highly truncated pNSE120CAT, pNSE95CAT and 
pNSE65CAT, were transfected into two permissive cell lines of neuronal origin 
(Neuro-2A and NB4-1 A3 neuroblastoma cells) and two nonpermissive cell lines of 
nonneuronal origin (Ltk- and HeLa cells). All except the HeLa cells were derived 
from murine sources, the HeLa cells being derived from a human carcinoma. As 
discussed above, studies involving the first series of constructs using one permissive 
and one nonpermissive cell line indicated that regulatory elements required for cell- 
type specific expression of NSE were probably located downstream of the Xho I site 
at position -255 (the upstream boundary of construct pNSE300CAT). For this 
reason, it was considered unnecessary to use all of the larger constructs for 
subsequent analysis and the intermediate-sized pNSE1200CAT was dropped from 
further transfection studies
6.4 Transfection with full series o f NSE-cat constructs
6.4.1 Transfection of Ltk- cells
Experiments designed to optimise the transfection parameters of the two 
neuroblastoma cell lines showed that neither could be successfully transfected using 
DEAE-dextran (see sections 5.4.4 and 5.4.5). However, DNA could be introduced 
into Neuro-2A cells with great efficiency using calcium phosphate whilst NB4-1A3 
cells could only take up DNA in the presence of liposomes. As experiments with 
the positive and negative cell lines were generally carried out in parallel, it was 
convenient to transfect Ltk- cells using both of these methods. As well as 
convenience, however, the Ltk- transfection experiments also served as a useful 
control for the effect of transfection method on the performance of the NSE-cat 
constructs. The results below reflect both calcium phosphate- and LipofectAMINE- 
mediated transfections as indicated in the figure legends. Under the conditions 
described in sections 5.4.1.2 and 5.4.1.3, Ltk- fibroblasts were transfected with the 
full series of NSE-cat constructs and controls. Data from three individual 
experiments are presented in Figures 6.13-6.15, followed by combined results in 
Figure 6.16. A representative CAT assay is shown in Figure 6.17. The results 
confirmed those obtained from DEAE-dextran-mediated transfection and indicated 
that the Relative CAT Activities of the first series of NSE-cat deletion constructs 
fell within the range 10-20%. The more truncated construct, pNSE120CAT, 
displayed mean Relative CAT Activities of 30-60%, generally a doubling over
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corresponding values for pNSE300CAT which could be attributed to the removal of 
the 135 bp fragment separating the upstream boundaries of the two constructs. 
Transfection with pNSE95CAT generated mean Relative CAT Activities within the 
range 25-30%, reflecting a minor loss of reporter activity compared to the next 
largest construct. Finally, the most truncated construct pNSE65CAT demonstrated 
mean Relative CAT Activities of around 0%, indicating that very little transcription 
of the reporter gene had taken place.
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C o n s t r u c t
Figure 6.13: Table and histogram showing data from the first transfection of Ltk- cells with the full 
series of NSE-cat deletion constructs. Transfection was carried out using calcium phosphate. 
Abbreviations used in table headings: CAT - CAT (chloramphenicol acetyltransferase) activity; GAL 
- P-galactosidase activity; MEC - Molar Equivalence Constant; ACA - Actual CAT Activity, xACA - 
mean Actual CAT Activity of control constructs; RCA - Relative CAT Activity; xRCA - mean 
Relative CAT Activity; semRCA - standard error of the mean Relative CAT Activity. A brief 
explanation of these terms can be found in Figure 6.1, a fuller explanation in section 5.5. The 
histogram shows mean Relative CAT Activities for each construct with error bars representing 
standard errors.
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Construct CAT GAL MEC ACA xACA RCA xRCA semRCA
Control
32950 188
1.30
134.82 109.27
100.00 6.5324573 174 108.63 123.72 87.39
28556 172 127.71 103.33
Basic
1056 184
1.41
4.07
4.04
0.02
0.00 0.30877 134 4.64 0.50
683 142 3.41 -0.53
NSE1800
2562 88 29.20 21.02
16.73 2.152995 141 1.00 21.24 14.37
2870 132 21.74 14.79
NSE1000
5956 199 26.49 18.75
21.56 1.805661 148 1.13 33.85 24.91
6107 185 29.21 21.03
NSE300
3569 100
1.30
27.45 19.56
15.92 4.713929 101 29.92 21.63
1887 122 11.90 6.56
NSE120
22746 232
1.34
73.17 57.76
56.97 5.5418745 232 60.30 47.00
27423 246 83.19 66.13
NSE95
3563 60 44.05 33.43
33.37 3.293118 62 1.35 37.12 27.64
2264 33 50.76 39.04
1004 188 3.% -0.07
NSE65 993 164 1.35 4.49 0.37 -0.41 0.57
574 192 2.21 -1.53
Control Basic NSE1800 NSE1000 NSE300 NSE120 NSE95 NSE65
C o n s t r u c t
Figure 6.14: Table and histogram showing data from the second transfection of Ltk- cells with the 
full series of NSE-cat deletion constructs. Transfection was carried out using calcium phosphate. 
Abbreviations used in table headings: CAT - CAT (chloramphenicol acetyltransferase) activity; GAL 
- P-galactosidase activity; MEC - Molar Equivalence Constant; ACA - Actual CAT Activity, xACA - 
mean Actual CAT Activity of control constructs; RCA - Relative CAT Activity; xRCA - mean 
Relative CAT Activity; semRCA - standard error of the mean Relative CAT Activity. A brief 
explanation of these terms can be found in Figure 6.1, a fuller explanation in section 5.5. The 
histogram shows mean Relative CAT Activities for each construct with error bars representing 
standard errors.
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Construct CAT GAL MEC ACA xACA RCA xRCA semRCA
Control
310946 177
1.30
1351.35 94.56
100.00 6.93258788 123 1618.44 1427.01 113.75
204555 120 1311.25 91.68
Basic
1775 133
1.41
9.47
35.10
-1.84
0.00 1.048440 165 36.28 0.08
12935 154 59.57 1.76
NSE 1800
44967 132
1.00
340.66 21.95
14.09 4.3739110 176 222.22 13.44
40634 311 130.66 6.86
NSE1000
37346 211
1.13
156.63 8.73
9.94 1.0837921 165 203.38 12.09
36440 201 160.44 9.00
NSE300
71399 225
1.30
244.10 15.01
20.26 8.2775469 107 542.55 36.46
75101 351 164.59 9.30
NSE120
125105 111
1.34
841.10 57.90
45.29 6.45122745 168 545.24 36.65
1013% 124 610.23 41.32
NSE95
68336 156
1.35
324.48 20.79
25.09 7.1574531 221 249.81 15.43
81252 104 578.72 39.05
7758 175 32.84 -0.16
NSE65 3523 184 1.35 14.18 -1.50 -1.00 0.42
4955 222 16.53 -1.33
Control Basic NSE1800 NSE1000 NSE300 NSE120 NSE95 NSE65
C o n s t r u c t
Figure 6.15: Table and histogram showing data from the third transfection of Ltk- cells with the full 
series of NSE-cat deletion constructs. Transfection was carried out using LipofectAMINE. 
Abbreviations used in table headings: CAT - CAT (chloramphenicol acetyltransferase) activity; GAL 
- P-galactosidase activity; MEC - Molar Equivalence Constant; ACA - Actual CAT Activity, xACA - 
mean Actual CAT Activity of control constructs; RCA - Relative CAT Activity; xRCA - mean 
Relative CAT Activity; semRCA - standard error of the mean Relative CAT Activity. A brief 
explanation of these terms can be found in Figure 6.1, a fuller explanation in section 5.5. The 
histogram shows mean Relative CAT Activities for each construct with error bars representing 
standard errors.
179
Results: Chapter 6
1| \  %
•  % •  i
X
{/)
1 «  1 *
H
d) •  « • S
0
a ? •  • • 1
0
5 Oh
•  1 •
•  • • J
¿3
a
o
J■ •  « • 1
w
a .
C/D
, I f  1 1
# 1 1  .0
1  c«
Q
—i # 1 1  1w  S
o<
I I  •  4
U U
190
Fi
gu
re
 6
.2
3:
 C
A
T 
as
sa
y 
fro
m
 th
e 
in
iti
al
 N
eu
ro
-2
A
 tr
an
sf
ec
tio
n 
ex
pe
rim
en
t (
Fi
gu
re
 6
.1
8)
 u
sin
g 
th
e 
fu
ll 
se
rie
s o
f 
NS
E-
ca
t c
on
str
uc
ts 
ex
cl
ud
in
g 
pN
SE
65
CA
T 
bu
t i
nc
lu
di
ng
 p
N
SE
12
00
CA
T,
 w
hi
ch
 w
as
 
la
te
r d
ro
pp
ed
 f
ro
m
 tr
an
sf
ec
tio
n 
ex
pe
rim
en
ts.
 
Ea
ch
 c
on
str
uc
t w
as
 tr
an
sf
ec
te
d 
in
 tr
ip
lic
at
e 
an
d 
th
e 
la
ne
s 
on
 th
e 
TL
C
 p
la
te
 w
er
e 
gr
ou
pe
d 
ac
co
rd
in
gl
y.
 
A
bb
re
vi
at
io
ns
: 0
 =
 o
rig
in
; C
 =
 c
hl
or
am
­
ph
en
ic
ol
; 
1A
 =
 1
-a
ce
ty
lc
hl
or
am
ph
en
ic
ol
; 3
A
 =
 3
-a
ce
ty
lc
hl
or
am
ph
en
ic
ol
.
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Figure 6.22 (Opposite page): Table and histogram showing combined data from the transfection of 
Neuro-2A cells with the full series of NSE-cat deletion constructs. Abbreviations used in the table: 
RCA1, RCA2, RCA3, RCA4 - Relative CAT Activities from the four individual experiments (as 
shown in Figures 6.17-6.20); xRCA1234 - combined mean Relative CAT Activity for each construct 
over four experiments (maximum of twelve transfections); semRCA1234 - standard error of the 
combined mean Relative CAT Activities. Gaps in the table indicate where particular constructs were 
not used. A brief explanation of these terms can be found in Figure 6.1, a fuller explanation in 
section 5.5. The histogram shows combined mean relative CAT activity for each construct and 
illustrates the trend in reporter gene activity for reporter constructs containing stepwise deletions of 
the rat NSE 5’ flanking region. Error bars represent standard errors of the combined mean Relative 
CAT Activities.
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Construct RCA1 RCA2 RCA3 RC A4 xRCA1234 semRCA1234
Control 141.01 94.29 90.85 117.67 100.00 5.37
84.54 89.17 106.34 80.99
74.45 116.54 102.81 101.34
Basic -5.07 5.80 -1.99 -0.23 0.00 1.65
13.25 -6.90 1.35 -0.04
-8.18 1.10 0.64 0.26
NSE 1800 160.73 117.67 129.55 121.11 132.59 12.02
192.96 68.56 106.81 134.33
209.32 75.32 126.40 148.27
NSE 1200 105.58 124.96 25.36
175.24
94.05
NSE1000 167.09 97.54 101.04 106.42 133.01 14.86
151.28 160.43 84.46 144.98
269.28 94.85 99.37 119.34
NSE300 137.05 201.80 130.90 117.61 108.24 10.64
80.76 102.00 67.31 100.93
100.03 103.38 81.36 75.84
NSE 120 591.70 243.04 286.99 191.46 291.07 30.98
319.84 183.36 279.11 251.40
273.37 367.68 237.59 267.26
NSE95 407.39 167.55 21.56 178.22 206.70 26.47
231.89 262.65 192.85 160.19
278.45 241.28 163.10 175.28
NSE65 -2.65 0.23 0.61 -1.49 0.79
-7.29 -0.86 -0.54
-0.85 -0.92 -1.16
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6.4.2 Transfection of Neuro-2A cells
Neuro-2A cells were made available just as the experiments involving U-138 MG 
glioma cells were coming to an end. The first transfection took place before any 
conclusions had been drawn from the U-138 MG experiments and before the most 
truncated construct used in this study, pNSE65CAT, had been produced.
Therefore, Neuro-2A cells were, in the first instance, transfected with a mixed 
group of constructs comprising pNSE1800CAT, pNSE1200CAT, pNSElOOOCAT, 
pNSE300CAT, pNSE120CAT and pNSE95CAT. The second and subsequent 
transfections followed a more orthodox pattern (in accordance with the routine 
introduction of DNA into other cell lines), with the following constructs used: 
pNSE1800CAT, pNSElOOOCAT, pNSE300CAT, pNSE120CAT, pNSE95CAT and 
pNSE65CAT. Neuro-2A cells were transfected using calcium phosphate under the 
conditions described in section 5.4.4. Data from the first transfection and three 
subsequent transfections are presented in Figures 6.18-6.21, followed by combined 
results in Figure 6.22. Representative CAT assays are shown in Figures 6.23 and 
6.24. The results, in common with other transfections mediated by calcium 
phosphate, showed a degree of variability between experiments. The initial series 
of NSE-cat constructs generally showed mean Relative CAT Activities in the range 
90-140%, with standard error values to indicate that the differences between them 
were not significant. In the first transfection experiment, the mean Relative CAT 
Activities for these constructs were somewhat higher, falling within the range 100- 
200%, however, as found for the third U-138 MG transfection experiment (see 
section 6.3.2), the standard error value for the control vector, pCAT-Control, was 
greater than the arbitrary maximum of 15% of the mean, indicating that at least one 
of the data points in the control transfection was nonrepresentative. The 
consequence of one uncharacteristically low Actual CAT Activity for the control 
vector would be the reduction of the mean Actual CAT Activity and this would have 
a knock-on effect, generating unrealistically high Relative CAT Activities for each 
of the NSE-cat vectors. The scenario described above is most likely to be the case 
for this first experiment as the mean Relative CAT Activities for the whole series of 
constructs were higher than those for the same constructs in the subsequent three 
transfection experiments. Over the last three transfection experiments, the construct 
pNSE120CAT demonstrated mean Relative CAT Activities in the narrow range 
235-270%, reflecting a two- to threefold increase upon the mean RCA values of 
pNSE300CAT. One again, the first transfection experiment generated a 
substantially higher mean Relative CAT Activity for this construct, approximately 
400%, and the standard error was higher than 15%. The further truncated vector,
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pNSE95CAT, demonstrated mean Relative CAT Activities in the range 125-225% 
over transfections 2, 3 and 4. The lower value was obtained in the third 
transfection experiment and the standard error for this construct was 42% of the 
mean. It is therefore very likely that one of the data points for this transfection was 
nonrepresentative, and from the sample of Relative CAT Activities shown for this 
construct in Figure 6.22, it can be seen that all values fall within the range 160- 
260% except one of 22% from the third experiment. It is clear that this aberrant 
result is responsible for the spread of Relative CAT Activities in the third 
transfection. Once again, the mean Relative CAT activity for pNSE95CAT was 
much higher in the first transfection (305%, with standard error in excess of 15%) 
for the reasons already discussed. The final construct, pNSE65CAT, showed mean 
Relative CAT Activities around 0% in all experiments, indicating that no 
transcription above the background value of the negative control vector, pCAT- 
Basic, had occurred.
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Construct CAT GAL MEC ACA xACA RCA xRCA semRCA
Control
92090 264
1.30
268.33 141.01
100.00 20.7184789 374 174.39 200.11 84.54
57578 281 157.62 74.45
Basic
13365 374
1.41
25.34 -5.07
0.00 6.6823684 301 55.80 33.77 13.25
10404 366 20.16 -8.18
NSE1800
89135 2%
1.00
301.13 160.73
187.67 14.27118841 335 354.75 192.96
98545 258 381.96 209.32
NSE1200
74379 320
1.11
209.40 105.58
124.96 25.36119868 332 325.27 175.24
80658 382 190.22 94.05
NSE1000
115530 328
1.13
311.70 167.09
195.88 36.98107399 333 285.42 151.28
154041 283 481.69 269.28
NSE300
107527 316
1.30
261.75 137.05
105.95 16.5289385 409 168.11 80.76
82485 317 200.16 100.03
NSE120
321939 236
1.34
1018.02 591.70
394.97 99.28206220 272 565.79 319.84
166266 254 488.50 273.37
308298 321 711.43 407.39
NSE95 189717 335 1.35 419.50 231.89 305.91 52.49
251584 375 496.96 278.45
Construct
Figure 6.18: Table and histogram showing data from the first transfection of Neuro-2A cells. 
Abbreviations used in table headings: CAT - CAT (chloramphenicol acetyltransferase) activity; GAL
- (3-galactosidase activity; MEC - Molar Equivalence Constant; ACA - Actual CAT Activity, xACA
- mean Actual CAT Activity of control constructs; RCA - Relative CAT Activity; xRCA - mean 
Relative CAT Activity; semRCA - standard error of the mean Relative CAT Activity. A brief 
explanation of these terms can be found in Figure 6.1, a fuller explanation in section 5.5. The 
histogram shows mean Relative CAT Activities for each construct with error bars representing 
standard errors.
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C o n s t r u c t
Figure 6.19: Table and histogram showing data from the first transfection of Neuro-2A cells with the 
full series of NSE-cat deletion constructs. Abbreviations used in table headings: CAT - CAT 
(chloramphenicol acetyltransferase) activity; GAL - p-galactosidase activity; MEC - Molar 
Equivalence Constant; ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control 
constructs; RCA - Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard 
error of the mean Relative CAT Activity. A brief explanation of these terms can be found in Figure 
6.1, a fuller explanation in section 5.5. The histogram shows mean Relative CAT Activities for each 
construct with error bars representing standard errors.
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Construct CAT GAL MEC ACA xACA RCA xRCA semRCA
Control
452372 427 814.94
894.97
90.85
100.00 4.68429968 348 1.30 950.42 106.34
463822 388 919.55 102.81
Basic
1044 297
1.41
2.49
19.87
-1.99
0.00 1.0116342 366 31.67 1.35
12994 362 25.46 0.64
NSE1800
539853 468
1.00
1153.53 129.55
120.92 7.11603274 632 954.55 106.81
593387 527 1125.97 126.40
NSE1000
668336 666
1.11
904.06 101.04
94.95 5.27588873 699 758.96 84.46
679232 688 889.42 99.37
NSE300
666570 440
1.30
1165.33 130.90
93.19 19.29379943 480 608.88 67.31
396721 417 731.82 81.36
NSE120
1339820 395
1.34
2531.31 286.99
267.90 15.321164733 353 2462.33 279.11
1206660 429 2099.05 237.59
NSE95
109816 390
1.35
208.58 21.56
125.84 52.841081100 469 1707.49 192.85
1090112 558 1447.12 163.10
12887 437 21.84 0.23
NSE65 9732 585 1.35 12.32 -0.86 -0.52 0.37
9410 589 11.83 -0.92
Figure 6.20: Table and histogram showing data from the second transfection of Neuro-2A cells with 
the full series of NSE-cat deletion constructs. Abbreviations used in table headings: CAT - CAT 
(chloramphenicol acetyltransferase) activity; GAL - P-galactosidase activity; MEC - Molar 
Equivalence Constant; ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control 
constructs; RCA - Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard 
error of the mean Relative CAT Activity. A brief explanation of these terms can be found in Figure 
6.1, a fuller explanation in section 5.5. The histogram shows mean Relative CAT Activities for each 
construct with error bars representing standard errors.
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Figure 6.21: Table and histogram showing data from the third transfection of Neuro-2A cells with the 
full series of NSE-cat deletion constructs. Abbreviations used in table headings: CAT - CAT 
(chloramphenicol acetyltransferase) activity; GAL - P-galactosidase activity; MEC - Molar 
Equivalence Constant; ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control 
constructs; RCA - Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard 
error of the mean Relative CAT Activity. A brief explanation of these terms can be found in Figure 
6.1, a fuller explanation in section 5.5. The histogram shows mean Relative CAT Activities for each 
construct with error bars representing standard errors.
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Results: Chapter 6
Construct RCA1 RCA2 RCA3 XRCA123 semRCA123
Control 112.42 109.27 94.56 100.00 4.75
114.43 87.39 113.75
73.14 103.33 91.68
Basic -1.02 0.02 -1.84 0.00 0.35
0.36 0.50 0.08
0.66 -0.53 1.76
NSE 1800 15.22 21.02 21.95 14.97 1.54
16.13 14.37 13.44
10.92 14.79 6.86
NSE1000 4.28 18.75 8.73 12.80 2.35
8.55 24.91 12.09
7.82 21.03 9.00
NSE300 13.47 19.56 15.01 17.16 2.87
15.36 21.63 36.46
17.06 6.56 9.30
NSE 120 31.45 57.76 57.90 44.67 4.39
30.71 47.00 36.65
33.14 66.13 41.32
NSE95 28.92 33.43 20.79 27.47 2.81
21.01 27.64 15.43
21.94 39.04 39.05
NSE65 1.67 -0.07 -0.16 -0.01 0.42
0.98 0.37 -1.50
1.46 -1.53 -1.33
Construct
Figure 6.16: Table and histogram showing combined data from the transfection of Ltk- cells with the 
full series of NSE-cat deletion constructs. Abbreviations used in the table: RCA1, RCA2, RCA3 - 
Relative CAT Activities from the three individual experiments (as shown in Figures 6.13-6.15); 
XRCA123 - combined mean Relative CAT Activity for each construct over three experiments (nine 
transfections); semRCA123 - standard error of the combined mean Relative CAT Activities. A brief 
explanation of these terms can be found in Figure 6.1, a fuller explanation in section 5.5. The 
histogram shows combined mean relative CAT activity for each construct and illustrates the trend in 
reporter gene activity for reporter constructs containing stepwise deletions of the rat NSE 5’ flanking 
region. Error bars represent standard errors of the combined mean Relative CAT Activities.
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Results: Chapter 6
6.4.3 Transfection of NB4-1A3 cells
Under the conditions described in section 5.4.5, NB4-1A3 neuroblastoma cells were 
transfected with the full series of NSE-cat constructs and controls using 
LipofectAMINE. Data from two individual experiments are presented in Figures 
6.25 and 6.26, followed by combined results in Figure 6.27. A representative CAT 
assay is shown in Figure 6.28. The results for the longest construct, 
pNSE1800CAT, were consistent within each experiment but varied between them, 
with a mean Relative CAT Activities of 35 % for the first transfection and 67 % for 
the second. For the majority of the other constructs, the results appeared more 
repeatable. The shorter construct pNSElOOOCAT demonstrated a low mean 
Relative CAT Activity of 5-6%, whereas pNSE300CAT demonstrated a mean 
Relative CAT Activity of 25-27%. The more truncated construct, pNSE120CAT, 
generally displayed Relative CAT Activities in the range 20-30%, however, in the 
second transfection, a one-off value of 81% increased the mean Relative CAT 
Activity to 43 % and generated a standard error of 45 %; it is therefore likely that 
this data point was nonrepresentative of this construct. Like pNSE1800CAT, the 
further truncated construct pNSE95CAT demonstrated a higher mean Relative CAT 
Activity in the second transfection compared to the first (32% compared to 17%), 
whilst in each individual transfection, the values were more consistent. Finally, the 
most truncated construct pNSE65CAT, displayed Relative CAT Activities of 
approximately 2% in each experiment.
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Coast ruct CAT GAL MEC ACA xACA RCA xRCA semRCA
Control
422623 188 1729.23 94.01
100.00 8.19491762 229 1.30 1651.87 1839.06 89.79
466520 168 2136.08 116.20
Basic
2163 233 6.58
5.50
0.06
0.00 0.07871 216 1.41 2.86 -0.14
2109 212 7.06 0.08
NSE1800
64046 142 452.14 24.36
35.23 5.52102304 142 1.00 719.94 38.96
139302 178 782.03 42.35
NSE1000
23889 142 151.56 7.97
5.52 1.2514319 141 1.11 91.49 4.69
14521 170 76.95 3.90
NSE300
164141 227 556.22 30.04
27.31 1.50181001 302 1.30 461.03 24.84
185875 285 501.69 27.06
NSE120
62521 166 281.07 15.03
23.64 4.9182923 104 1.34 593.09 32.05
100208 169 442.58 23.84
NSE95
78161 250 231.59 12.33
17.32 2.55105355 203 1.35 385.29 20.71
106044 223 352.32 18.92
14259 220 48.01 2.32
NSE65 11265 251 1.35 33.24 1.51 1.76 0.28
9312 215 32.08 1.45
Construct
Figure 6.25: Table and histogram showing data from the first transfection of NB4-1A3 cells with the 
full series of NSE-cal deletion constructs. Abbreviations used in table headings: CAT - CAT 
(chloramphenicol acetyltransferase) activity; GAL - [i-galactosidase activity; MEC - Molar 
Equivalence Constant; ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control 
constructs; RCA - Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard 
error of the mean Relative CAT Activity. A brief explanation of these terms can be found in Figure 
6.1, a fuller explanation in section 5.5. The histogram shows mean Relative CAT Activities for each 
construct with error bars representing standard errors.
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C o n s tr u c t
Figure 6.26: Table and histogram showing data from the second transfection of NB4-1 A3 cells with 
the full series of NSE-cal deletion constructs. Abbreviations used in table headings: CAT - CAT 
(chloramphenicol acetyltransferase) activity; GAL - p-galactosidase activity; MEC - Molar 
Equivalence Constant; ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control 
constructs; RCA - Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard 
error of the mean Relative CAT Activity. A brief explanation of these terms can be found in Figure 
6.1, a fuller explanation in section 5.5. The histogram shows mean Relative CAT Activities for each 
construct with error bars representing standard errors.
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Construct RCAI RCA2 xRCA12 semRCA12
Control 94.01 114.68 100.00 5.06
89.79 87.99
116.20 97.33
Basic 0.06 0.17 0.00 0.05
-0.14 -0.16
0.08 0.00
NSE18(X) 24.36 71.23 51.33 7.67
38.96 63.79
42.35 67.28
NSE 1 (XX) 7.97 8.44 5.98 1.13
4.69 2.12
3.90 8.73
NSE300 30.04 35.08 26.19 3.78
24.84 31.37
27.06 8.73
NSE120 15.03 20.05 33.18 9.85
32.05 27.16
23.84 80.96
NSE95 12.33 35.08 24.67 3.74
20.71 35.10
18.92 25.88
NSE65 2.32 1.50 1.86 0.22
1.51 1.61
1.45 2.75
C o n s t r u c t
Figure 6.27: Table and histogram showing combined data from the transfection of NB4-1A3 cells 
with the full series of NSE-cat deletion constructs. Abbreviations used in the table: RCAI and RCA2 
- Relative CAT Activities from the two individual experiments (as shown in Figures 6.24 and 6.25); 
xRCA12 - combined mean Relative CAT Activity for each construct over two experiments (six 
transfections); semRCA12 - standard error of the combined mean Relative CAT Activities. A brief 
explanation of these terms can be found in Figure 6.1, a fuller explanation in section 5.5. The 
histogram shows combined mean relative CAT activity for each construct and illustrates the trend in 
reporter gene activity for reporter constructs containing stepwise deletions of the rat NSE 5’ flanking 
region. Error bars represent standard errors of the combined mean Relative CAT Activities.
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Figure 6.30: Table and histogram showing data from the second transfection of HeLa cells with the 
full series of NSE-cat deletion constructs. Abbreviations used in table headings: CAT - CAT 
(chloramphenicol acetyltransferase) activity; GAL - P-galactosidase activity; MEC - Molar 
Equivalence Constant; ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control 
constructs; RCA - Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard 
error of the mean Relative CAT Activity. A brief explanation of these terms can be found in Figure 
6.1, a fuller explanation in section 5.5. The histogram shows mean Relative CAT Activities for each 
construct with error bars representing standard errors.
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Construct CAT GAL MEC ACA xACA RCA xRCA semRCA
1125395 299 2895.28 100.99
Control 1332592 313 1.30 3274.99 2867.25 114.43 100.00 8.63
948277 300 2431.48 84.58
17184 266 45.82 0.13
Basic 20834 281 1.41 52.58 42.06 0.37 0.00 0.26
11237 287 27.77 -0.51
94721 325 291.45 8.83
NSE1800 82278 297 1.00 277.03 8.32 9.34 0.78
47121 135 349.04 10.87
37128 131 250.81 7.39
NSE1000 46555 144 1.13 286.10 8.64 7.84 0.40
42194 147 254.01 7.50
52568 167 242.14 7.08
NSE300 49144 141 1.30 268.11 8.00 6.77 0.81
25199 102 190.04 5.24
23771 150 118.26 2.70
NSE120 20067 112 1.34 133.71 3.24 2.97 0.16
25671 152 126.04 2.97
10503 105 74.10 1.13
NSE95 16005 113 1.35 104.92 2.22 1.75 0.32
13571 105 95.74 1.90
8031 165 36.05 -0.21
NSE65 12455 149 1.35 61.92 0.70 0.92 0.73
13923 97 106.32 2.27
Figure 6.31: Table and histogram showing data from the third transfection of HeLa cells with the full 
series of NSE-cat deletion constructs. Abbreviations used in table headings: CAT - CAT 
(chloramphenicol acetyltransferase) activity; GAL - (3-galactosidase activity; MEC - Molar 
Equivalence Constant; ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control 
constructs; RCA - Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard 
error of the mean Relative CAT Activity. A brief explanation of these terms can be found in Figure 
6.1, a fuller explanation in section 5.5. The histogram shows mean Relative CAT Activities for each 
construct with error bars representing standard errors.
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Construct RCA1 RCA2 RCA3 XRCA123 semRCA123
Control 122.50 92.71 100.99 100.00 5.25
88.18 85.02 114.43
89.32 122.28 84.58
Basic -0.63 -0.84 0.13 0.00 0.25
0.77 1.44 0.37
-0.13 -0.60 -0.51
NSE 1800 6.24 18.20 8.83 7.96 1.50
6.50 3.64 8.32
5.12 3.89 10.87
NSE 1000 2.76 2.03 7.39 4.38 0.94
4.79 3.32 8.64
2.15 0.87 7.50
NSE300 2.71 6.06 7.08 4.83 0.79
4.20 0.75 8.00
6.47 2.94 5.24
NSE120 2.62 1.74 2.70 2.33 0.31
1.73 1.74 3.24
3.58 0.67 2.97
NSE95 1.90 1.13 1.13 1.54 0.16
1.16 2.02 2.22
0.99 1.42 1.90
NSE65 0.56 -0.13 -0.21 0.54 0.26
0.59 0.19 0.70
1.06 -0.20 2.27
Figure 6.32: Table and histogram showing combined data from the transfection of HeLa cells with 
the full series of NSE-cat deletion constructs. Abbreviations used in the table: RCA1, RCA2, RCA3 
- Relative CAT Activities from the three individual experiments (as shown in Figures 6.28-6.30); 
xRCA123 - combined mean Relative CAT Activity for each construct over three experiments (nine 
transfections); semRCA123 - standard error of the combined mean Relative CAT Activities. A brief 
explanation of these terms can be found in Figure 6.1, a fuller explanation in section 5.5. The 
histogram shows combined mean relative CAT activity for each construct and illustrates the trend in 
reporter gene activity for reporter constructs containing stepwise deletions of the rat NSE 5’ flanking 
region. Error bars represent standard errors of the combined mean Relative CAT Activities.
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Results: Chapter 6
6.4.5 Conclusions from the full series of transfections
Transfection studies using the full series of NSE-cat constructs have provided a 
wealth of information concerning the cell type-specific regulation of NSE. In the 
first instance, the Ltk- cell line transfections have shown that the method used to 
introduce DNA into the cells has little effect upon the performance of the 
constructs. Initially, this conclusion might appear insignificant, as one would 
expect that a given construct would behave in the same manner once inside a cell 
regardless of its strategy for gaining access. However, due to the preferences of 
different cells, a number of alternative transfection strategies were utilised in this 
study, and it would be naive to directly compare the results from two cell lines 
transfected by different methods without controlling for the effect of transfection 
technique. The most suitable control would be to find a cell line which could be 
transfected by all the available procedures and compare the results obtained by each 
method. The Ltk- cell line has fulfilled this role in the present study.
Analysis of the highly truncated constructs in Ltk- cells showed that deletion from 
position -255 (the upstream boundary of pNSE300CAT) to position -120 (the 
upstream boundary of pNSE120CAT) resulted in a two-to-threefold increase in 
reporter activity. This suggested the presence of a negative regulatory element 
between -255 and -120 bp upstream of the first intron. Further deletion to position 
-95 resulted in a drop in reporter activity to a level approximately 1.5-fold that of 
the longer constructs. Finally, deletion to position -65 resulted in a sharp fall in 
reporter activity to a level comparable with the negative control construct, pCAT- 
Basic. These results suggested that 95 bp of regulatory information upstream of 
the transcriptional start site was sufficient for basal expression of NSE whilst 
removal of a further 30 bp resulted in a complete loss of expression. It is 
interesting to note that the upstream boundary of pNSE65CAT lies one nucleotide 
downstream of the putative TATA-like box of the NSE gene, indicating that this 
element is essential for gene expression. It is unclear whether the observed increase 
in reporter activity, when comparing pNSE120CAT to pNSE300CAT is significant: 
it has already been discussed that the level of NSE-cat construct expression in Ltk- 
cells is greater than would be expected from analysis of endogenous gene 
expression. It is therefore not inconceivable that the observed upregulation, clear as 
it is from the transfection studies, could play only a minor role, if at all, in 
nonneuronal cells in vivo. Whether significant or not, studies in neuronal cells were 
required to show whether this upregulation was cell type-specific or constitutive in 
nature. In Neuro-2A cells, the long constructs showed a pattern of activity similar
203
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to that shown by the U-138 MG cells. Analysis of the shorter constructs identified 
a similar increase in reporter activity upon reduction from 255 bp to 120 bp of 5’ 
flanking sequence, although in this cell line, the original level of activity was much 
higher relative to pCAT-Control. Once again, further deletion to position -95 
resulted in a fall in reporter activity, but not quite to the level demonstrated by the 
longer constructs, and deletion to position -65 resulted in reduction of reporter gene 
activity to background levels. These results suggested that a negative control 
element was indeed located between positions -255 and -120 relative to the 
transcriptional start, and that it was active in both neuronal and nonneuronal cells. 
Although the difference in the levels of reporter activity between pNSE300CAT and 
pNSE120CAT was approximately twofold in Neuro-2A cells, it ranged from 
threefold to fivefold in the Ltk- cells, suggesting a preference for the nonneuronal 
cell line. It is possible that a negative regulatory factor could be present in both 
neuronal and nonneuronal cells, but more abundantly or preferentially active in the 
latter. Also, the fact that neuroblastoma cells are derived from an early stage in the 
pathway of neuronal differentiation suggests that they might contain such a factor in 
greater quantities compared to mature neuronal cells.
Further analysis in other permissive and nonpermissive cells, however, failed to 
identify a similar phenomenon. In both NB4-1 A3 neuroblastoma cells and HeLa 
cells, reduction of the NSE regulatory region from position -255 to position -120 
had no significant stimulatory effect upon reporter gene expression. In NB4-1A3 
cells, the levels of reporter gene expression were generally much lower than those 
in Neuro-2A cells. This might have reflected differences in the state of neuronal 
maturation each cell line was able to attain in culture as discussed in Chapter 9. In 
agreement with this, the levels of reporter activity in NB4-1A3 cells transfected 
with the full length construct pNSE1800CAT reached only 50% of the levels found 
in Neuro-2A cells. One surprising finding from the NB4-1A3 cell transfections was 
the sharp drop in reporter activity (to 10% of the pNSE1800 value) when the NSE 
promoter was reduced to 1 kbp in length. This was followed by a rise (to 
approximately 50% of the pNSE1800 value) when the promoter was truncated 
further to 255 bp. These data suggest that a strong, positive-acting element, located 
between 1800 and 1000 bp upstream of the transcriptional start, was removed to 
generate the levels of reporter activity observed in NB4-1A3 cells transfected with 
pNSElOOOCAT. Further truncation sponsored a levelling of reporter expression, 
perhaps indicating that negative elements, located between 1000 and 255 bp 
upstream of the transcriptional start, were removed. It is unclear why this effect 
should be restricted to NB4-1A3 cells. Similarly, the upregulation observed in Ltk-
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Construct RCA1 RCA2 RCA3 \RCA123 semRCA123
Control 82.81 95.00 139.68 100.00 6.93
98.12 100.41 94.12
119.07 104.59 66.20
Basic 0.32 1.70 0.56 0.00 0.31
0.27 -1.07 0.58
-0.59 -0.63 -1.14
NSE1800 13.79 13.46 11.54 13.13 1.19
12.18 19.20 7.85
18.15 10.97 11.07
NSE1200 11.57 16.67 9.33 13.28 1.43
10.46 17.68 20.79
11.86 13.43 7.75
NSE1000 12.47 16.13 16.42 12.74 0.95
13.93 12.09 9.35
10.65 14.99 8.59
NSE300 16.49 25.51 20.50 20.47 1.09
23.67 20.65 17.25
23.68 19.41 17.03
Construct
Figure 6.5: Table and histogram showing combined data from the transfection of Ltk- cells with the 
initial series of NSE-cat deletion constructs. Abbreviations used in the table: RCA1, RCA2, RCA3 - 
Relative CAT Activities from the three individual experiments (as shown in Figures 6.2-6.4); 
XRCA123 - combined mean Relative CAT Activity for each construct over three experiments (nine 
transfections); semRCA123 - standard error of the combined mean Relative CAT Activities. A brief 
explanation of these terms can be found in Figure 6.1, a fuller explanation in section 5.5. The 
histogram shows combined mean relative CAT activity for each construct and illustrates the trend in 
reporter gene activity for reporter constructs containing stepwise deletions of the rat NSE 5’ flanking 
region. Error bars represent standard errors of the combined mean Relative CAT Activities.
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cells, when the fragment of regulatory information lying between positions -255 and 
-120 relative to the transcriptional srart site was removed, was not observed in 
HeLa cells. Generally, the observed level of reporter expression in HeLa cells was 
lower, construct for construct, than that in Ltk- cells. If anything, the trend in 
HeLa cells is reduced expression as the 5’ flanking region is progressively deleted.
It is clear from this series of transfections that information concerning the regulation 
of NSE is located throughout the 5’ flanking sequence, although that located 
downstream from position -65 is insufficient alone to promote transcription. The 
varying behaviour of the reporter constructs in different cell lines with similar 
properties may reflect different mechanisms of neuronal gene expression in vivo.
As discussed in Chapter 1, neurons isolated from different parts of the nervous 
system and from different developmental stages vary considerably in the amount of 
NSE gene products they express. Although no clear-cut mechanism of neuron- 
specific gene expression has emerged from this study, several regions of the 5’ 
flanking sequence have been observed to influence the expression of a reporter 
gene. Experiments designed to investigate the nature of such fragments further are 
described in Chapter 8.
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6.5 N SE  gene regulation during ex vivo neuronal differentiation
As discussed above, the dissection of regulatory elements in cell lines maintained 
under constant and normal growth conditions can reveal the position of constitutive 
and cell type-specific m-acting motifs. A more challenging application of the 
deletion-transfection approach, however, is to investigate the molecular basis of 
inductive responses. Where an endogenous gene responds to a given agent, and the 
mechanism of that response lies in the flanking regions of the gene, transfection of 
cells with reporter constructs containing various deletions in the flanking region can 
identify elements responsible for the inductive effect as variants with deletions 
covering the region involved will not respond to the inducing agent in the 
appropriate manner. If specific inductive responses can be tested, e.g. by 
introducing novel trans-acting factors into the system, the binding sites of such 
factors might be revealed. For example, such an approach was used by Dawson et 
al. (1994) to identify the site at which Oct-2 bound to the tyrosine hydroxylase 
promoter. Otherwise, more general responses can be studied, such as neuronal 
differentiation induced by retinoic acid or NGF. Such processes are known to 
involve complex signalling pathways and the switching of batteries of genes 
encoding transcriptional regulators and other neuronal proteins (see Barde, 1991), 
however, at the level of the NSE gene, there is likely to be a point where this 
hierarchy of unfolding events stops, and a region of the promoter which mediates 
the observed upregulation may be found. The molecular basis of neuronal 
differentiation is still poorly understood in mammals, although the recent 
identification of mammalian homologues of Drosophila proneural and neurogenic 
genes (e.g. Mashl, Proxl), other genes known to influence the determination of 
neuronal phenotype (e.g. NeuroD), and still other genes encoding transcription 
factors which are expressed at the right time and place (e.g. Sox2, S o x ll) has 
allowed some advance in our knowledge of neuronal differentiation in vivo (see 
Chapter 2). Retinoic acid-mediated neuronal differentiation was investigated in P19 
EC cells as these cells provide a unique opportunity for studying the process of 
differentiation from nonneuronal, MSE-nonpermissive stem cells through to NSE- 
permissive, differentiated neurons in an ex vivo environment. Although both NGF- 
treated and untreated PC 12 cells were found to express similar levels of NSE 
mRNA and NSE protein, there was a slight induction following NGF treatment 
accompanying neurite outgrowth and exit from the cell cycle. The regulation of 
NSE gene expression was also investigated in these cells.
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Construct
Figure 6.3: Table and histogram showing data from the second transfection of Ltk- cells with the 
initial series of NSE-cat deletion constructs. Abbreviations used in table headings: CAT - CAT 
(chlor-amphenicol acetyltransferase) activity; GAL - P-galactosidase activity; MEC - Molar 
Equivalence Constant; ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control 
constructs; RCA - Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard 
error of the mean Relative CAT Activity. A brief explanation of these terms can be found in Figure 
6.1, a fuller explanation in section 5.5. The histogram shows mean Relative CAT Activities for each 
construct with error bars representing standard errors.
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As discussed in section 1.5.3, the rat PC12 cell line represents an excellent ex vivo 
model of neuronal differentiation. Upon exposure to low doses of NGF, PC12 cells 
undergo a dramatic change of morphology, spreading out, developing neurites and 
eventually forming synaptic associations (Green and Tischler, 1976). Concomitant 
with this shift towards a neuronal phenotype, is the reported induction of NSE gene 
expression (Vinores et al., 1981) although in the present study, only a moderate 
elevation of gene expression was observed following treatment (see section 5.2.8). 
To investigate the molecular basis of NGF-mediated induction of NSE, 
undifferentiated and differentiated PC12 cells were transfected with the full series of 
NSE-cat constructs and the results were compared.
6.5.1 Transfection of PC12 cells
6.5.1.1 Transfection of undifferentiated PC12 cells
Under the conditions described in section 5.4.2.2, PC12 cells were transfected with 
the full series of NSE-cat constructs and control vectors using LipofectAMINE. 
Data from individual experiments are presented in Figures 6.34 and 6.35 followed 
by combined results in Figure 6.36. A representative CAT assay is shown in 
Figure 6.37. The results showed that, like other neuronal cell types, PC12 cells 
transfected with pNSE1800CAT demonstrated high levels of reporter activity, 
approximately equal to the activity of the positive control construct pCAT-Control. 
In the First transfection experiment (Figures 6.34 and 6.37), one dish of cells 
transfected with this construct gave an unusually low level of CAT activity, 
generating a Relative CAT activity of 32%. Compared to the other five values, 
which lie in the range 90-120%, this individual result can be regarded as aberrant 
and probably nonrepresentative. The mean Relative CAT activity of 85% is 
therefore probably underestimated. Reduction of the NSE 5’ flanking region to 1 
kbp and further to 255 bp appeared to cause an approximate 50% drop in reporter 
activity. The error range in transfections involving these two constructs suggested 
that there was no significant difference between them. Further reduction of the 
regulatory sequence to 120 bp resulted in a five- to sixfold reduction in CAT 
activity, suggesting that one or more m-acting elements located in the 130 bp 
region between the upstream boundaries of pNSE300CAT and pNSE120CAT were 
responsible for elevated transcriptional activity of the gene in PC12 cells. It was 
interesting to note that experiments with Ltk- cells, described earlier in the chapter, 
also indicated the importance of this region of the promoter. As observed in
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Construct
Figure 6.2: Table and histogram showing data from the first transfection of Ltk- cells with the initial 
series of NSE-cat deletion constructs. Abbreviations used in table headings: CAT - CAT (chlor­
amphenicol acetyltransferase) activity; GAL - fi-galactosidase activity; MEC - Molar Equivalence 
Constant; ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control constructs; 
RCA - Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard error of 
the mean Relative CAT Activity. A brief explanation of these terms can be found in Figure 6.1, a 
fuller explanation in section 5.5. The histogram shows mean Relative CAT Activities for each 
construct with error bars representing standard errors.
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Construct RCA1 RCA2 xRCA12 semRCA12
Control 110.49 97.05 100.00 14.34
148.50 90.98
41.01 111.97
Basic -0.07 -0.12 0.00 0.08
-0.05 -0.22
0.12 0.33
NSE 1800 121.44 94.19 91.14 12.46
101.93 103.58
32.33 93.36
NSE 1000 49.73 70.55 53.40 7.29
24.23 55.23
73.34 47.34
NSE300 29.10 54.33 55.59 12.49
113.87 56.26
33.18 46.81
NSE120 5.12 7.00 9.05 1.30
11.24 14.08
8.20 8.63
NSE95 3.25 5.78 5.76 0.68
5.59 8.42
5.32 6.18
NSE65 -0.57 -0.05 -0.31 0.11
-0.56 -0.13
-0.52 0.00
1 00  - i
80 -  
60 -
40 - 
20 -  
0
-20 - 1
Control Basic NSE1800 NSEI000 NSE300 NSE120 NSE95 NSE65 
C o n s t r u c t
Figure 6.36: Table and histogram showing combined data from the transfection of undifferentiated 
PC12 cells with the full series of NSE-cat deletion constructs. Abbreviations used in the table: RCA1 
and RCA2 - Relative CAT Activities from the two individual experiments (as shown in Figures 6.34 
and 6.35); xRCA12 - combined mean Relative CAT Activity for each construct over two experiments 
(six transfections); semRCA12 - standard error of the combined mean Relative CAT Activities. A 
brief explanation of these terms can be found in Figure 6.1, a fuller explanation in section 5.5. The 
histogram shows combined mean relative CAT activity for each construct and illustrates the trend in 
reporter gene activity for reporter constructs containing stepwise deletions of the rat NSE 5’ flanking 
region. Error bars represent standard errors of the combined mean Relative CAT Activities.
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Following differentiation under the influence of NGF as described in section 4.2.3, 
PC12 cells were transfected with the full series of NSE-cat constructs to determine 
the effects of NGF-induction. Data from individual experiments are presented in 
Figures 6.38 and 6.39, followed by combined results in Figure 6.40. A 
representative CAT assay is shown in Figure 6.41. It was immediately noticeable 
that neuronal differentiation caused a dramatic reduction in the efficiency of 
transfection. Whereas, in the case of the untreated cells, (3-galactosidase activity 
was measured after two hours, a minimum assay time of six hours was required for 
the NGF-treated cells. It was thought that several factors contributed to this 
reduction in transfection efficiency. Firstly, the number of cells growing in each 
dish at the time of transfection was approximately half that observed for 
undifferentiated cells; secondly, whereas the untreated cells became confluent prior 
to harvesting, the treated cells did not proliferate; and thirdly, the PC12 neurons 
were probably more resistant to DNA uptake than the stem cells, as has been 
observed by other investigators (Kingston et al., 1990) . The results obtained from 
NGF treated cells were similar to those obtained with untreated cells in that 
reduction of the regulatory sequence to 120 bp caused a dramatic reduction in 
reporter gene expression. All constructs containing more than 255 bp of regulatory 
information were expressed at levels similar to or above those of the positive 
control vector pCAT-Control. The major difference between untreated and treated 
PC 12 cells therefore appeared to be the maintenance of high level reporter 
expression in cells transfected with pNSElOOOCAT and pNSE300CAT. In the 
untreated cells, these constructs were expressed at approximately one half the level 
of the longest construct, pNSE1800CAT, whereas in the treated cells, all three of 
these constructs were expressed within a range 95-140% of the positive control 
vector pC AT-Control. Truncation to 120 bp of regulatory information reduced 
reporter expression to less than 5% of the positive control value, underscoring the 
evidence from untreated cells suggesting the presence of a critical enhancer element 
in the region between 255 and 120 bp upstream of the NSE gene transcriptional start 
site. In common with the undifferentiated cells and other cell lines, the most 
truncated construct was expressed at only background levels.
6.5 .1 .2  Transfection o f NGF-treated PC12 cells
2 1 3
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Construct CAT GAL MEC ACA xACA RCA xRCA semRCA
Control
18466 163
1.30
87.14 88.03
100.00 9.6426845 177 116.67 98.53 119.07
18134 152 91.77 92.90
Basic
477 123
1.41
2.75 -0.69
0.00 0.75N/A 77 N/A 3.41 N/A
883 154 4.07 0.69
NSE1800
18344 153
1.00
119.90 122.46
119.45 7.0518278 144 126.93 129.86
16992 163 104.25 106.01
NSE1000
12574 122
1.13
91.21 92.31
95.17 13.2213744 104 116.95 119.37
11815 142 73.63 73.83
NSE300
19231 101
1.30
146.47 150.40
138.01 6.4020673 121 131.42 134.58
16237 99 126.16 129.05
NSE120
1099 155
1.34
5.29 1.98
4.30 1.481254 132 7.09 3.87
1776 131 10.12 7.05
NSE95
833 152
1.35
4.06 0.68
1.51 0.99916 105 6.46 3.21
827 183 3.35 -0.06
371 155 1.77 -1.72
NSE65 427 172 1.35 1.84 1.65 -1.63 0.06
511 193 1.96 -1.52
C onstruct
Figure 6.38: Table and histogram showing data from the first transfection of NGF-treated PC12 
(Sheffield) cells with the full series of NSE-cat deletion constructs. Transfection was carried out 
using LipofectAMINE. Abbreviations used in table headings: CAT - CAT (chloramphenicol 
acetyltransferase) activity; GAL - P galactosidase activity; MEC - Molar Equivalence Constant; 
ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control constructs; RCA - 
Relative CAT Activity; xRCA - mean Relative CAT Activity; scmRCA - standard error of the mean 
Relative CAT Activity. A brief explanation of these terms can be found in Figure 6.1, a fuller 
explanation in section 5.5. The histogram shows mean Relative CAT Activities for each construct 
with error bars representing standard errors.
2 1 4
Results: Chapter 5
The general strategy for cotransfection experiments was described in section 4.2.5. 
The validity of conclusions drawn from such experiments, vis-a-vis the relative 
activity of various stepwise deletion mutants of the rat NSE 5' flanking region, relied 
very much on the manner in which the raw data were analysed, as discussed below.
5.5 Processing data from cotransfection experiments
5.5.1 Correcting and normalising the primary data
There were two sources of primary data arising from each transfection, viz the CAT 
activity, determined by phosphorimaging the acetylated chloramphenicol bands from 
the TLC plates, and the P-galactosidase activity, determined by a colourimetric assay. 
As discussed in section 4.2.5, all cells, including those transfected with the CAT 
control plasmids, were cotransfected with the same amount of pSV-P-Galactosidase in 
order to normalise CAT activities for transfection efficiency. It was also necessary to 
consider the molar amounts of each CAT plasmid introduced into the cells. This was 
because transfections were optimised according to the total mass o f DNA in the 
transfection mix, with the consequence that less transcriptional start sites were 
available for cells transfected with the larger constructs compared to those transfected 
with smaller constructs. To take this factor into account, a dimensionless constant 
was calculated for each construct, which was termed the molar equivalence constant 
(MEC). MECs were determined by dividing the size (in nucleotides) of the largest 
construct (pNSEl 800CAT) by the sizes of each of the other constructs as shown in 
Table 5.1.
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Construct CAT GAL MEC ACA xACA RCA xRCA semRCA
Control
22533 112
1.30
154.76 87.25
100.00 6.8235912 142 194.54 176.52 110.55
42183 180 180.27 102.19
Basic
823 147
1.41
3.97
5.82
-1.08
0.00 1.18226 151 1.06 0.00
1103 102 7.67 1.08
NSE1800
48956 178 275.03 157.71
114.02 22.6623884 132 180.94 102.59
14101 97 145.37 81.75
NSE1000
44231 146
1.13
268.10 153.65
99.34 27.1616394 114 127.26 71.14
17298 117 130.84 73.24
NSE300
1546 87
1.30
13.67 4.60
20.74 15.481677 81 15.93 5.92
12105 99 94.06 51.69
NSE120
6193 177
1.34
26.11 11.89
16.70 3.887222 183 29.45 13.84
11947 188 47.42 24.37
NSE95
9231 172
1.35
39.75 19.88
18.99 1.1310074 184 40.56 20.35
8453 182 34.40 16.74
1104 172 4.75 -0.62
NSE65 822 154 1.35 3.95 -1.09 -0.75 0.18
746 112 4.93 -0.52
C o n s t r u c t
Figure 6.39: Table and histogram showing data from the second transfection of NGF-treated PC12 
(Sheffield) cells with the full series of NSE-cat deletion constructs. Transfection was carried out 
using LipofectAMINE. Abbreviations used in table headings: CAT - CAT (chloramphenicol 
acetyltransferase) activity; GAL - P-galactosidase activity; MEC - Molar Equivalence Constant; 
ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control constructs; RCA - 
Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard error of the mean 
Relative CAT Activity. A brief explanation of these terms can be found in Figure 6.1, a fuller 
explanation in section 5.5. The histogram shows mean Relative CAT Activities for each construct 
with error bars representing standard errors.
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Figure 5.33: Optimisation of LipofectAMINE-mediated transfection of PI9 stem cells and neurons by 
varying the amount of liposome. Other parameters: cells transfected at confluence of 80% (stem cells) 
or 60-70% (neurons), duration of transfection 5 hour, 2pg DNA per 35mm dish. Negative controls 
were transfected without LipofectAMINE, other conditions remaining constant (shown at position 0 on 
x-axis). Note that because both experiments were carried out in parallel, the highest OD readings for 
stem cells are outside the linear range of the assay, reflecting the relatively long assay time (6 hours) 
required to detect p-galactosidase activity in the transfected neurons.
Figure 5.34: Optimisation of LipofectAMINE-mediated transfection of PI9 stem cells and neurons by 
varying the amount of DNA. Other parameters: cells transfected at confluence of 80% (stem cells) or 
60-70% (neurons), duration of transfection 5 hours, amount of LipofectAMINE per 35mm dish lOpI 
(stem cells) or 8pl (neurons). Untransfected cells were exposed to the same experimental conditions as 
the transfected cells with no LipofectAMINE in the transfection mixture. Assay time for stem cells 
was 2 hours, for neurons was 6 hours.
154
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HeLa cells were transfected using the BBS calcium phosphate protocol optimised for 
the U-138 MG and U-373 MG lines as described in section 5.4.3. The transfection 
efficiency, using identical parameters, was found to be high and no attempt at further 
optimisation was made.
5 .4 .6  T r a n sfe c tio n  o f  H eL a  c e l l s  u s in g  c a lc iu m  p h osp h ate
5.4.7 Optimisation of liposome-mediated transfection of P19 EC cells
It has been reported that PI9 EC cells transfect with only minimal efficiency using 
calcium phosphate (Rudnicki and McBumey, 1987). The calcium phosphate 
approach was therefore forsaken and LipofectAMINE was used. Transfections were 
optimised according to manufacturers' recommendations starting with the following 
parameters: transfections were carried out at 80% confluence (stem cells) or 60-70% 
confluence (neurons). A lower density of neurons was used because high density 
plating has been reported to reduce neurite outgrowth (Green et al., 1987), which 
might have unpredictable effects on the expression of NSE. In each case, the duration 
of transfection was 5 hours, and 2pg of DNA was used per 35mm well. The amount 
of LipofectAMINE was varied from 0 to lOpl per 35mm well. Cells were collected 
48hrs posttransfection and higher transfection efficiency was evident in the stem cells 
compared to the neurons, probably reflecting cell proliferation (PI9 stem cells 
proliferate voraciously) rather than ability to take up DNA. It was found that lOpl 
LipofectAMINE per 35mm well was optimal for the stem cells whilst 8pl was optimal 
for the neurons. These results are shown in Figure 5.33. The amount of DNA used 
per transfection was then optimised, using the LipofectAMINE reagent at its optimal 
dose. Keeping the other parameters unchanged, the amount of DNA was varied 
between 0.5 and 3 pg per 35mm well and it was found that 2pg per well was the 
optimal dose for P I9 cells whereas P19 neurons demonstrated very similar 
transfection efficiencies over a broader range of DNA concentrations, with an optimal 
dose of 1,5pg per transfection. These results are shown in Figure 5.34.
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As discussed in section 5.2.7, the murine P19 EC cell line is a prime candidate for 
the study of ex vivo neuronal differentiation (Rudnicki and McBurney, 1987). Upon 
exposure to low doses of retinoic acid under conditions where attachment to a 
substrate is not possible, P19 stem cells form dense cell aggregates. When these are 
dispersed into medium without retinoic acid , the cells differentiate into large 
numbers of neurons and other neural cell types, the latter of which can be 
selectively destroyed by inhibitors of the cell cycle (Rudnicki and McBurney,
1987). Concomitant with this shift towards a neuronal phenotype is the induction of 
NSE gene expression (see section 5.2.7), making this cell line a good candidate for 
the study of NSE gene regulation during neuronal differentiation. To investigate the 
molecular basis of this process, undifferentiated and differentiated P19 EC cells 
were transfected with the full series of NSE-cat constructs and the results were 
compared.
6.5 .2  Transfection of P19 EC cells
6.5.2.1 Transfection of P19 stem cells
P19 stem cells were transfected under the conditions described in section 5.4.7 with 
the full series of NSE-cat constructs and controls. Data from individual 
experiments are shown in Figures 6.42 and 6.43, followed by combined results in 
Figure 6.44. A representative CAT assay is shown in Figure 6.45. P19 EC cells 
are proliferative cells which were found to take up pSV-p-galactosidase plasmid 
DNA with ease (see Figure 5.34). It was therefore surprising and disappointing to 
find that, unlike the pilot experiments described in section 5.4.7, the cotransfection 
experiments were marred by poor transfection efficiency. Moreover, construct 
pNSE95CAT appeared to be unaffected by the problems which dogged the 
transfections with other constructs, and transfection efficiencies up to fivefold 
greater that those found with other constructs were observed. It was thought at first 
that the origin of this problem was contamination of the plasmid DNA stocks. 
However, inoculation of sterile medium with each plasmid DNA failed to 
demonstrate bacterial or fungal contamination and the same plasmid stocks were 
used for the subsequent transfection of other cell lines without similar problems. 
Local contamination of the cell cultures was also discounted as an explanation: the 
morphology of all the parallel cultures was similar both pretransfection and 
posttransfection, and all the cultures appeared to proliferate in a similar fashion, 
becoming confluent approximately 36 hours posttransfection; subculturing 
posttransfection cells into fresh medium also failed to reveal contamination by
2 1 8
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Neuro-2A cells were found to be refractory to DEAE-dextran mediated transfection 
although the same optimisation protocol was followed as for Ltk- cells and the other 
cell types. Calcium phosphate-mediated transfection was therefore attempted, using 
the same parameters optimised for the U-l 38 MG and U-373 MG cells and it was 
found that these conditions yielded very high transfection efficiencies. The cells were 
tested with a range of DNA concentrations, but the initial parameters were found to be 
ideal (Figure 5.30).
5 .4 .4  O p tim isa t io n  o f  tr a n sfe c tio n  o f  N e u r o -2 A  c e l ls
Transfected ~ ■  Untransfected Control
Amount of D N A  per triplicate < i^g)
Figure 5.30: Optimisation of calcium phosphate-mediated transfection of Neuro-2A cells by varying 
the amount of DNA: Other parameters: cells transfected at 70% confluence, duration of transfection 18 
hours, BBS at pH 6.95. Untransfected cells were exposed to the same experimental conditions as the 
transfected cells with the exception that no CaCl2 was included in the transfection mixture.
1 5 0
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Figure 6.42: Table and histogram showing data from the first transfection of undifferentiated P19 EC 
cells with the full series of NSE-cat deletion constructs. Transfection was carried out using 
LipofectAMINE. Abbreviations used in table headings: CAT - CAT (chloramphenicol 
acetyltransferase) activity; GAL - P-galactosidase activity; MEC - Molar Equivalence Constant;
ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control constructs; RCA - 
Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard error of the mean 
Relative CAT Activity. A brief explanation of these terms can be found in Figure 6.1, a fuller 
explanation in section 5.5. The histogram shows mean Relative CAT Activities for each construct 
with error bars representing standard errors.
2 2 0
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Construct CAT GAL MEC ACA xACA RCA xRCA semRCA
Control
18254 106
1.30
132.47
127.63
103.90
100.00 3.8619101 111 132.37 103.82
15192 99 118.04 92.28
Basic
476 106 3.18 -0.30
0.00 0.47722 109 1.41 4.70 3.55 0.92
512 131 2.77 -0.63
NSE1800
1011 124
1.00
8.15 3.71
4.63 0.791182 105 11.26 6.21
993 117 8.49 3.98
NSE1000
1182 98
1.13
10.67 5.74
3.38 1.18883 126 6.20 2.14
994 138 6.37 2.28
NSE300
956 115 6.39 2.29
3.39 0.571073 94 1.30 8.78 4.21
1042 99 8.10 3.66
NSE120
991 106 6.98 2.76
2.22 0.36958 131 1.34 5.46 1.54
893 103 6.47 2.35
NSE95
1091 225
1.35
3.59 0.03
-0.54 0.29986 301 2.43 -0.91
846 237 2.64 -0.73
891 107 6.17 2.11
NSE65 1052 103 1.35 7.57 3.24 2.60 0.33
1130 127 6.59 2.45
100 -I
•S 80 -
H<u 60 -
40 -
20 -
B.
a
-20
Control Basic NSE1800 NSE1000 NSE300 NSEI20 NSE95 NSE65 
C o n s t r u c t
Figure 6.43: Table and histogram showing data from the second transfection of undifferentiated P19 
EC cells with the full series of NSE-cat deletion constructs. Transfection was carried out using 
LipofectAMINE. Abbreviations used in table headings: CAT - CAT (chloramphenicol 
acetyltransferase) activity; GAL - Pgalactosidase activity; MEC - Molar Equivalence Constant; 
ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control constructs; RCA - 
Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard error of the mean 
Relative CAT Activity. A brief explanation of these terms can be found in Figure 6.1, a fuller 
explanation in section 5.5. The histogram shows mean Relative CAT Activities for each construct 
with error bars representing standard errors.
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Construct RCA1 RCA2 xRCA12 semRCA12
Control 117.04 103.90 100.00 5.22
103.60 103.82
79.35 92.28
Basic 0.67 -0.30 0.00 0.29
0.18 0.92
-0.85 -0.63
NSE18(X) 3.42 3.71 5.33 0.92
5.23 6.21
9.40 3.98
NSE1000 3.32 5.74 3.13 0.64
3.91 2.14
1.36 2.28
NSE3(X) 1.30 2.29 2.30 0.62
0.03 4.21
2.30 3.66
NSE 120 2.72 2.76 2.90 0.55
5.48 1.54
2.54 2.35
NSE95 12.97 0.03 3.68 2.21
4.76 -0.91
5.93 -0.73
NSE65 -0.49 2.11 1.31 0.61
0.17 3.24
0.39 2.45
Figure 6.44: Table and histogram showing combined data from the transfection of undifferentiated 
P19 EC cells with the full series of NSE-cat deletion constructs. Abbreviations used in the table: 
RCA1 and RCA2 - Relative CAT Activities from the two individual experiments (as shown in 
Figures 6.42 and 6.43); XRCA12 - combined mean Relative CAT Activity for each construct over 
two experiments (six transfections); semRCA12 - standard error of the combined mean Relative CAT 
Activities. A brief explanation of these terms can be found in Figure 6.1, a fuller explanation in 
section 5.5. The histogram shows combined mean relative CAT activity for each construct and 
illustrates the trend in reporter gene activity for reporter constructs containing stepwise deletions of 
the rat NSE 5’ flanking region. Error bars represent standard errors of the combined mean Relative 
CAT Activities.
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Results: Chapter 6
P19 neurons were transfected under the conditions described in section 5.4.7 with 
the full series of NSE-cat constructs and controls. Individual experiments are 
shown in Figures 6.46 and 6.47, followed by combined results in Figure 6.48. A 
representative CAT assay is shown in Figure 6.49. The transfection efficiency of 
neurons was variable, and this probably reflected differences in the number and 
distribution of transfection-competent cells per dish. Cells were seeded as small 
aggregates because monodispersed cells grew and attached poorly whilst large 
aggregates tended to yield densely crowded cells which produced few neurites and 
transfected poorly. The small aggregates were prepared by disruption of large 
aggregates (after four days in retinoic acid-supplemented medium) by gentle 
repeated passage through a 10ml pipette. The number of transfection-competent 
neurons per dish depended upon how these aggregates were dispersed. If too many 
aggregates were seeded, or where several aggregates attached close together, the 
neurons became crowded together and were difficult to transfect. If too few 
aggregates were seeded, the neurons were widely spaced and produced long 
processes which formed synaptic associations within a few days, but the number of 
cells was too low to yield results within the linear range of the soluble P- 
galactosidase assay. The trick was to seed enough aggregates for adequate 
numbers of cells but not too many to produce overcrowding, usually 10-20 per 
3.5cm well, however, regional variations in the separation of aggregates resulted in 
variable transfection efficiency between parallel cultures. Normalised transfection 
results showed that neurons transfected with most of the NSE-cat constructs 
expressed relatively high levels of CAT. In the first experiment, all constructs from 
pNSE1800CAT through to pNSE95CAT showed mean Relative CAT Activities of 
approximately 100%; a lower level of activity was observed for pNSE1800CAT- 
transfected cells, but the transfection efficiencies for this triplicate were outside the 
linear range of the soluble p-galactosidase assay and the normalised CAT activities 
were likely to be underestimated. In the second experiment, the longer constructs 
demonstrated approximately twice the relative CAT activities of the corresponding 
constructs in the first experiment, although the trend in reporter activity was 
similar, indicating perhaps that the control transfections were not comparable. 
Accordingly, the standard error of the mean for pCAT-Control transfections in the 
first experiment was above the maximum permitted 15% of the mean value. For 
transfections with pNSE95CAT, there appeared to be a twofold reduction in 
reporter activity (compared to the longer construct pNSE120CAT) only in the 
second experiment, whilst no significant reduction in reporter expression was
6.5 .2 .2  Transfection of P19 neurons
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observed in the first experiment. One of the pNSE95CAT Relative CAT Activities 
in the second experiment was 111% whilst the other two were approximately 50%. 
It is possible that these values were nonrepresentative and the standard error with 
respect to this transfection was approximately 25% of the mean, indicating that a 
nonrepresentative datum was found in this field. The levels of reporter activity 
from pNSE65CAT, which were at background levels in most cell lines, were 
uncharacteristically high in the first transfection of neuronal cells (approximately 
5% of the control value) but not in the second transfection (approximately 0.2% of 
the control value).
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Construct CAT GAL MEC ACA xACA RCA xRCA semRCA
Control
145231 775 144.15
211.64
67.18
100.00 17.72210655 602 1.30 269.17 127.97
192732 669 221.61 104.84
Basic
3991 363
1.41
7.80 0.88
0.00 0.632011 411 3.47 5.98 -1.22
2814 299 6.67 0.34
NSE1800
15652 89
1.00
175.87 82.60
70.96 7.198994 72 124.92 57.83
14101 91 154.96 72.44
NSE1000
35741 117
1.13
270.34 128.54
113.97 7.3426372 105 222.27 105.17
30991 120 228.55 108.22
NSE300
28873 106
1.30
209.53 98.97
93.80 3.5729461 112 202.34 95.48
30032 125 184.81 86.95
NSE120
57823 205
1.34
210.50 99.44
111.37 8.8054992 183 224.26 106.13
46729 129 270.33 128.53
NSE95
33250 104
1.35
236.82 112.24
103.17 5.9135712 119 222.30 105.18
34811 132 195.35 92.08
5285 193 20.28 6.95
NSE65 4769 176 1.35 20.07 6.85 5.48 1.43
4316 281 11.38 2.62
Control Basic NSE1800NSE1000 NSE300 NSE120 NSE95 NSE65
C o n s t r u c t
Figure 6.46: Table and histogram showing data from the first transfection of P19 neurons with the 
full series of NSE-cal deletion constructs. Transfection was carried out using LipofectAMINE. 
Abbreviations used in table headings: CAT - CAT (chloramphenicol acetyltransferase) activity; GAL 
- P-galactosidase activity; MEC - Molar Equivalence Constant; ACA - Actual CAT Activity, xACA ■ 
mean Actual CAT Activity of control constructs; RCA - Relative CAT Activity; xRCA - mean 
Relative CAT Activity; semRCA - standard error of the mean Relative CAT Activity. A brief 
explanation of these terms can be found in Figure 6.1, a fuller explanation in section 5.5. The 
histogram shows mean Relative CAT Activities for each construct with error bars representing 
standard errors.
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Figure 6.47: Table and histogram showing data from the second transfection of P19 neurons with the 
full series of NSE-cal deletion constructs. Transfection was carried out using LipofectAMINE. 
Abbreviations used in table headings: CAT - CAT (chloramphenicol acetyltransferase) activity; GAL 
- P galactosidase activity; MEC - Molar Equivalence Constant; ACA - Actual CAT Activity, xACA - 
mean Actual CAT Activity of control constructs; RCA - Relative CAT Activity; xRCA - mean 
Relative CAT Activity; semRCA - standard error of the mean Relative CAT Activity. A brief 
explanation of these terms can be found in Figure 6.1, a fuller explanation in section 5.5. The 
histogram shows mean Relative CAT Activities for each construct with error bars representing 
standard errors.
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Construct RCA1 RCA2 xRCA12 semRCA12
Control 67.18 90.61 100.00 8.24
127.97 101.36
104.84 108.02
Basic 0.88 1.20 0.00 0.40
-1.22 -0.29
0.34 -0.91
NSE18(X) 82.60 317.08 154.98 41.60
57.83 191.87
72.44 208.07
NSE1000 128.54 265.47 166.21 29.03
105.17 246.32
108.22 143.52
NSE300 98.97 250.74 153.26 29.52
95.48 156.98
86.95 230.44
NSE120 99.44 175.86 129.86 17.50
106.13 187.23
128.53 81.96
NSE95 112.24 111.29 89.44 10.43
105.18 54.35
92.08 61.50
NSE65 6.95 2.67 2.83 1.45
6.85 -1.05
2.62 -1.04
C o n s t r u c t
Figure 6.48: Table and histogram showing combined data from the transfection of P19 neurons with 
the full series of NSE-cal deletion constructs. Abbreviations used in the table: RCA1 and RCA2 - 
Relative CAT Activities from the two individual experiments (as shown in Figures 6.46 and 6.47); 
xRCA12 - combined mean Relative CAT Activity for each construct over two experiments (six 
transfections); semRCA12 - standard error of the combined mean Relative CAT Activities. A brief 
explanation of these terms can be found in Figure 6.1, a fuller explanation in section 5.5. The 
histogram shows combined mean relative CAT activity for each construct and illustrates the trend in 
reporter gene activity for reporter constructs containing stepwise deletions of the rat NSE S' flanking 
region. Error bars represent standard errors of the combined mean Relative CAT Activities.
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Results: Chapter 5
5 .4  O p t i m i s a t i o n  o f  t r a n s f e c t i o n  p a r a m e t e r s
5 .4 .1  O p t i m i s a t i o n  o f  t r a n s f e c t i o n  o f  L t k -  c e l l s
5 .4 .1 .1  O p t i m i s a t i o n  o f  t r a n s f e c t i o n  o f  L t k -  c e l l s  u s i n g  D E A E - d e x t r a n
DEAE-dextran-mediated transfection of Ltk- cells was attempted before any other 
method because a detailed protocol optimised for this cell line had been published 
(Selden, 1987). The published method recommended the use of 4pg DNA per 
100mm dish with 200pg ml"1 DEAE-dextran in 12ml OptiMEM serum-reduced 
medium. To adjust this method for 35mm dishes, the concentrations were kept 
constant but the total volumes were reduced eightfold to account for the difference in 
area (and thus cell number) between the two types of dish. For the first experiment, 
therefore, 0.5pg DNA was used in a total volume of 1,5ml OptiMEM with 200pg mT1 
DEAE-dextran. As recommended, proliferating cells were transfected at 50% 
confluence and the duration of the transfection was 4 hours, followed by a 2 minute 
DMSO shock. It was found, however, that this treatment was extremely toxic and that 
the morphology of the cells changed from flat and fibroblastoid to thin and spindly by 
12 hours posttransfection. Extensive cell death occurred in the next 24 hours and by 
48 hours posttransfection, there were no attached cells remaining to be harvested.
The toxicity of DEAE-dextran mediated transfection is known to be both dose- and 
time-dependant. Experience has shown that transfections carried out using this 
method should be either of short duration with high doses of the reagent or of long 
duration with lower doses (Sambrooke et al., 1989). Attempts were made to optimise 
transfection parameters by trying a range of very short transfection times, but keeping 
the other conditions constant. The results of this experiment are shown in Figure 
5.20.
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pNSE95CAT was generated by digestion with Sma I (which cleaves within the insert) 
and Hind III (which cleaves in the polylinker). The Hind III site was then blunted by 
end-filling and the vector reclosed. Finally, pNSE65CAT was generated by complete 
digestion with Hind III followed by partial digestion with Nar I. The latter enzyme 
cuts once within the NSE 5’ flanking region, but also between the SV40 large T region 
and the Ampr gene of pCAT-Basic. The partial digestion was followed by gel 
isolation of the correct sized fragment (4.4 kbp), blunting by end-filling and reclosing 
of the vector. The Nar I site lies just downstream of the TATA box, just lbp 
upstream of the most 5' transcriptional start site - this fragment thus probably lacks the 
basal promoter o f the NSE gene.
5 .3 .4  V e r i f i c a t i o n  o f  c o n s t r u c t s
The first generation of constructs, pNSE1800CAT, pNSE1200CAT, pNSElOOOCAT, 
pNSE300CAT were verified by restriction mapping (data not shown). The more 
truncated constructs, pNSE120CAT, pNSE95CAT and pNSE65CAT were verified by 
restriction mapping and sequencing (data not shown).
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(a)
Hind III Pst I Xho I Pst I Sma I Nar I
Hind III ZliLl
///nd III
Hind III
(b)
pNSEI20CAT
pNSE95CAT
pNSE65CAT
Figure 5.19. Cloning strategy and structure o f  the highly truncated second series o f  NSE-cat constructs 
The starting material was vector pN SEI800C A T as shown in (a). The NSE  regulatory sequence is 
lightly shaded, the cal gene is shown in black, the pCAT-Basic m ultiple cloning site is shown as a 
hatched box and vector sequence is unshaded. Restriction endonuclease sites used in this subcloning 
strategy are shown, b) Generation o f the constructs: pNSE120CAT was made by partial digestion 
using the underlined Psi I sites and religation o f  the vector without the insert. pN SE95C A T and 
pNSE65CAT were made by digestion with Sm a  I and Nar I respectively, in com bination with Hind III 
Note that the Hind III site originally used to subclone the complete N SE  regulatory sequence into 
pCAT-Basic (see Figure 5.18) was destroyed in this procedure and did not interfere with the 
subsequent cloning events described here.
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(a)
NSE 5’ flanking region
£coR I Hph I Bsa I Xho I Hind III
(b)
pNSE1800CAT
£coR I Hind III
pNSEI200CAT
Hph I Hind III
pNSElOOOCAT
Bsa I Hind III
pNSE300CAT
Xho I Hind III
(C)
Hinti III Sph I Pst I Sal I Acc I Xba I
(d)
Figure 5.18. Cloning strategy and structure of the initial NSE-cat series of deletion constructs, a) The 
complete NSE regulatory sequence (light shading) was situated upstream of the tacZ gene (dark 
shading) in plasmid pNSEIacZ (vector sequence unshaded). Restriction endonuclease sites used for 
subcloning are shown, b) The complete 1.8 kbp NSE regulatory sequence and other deletion 
derivatives of this sequence were removed using the restriction endonucleases shown in combination 
with Hind III, and blunted using bacteriophage T4 DNA polymerase, c) The multiple cloning 
sequence (hatched) in pCAT-Basic (vector sequence unshaded) lies upstream of the cat gene (black), 
d) Each of the NSE fragments shown in (b) was ligated into the Xba I site in the pCAT-Basic multiple 
cloning sequence to generate the first series of constructs. Diagrams not to scale.
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than pCAT-Control, with a mean Relative CAT Activity of 120-140%. In the 
presence of Sox2 and Sox3 expression vectors, transfection efficiency was reduced 
approximately twofold. As the same mass of pSV-p-galactosidase DNA was 
transfected in each case, the transfection efficiencies for the Sox cotransfections 
should have been similar to those for the control experiment. The different 
efficiencies observed therefore suggested that there was either an effect brought 
about by the Sox-cDNA-containing plasmids, or that the Sox factors were 
influencing the control plasmid promoters. Normalised CAT activities unexpectedly 
showed that both Sox2 and Sox3 caused a rise in MSE-driven reporter activity, and 
in the case of Sox3, a two- to threefold upregulation was observed. It was 
apparent, however, that the actual source levels of CAT activity from the control 
vector pCAT-Control were modulated by cotransfection, suggesting that the control 
vectors were indeed influenced by Sox expression. This point is expanded in the 
conclusion (section 6.7) and discussed in Chapter 9.
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Construct CAT GAL MEC ACA xACA RCA xRCA semRCA
Control
45734 232
1.30
151.64
147.95
102.63
100.00 2.9948221 243 152.65 103.34
46266 255 139.57 94.03
Basic
2465 212
1.41
8.25 0.51
0.00 0.662771 346 5.68 7.53 -1.32
3263 267 8.67 0.81
NSE1800
57235 291
1.00
196.68 134.71
123.03 9.6344195 288 153.45 103.92
58176 305 190.74 130.47
Control + 
Sox2
79345 111
1.30
549.86 95.10
100.00 2.4581433 106 590.95 577.74 102.32
76243 99 592.41 102.58
Basic + 
Sox2
1556 113
1.41
9.77
8.51
0.22
0.00 0.221723 125 9.78 0.22
1139 135 5.98 -0.44
NSE1800 +
Sox2
99453 117
1.00
850.03 147.83
143.12 3.29102325 130 787.12 136.78
97391 117 832.40 144.74
Control + 
Sox3
29364 102
1.30
221.45 108.85
100.00 9.2630015 134 172.30 205.55 81.49
36220 125 222.89 109.66
Basic +  
Sox3
5119 120
1.41
30.25 2.42
0.00 1.213923 116 23.99 25.90 -1.07
3673 111 23.47 -1.36
88342 133 664.23 355.32
NSE1800 + 91760 126 1.00 728.25 390.97 384.63 15.42
Sox3 91732 121 758.12 407.59
C o n s tr u c t
Figure 6.50: Table and histogram showing data from the first transfection of NB4-1A3 cells with 
pNSE1800CAT, CAT control vectors and Sox expression vectors.. Transfection was carried out 
using LipofectAMINE. Abbreviations used in table headings: CAT - CAT (chloramphenicol 
acetyltransferase) activity; GAL - P galactosidase activity; MEC - Molar Equivalence Constant; 
ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control constructs; RCA - 
Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard error of the mean 
Relative CAT Activity. A brief explanation of these terms can be found in Figure 6.1, a fuller 
explanation in section 5.5. The histogram shows mean Relative CAT Activities for each construct 
with error bars representing standard errors.
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Construct CAT GAL MEC ACA xACA RCA xRCA semRCA
Control
60722 277
1.30
168.63
175.60
95.84
100.00 2.8465182 289 173.49 98.74
64823 270 184.68 105.42
Basic
5912 312 13.44
8.03
3.23
0.00 1.643006 344 1.41 6.20 -1.09
1884 301 4.44 -2.14
NSE1800
87643 332
1.00
263.98
246.73
152.74
142.44 8.2284199 328 256.70 148.40
79237 361 ^ 219.49 126.19
Control + 
Sox2
45193 151
1.30
230.22
246.67
92.98
100.00 8.7738720 134 222.27 89.59
50832 136 287.51 117.42
Basic + 
Sox2
1678 144
1.41
8.26
12.27
-1.71
0.00 1.481402 106 9.38 -1.23
3921 145 19.18 2.95
NSE1800 + 
Sox2
72671 167
1.00
435.16
434.73
180.41
180.23 0.1877892 179 435.15 180.41
78100 180 433.89 179.87
Control + 
Sox3
21166 155
1.30
105.04
105.82
99.23
100.00 8.5125812 164 121.07 115.11
20425 172 91.35 85.66
Basic + 
Sox3
1053 151
1.41
4.95
4.88
0.06
0.00 0.09944 134 5.00 0.12
1007 152 4.70 -0.18
26149 104 251.43 244.26
NSE1800 + 32035 116 1.00 276.16 247.61 268.76 240.48 17.52
Sox3 23462 109 215.25 208.41
C o n s tr u c t
Figure 6.51: Table and histogram showing data from the second transfection of NB4-1A3 cells with 
pNSE1800CAT, CAT control vectors and Sox expression vectors. Transfection was carried out 
using LipofectAMINE. Abbreviations used in table headings: CAT - CAT (chloramphenicol 
acetyltransferase) activity; GAL - p-galactosidase activity; MEC - Molar Equivalence Constant;
ACA - Actual CAT Activity, xACA - mean Actual CAT Activity of control constructs; RCA - 
Relative CAT Activity; xRCA - mean Relative CAT Activity; semRCA - standard error of the mean 
Relative CAT Activity. A brief explanation of these terms can be found in Figure 6.1, a fuller 
explanation in section 5.5. The histogram shows mean Relative CAT Activities for each construct 
with error bars representing standard errors.
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Construct RCA1 RCA2 XRCA12 semRCA12
Control 102.63 95.84 100.00 1.84
103.34 98.74
94.03 105.42
Basic 0.51 3.23 0.00 0.79
-1.32 -1.09
0.81 -2.14
NSE18(X) 134.71 > 152.74 132.74 7.13
103.92 148.40
130.47 126.19
Control 95.10 92.98 100.00 4.07
+ Sox2 102.32 89.59
102.58 117.42
Basic 0.22 -1.71 0.00 0.67
+ Sox2 0.22 -1.23
-0.44 2.95
NSE1800 147.83 180.41 161.67 8.43
+ Sox2 136.78 180.41
144.74 179.87
Control 108.85 99.23 100.00 5.62
+ Sox3 81.49 115.11
109.66 85.66
Basic 2.42 0.06 0.00 0.54
+ Sox3 -1.07 0.12
-1.36 -0.18
NSE1800 355.32 244.26 312.55 33.87
+ Sox3 390.97 268.76
407.59 208.41
*■ Sox2 + Sox2
C o n str u c t
Figure 6.52: Table and histogram showing combined data from the transfection of NB4-1A3 cells 
with pNSE1800CAT, CAT control vectors and Sox expression vectors. Abbreviations used in the 
table: RCA1 and RCA2 - Relative CAT Activities from the two individual experiments (as shown in 
Figures 6.49 and 6.50); XRCA12 - combined mean Relative CAT Activity for each construct over 
two experiments (six transfections); semRCA12 - standard error of the combined mean Relative CAT 
Activities. A brief explanation of these terms can be found in Figure 6.1, a fuller explanation in 
section 5.5. The histogram shows combined mean relative CAT activity for each construct and 
illustrates the trend in reporter gene activity for reporter constructs in the presence of Sox 
transcription factors. Error bars represent standard errors of the combined mean Relative CAT 
Activities.
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. ■ *
r i- %
o '  ?
pNSE1800CAT pCAT-Control pCAT-Basic
pNSE1800CAT pCAT-Control pCAT-Basic
pNSE1800CAT pCAT-Control pCAT-Basic
Figure 6.53: Representative CAT assay from the transfection of NB4-1A3 cells with 
pNSE1800CAT, pCAT-Control, pCAT-Basic and expression vectors for Sox2 and Sox3 transcription 
factors. Each construct was transfected in triplicate and the lanes of the TLC plate were grouped 
accordingly. The assay shown above corresponds to the experiment shown in Figure 6.50. 
Abbreviations: O = origin; C = chloramphenicol; 1A = 1-acetylchloramphenicol; 3A =
3-ace tylchloramphenicol.
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previous studies of rat NSE ontogeny (Forss-Petter et al., 1986; Di Liergo et al. ,
1991).
7.2.2 In situ detection of endogenous NSE  gene products during mouse 
development
The expression of NSE mRNA and NSE protein was investigated by in situ 
hybridisation and in situ immunohistochemical analysis respectively. In situ 
immunohistochemical analysis was also used extensively by Forss-Petter and 
colleagues when the first NSE-lacZ transgenic mice were generated (Forss-Petter et 
al., 1990). This was so because NSE protein and p-galactosidase could be detected 
on the same or serial sections, making comparative analysis relatively simple. The 
procedure was therefore granted similar predominance in the present investigation. 
Forss-Petter and her coworkers avoided an exhaustive immunohistological survey of 
NSE ontogeny, but published an account which was sufficient for detailed 
comparison with their transgene expression pattern. NSE protein and p- 
galactosidase were first detected in situ at E10.5. In the present study, therefore, 
NSE protein expression was investigated between E9.5 (early neurogenesis, when 
the neural tube has closed along most o f its length) and E14.5 (later neurogenesis, 
when all the major events of nervous system development, such as régionalisation of 
the brain and spinal cord and definitive specialisation of neuronal cell populations, 
have been completed). NSE mRNA expression was investigated in embryos at E8.5 
and E9.5, during the first stages of neurogenesis.
7.2.3 Expression of endogenous NSE  mRNA - in situ hybridisation analysis
Although NSE expression in neuroglial precursor cells of the hypothalamus has 
been reported in early mouse embryos lacking mature neurons (De Vitry et al., 
1980), the onset of NSE protein synthesis is commonly accepted as a marker of 
overt neuronal differentiation. It was important to establish the nature of NSE
242
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mRNA expression in neurogenic mouse embryos because several investigators have 
provided evidence for the accumulation of NSE mRNA prior to expression of the 
protein (Forss-Petter et al., 1986; Di Liergo et al., 1991). NSE mRNA (but not 
protein) has also been detected in murine embryonic stem cells, blastocysts and 
morulae (Alouani et al., 1993). As E10.5 is the earliest stage at which NSE protein 
expression has been reported (Forss-Petter et al., 1990), NSE mRNA expression 
was investigated in embryos at E9.5 and E8.5. The expression of NSE mRNA has 
been studied in situ in the brains of foetal and adult rats (Watanabe et al., 1990; 
1993; Katagiri et a l., 1993; Keller et al., 1994) and humans (Schmechel et al. ,
1987) but not previously in mouse embryos. In situ hybridisation studies of MSE 
mRNA in early myogenic structures such as the E7.25 cardiac tube demonstrated 
the onset of MSE gene expression much earlier than had originally been shown 
(Keller et al., 1992a).
7.2.3.1 Construction of the transcription vector
In situ hybridisation, using in vitro transcribed antisense RNA probes incorporating 
digoxigenin-labelled UTP, is an established method for the analysis of patterns of 
mRNA expression in wholemount specimens (Holtke and Kessler, 1990). Before in 
situ hybridisation analysis was possible, however, it was necessary to construct a 
vector which would allow such a probe to be generated. A suitable basis for this 
transcription construct was pBluescriptHKS + , a plasmid containing a multiple 
cloning site flanked by promoters specific for the RNA polymerase enzymes 
encoded by bacteriophages T7 and T3 respectively (Figure 7.2). To generate the 
recombinant transcription vector, a 1.3 kbp Hind III - Sma I restriction fragment 
was isolated from the rat NSE cDNA sequence, carried in plasmid pcD169 (Forss- 
Petter et al., 1986). This fragment contained the distal 1 kbp of the NSE coding 
sequence and the proximal 300 bp of 3’ untranslated region. As discussed in 
section 5.2.1, all enolase coding regions are highly conserved, and cross­
hybridisation to MSE and NNE transcripts would be likely to occur - especially 
across species boundaries - if the NSE coding region was used as a probe. For the
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nonambigous detection of NSE transcripts, the probe had therefore to be derived 
from the isogene-specific 3’ untranslated region of the cDNA. The template 
fragment was subcloned into pBluescriptHKS + using the Hind III and Sma I sites 
within the polylinker, and the recombinant was called pNSEprobel. The template 
was linearised using a unique Nco I site within the NSE 3’ untranslated region. 
Antisense RNA probes 330 b in length, complementary to the NSE 3’ untranslated 
region, were generated using T7 RNA polymerase. As a negative control, sense 
RNA probes of 1100 b in length, corresponding to the NSE coding region, were 
generated using T3 RNA polymerase. Both probes contained approximately 70 b of 
vector sequence representing the polylinker region between the appropriate 
promoter and the position of insertion. The cloning strategy is shown in Figure
7.3.
244
Results: Chapter 5
determination step, which involves the switching off of NSE. Otherwise, the level of 
NSE mRNA in the PI9 cells may simply be too low to be detected by the methods 
used in this study. Notwithstanding these contradictory reports, the results obtained in 
this study suggested that the PI9 EC line represented and excellent model for the 
study of NSE gene regulation during ex vivo neuronal differentiation.
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GGACGTCGGGCCCCCIAGGTGATCAAGATCTCGCCGGCGGTGGCGCCACCTCGAGGTTAAGCGGGATATCACTCAGCATAATGCGCGCGAGTGACCGGCAGCAAAATGTT S
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( • )
I • )
3 ' CTAGGTGATCAAGATCT S ’ 
SK Prim er
3 ' GATATCACTCAGCATAA 5' 3 ' TGACCGGCAGCAAAATG 5*
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Figure 7.2: pBluescriptIIKS + , the source plasmid used to construct transcription plasmid 
pNSEprobel. a) Plasmid map, showing the position of the ampicillin resistance gene (Ampicillin), 
the origin of replication (ColEl ori), the lacZ gene (lacZ) the bacteriophage fl ( + ) origin of 
replication (fl ( +  ) origin) and the multiple cloning site (MCS), indicating the direction of 
transcription from the bacteriophage promoters (T7, T3). A number of restriction endonuclease sites 
are also shown, b) Sequence of the pBluescriptIIKS+ multiple cloning site. The Hind III and Sma I 
restriction endonuclease sites, used to insert the NSE cDNA fragment, are underlined. The position 
of the bacteriophage T7 and T3 promoters are indicated, and the direction and start of transcription 
from each promoter are indicated by -» and +1 respectively. Both diagrams taken from Stratagene 
Product Catalogue, 1993.
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5.2.7 N SE  gene expression in P19 EC cells and their neuronal derivatives
PI9 embryonal carcinoma (EC) cells may be persuaded to differentiate into neurons in 
vitro when treated with low doses (0.3pA/) of retinoic acid (Rudnicki and McBurney, 
1987). This cell line therefore represented an excellent system for the analysis of NSE 
induction as part of neuronal differentiation. Although one would expect 
undifferentiated stem cells to lack neuronal gene products, Alouani and colleagues 
have recently reported the presence of endogenous NSE mRNA (but not protein) in 
embryonic stem cells and preimplantation murine embryos, suggesting that the factors 
responsible for cell type-specific transcription of the NSE gene were already present in 
these pluripotent cells (Alouani et al., 1993). It was therefore very important to 
characterise the endogenous expression of NSE in the PI 9 cells because comparison 
between undifferentiated and differentiated cells transfected with NSE-cat reporter 
constructs would depend upon the potential of each construct for transcription of the 
reporter gene. Proliferating P I9 cells were stimulated to differentiate into neurons as 
described in section 4.2.4 and both stem cells and neurons were studied by northern 
and western analysis as described in section 5.2.3. Figures 5.10a-c show the process 
of retinoic acid-mediated differentiation. Figures 5.1 la  and 5.1 lb show the results of 
northern and western analysis. As expected, western analysis demonstrated that NSE 
protein was undetectable in stem cells but abundant in neurons, more so than in adult 
brain (Figure 5.1 lb). Northern analysis showed a similar pattern, suggesting that NSE 
mRNA was not present in stem cells but was present in neurons, again at levels in 
excess of those observed in the brain. It is unknown why the results of the northern 
analysis described above disagreed with the data published by Alouani and 
colleagues. The cell lines used in the two studies were not the same (Alouani et al. 
used ES-12957 embryonic stem cells whilst P I9 embryonic carcinoma cells were used 
in the present study) and perhaps the discrepancy reflects this difference. It is more 
likely, however, that different sensitivities of the detection methods were responsible, 
as discussed in Chapter 9. Alounai et al. also noted that levels of endogenous NSE 
mRNA fell before rising during neuronal differentiation, and it is possible that the P19 
cell line reflects a molecular environment which has proceeded further towards this
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(a)
BssH
SariApn I
(b)
5’
3’
Hind III
, CODING REGION 3’UTR 3’
1 1 5’Nco I Sma I
(C)
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3’
Hind III
CODING REGION 
Sense Strand 
Antisense Strand
T3--------  - ------------- ----------- ►
Sense RNA
Antisense RNA
Sma I
Figure 7.3: Strategy for the generation of antisense RNA probes for the in situ detection of NSE 
mRNA and sense RNA probes for negative control hybridisations, a) The multiple cloning site of 
pBluescriptIIKS+ (hatched) lies within the lacZ gene (dark bar, with arrow indicating orientation) 
and is flanked by BssH II sites. The restriction endonuclease sites above (Kpn I, Sac I) indicate 
orientation of the polylinker whilst those below (Hind 111, Sma I) indicate the site of insertion of the 
NSE sequence, b) A Hind III - Sma I restriction fragment containing both coding (unshaded) and 
untranslated (shaded) regions of the rat NSE cDNA was subcloned into the multiple cloning site of 
pBluescriptIIKS+ (hatched), c) The recombinant vector was linearised at a unique Nco I site within 
the insert and antisense RNA complementary to the untranslated region was generated by run-off 
transcription from the bacteriophage T7 promoter. Sense RNA corresponding to the coding region 
was generated by run-off transcription from the bacteriophage T3 promoter.
2 4 6
aNSE- -2 .37
-1.35
9 -
1 2 3
Figure 5.9: Northern and western analysis of HeLa cells, a) Northern analysis using the Sma I - Nco I 
fragment of the rat NSE 3’ UTR as a probe - lanes loaded equally for total RNA, lOpg per lane: 1 - 
mouse brain, 2 - mouse liver, 3 - HeLa cells. Markers are Gibco BRL RNA ladder, b) Western 
analysis using anti-human NSE, detected with horseradish peroxidase-conjugated goat anti-rabbit IgG 
and revealed by staining with diaminobenzidine tetrahydrochloride without metal ion enhancement - 
lanes loaded equally for total protein, 5pg per lane: 1 - mouse brain, 2 - mouse liver, 3 - HeLa cells. 
45kDa marker is ovalbumin. Immunocytochemical analysis o f HeLa cells was also carried out and no 
staining for NSE protein was evident (results not shown).
122
Results: Chapter 7
7.2.3.2 In vitro transcription of antisense and sense RNA probes
Following verification of pNSEprobel by restriction mapping (data not shown), 
caesium chloride equilibrium centrifugation was carried out to prepare a large 
quantity of the vector, essentially free of randomly nicked and linearised material. 
Homogenous linearised template was prepared from lOpg plasmid DNA by 
digestion with Nco I as described in section 4.1.2.1 and purification of the DNA 
was carried out as described in section 4.1.4. lp g  of linearised template was used 
for each in vitro transcription reaction, as described in section 4.1.6.3. The results 
of one set of such synthesis reactions are shown in Figure 7.4.
-1 100
-330
Figure 7.4: Confirmation of digoxigenin-UTP-labelled RNA probe synthesis. Polaroid photographs 
show 2% w/v agarose gels after 10 minutes electrophoresis at 200V in lx TBE buffer. Lanes were 
loaded with lpl aliquots from 20pl probe synthesis reactions or O.lpg aliquots of linearised 
template: 1 - antisense probe (T7) transcription, post DNase treatment; 2 - antisense probe (T7) 
transcription, pre DNase treatment; 3 - O.lpg linearised template; 4 - sense probe (T3) 
transcription, post DNase treatment; 5 - sense probe (T3) transcription, pre DNase treatment, 6 - 
O.lpg linearised template. Markers are Gibco BRL RNA ladder (MR) and 1 kb DNA ladder (MD).
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5.2.6 Endogenous NSE expression in HeLa cells
HeLa cells are nonneuronal cells which have been used as the nonpermissive cell line 
in the study of numerous neuronal genes, including NSE (Sakimura et al., 1995; see 
Chapter 2). HeLa cells were used as a second nonpermissive cell line in the present 
study for this reason, even though their human origin was at odds with most of the 
other sources of biological material. To confirm that HeLa cells were nonpermissive 
for NSE gene expression, protein and mRNA were analysed as described in section
5.2.3. It is acknowledged by the author that no attempt was made to test the rat NSE 
3’ UTR probe on neuronal material of human origin to confirm that it would detect 
human NSE mRNA. However, the level of sequence identity between the human and 
rat NSE 3’ UTRs is approximately 70% over the entire comparable region, with 
pockets of higher identity particularly surrounding the AT-rich repetitive motif 
encompassed by the probe (Oliva et al., 1989). It is therefore likely that, under the 
moderate stringency conditions used in the posthybridisation washes (55°C, 
equivalent to 0.4x SSC), some of the human NSE message would be detected should it 
be present. Notwithstanding this conjecture, it is certain that human NSE protein 
would be detected by the antiserum used in this study, as it was originally raised 
against the human protein. The results, which are shown in Figures 5.9a and 5.9b, 
confirm that HeLa cells express NSE protein, and probably NSE mRNA also, at 
undetectable levels and are good candidates for nonpermissive cells.
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Figure 7.6: Mouse rostral neural tube at E14.5 stained for NSE protein, a) Normal 
experimental conditions, i.e. section incubated with primary antiserum, b) Negative 
control serial section incubated without primary antiserum. NSE was detected with 
primary antiserum raised against human NSE and a secondary FITC-conjugated antiserum 
specific for rabbit IgG. Photographs were taken under epifluorescent micoscopy using a 
20x D1C objective.
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7.2.4.1 Expression of endogenous NSE protein at E9.5
Transverse 10pm sections were taken through the head and anterior trunk of E9.5 
mouse embryos and attempts were made to detect NSE protein as described above. 
In agreement with previous investigations (Forss-Petter et al., 1990), NSE protein 
could not be detected in these embryos. As an example, Figure 7.7 shows a 
transverse section across the anterior neural tube of such an embryo, showing that 
no fluorescence was evident.
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5.2.4 Endogenous N SE  gene expression in U-138 MG and U-373 MG cells
Initial transfection experiments using the PC 12 (Geneva) line were totally 
unsuccessful (see section 5.4.2.1). In the interests of continuing the investigation 
without delay, further permissive cell lines were sought within the department. 
Although no neuronal cell lines were available, two transformed cell lines of glial 
origin (U-138 MG glioblastoma and U-373 MG astrocytoma) were analysed. It is 
well known that although glial cells in vivo do not express NSE, transformed cell lines 
of glial origin often express relatively high levels of the gene product (Zomzely- 
Neurath, 1983). This property may reflect the common neurectodermal origin of 
neurons and glia, showing that relatively few genetic changes (i.e. those associated 
with growth transformation) are required to confer some aspects of neuronal 
phenotype upon glial cells. It has also been reported that neuroglial precursors 
express NSE protein in the early mouse embryo (De Vitry et al., 1980; Schubert et al, 
1983). Northern, western and immunocytochemical analysis was carried out upon 
these cell lines as described in section 5.2.3 and the results of these experiments are 
shown in Figures 5.6a-c. Both glial lines appeared to express NSE mRNA and NSE 
protein at significant levels, albeit lower than those observed in mouse brain.
Northern and immunocytochemical analysis indicated that U-138 MG cells expressed 
more of the gene product than U-373 MG cells, whilst the western analysis showed 
approximately equivalent levels of NSE protein in each cell line. The results of these 
experiments confirmed that either glial line could be used as a permissive system for 
the analysis of NSE gene expression. The U-138 MG cell line was eventually chosen, 
based upon its higher level of NSE transcription and its ease of transfection (see 
section 5.4.3).
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Figure 7.7: Following two pages
Figure 7.7: Expression of NSE protein in mouse embryos at E9.5. a) Size and appearance of mouse 
embryo at E9.5 showing the position of the section to which the drawing and photograph in this 
figure refers, b) Schematic representation (with anatomical landmarks identified) and c) 
photomicrograph of a transverse section, magnification x85, showing the absence of NSE protein in 
the E9.5 mouse embryo. Attempts to detect NSE were made using a polyclonal antiserum raised 
against human NSE and a secondary FITC-conjugated antiserum specific for rabbit IgG. The 
photograph was enlarged from an original slide taken under epifluorescent microscopy using a x20 
D1C objective lens.
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a b
Figure 5.5: Northern, western and immunocytochemical analysis of Ltk- and PC12 (Geneva) cells, a) 
Northern analysis using the Sma I - Nco I fragment of the rat NSE 3’ UTR as a probe - lanes loaded 
equally for total RNA, lOpg per lane: 1 - PC 12, 2 - Ltk-, 3 - mouse liver, 4 - mouse brain. Markers are 
Gibco BRL RNA ladder, b) Western analysis using anti-human NSE, detected with horseradish 
peroxidase-conjugated goat anti-rabbit IgG and revealed by staining with diaminobenzidine 
tetrahydrochloride without metal ion enhancement - lanes loaded equally for total protein, 5pg per 
lane: 1 - PC 12, 2 - Ltk-, 3 - mouse liver, 4 - mouse brain. 45kDa marker is ovalbumin, c) 
Immunocytochemical analysis o f PC 12 (Geneva) cells using anti-human NSE, detected with FITC- 
conjugated goat anti-rabbit IgG, x20 under epifluorescence microscopy. Intense staining was observed 
throughout the cell body of PC 12 cells whilst none was seen in Ltk- cells treated in parallel (data not 
shown).
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7.2.4.3 Expression of endogenous NSE protein at El 1.5
Transverse 10pm sections were taken throughout El 1.5 mouse embryos and NSE 
protein was detected as described in section 7.2.4. The protein could be detected in 
sections of brain at all levels and in the rostral part of the neural tube. The domain 
of NSE expression in the neural tube had spread both rostrally and caudally 
compared to E10.5, although no expression was evident throughout the tail neural 
tube (data not shown). In the brain, NSE expression was restricted to small 
numbers of cells in the thin mantle layer, whilst no expression was evident in the 
inner ependymal layer. Representative transverse sections showing such staining in 
the wall of the midbrain and hindbrain are shown in Figures 7.9(i) and 7.9(ii). It 
was also apparent from this early stage of development that NSE was expressed in a 
rostrocaudal gradient of increasing intensity in the brain. Figure 7.9(iii) shows the 
midbrain-hindbrain boundary at a level corresponding to the rostral extremity of the 
otic vesicle. Intense staining could be seen in the mantle layer of the posterior wall 
of the fourth ventricle whilst staining of the anterior wall of the mesencephalic 
ventricle was much fainter. In the neural tube, ventrolateral staining of motor 
neurons had increased in intensity from E10.5, concomitant with the accumulation 
of postmitotic neuronal cell bodies in the mantle layer (Figure 7.9(iv)). There was 
also evidence of NSE-positive neurons in the dorsal root ganglia and of NSE- 
positive axons comprising the mixed spinal nerves. The accumulation of NSE- 
positive axons was also reflected in the intense staining observed in the marginal 
layer at the ventral extremity of the neural tube (Figure 7.9(iv)). This layer 
underlies both the central, NSE-negative, ependymal layer and the lateral, NSE- 
positive, mantle layer. Weak staining for NSE was also observed in the lateral 
marginal layer of the neural tube, extending dorsally. This staining became 
particularly intense at the level of the dorsal root, where efferent nerve fibres 
emanating from the ganglion could also be observed.
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Figure 7.9: Following two pages
Figure 7.9. Expression of NSE protein in mouse embryos at El 1.5. a) Size and appearance of 
mouse embryo at El 1.5 showing the positions of sections to which the drawings and photographs in 
this figure refer, b) Schematic representations of the E l l .5 mouse embryo in transverse section (the 
position of each section is shown in (a)), with anatomical landmarks identified, and the photographic 
field of each photomicrograph (as shown in (c)) marked with a dashed line, c) Photomicrographs of 
representative transverse sections, magnification x85, showing the expression of NSE protein in the 
El 1.5 mouse embryo. NSE was detected using a polyclonal antiserum specific for human NSE and a 
secondary FITC-conjugated antiserum specific for rabbit IgG. Photographs were enlarged from 
slides taken under epifluorescent microscopy using a x20 DIC objective lens.
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7.2.4.4 Expression of endogenous NSE protein at E12.5
Transverse 10pm sections were taken throughout E l2.5 mouse embryos and NSE 
protein was detected as described in section 7.4.2. The protein could be detected in 
sections of brain at all levels and throughout the neural tube, excluding the very 
caudal extremity of the tail (data not shown). In the brain, NSE expression was 
observed as a broad band of fluorescent cells corresponding to the thickening mantle 
layer. Sections corresponding the lateral wall of the hindbrain at the coronal apex 
and the anterior wall of the metencephalon (future pons and cerebellum) are shown 
in Figures 7.10(i) and 7 .10(ii). In the more rostral segments of the neural tube, the 
domain of NSE expression had spread dorsally through the mantle layer whilst 
axonal accumulation was evident from intense staining in the marginal layer, 
forming an incomplete ring (Figure 7 .10(iii)A). The dynamic impression of NSE 
ontogeny in the neural tube was thus like a closing pincer, with the jaws coming 
together towards the dorsal midline. Marginal staining was again particularly 
intense at the dorsal root (Figure 7 .10(iii)B), with staining also present in the 
afferent nerve fibres originating from the dorsal root ganglion. NSE positive 
neuronal cell bodies were obvious in the dorsal root ganglion itself, and both 
efferent and afferent nerve fibres were visible in the mixed spinal nerves (Figure 
7 .10(iii)A). Caudal segments of the neural tube showed a progressively less 
extensive domain of NSE expression (data not shown) so that the rostrocaudal axis 
mirrored the temporal sequence of NSE ontogeny in reverse. Thus, NSE 
expression in the tail of E12.5 embryos was reminiscent of NSE expression in the 
rostral extremity of the neural tube in E10.5 embryos. The observed spatiotemporal 
sequence was coincident with the accumulation of mature, postmitotic neurons in 
the developing spinal cord.
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Figure 7.10: Following two pages
Figure 7.10: Expression of NSE protein in mouse embryos at E12.5. a) Size and appearance of 
mouse embryo at E12.5 showing the positions of sections to which the drawings and photographs in 
this figure refer, b) Schematic representations of the E12.5 mouse embryo in transverse section (the 
position of each section is shown in (a)), with anatomical landmarks identified and the photographic 
field of each photomicrograph (as shown in (c)) marked with a dashed line, c) Photomicrographs of 
representative transverse sections, magnification x85 (i, ii, iiiB) or x40 (iiiA), showing the expression 
of NSE protein in the E12.5 mouse embryo. NSE was detected using a polyclonal antiserum specific 
for human NSE and a secondary FITC-conjugated antiserum specific for rabbit IgG. Photographs 
were enlarged from slides taken under epifluorescent microscopy using a x 10 or x20 DIC objective 
lens.
266


Results: Chapter 7
7.2.4.5 Expression of endogenous NSE protein at E13.5
NSE protein expression was studied in greater detail in E13.5 embryos because this 
was the stage at which transgenic embryos were first isolated and examined. 
Transverse 10pm sections were taken throughout E13.5 mouse embryos and NSE 
protein was detected as described in section 7.2.4. The protein could be detected in 
sections of brain at all levels and throughout the neural tube. Examination of brain 
sections showed that NSE protein was abundant in the midbrain-hindbrain region 
but restricted to a narrow external bands of cells in the neopallial cortex (future 
cerebral cortex). Figure 7.11 shows NSE expression in cranial sections of the 
E13.5 brain. The extent of NSE protein in the midbrain is clear from Figure 
7.11(i)A, as only a narrow band of NSE-negative cells can be observed in the 
ependymal layer surrounding the cerebral aqueduct. Conversely, Figure 7.11 (i)C 
shows only a narrow band of NSE-positive cells on the lateral curve of the cortex. 
The lamina terminalis (roof of the midbrain) shows a curious pattern of NSE protein 
expression, with dense crowds of NSE-positive cells following the perimeter of the 
ependymal layer, as shown in Figure 7.11(i)B. Figure 7.1 l(ii)A shows the 
midbrain-hypothalamic boundary, with a greater intensity of NSE protein obvious in 
the midbrain. NSE protein was present in the hypothalamus, but the domain of 
expression narrowed towards its ventral extremity (Figure 7.1 l(ii)B) until, at the 
lamina terminalis, the protein was restricted to bilateral horns, tapering towards the 
ventral surface (Figure 7.1 l(ii)C). More caudal structures of the E13.5 mouse 
embryo are shown in Figure 7.12. In the brain, NSE protein was observed in the 
mantle layer (Figures 7.12(i)B and 7.12(i)C) and more abundantly in the marginal 
layer (Figure 7.12(i)B) but not in the ependymal layer (Figure 7.12(i)C) of the 
medulla oblongata. Once again, NSE expression in the cerebral cortex was reduced 
to a thin band of cells (data not shown). The rostral extremity of the spinal cord 
expressed NSE in a similar pattern to that observed in the medulla (Figure 
7.12(i)A). More caudal sections showed a distinctive expression pattern in the 
spinal cord, characterised by abundant staining throughout the mantle layer, but 
superabundant staining in the peripheral marginal layer (Figures 7.12(ii)A-C).
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Particularly noticeable at this stage of development was the appearance of bilaterally 
symmetrical spurs of NSE-positive cells in the marginal layer at the dorsal midline 
(Figures 7.12(ii)A and 7.12(ii)B), further reinforcing the 'pincerlike' image of NSE 
ontogeny during the development of the spinal cord.
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Figure 7.11: Following three pages
Figure 7.11: Expression of NSE protein in mouse embryos at E13.5. a) Size and appearance of 
mouse embryo at E13.5 showing the positions of sections to which the drawings and photographs in 
this figure refer, b) Schematic representations of the E13.5 mouse embryo in transverse section (the 
position of each section is shown in (a)), with anatomical landmarks identified and the photographic 
field of each photomicrograph (as shown in (c)) marked with a dashed line, c) Photomicrographs of 
representative transverse sections, magnification x85, showing the expression of NSE protein in the 
E13.5 mouse embryo. NSE was detected using a polyclonal antiserum specific for human NSE and a 
secondary FITC-conjugated antiserum specific for rabbit IgG. Photographs were enlarged from 
slides taken under epifluorescent microscopy using a x20 DIC objective lens.
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Figure 7.12: Following three pages
Figure 7.12: Expression of NSE protein in mouse embryos at E13.5. a) Size and appearance of 
mouse embryo at E13.5 showing the positions of sections to which the drawings and photographs in 
this figure refer, b) Schematic representations of the E13.5 mouse embryo in transverse section (the 
position of each section is shown in (a)), with anatomical landmarks identified and the photographic 
field of each photomicrograph (as shown in (c)) marked with a dashed line, c) Photomicrographs of 
representative transverse sections, magnification x85 (x40 for c(ii)A), showing the expression of NSE 
protein in the E l3.5 mouse embryo. NSE was detected using a polyclonal antiserum specific for 
human NSE and a secondary FITC-conjugated antiserum specific for rabbit IgG. Photographs were 
enlarged from slides taken under epifluorescent microscopy using a xlO or x20 DIC objective lens.
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7.2.4.6 Expression of endogenous NSE protein at E14.5
E14.5 was the final stage at which NSE protein expression was investigated. 
Transverse lOpm sections were taken throughout E14.5 mouse embryos and NSE 
protein was detected as described in section 7.2.4. NSE protein could be detected 
in sections of brain at all levels and throughout the neural tube. Examination of 
brain sections showed that the rostrocaudal gradient of NSE expression was similar 
at E13.5 and E14.5. Cranial sections showed that most of the midbrain was NSE- 
positive (Figures 7.13(i)A and 7.13(i)B) whilst in the cerebral cortex, NSE protein 
was restricted to a peripheral band of cells. It was apparent that, unlike the E13.5 
cerebral cortex where NSE-positive cells were restricted to the lateral curve, the 
E14.5 cortex displayed a complete ring of NSE-positive cell bodies (Figure 7.13(i)C 
shows the central region of the telencephalon). The epiphysis was NSE-negative 
(data not shown). The hindbrain structures (medulla oblongata and pons, Figure 
7.13(ii)A) once again displayed a more intense level of NSE expression than the 
hypothalamus (Figures 7.13(ii)A-C). The regression of the NSE expression domain 
towards the anterior extremity of the hypothalamus was similar in pattern to that 
observed at E13.5 (Figure 7.13(ii)C). The difference in NSE expression levels 
between the medulla and hypothalamus could also be observed in more caudal 
sections (Figure 7.14(i)A). There was extensive staining throughout the medulla, 
with particularly intense staining in bilateral lanes flanking the narrow ependymal 
layer (Figure 7.14(i)B). NSE expression was again most intense in the marginal 
layer, continuous with the rostral extremity of the spinal cord (Figure 7.14(i)A).
The expression of NSE in other neural structures was also investigated. In the 
E14.5 eye, NSE could be detected in the neural retina, but also in the pigmented 
layer which is not a neuronal structure (Figure 7.14(ii)B). Single NSE-positive cell 
bodies were also observed in the olfactory neuroepithelium (Figure 7 .14(ii)C). 
Rostral sections of the spinal cord indicated a ventrodorsal gradient of NSE protein 
(Figure 7.15(i)A). NSE protein was abundant in the ventral marginal layer and 
ventral mantle layer (ventral grey horn), but the intensity of expression decreased 
towards the dorsal surface (dorsal grey horn, Figures 7.14(ii)A and 7.15(i)A). NSE
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protein was also abundant in the dorsal marginal layer (Figures 7.15(i)A and 
7.15(i)B) and the spurs of NSE-positive cells observed at E13.5 (Figure 7 .12(ii)A) 
had fused at the median fissure and ingressed towards the central canal (Figure 
7.15(i)A). NSE-positive cell bodies were particularly evident in the dorsal root 
ganglia (Figures 7.15(i)C and 7.15(i)D) and mixed spinal nerves also stained very 
intensely (Figure 7.15(i)D).
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Figure 7.13: Following three pages
Figure 7.13: Expression of NSE protein in mouse embryos at E14.5. a) Size and appearance of 
mouse embryo at E14.5 showing the positions of sections to which the drawings and photographs in 
this figure refer, b) Schematic representations of the E14.5 mouse embryo in transverse section (the 
position of each section is shown in (a)), with anatomical landmarks identified and the photographic 
field of each photomicrograph (as shown in (c)) marked with a dashed line, c) Photomicrographs of 
representative transverse sections, magnification x85, showing the expression of NSE protein in the 
E14.5 mouse embryo. NSE was detected using a polyclonal antiserum specific for human NSE and a 
secondary FITC-conjugated antiserum specific for rabbit IgG. Photographs were enlarged from 
slides taken under epifluorescent microscopy using a x20 DIC objective lens.
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Figure 7.14: Following three pages
Figure 7.14: Expression of NSE protein in mouse embryos at E14.5. a) Size and appearance of 
mouse embryo at E14.5 showing the positions of sections to which the drawings and photographs in 
this figure refer, b) Schematic representations of the E14.5 mouse embryo in transverse section (the 
position of each section is shown in (a)), with anatomical landmarks identified and the photographic 
field of each photomicrograph (as shown in (c)) marked with a dashed line, c) Photomicrographs of 
representative transverse sections, magnification x85, showing the expression of NSE protein in the 
E14.5 mouse embryo. NSE was detected using a polyclonal antiserum specific for human NSE and a 
secondary FITC-conjugated antiserum specific for rabbit IgG. Photographs were enlarged from 
slides taken under epifluorescent microscopy using a x20 DIC objective lens.
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Figure 7.15: Following two pages
Figure 7.15: Expression of NSE protein in mouse embryos at E14.5. a) Size and appearance of 
mouse embryo at E14.5 showing the positions of sections to which the drawings and photographs in 
this figure refer, b) Schematic representations of the E14.5 mouse embryo in transverse section (the 
position of each section is shown in (a)), with anatomical landmarks identified and the photographic 
field of each photomicrograph (as shown in (c)) marked with a dashed line, c) Photomicrographs of 
representative transverse sections, magnification x85 (x40 for 15c(i)A), showing the expression of 
NSE protein in the E14.5 mouse embryo. NSE was detected using a polyclonal antiserum specific 
for human NSE and a secondary FITC-conjugated antiserum specific for rabbit IgG. Photographs 
were enlarged from slides taken under epifluorescent microscopy using a xlO or x20 DIC objective 
lens.
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7.3 Generation of NSE-lacZ transgenic embryos
7.3.1 Construction of transgenes
Material for the generation of transgenes was derived directly and exclusively from 
plasmid pNSElacZ, the source of transgenes in the original study of NSE-lacZ 
transgenic mice (Forss-Petter et al., 1990). As a preliminary experiment, 
pNSElacZ was transfected into permissive NB4-1A3 cells and nonpermissive Ltk- 
cells to ensure that the construct was capable of expression. The cells were fixed 
and assayed in situ for [i-galactosidase activity by staining with X-gal as described 
in section 4.5.4. NB4-1 A3 cells expressed p-galactosidase as expected whilst no 
such activity was observed in the Ltk- cells (data not shown).
Having demonstrated that the construct was capable of neuron-specific expression in 
an ex vivo context, two transgenes were generated to investigate NSE gene 
regulation in vivo. The first transgene contained the 1.8 kbp complete NSE 
regulatory sequence and this was prepared by linearisation of pNSElacZ with BamH 
I followed by partial digestion with EcoR I as shown in Figure 7.16a. This 
transgene was equivalent in information content to transfection construct 
pNSE1800CAT. The second transgene contained 255 bp of 5' flanking sequence 
and was prepared by digestion of the longer transgene with Xho I as shown in 
Figure 7.16b. This construct contained the same amount of regulatory information 
as the transfection construct pNSE300CAT, which had been shown previously to be 
capable of full cell type-specific reporter expression ex vivo. The purpose of this 
shorter construct was therefore to determine if the same truncated regulatory 
information was capable of directing neuron-specific gene expression in vivo.
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a)
1.8 kbp 3.3 kbp 1.2 kbp
1 NSE lacZ SV40 |
EcoR 1 EcoR 1 £coR I BamH I
b)
255 bp 2.6 kbp 1.2 kbp
NSE lacZ
Xho I EcoR I EcoR I Bam H I
Figure 7.16: Generation of NSE-lacZ transgenes. White boxes represent NSE gene regulatory 
sequence, grey boxes represent the E.coli lacZ gene, black boxes represent the SV40 polyadenylation 
site and the line represents pNSElacZ vector sequence, a) TGNSE1800, 6.3 kbp in length, contained 
the complete NSE regulatory sequence and was generated by linearisation of pNSElacZ with BamW I 
followed by partial digestion with EcoR I. b) TGNSE300, 4.75 kbp in length, contained the 
proximal 255 bp of the NSE 5’ flanking region and was generated by digestion of TGNSE1800 with 
Xho I.
7.3.2 Generation of transgenic embryos
Transgenic mice were generated by pronuclear microinjection as described in 
section 4.5.2. No attempts were made to generate transgenic lines, as this type of 
experiment was not feasible within the time allowed for the project. All 
microinjections and embryo transfer procedures were carried out by Dr D Stott 
whose help in this area is gratefully acknowledged.
7.3.3 Identification of transgenic embryos
Transgenic mice were identified by testing genomic DNA for the presence of the E. 
coli lacZ coding region using a PCR-based assay as described in section 4.5.3.2. 
The detection of a 204 bp PCR product was taken as positive evidence for the 
successful integration of the transgene as genomic DNA from known nontransgenic 
mice did not yield such a band. In each experiment, genomic DNA from a known
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lacZ-transgenic mouse was used as a positive control and genomic DNA from a 
wild type mouse was used as a negative control. A second negative control lacking 
DNA altogether was used to confirm the integrity of the reagents. Figure 7.17 
shows a schematic diagram representing the PCR assay and a Polaroid photograph 
of such an experiment.
LC1—»
|------------ NSE------------ H O B
<—LC2◦
SV40
b
M 1B2 1BI 1A3IA2 IAI
M o  -  +■ IB4 IB3
Z  
>
I
o
*
-204
o
*
-204
Figure 7.17: PCR test to identify transgenic embryos, a) Diagram showing transgene (white block 
represents NSE regulatory sequence, grey block represents E. coli lacZ coding region, black block 
represents SV40 polyadenylation site) integrated into genomic DNA (line). Primers (LC1 and LC2) 
anneal to the positions shown and DNA synthesis occurs in the direction of the arrows to yield an 
expected PCR product of 204 bp in length, b) Polaroid photograph of 1.5% w/v agarose gel showing
the results of such an assay. Lanes labelled 1A1, 1A2, 1A3..... 1B1, 1B2... etc. refer to individual
embryos. The numbering system reflects the experiment number, the mother and the embryo, thus 
1B2 refers to the second embryo isolated from the second mother in the first experiment. + 
indicates positive control, - refers to wild type mouse control and DNA- indicates negative control 
without DNA. Markers are Gibco BRL 1 kb ladder (M). O = origin.
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7.3.4 Analysis of NSE-driven reporter expression in transgenic embryos
Embryos were isolated at E l3.5 and prepared for X-gal staining as described in 
section 4.5.4. Transgenic embryos identified by the PCR assay described above 
were stained for 36-72 hours as wholemount specimens, as described in section
4.5.4, and then cleared in Murray's reagent for observation. The embryos were 
then washed in methanol to remove the clearing agent, equilibrated through a 
decreasing methanol/PBS series and finally incubated in PBS with 0.1% v/v Tween 
20 for one hour. The embryos were then embedded and cryostat sectioned, as 
described in sections 4.3.2 and 4.3.3. p-galactosidase was detected using a 
polyclonal antiserum and cells expressing the protein were revealed using a 
horseradish peroxidase-conjugated secondary antiserum and diaminobenzidine 
tetrahydrochloride without metal ion enhancement.
7.3.5 Expression of transgene TGNSE1800
Of nineteen embryos isolated from implanted females, seven were identified as 
transgenic based on the results of PCR analysis. Of those seven, five were found to 
express no detectable p-galactosidase, even following prolonged (72hr) staining with 
X-gal. These embryos were removed from the staining solution, equilibrated by 
several hour-long washes with PBST, and incubated as wholemount specimens with 
rabbit anti-P-galactosidase antiserum, followed by detection with horseradish 
peroxidase-conjugated goat anti-rabbit IgG and diaminobenzidine tetrahydrochloride 
without metal ion enhancement. Staining was observed, but it was diffuse and 
nonspecific and similar staining was observed in nontransgenic littermates subjected 
to the same procedure (data not shown). It was concluded that these mice had failed 
to express the transgene, either because the transgene itself had been modified upon 
integration or because of unfavourable position effects, and they were not 
investigated further.
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The remaining two embryos demonstrated weak p-galactosidase activity as shown in 
Figures 7.18a and 7.18b. Embryo 1A3 demonstrated P-galactosidase activity in the 
head and thoracic region. In the head, weak blue staining was observed in the 
dorsal extremity of the midbrain and hindbrain, continuous with the dorsal midline 
of the neural tube. This staining can be seen clearly from a ventral perspective 
(Figure 7.18a(i)) as a central blue line running along the rostrocaudal axis. From a 
lateral perspective (Figure 7.18a(ii)), it can be seen that this line follows the 
curvature of the hindbrain and stops at the rostral extremity of the neural tube (these 
structures are shown by a dotted line in Figure 7.18a). No p-galactosidase activity 
was observed in the neural tube of either embryo. Staining was also observed in 
other regions of the head: Greater magnification from a lateral perspective showed 
bilateral blue-stained structures in the basal region of the brain behind each eye 
(Figures 7.18a(iii) and 7.18a(iv), indicated by thin arrows). It was thought at first 
that these were the optic nerves. However, unlike endogenous NSE protein, 
P-galactosidase is not axonally transported and remains restricted to the cell body 
when expressed in neurons (see Forss-Petter et al., 1990). Thus the optic nerves, 
which comprise bundles of sensory axons, would be unlikely to display 
P-galactosidase activity. It was more likely that these structures represented the 
primordial vestibular apparatuses or cochlea, both of which are found in the otic 
region of the skull (and, in birds, have been shown to express NSE at an equivalent 
stage of development (Whitehead et al., 1982)). Weaker staining was observed in 
the nasopharyngeal region of the head which, from a lateral perspective, appeared 
nonspecific (Figures 7.18a(ii) and 7.18a(iii)). However, from a ventral perspective, 
the diffuse staining coalesced into several nodal regions which might well 
correspond to the facial and cervical ganglia (Figure 7.18a(i), indicated by thin 
arrows). In the body, staining was observed above the liver, probably representing 
the dorsal primordium of the pancreas which contains many NSE-expressing 
endocrine cells (Figure 7.18a(iii), indicated by thick arrow). Embryo 2B1 showed a 
similar, but weaker and less extensive pattern of P-galactosidase activity (Figure 
7.18b). The ventral perspective (Figure 7.18b(i)) shows that the brain lacked 
P-galactosidase activity completely, except for a small dorsicentral region in the 
hindbrain at the rostral extremity of the neural tube (indicated by thick arrow). The
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bilateral structures in at the base of the brain, appearing to extend towards the otic 
regions of the head were also stained (Figures 7.18b(i), 7 .18b(ii) and 7.18b(iii), 
indicated by thin arrows) and there was a further, weakly stained region in the roof 
of the thoracic cavity (Figure 7.18b(ii), indicated by broken arrow).
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Figure 7.18a: Spatial expression of TGNSE1800 in embryo 1 A3 (i) ventral perspective, (ii) lateral 
perspective, x5; (iii) lateral perspective of head, xlO; (iv) lateral perspective of otic region, xl5. 
Arrows indicate specific regions of the embryo staining positive for p-galactosidase (these regions are 
discussed in the text). Dotted line traces lacZ expression in dorsal midline of nudbrain and hindbrain 
Embryo is shown poststaining, cleared with Murray's reagent
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7.3.6 Comparison of transgene and endogenous gene expression
The TGNSE1800 transgene was expressed in only two out of seven transgenic 
embryos and in these two, the level of P-galactosidase activity was weak. 
Comparison of transgene and endogenous gene expression was carried out by taking 
cryostat sections of the stained transgenic embryos. No p-galactosidase activity was 
detected in sectioned embryos (data not shown), probably indicating that the level of 
enzyme activity was too low to be detected in thin tissue segments. The sections 
were subjected to immunohistochemical staining using a polyclonal antiserum raised 
against recombinant E. coli P-galactosidase and positive cells were revealed using a 
secondary horseradish peroxidase-conjugated goat anti-rabbit IgG followed by 
staining with diaminobenzidine tetrahydrochloride. As expected, few P-galacto- 
sidase-positive cells were revealed by this procedure and those that were 
corresponded to the regions displaying P-galactosidase activity in the wholemount 
specimens. In embryo 1A3, P-galactosidase-positive cells were observed in the 
midbrain and hindbrain at the dorsal midline (Figure 7.19a). Other regions of the 
brain contained no detectable staining cells, and as an example, a lateral segment of 
the medulla oblongata, which displays high levels of endogenous NSE protein (see 
Figure 7.12(ii)) is shown to be completely devoid of P-galactosidase-expressing 
cells in Figure 7.19b. Analysis of sections also ailowed expression of the NSE-lacZ 
transgene to be investigated in the eye: in wholemount specimens, the dark 
pigmentation of the retina prevented observation of blue stained cells. However, 
the eye also displayed a lack of p-galactosidase expression (Figure 7.20a). The 
paired P-galactosidase-positive structures in the basal region of the brain were of 
particular interest. Transverse sections taken throuh this region of the head 
revealed a bilateral and distinct line of positive cells at the ventral wall of the neural 
componenet of the pituitary gland, whilst the bilobar anterior pituitary contained no 
positive cells. The hypothalamus, lying dorsally to the pituitary gland, also 
contained no positive staining cells. These data are presented in Figure 20b.
300
Fi
gu
re
 7
.1
9:
 T
ra
ns
ve
rs
e 
cr
yo
sta
t s
ec
tio
ns
 o
f a
) m
id
br
ai
n 
an
d 
b)
 m
ed
ul
la
 o
bl
on
ga
ta
 (x
85
) t
ak
en
 fr
om
 e
m
br
yo
 1 
A3
 a
nd
 st
ai
ne
d 
im
m
un
ol
og
ic
al
ly
 fo
r P
-g
al
ac
to
sid
as
e 
pr
ot
ei
n 
us
in
g 
a 
po
ly
cl
on
al
 a
nt
ise
ru
m
. 
Si
gn
al
 w
as
 d
et
ec
te
d 
us
in
g 
a 
ho
rs
er
ad
ish
 p
er
ox
id
as
e-
co
nj
ug
at
ed
 se
co
nd
ar
y 
an
tis
er
um
 a
nd
 st
ai
ni
ng
 w
as
 c
ar
rie
d 
ou
t 
us
in
g 
di
am
in
ob
en
zi
di
ne
 
te
tra
hy
dr
oc
hl
or
id
e 
O
n 
th
e 
up
pe
r s
he
et
, d
as
he
d 
lin
e 
re
pr
es
en
ts 
do
rs
al
 m
id
lin
e 
of
 th
e 
m
id
br
ai
n 
an
d 
ar
ro
w
s 
in
di
ca
te
 (i
) c
er
eb
el
la
r a
qu
ed
uc
t, 
(ii
) f
ou
rth
 v
en
tri
cl
e 
an
d 
(ii
i) 
al
ar
 
pl
at
e 
of
 th
e 
m
ed
ul
la
 o
bl
on
ga
ta
. 
Ph
ot
og
ra
ph
s w
er
e 
ta
ke
n 
un
de
r p
ha
se
 c
on
tra
st 
m
ic
ro
sc
op
y 
us
in
g 
a 
x2
0 
ob
je
ct
iv
e.

Results: Chapter 7
7.3.7 Conclusions from the transgenic studies
The transgenic studies were disappointing because high levels of P-galactosidase 
staining were not observed, and this inability to repeat the results of previous 
studies using the same material prevented shorter constructs from being used. It is 
clear that in both previous studies of NSE transgenic mice, lines were used instead 
of single embryos in order to generate a large amount of material for analysis. The 
success rate was far from high, however, and it is possible that the generation of 
transgenic lines is the only way to push forward this investigation. Forss-Petter 
and coworkers generated eighty lines, of which eight successfully integrated a 
transgene (Forss-Petter et al., 1990). Of those eight, one contained a partial 
insertion and was discarded whilst the remianing seven demonstrated variable levels 
of reporter expression. Only two demonstrated panneuronal expression and these 
were chosen for further analysis. Although strong, panneuronal transgene 
expression was not observed in this project, the construct driven by the complete 
NSE regulatory sequence appeared to be expressed in certain neuronal structures 
such as the pituitary gland, dorsal midline of the brain, and ganglia. It would be 
interesting to compare the expression of lacZ in transgenic animals containing 
shorter regions of the NSE 5' flanking region, however the variability observed in 
the patterns of transgene expression in single embryos may indicate that the 1.8 kbp 
NSE flanking sequence is malleable and very subject to position effects. Possible 
solutions to this problem and ways to further the investigation are discussed in 
Chapter 9.
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C h ap ter 8  - P re lim in ary  stu d ies o f  p ro te in -D N A  in terac tion  in th e  NSE S' 
f la n k in g  region
8.1 Chapter summary
The original aims of the project were to investigate NSE gene regulation using both ex 
vivo and in vivo analysis. From these opposite but complementary approaches, it was 
hoped that regions in the 5' flanking sequence could be identified which were 
responsible for cell type-specific and inducible gene expression, and that these could 
be subject to further analysis in vitro.
As discussed in the previous chapter, limited transgene expression ordained that the in 
vivo analysis was not pursued very far. However, the ex vivo analysis yielded a 
substantial amount of data concerning the regulation of NSE in various permissive and 
nonpermissive cell lines. The pattern of gene regulation emerging from these studies 
was complex, and different cell lines of the same type did not produce consistent 
trends of expression. This phenomenon probably reflected the lack of suitable cell 
lines, a problem discussed at some length in Chapter 9.
Notwithstanding these complications, the results of transient transfection studies 
revealed a number of regions within the 5' flanking sequence which, based upon their 
effects upon reporter gene expression in transfected cells, could contribute to the 
regulation of NSE. The regions demonstrating the most profound effects were chosen 
for preliminary analysis in vitro.
8.2 Summary of transfection data and choice of regions for in vitro analysis
The results of preliminary experiments described in the first part of Chapter 6 
suggested that the proximal 255 bp of the NSE 5' flanking sequence plus the entire 
first (noncoding) exon was sufficient for cell type-specific gene expression. Although 
later experiments identified more upstream regions with putative regulatory roles in 
individual cell lines, it was this proximal element which drew initial attention, 
suggesting it should be truncated further.
Figure 8.1 summarises the results of transfection experiments involving the extremely 
truncated constructs pNSE300CAT, pNSE120CAT, pNSE95CAT and pNSE65CAT. 
These experiments showed that the proximal fragment of the NSE regulatory sequence
3 0 4
Results: Chapter 8
could be divided into four regions. Region A extended between the Xho I site at 
position -255 and the Pst I site at position -120. Region B extended from this Pst 1 
site to the Sma 1 site at position -95. Region C extended from this Sma 1 site to the 
Nar I site at position -65 and included the TATA-like box thought to be required for 
basal transcriptional initiation of the NSE gene. Finally, region D extended from the 
Nar I site at position -65 to the beginning of the first intron. When region A was 
removed, there was a proportionally similar upregulation of reporter gene expression 
in Ltk- and Neuro-2A cells, slightly greater in the case of Ltk- cells, whilst in PC 12 
cells, deletion of region A caused a dramatic reduction in the levels of CAT activity. 
There appeared to be no significant effect when this element was deleted in 
transfected HeLa or PI 9 cells, although the very low levels of reporter activity 
observed in the former and the stem cells of the latter might have precluded such 
effects from being noticed. On aggregate, a moderate rise in reporter activity was 
observed in NB4-1 A3 cells upon removal of region A, although the error range in this 
series of transfections suggested that further experiments were necessary to clarify the 
exact role of this element. These results indicated that region A could be important in 
Ltk-, Neuro 2A and PC 12 cells and that these lines should be selected for further in 
vitro analysis. Region A was an ideal size for analysis by gel retardation assay and 
this approach was duly chosen (Dent and Latchman, 1993). The proximal 120 bp of 
the NSE promoter was able to confer high level reporter gene expression in P19 
neurons and Neuro-2A cells but not in PC 12 or NB4-1 A3 cells. A higher level of 
reporter activity was also observed in Ltk- cells but not in HeLa cells nor P I9 stem 
cells. Removal of region B had no significant effect in PI 9 neurons nor in PC 12 cells 
(although the former demonstrated high levels of gene expression whilst the latter did 
not), nor was any significant effect observed in NB4-1 A3 cells, HeLa cells or PI9 
stem cells. There was, however, an approximate 25% drop in reporter activity in both 
Ltk- and Neuro-2A cells. Removal of region C reduced reporter expression to 
background levels in all cell lines indicating the presence of a sequence critical for 
transcriptional initiation in this 30 bp segment. Although not rigorously tested, this 
sequence was probably the TATA-like box, which is known to be the centre at which 
the transcriptional complex forms in many, if not most, eukaryotic protein-encoding 
genes (Alberts et al., 1994). The moderate to high levels of reporter expression 
observed in some of the cells lines when only 30 bp of 5' flanking sequence remained 
upstream of the TATA-like box suggested one of two possibilities. Either the 
elements responsible for cell type specific expression overlapped the TATA box, as 
they were found to do in the peripherin gene (Desmaris et al., 1994) or such elements 
lay downstream of the TATA-box and removal of region C, whilst leaving these 
elements intact, switched off gene expression simply by preventing facilitation of the
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basal transcriptional initiation process. Whatever the explanation, these results 
suggested that any analysis of the very proximal 5' Hanking region and exon 
sequences would have to be undertaken at the nucleotide level. Such experiments 
would involve transfection of constructs altered by in vitro mutagenesis to generate 
single base substitutions and linker scanning mutations, and the investigation of 
protcin-DNA interactions by in vitro footprinting and, if necessary, by in vivo 
footprinting and méthylation interference assays.
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-255 -120 -95 -65
B
Xho I Pst 1 Sma I Nar I
Properties: High level reporter gene expression in all permissive lines, minimal expression in 
nonpermissive lines.
Properties: High level reporter gene expression in P19 neurons, Neuro-2A and Ltk- cells, minimal 
expression in PC12 cells, P19 stem cells, HeLa cells, NB4-1A3 cells.
Effects of deletion: Upregulation in Ltk- cells and Neuro-2A cells, Dramatic downregulation in PC 12
Properties: High level reporter gene expression in neurons, moderate levels in Ltk- cells and Neuro- 
2A cells, minimal levels in other cell types.
Effect of deletion: Approximate 25% drop in reporter gene activity in Ltk- cells and Neuro-2A cells. 
No significant effect in other cell types.
Properties: Shutdown of gene expression in all cell lines.
Effect of deletion: Presumed to remove element critical for basal transcriptional initiation.
Figure 8.1: Summary of the results of transfection experiments involving the most truncated NSE-cat 
constructs. Regions are defined as A, B, C and D with the flanking restriction endonuclease sites and 
position with respect to the transcriptional start site shown. The properties of each segment are 
described and the effects of each deletion discussed.
-120 -95 -65
B C
Pst I Sma I Nar I
cells, no significant effect in P19 stem cells and neurons, HeLa cells, NB4-1A3 
cells.
-95 -65
Sma I Nar I
-65
Nar I
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8.3 Preliminary analysis of region A by gel retardation assay
To determine whether region A could bind to proteins in extracts of cell lines wherein 
it had been shown to be of functional importance, a 135 bp Xho I - Pst I restriction 
fragment corresponding to this region was isolated from construct pNSE1800CAT 
and labelled at the Xho I cohesive end by end filling. This fragment was incubated 
with extracts of proliferating Ltk-, undifferentiated PC 12 and NGF-treated PC 12 cells 
as described in section 4.6.3 and the reaction products were resolved by 
nondenaturing polyacrylamide gel electrophoresis as described in section 4.6.4.
For preliminary analysis, incubations were carried out with increasing concentrations 
of nonspecific competitor DNA to titrate out the ubiquitous and abundant proteins 
which bind to DNA either without sequence specificity or to free ends (Dent and 
Latchman, 1993). Figure 8.2 shows the results of such analysis and indicates the 
presence of at least three binding complexes in Ltk- cells but no specific binding 
complexes in PC 12 cells. This was surprising because the effect of removing region 
A in the PC 12 transfection experiments was very clear, indicating the presence of a 
strong neuronal enhancer. The binding conditions were modified in an attempt to 
optimise binding in extracts of PC 12 cells. Firstly, alternative nonspecific competitor 
DNAs were used with no improvement. Figures 8.3 and 8.4 show the results of using 
calf thymus DNA and poly[dI.dC] (polydeoxyinosinic-deoxycytidylic acid) 
respectively. In further experiments (results not shown), the binding reaction was 
carried out at room temperature instead of the usual 30°C and probe was added to the 
reaction immediately rather than following an initial 10 minute incubation. These 
steps were reported to affect the binding specificity of protein-DNA complexes and 
allow optimisation of binding conditions (H. Taylor, pers. comm.), however, neither 
of these modifications improved the binding conditions although the temperature 
change did cause the autoradiograph to appear fuzzy and ill-defined (results not 
shown).
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Figure 8.2: Preliminary analysis o f DNA-proIein interaction in region A o f the NSE 5' flanking region 
using extracts of Ltk- and PC 12 cells. Lanes were loaded equally for total protein (4 pg) and contained 
1 ng probe. Lane 1 - probe in isolation. Lanes 2-5 contained extract of undifferentiated PC 12 cells, 
lane 2 including Ipg sonicated salmon sperm DNA, lane 3 including 2.5pg sonicated salmon sperm 
DNA, lane 4 including 5pg sonicated salmon sperm DNA and lane 5 lacking nonspecific competitor. 
Lanes 6-9 contained extract of PC 12 cells differentiated with NGF, lane 6 including Ipg sonicated 
salmon sperm DNA, lane 7 including 2.5pg sonicated salmon sperm DNA, lane 8 including 5pg 
sonicated salmon sperm DNA and lane 9 lacking nonspecific competitor. Lanes 10-13 contained 
extract of Ltk- cells, lane 10 including lpg sonicated salmon sperm DNA, lane 11 including 2.5pg 
sonicated salmon sperm DNA, lane 12 including 5pg sonicated salmon sperm DNA and lane 13 
lacking nonspecific competitor. The positions of binding complexes, labelled NSE1, NSE2 and NSE3, 
are indicated by arrows.
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Figure 8.3: Attempts to identify prolein-DNA binding activity with region A of the NSE 5’ flanking 
region in PC 12 cells. Lanes were loaded equally for total protein (4 pg) and contained I ng probe. 
Lane I - probe in isolation. Lanes 2-5 contained extract of undifferentiated PC12 cells, lane 2 lacking 
nonspecific competitor and lanes 3-5 including I pg, 2.5pg and 5pg respectively of calf thymus DNA. 
Lanes 6-9 contained extract o f PC12 cells differentiated with NGF, lane 6 lacking nonspecific 
competitor and lanes 7-9 including lpg, 2.5pg and 5pg respectively of calf thymus DNA. No binding 
complexes were observed.
310
Results: Chapter 8
1 2 3 4 5 6 7 8 9
undifferentiated PC 12 NGF-treated PC 12
Figure 8.4: Further attem pts to identify protein-DNA binding activity with region A o f  the N SE  5 ’ 
flanking region in PC 12 cells. Lanes were loaded equally for total protein (4 pg) and contained 1 ng 
probe. Lane 1 - probe in isolation. Lanes 2-5 contained extract o f  undifferentiated PC 12 cells, lane 2 
lacking nonspecific com petitor and lanes 3-5 including lp g , 2 .5pg and 5pg respectively o f  poly[dl.dC] 
DNA. Lanes 6-9 contained extract o f  PC I2 cells differentiated with N GF, lane 6 lacking nonspecific 
com petitor and lanes 7-9 including lp g , 2 .5pg and 5pg respectively o f  poly[dl.dC ] DNA. No binding 
complexes were observed.
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Neuro-2A HeLa
figure 8.5: Prelim inary analysis o f  DNA-protein interaction in region A o f  the NSE  5' flanking region 
using extracts o f  N euro-2A  and HeLa cells. Lanes were loaded equally  for total protein (4 pg) and 
contained I ng probe. Lane I - probe in isolation. Lanes 2-5 contained extract o f Neuro-2A cells, lane 
2 lacking nonspecific com petitor, lane 3 including Ipg  sonicated salm on sperm DNA, lane 4 including 
2.5pg sonicated salmon sperm DNA and lane 5 including 5pg sonicated salmon sperm DNA. Lanes 6- 
9 contained extract o f  HeLa cells, lane 6 lacking nonspecific com petitor, lane 7 including I pg 
sonicated salmon sperm  DNA, lane 8 including 2.5pg sonicated salm on sperm DNA and lane 9 
including 5pg sonicated salmon sperm DNA. The positions o f b ind ing  complexes, labelled NSHI, 
NSE2 and NSE3, are indicated by arrows.
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Region A was also shown to be active in Neuro-2A cells but not in HeLa cells, these 
two cell lines were subjected to gel retardation analysis as described above, with the 
latter acting as a negative control. The surprising result from this analysis (as shown 
in Figure 8.5) was that whilst no binding activity could be detected with Neuro-2A 
cell extracts, three binding complexes were observed in the HeLa cell extracts at a 
similar position to those observed in the Ltk- cell extracts.
8.4 Further analysis of binding complexes on region A in nonneuronal cells
Three similar binding complexes were observed in the same region of the NSE 
promoter in two nonneuronal cell lines. This suggested a common regulatory 
mechanism was operating in nonneuronal cells. To confirm that the complexes bound 
specifically to region A, competition experiments were carried out in which specific 
fragments, one corresponding to region A and one bearing no resemblance to region A 
were added to the binding reaction. This is the standard procedure used to determine 
the specificity of binding to a given fragment of DNA . The results, shown in Figures 
8.6a and 8.6b, indicated that in both cell lines, the binding complexes observed were 
specific to region A. In the presence of lx unlabelled region A, there was little 
specific reduction in the abundance of the three binding complexes. Similar results 
were obtained with the irrelevant specific competitor M.OCT, an unrelated fragment 
of similar length to the probe, which contained a nonfunctional octamer site. In the 
presence of lOx unlabelled region A, a marked decrease in the abundance of all three 
binding complexes was noted, but this effect was not observed in the presence of lOx 
M.OCT (Figures 8.6a and 8.6b, lanes 7 and 10). Of the three complexes, NSE2 was 
present in the lowest amounts and was almost totally outcompeted by 1 Ox unlabelled 
region A. Complexes NSE1 and NSE3 were more abundant and were still visible, 
albeit at a much lower level, in the presence of 1 OOx unlabelled region A. However, 
the abundance of the three complexes was unaffected by lOOx M.OCT (Figures 8.6a 
and 8.6b, lanes 8 and 11).
To confirm that specific competition could completely remove the binding complexes, 
the experiment was repeated using 200x competition in addition to the original 
conditions. This experiment was carried out using a fresh batch of Ltk- and HeLa 
protein extracts. The results, shown in Figures 8.7a and 8.7b indicated that in the 
presence of 200x unlabelled region A, all three binding complexes were absent whilst 
in the presence of 200x M.OCT the abundance of the complexes were unchanged. 
This experiment did show, however, that NSE1 was far more prevalent than the other
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two complexes in freshly prepared protein extracts compared to those prepared and 
stored at -70°C for several months. This perhaps indicated that the multiple 
complexes observed were more likely to represent protein degradation products rather 
than individual binding activities. It is also possible that multiple proteins bind to this 
region and that the three complexes observed might reflect different stages of 
assembly of the multicomponent structure.
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Figure 8.6: Com petition assays to determ ine the specificity o f  three binding com plexes on region A in 
extracts o f  (a) Ltk- cells and (b) HeLa cells. Lanes were loaded equally for total protein (4pg) and 
contained 1 ng probe. Lane 1 probe in isolation. Lanes 2-5 contained extract o f  (a) Ltk- or (b) HeLa 
cells, lane 2 lacking nonspecific com petitor and lanes 3-5 including lp g , 2 .5pg and 5pg respectively o f  
sonicated salmon sperm DNA. Lanes 6-11 contained extract o f (a) Ltk- or (b) HeLa cells and 5pg 
sonicated salmon sperm DNA plus the indicated amount o f specific unlabelled com petitor, lanes 6-8 
containing unlabelled region A, lanes 9 -1 1 containing unlabelled M .OCT. The positions o f  binding 
complexes, labelled N S E I, NSE2 and NSE3, are indicated by arrows.
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Figure 8.7: F urther competition assays to determine the specificity o f  three binding com plexes on 
region A in ex trac ts o f (a) Ltk- cells and (b) HeLa cells. Lanes w ere loaded equally  for total protein (4 
pg) and con ta ined  1 ng probe. Lane 1 probe in isolation. Lanes 2-5 contained extract o f  (a) Ltk- or (b) 
HeLa cells, lane 2 lacking nonspecific competitor and lanes 3-5 including Ipg , 2 .5 p g  and 5pg 
respectively o f  sonicated salmon sperm DNA. Lanes 6-13 contained extract o f  (a) Ltk- or (b) HeLa 
cells and 5 p g  sonicated salmon sperm DNA plus the indicated am ount o f  specific unlabelled 
competitor, lanes 6-9 containing unlabelled region A, lanes 10-13 containing unlabelled M.OCT. The 
positions o f  bind ing  complexes, labelled NSE1, NSE2 and NSE3, are indicated by arrows.
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8.5 Preparation for analysis of the proximal 120 bp of the N SE  5' flanking region
The proximal region of the NSE regulatory sequence, extending from the Pst I site at 
position -120 to the beginning of the first intron, could not be excised and labeled in 
the manner of the more distal region A because it could only be isolated with 
endonucleases generating 3’ overhanging. To facilitate the labelling of this fragment 
for future analysis of regions B, C and D, it was subcloned into the Pst 1 site of 
pBluescriptIIKS+. Two recombinant vectors were obtained with the insert cloned in 
opposite orientations. These vectors were named pNSE120>BS and pNSE120<BS. 
The insert can be excised using flanking sites which may or may not possess a 5' 
overhang and this facilitates labelling of either end of the fragment either individually 
or in combination. In vitro analysis of the proximal 120 bp of NSE 5' flanking 
sequence was not carried out due to time constraints. However, this cloning strategy 
should facilitate future studies.
8.6 Conclusions from in vitro studies of the N SE  gene
Although time constraints prevented full exploitation of techniques which can be used 
to investigate protein-DNA interactions, the limited analysis carried out has identified 
one or more binding activities on region A of the NSE 5' flanking region which appear 
to be specific to nonneuronal cells. Furthermore, region A has been shown to 
modulate reporter gene expression in Ltk- cells by silencing. This fits in with a model 
whereby a protein binding to region A would downregulate transcription from the 
remainder of the promoter in nonneuronal cells but not in neuronal cells. 
Unfortunately, silencing activity was not revealed during transient transfection 
analysis of this region in HeLa cells. Furthermore, silencing activity was observed in 
(neuronal) Neuro-2A cells, but no binding activity was found in extracts of these cells. 
Nor was binding activity detected in PC 12 cells even though region A was shown to 
be of great importance in this cell line. These results are discussed at some length in 
the following chapter with respect to the value of neuronal cell lines in the analysis of 
neuronal gene expression. It is also possible that further attempts to optimise binding 
activities or the use of alternative protocols (Dent and Latchman, 1993) might identify 
binding complexes which have not been observed in this study.
Obviously, firm conclusions cannot be drawn from this data without support from 
transgenic studies followed by the analysis of regions of the NSE promoter in vitro
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using extracts of endogenous tissue. It would also be advantageous to investigate the 
abundance of any specific binding complexes observed in these experiments in 
extracts of mouse embryos to see whether the complexes arise at the time of in vivo 
neuronal differentiation. It is likely that the complexity of NSE gene expression 
reported in vivo would also be reflected in the protein -DNA interactions in the 5' 
flanking region of the gene. As brain extracts would contain proteins isolated from 
many different classes of neuronal cells plus a great excess of glial protein, which 
might squelch any neuron-specific effects, the conclusions from such studies would 
have to be made very carefully. It is likely that extracts of primary cultured neurons 
and nonneuronal cells would be extremely valuable in such studies to prevent the 
mixing of effects from various cell types. The observation of proteins binding to the 
first intron of the NSE gene in isolates of primary cultured neurons has already been 
reported (Sakimura et al., 1995).
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Chapter 9 - Discussion, conclusions and fu tu re  work
9.1 Chapter summary
In this final Chapter, the experimental strategy used during the project, and the 
results of the experimental work set out in Chapters 5 through 8, are discussed in 
the light of the published literature. The results section was divided into four 
chapters reflecting the following major subject areas: (a) development of suitable 
systems for studying NSE gene regulation in cell lines; (b) analysis of NSE gene 
regulation in neuronal and nonneuronal cells and in the context of neuronal 
differentiation using transient transfection; (c) analysis of the NSE gene in vivo using 
transgenic mice; and (d) In vitro analysis of the NSE 5’ flanking region defined as 
important in the previous chapters. The discussion is subdivided in a similar 
manner, with particular attention directed towards the limitations of the presented 
work and further experiments which could help to clarify issues not made clear in 
the project.
9.2 Ex vivo analysis of gene regulation - suitability of the approach and criticism 
of the way systems were chosen, tested and applied.
9.2.1 Suitability of transient transfection analysis for the study of gene 
regulation
As discussed in Chapter 2, the ex vivo transient transfection approach to the analysis 
of gene regulation has a number of advantages and disadvantages compared to in 
vivo analysis using transgenic animals. To recap, the major advantages of this 
approach are that (a) it can be repeated many times with relative ease to generate 
large amounts of data for statistical analysis and (b) DNA introduced into cells is 
maintained in an extrachromosomal state and is not subject to the position effects of 
integrated transgenes (which can modify their pattern of expression in unpredictable 
ways). The ex vivo approach also allows specific inductive responses to be
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investigated simply by adding appropriate factors to the growth medium. The 
disadvantages of the ex vivo approach reflect its artificial nature. Established cell 
lines and the endogenous cells they represent often express different groups of genes 
and one example of this is the expression of NSE in glioma lines (Zomzely-Neurath, 
1983). Also, under certain circumstances, it may be difficult to obtain cell lines 
with appropriate properties, e.g. it is sometimes difficult to find cells which express 
transiently expressed developmental genes (there is no shortage of cell lines which 
express NSE, however). Finally, from a mechanistic perspective, a false impression 
of gene regulation may be obtained from transiently transfected cells if the 
endogenous gene responds to distant c/s-acting elements in the genome, or 
epigenetic factors such as DNA methylation or chromosome packaging as such 
factors are not represented in the extrachromosomal construct. Additionally, low 
abundance transcriptional regulators may be completely titrated out by the large 
molar amount of DNA introduced during transfection, resulting in abnormal 
expression from the excess free DNA. Some or all of these problems may influence 
the behaviour of transfected reporter genes in cultured cells. For some cell types, 
e.g. liver cells, cell lines appear to be almost perfectly representative of their 
endogenous counterparts. Neuronal cell lines are unusual, however, in that their 
very existence depends upon them differing fundamentally from endogenous 
neurons. This can make the interpretation of transfection experiments more 
difficult, a problem discussed in section 9.3.6.
9.2.2 Establishment of endogenous NSE  gene expression in cell lines
The regulation of NSE was considered in both neuronal and nonneuronal cells, the 
former being shown to be permissive for NSE gene expression, the latter 
nonpermissive. This strategy was chosen on the basis that both positive and 
negative aspects of gene regulation could be studied. The expression of genes in 
neurons is known to be controlled by both positive and negative factors, and to 
illustrate this point, several well-characterised systems have been described in 
Chapter 2. The expression of NSE in the nervous system overlaps with that of
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several putative positive regulators of neuronal gene expression, such as Brn-1 and 
other octamer-binding proteins (He et al., 1989; Ninkina et al., 1993; Lillycrop et 
al., 1992), NeuN (Mullen et al., 1992), BSF1 (Motejlek et al., 1994), and mKr2 
(Chowdhury et a l., 1988). The expression pattern is complementary to those of 
potential and known negative regulators of neuronal gene expression such as the 
NRSF (Schoenherr and Anderson, 1995) and Sox2 and Sox3 (Uwanogho et al., 
1995). Accordingly, previous studies of neuronal gene expression have often 
involved both permissive and nonpermissive cell lines (see section 2.5 and 
references therein) and this is also true of the most recent study of NSE gene 
regulation (Sakimura et al., 1995).
9.2.3 Justification of combined northern and western analysis of gene expression
As evidence for the suitability of various cell lines for their proposed purposes in 
transient transfection assays, most authors have cited the results of RNA expression 
experiments. Whether by northern blot, in vitro translation, RNase protection or 
quantitative RT-PCR, this approach reflects the fact that upstream regions of the 
gene under investigation, subject to control by transcriptional regulators, are usually 
chosen to drive the reporter. In such cases, reporter expression is controlled almost 
fully at the level of transcription and it is therefore necessary to analyse expression 
of the endogenous gene at the equivalent level in order to determine whether or not 
the chosen cell line is a useful system. Such analysis also allows endogenous gene 
expression to be used as a reference, so that ‘mutant’ constructs containing deleted 
derivatives of the endogenous flanking sequence can be compared to the ‘wild type’ 
endogenous gene.
In a growing number of cases, however, posttranscriptional regulation has been 
shown to play an important role in the regulation of gene expression, and several 
well-characterised examples of gene regulation at the levels of RNA processing, 
nuclear export, RNA degradation and protein synthesis have been described (Alberts 
et al., 1994). In this project, the reporter constructs contained not only upstream
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regulatory information, but also the part of the 5’ untranslated sequence delineated 
by exon 1 of the NSE gene. As there is some evidence for posttranscriptional 
regulation of NSE (Forss-Petter et al., 1986 and references therein) and because 
posttranscriptional regulation is often controlled by noncoding regions of the 
transcript (Kozak, 1989), it was considered wise to investigate endogenous 
expression at both the RNA and protein levels. It was possible that reporter 
expression could be influenced by posttranscriptionally active di-acting elements in 
the 5’ untranslated region as well as by transcriptionally active di-acting elements in 
the upstream region of the gene.
9.2.4 Comparison to previous investigations of NSE  gene expression in cell lines
Endogenous gene expression in cell lines was analysed by northern and western 
analysis, and distribution of the protein was investigated by in situ 
immunocytochemistry. The suitability of the methods used to detect NSE mRNA 
and NSE protein was discussed at length in section 5.2.1 and will not be reiterated 
here except to say that each proved adequate for its purpose, underscoring the 
results of previous studies which have emphasised the cross-species conservation of 
these molecules (Clark-Rosenberg and Marangos, 1980; Jackson et al., 1985; see 
Table 1.3). The results of northern and western analysis in different cell lines were 
set out in sections 5.2.2-5.2.8 and generally agreed well with previously published 
observations, as discussed below.
The expression of NSE mRNA and NSE protein in PC12 cells has been described 
previously in the context of neuronal differentiation following treatment with NGF 
(Vinores et al., 1981; Sakimura et al., 1995). Although, in the more recent study, 
no quantifiable data were presented, northern analysis appeared to suggest that 
levels of the NSE transcript were similar in untreated and treated cells (Sakimura et 
al., 1995). This was very different from the picture presented in the earlier study 
(Vinores et al., 1981) in which NSE protein was shown to be extremely sensitive to 
the NGF-induction in PC12 cells, with even low doses (1 ng m l') producing the
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maximal increase, a response not stimulated by EGF, growth hormone, insulin, 
cytochrome c or sodium butyrate. In the present study, only moderate stimulation 
of NSE gene expression was observed following NGF treatment of PC 12 cells - this 
was shown at both the mRNA and protein levels. It is not clear why these three 
attempts at the same experiment provided such contradictory results. The author 
acknowledges that no other NGF-induced neuronal markers were used as positive 
controls for NGF activity, although the dramatic change in PC 12 cell morphology 
accompanying exposure to NGF was thought adequate to verify the activity of the 
inducing agent. It is possible that differences in culture conditions, perhaps brought 
about by the distinct requirements of different PC12 subclones, contributed to the 
limited response. Unfortunately, details of NGF treatment and cell culture 
conditions were not provided in the report by Sakimura and colleagues (Sakimura et 
al., 1995) so it was neither possible to comment on their approach, nor to compare 
their methodology to those used herein and those of Vinores et al. It should be 
noted, however, that PC 12 cells also demonstrate density-dependent expression of 
NSE and that the response to NGF induction becomes less marked the longer the 
cells are cultured (Vinores et al., 1981). After three days in culture, Vinores et al. 
observed only a minimal induction of NSE protein compared to the twentyfold 
upregulation observed in proliferating cells. Both PC 12 clones used in the present 
project were also harvested after three days in culture, suggesting that the observed 
insensitivity to NGF reflected this density-dependent induction in undifferentiated 
cells. The two PC12 cell lines used in this project also demonstrated entirely 
different morphologies, growth conditions, and responses to transfection when 
compared to each other and to PC12 cells studied by others (Hawley-Nelson et al.,
1994). These factors may also have contributed to the different results obtained by 
Vinores et al. , Sakimura et al., and myself.
NSE gene expression has not been previously investigated in the other permissive 
cell lines used in this project (U-138 MG, Neuro-2A and NB4-1A3), although 
further glioma and neuroblastoma lines have been studied in some detail (Zomzely- 
Neurath, 1983). Generally, both cell types have been shown to express lower levels 
of the NSE gene products than brain, and whilst significant levels can be detected in
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many glioma lines, such as C6 (Sakimura et al., 1995), the levels found in 
proliferating neuroblastoma cells are generally very much lower. At the protein 
level, NSE in different neuroblastoma lines has been shown to contribute 0.1-7% of 
total enolase activity (Zomzely-Neurath, 1983). Furthermore, where NSE mRNA 
generates a strong hybridisation signal in northern blots of brain RNA, the transcript 
is barely detectable in equivalent amounts of RNA from neuroblastoma lines 
(Sakimura et al., 1995). The results presented in this project indicated that Neuro- 
2A and NB4-1A3 cells also expressed barely detectable levels of NSE mRNA and 
NSE protein, whilst NSE gene expression in the glioma line U-138 MG was more 
significant, but approximately tenfold less than that observed in adult brain.
As transfected cells were allowed to become confluent prior to harvesting, it was 
particularly interesting to note the observations of Matranga et al. with respect to 
NSE gene expression in confluent cultures of mouse N-115 neuroblastoma cells 
(Matranga et al., 1992). These investigators showed that the levels of NSE mRNA 
increased as the cells became more confluent, a phenomenon which had previously 
been observed at the protein level for another neuroblastoma line (Legault-Demare 
et a l . , 1980). Matranga and colleagues further suggested that the observed variation 
in the proportion of the brain enolase isoenzymes between different neuroblastoma 
cell lines (Zomzely-Neurath, 1983) might in part reflect unreported differences in 
cell density. The expression of NSE mRNA and NSE protein was investigated in 
cultures of Neuro-2A cells and it was found that a ten to twentyfold induction of 
gene expression occurred in confluent cells compared to proliferating cells. It was 
therefore apparent that although the proliferating cells could be regarded as 
nonpermissive or at least, not fully permissive for NSE gene expression, the 
posttransfection cells were suitable for use as a permissive system due to the high 
levels of NSE gene products resulting from this artefact of cell culture and 
transfection. It is possible that a second such artefact, serum withdrawal during 
transfection in semm-reduced medium, also resulted in a mild induction of NSE in 
some cell lines. However, exposure to serum-reduced medium was rarely longer 
than six hours, when fresh medium containing serum was added to the cells. It is 
therefore unlikely that serum withdrawal produced a significant effect, and any
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response would probably have been reversed by the refreshment provided following 
transfection.
Analysis of the murine embryonic carcinoma cell line P19 showed that both NSE 
mRNA and NSE protein were undetectable in stem cells but abundant in neurons 
after 14 days in culture. Previously, it had been reported that NSE mRNA was 
expressed in murine ES-12957 embryonic stem cells, although NSE protein was not 
detected (Alouani et al. , 1993). The apparent discrepancy between these results 
could reflect properties of the different cell lines used. However, it is much more 
likely that differences in the sensitivity of the detection systems were responsible. 
Alouani and coworkers used the extremely sensitive RT-PCR assay to detect the 
NSE message in their experiments, whilst northern analysis was used in the present 
project. As an indication of the sensitivity of their approach, it should be noted that 
Alouani and coworkers used Neuro-2A cells as a control for NSE expression and 
these cells generated a signal more than 100-fold greater than that of the ES cells.
As discussed above, NSE mRNA was barely detectable in proliferating Neuro-2A 
cells, even after a long (96 hour) exposure of northern filters. Expression of NSE 
mRNA in ES cells at levels two orders of magnitude less than those observed in 
Neuro-2A cells would therefore obviously lie well below the minimum threshold for 
detection by northern analysis. In this project, NSE mRNA and NSE protein were 
detected in differentiated P19 neurons after two weeks in culture, concomitant with 
the overt differentiation of neuronal cell types as judged by the formation of long 
neurites and synaptic associations. The levels of gene products were found to be at 
least as high as those found in adult brain, which was somewhat higher than those 
found by Alouani and coworkers in their differentiated cultures. This second 
discrepancy probably reflects the manner in which the differentiated cultures were 
treated. Alouani and coworkers allowed their cultures to differentiate freely, which, 
after several days, results in a large excess of proliferative nonneuronal cells 
(Rudnicki and McBurney, 1987). Conversely, the differentiated cultures generated 
in the present project were treated with mitotic inhibitors after four days to prevent 
the growth of such cells. In consequence, relatively pure neuronal cultures were 
obtained and the levels of NSE gene products were much higher. Neurons in the
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brain itself are grossly outnumbered by glial cells, thus one would expect pure 
neuronal cultures to express NSE gene products at approximately tenfold the levels 
found in brain (Di Liergo et al., 1992), and this is exactly what was found in 
primary cultures of rat neurons after five days in culture (Sakimura et al., 1995).
As the P19 neurons and brain expressed NSE at more or less the same level, this 
would indicate that the P19 neurons express NSE at levels tenfold less than those 
found for mature neurons in vivo. This suggests that P19 neurons (after 14 days in 
culture) are still relatively young and undifferentiated. Levels of endogenous NSE 
gene expression in neuronal derivatives of ES cells have been shown to rise further 
in long-term cultured cells concomitant with their maturing neuronal morphology 
(Alouani et al., 1993). These data supports earlier investigations where the levels of 
NSE gene products in neuronal cultures were shown to increase with time, 
correlating to the degree of morphological differentiation (Secchi et al., 1980; Bock 
et al., 1980; Schmechel et al., 1980; Ledig et al., 1982; Jirikowski et al., 1983; 
Weyhenmeyer and Bright, 1983; Di Liergo et al., 1991).
NSE gene expression has not been investigated in Ltk- cells, which were used as a 
nonpermissive cell line in this project and this cell line has not been used in previous 
studies of neuronal gene expression. The second nonpermissive cell line, HeLa, has 
been used for several such studies, including the recent investigation of NSE gene 
regulation (Sakimura et al., 1995). Other nonneuronal cell lines, such as BHK-1, 
which have been used for studies of NSE gene expression in the context of 
recombinant herpesvirus-mediated transductions (Roemer et al., 1995), were not 
considered for use in this project. Both Ltk- and HeLa cell lines were shown to 
express NSE mRNA and NSE protein at levels undetectable by northern and western 
analysis and from these results, they were considered suitable as nonpermissive 
systems. As mentioned in Chapter 5, the HeLa cell line is of human origin and no 
control experiments were performed to establish whether the rat NSE 3’ UTR probe 
could detect human NSE sequences. However, NSE mRNA was detected in U-138 
MG and U-373 MG cells, which were also of human origin, and Matranga et al. 
used the human NSE sequence to detect mouse NSE mRNA in neuroblastoma cell 
lines indicating that cross-hybridisation was successful (Matranga et al., 1992). The
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use of HeLa cells as a noexpressing line by Sakimura et al. (1995) also supports the 
role chosen for this cell line in this project.
9.2.5 Strategy for the generation of deletion constructs
The deletion constructs used in the project were simple stepwise truncations of the 
5’ flanking sequence, spanning the 1.8 kbp element which was used successfully to 
drive neuron-specific reporter gene expression in transgenic mice (Forss-Petter et 
al., 1990). In other studies, more extensive and complex strategies have been used 
for deletion analysis. For example, a recent study of peripherin gene regulation was 
facilitated by the generation of twenty stepwise deletion constructs spanning 3.5 kbp 
of flanking sequence (Desmaris et al., 1992), whilst the rat NSE gene itself has been 
studied with the help of thirty constructs including stepwise and internal deletions 
and rearrangements of the flanking region (Sakimura et al., 1995). The former 
study shows how such a maximalist approach can sometimes be inappropriate. 
Elements responsible for cell type-specific regulation of the peripherin gene were 
eventually located overlapping the TATA box, thus most of the constructs 
containing large tracts of upstream sequence were redundant. Pilot experiments 
could have been performed with two or three long constructs and the proximal 
elements could have been localised without all the effort involved in subcloning.
The first approach does have the advantage that, if functional elements are located, 
their position can be narrowed down immediately to a small region of the sequence 
under investigation. However, in the second approach, preliminary studies would 
provide a basis for the generation of further constructs, and the same information 
could be found without constructing so many vectors. This strategy was pursued in 
the current project, thus a small number of constructs were generated and tested 
initially, providing the evidence that further deletion constructs were required.
These constructs were then used to narrow down the regions of the NSE promoter 
required for cell type-specific activity, which, like those found in the peripherin 
gene promoter, were located close to the transcriptional start site of the gene.
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9.2.4 Transfection strategy and data handling
Transfection methodology was considered at some length in Chapters 4 and 5. An 
exhaustive discussion of the transfection optimisation experiments is unnecessary in 
the present chapter, as their purpose was obvious and their contribution to the study 
of NSE gene regulation only peripheral. Such experiments were carried out 
according to established protocols (Selden and Rose, 1991) and for cationic 
liposome reagents, according to manufacturers' recommendations. It is necessary, 
however, to consider two aspects of the transfection methodology in detail as these 
often provoke the most criticism. These are the validity of cotransfection as an 
internal control and the handling of transfection data.
Cotransfection of a standard control vector, such as pSV-P-galactosidase, is one of 
several methods used to normalise comparative transfection data for cell number and 
transfection efficiency. Other methods include measurement of total protein 
concentration and quantitative hybridisation analysis, using a probe specific for the 
transfected DNA. The former can sometimes generate misleading results because 
the protein content of different cells varies (e.g. differentiated PC12 cells contain 
more protein than their undifferentiated precursors, Vinores et al., 1981). The 
latter is labour intensive and time-consuming if many transfections are carried out. 
Cotransfection is advantageous in that reporter gene expression can be measured 
using a simple assay (in this project, by a soluble P-galactosidase assay) and that it 
does not depend upon any the property of the cell line used. The major 
disadvantage of cotransfection is that it is not easy to show, in a mixture of plasmid 
DNAs of known proportion, whether a representative proportion of each plasmid is 
taken up by the cells. Obviously, where numerous constructs are used, and one 
expects the level of reporter gene activity to differ between constructs, it is critical 
to normalise the primary transfection data without the control itself varying between 
parallel cultures. It has been reported that calcium phosphate-mediated transfection 
shows reliable cotransfection ratios (Kingston et al., 1990) and there are many 
examples in the literature where cotransfection has been used to normalise
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transfection data obtained by calcium phosphate-mediated and liposome-mediated 
protocols, including the recent study of NSE gene regulation (Sakimura el al. ,
1995). Generally, P-galactosidase is accepted as a good internal control reporter 
because of its sensitivity and broad linear range (Kain and Ganguly, 1995).
When presented with primary transfection data, it is not only the normalisation for 
transfection efficiency which has to be carried out, but also the relative molar 
amounts of plasmid DNA introduced into the cells has to be taken into account. 
Because transfections were optimised according to the mass of DNA in the 
transfection mix, smaller vectors were introduced into cells in relatively greater 
molar amounts than larger vectors. In published articles dealing with transfection 
analysis, this aspect of data handling is seldom mentioned. However, just as gene 
dosage can be critical for the correct functioning of a cell, reporter gene dosage is 
likely to influence the mechanism of gene regulation. For example: if a given 
transcriptional regulator is present at a low abundance, it may be titrated out by a 
large number of short constructs but not by a smaller number of large constructs, 
given that it binds once to the transcriptional start site of the gene. This scenario 
would result in a differential effect from two constructs, resulting not from 
structural differences between the constructs but from an artefact of transfection. To 
take this into account, primary transfection data were adjusted by a dimensionless 
constant termed the MEC (molar equivalence constant) as shown in section 5.5. 
Elsewhere, this problem has been solved by adding nonspecific carrier DNA, such 
as sonicated salmon sperm DNA, to transfection mixes in order to bring a known 
molar quantity of plasmid DNA up to the optimal mass for transfection (D. Stott, 
pers. comm.). This approach, whilst equally valid, does add another unknown 
factor to the transfection process, and for this reason, the former approach was 
favoured.
The interpretation of transfection data also relied on valid comparison of parallel 
cultures within and between experiments using the same and different cell lines. 
Within an experiment, it was permissible to directly compare the absolute CAT 
activities when corrected for transfection efficiency and molar ratio, as all other
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parameters would be expected to be identical. When comparing transfection data 
across experiments using the same cell line, the absolute CAT activities were 
unreliable, as even relatively minor modifications to technique or assay times could 
result in wide differences between absolute values, rendering such comparisons 
meaningless. This can be clearly seen if one compares absolute CAT activities 
across the experiments presented in Chapter 6. However, by expressing the 
absolute CAT activities, referred to as Actual CAT Activities (ACAs), as a 
percentage of the positive control vector, pCAT-Control, comparison between 
experiments was made valid because variations occurring between experiments 
would affect not only the experimental constructs, but the control vectors also. The 
percentage of control value, referred to as Relative CAT Activity (RCA), allowed 
large amounts of data to be accumulated and subjected to statistical analysis. This 
approach is common in transfection studies, and the control vector is generally 
driven by a viral promoter which would be expected to behave in a similar manner 
in most environments. This presumption is rarely tested, however, and nor were 
control-testing experiments carried out in this project. It is therefore not clear 
whether data should be legitimately compared across experiments using different cell 
lines, however, the precedent is for such comparisons to be made with impunity and 
certainly there are many examples of transfection studies in the literature where this 
aspect of data handling has not been addressed. This includes the recent study of 
NSE gene regulation by Sakimura et al. (1995).
Statistical analysis of the results was restricted to presenting means and standard 
errors from individual transfection experiments and the results of complete 
experimental series. One possible source of criticism is the use of mean control 
values to calculate the Relative CAT Activities of the experimental constructs: the 
control values themselves were subject to variation and this must have had a knock- 
on effect in the calculation of Relative CAT Activities for NSE-cat vectors. In an 
ideal world, the statistical reliability of the data would be unimpeachable. This 
however, would involve performing each experiment tens or hundreds of times and 
selecting data randomly for this population before carrying out the statistics. Of 
course, such an approach would be regarded as ridiculous by most researchers
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outside the field of hardcore statistics, and the potential benefits would be far 
outweighed by the sheer cost and inconvenience of monotonous repetition. Each 
transfection was performed at least six times (each experiment twice in triplicate), or 
nine times (each experiment thrice in triplicate) for calcium phosphate and DEAE- 
dextran-mediated transfections. The confirmation of transfection data by at least one 
repetition is generally considered to be suitable proof of its reliability and this 
minimal prerequisite was certainly exceeded during this project.
9.3 Transfection experiments
Chapter 6 comprised the data from transfection experiments using the optimised and 
tested systems described in Chapter 5. Although the results were discussed at the 
end of each relevant section, it is necessary to place the data in the context of other 
investigations of neuronal gene expression, especially that of Sakimura and 
colleagues who have recently published an extensive analysis of NSE gene regulation 
using an identical strategy to the one used in this project (Sakimura et al. , 1995)
9.3.1 Preliminary attempts to isolate neuron-specific elements in the NSE 5' 
flanking region
In the first part of Chapter 6, the results of some preliminary experiments were 
presented, concerning the behaviour of NSE-cat constructs in one permissive and 
one nonpermissive cell line. These experiments showed quite conclusively that 255 
bp of the 5' flanking region (i.e. the sequence up to and including the proximal Xho 
I site) were capable of conferring high level reporter gene expression in the 
permissive line but only minimal expression in the nonpermissive line. These 
results were backed up by studies in other cell lines: neuroblastoma cells, PC12 cells 
and P19 neurons transfected with construct pNSE300CAT demonstrated high levels 
of CAT activity whilst only minimal activity was observed in HeLa cells and P19
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EC stem cells. The impression from these experiments taken as a whole was that 
elements required for cell type-specific expression were likely to reside downstream 
from position -255, in the very proximal region of the promoter. How did these 
firm conclusions stand up in the light of further transfection data from other 
researchers? Sakimura and colleagues showed that the most important regulator of 
neuronal gene expression did indeed lie downstream from position -255, although in 
an intergenic region not included in the constructs used during this project 
(Sakimura et al., 1995); the importance of this intron-bound element is discussed in 
section 9.3.5. Even without the intron, however, the constructs used by Sakimura 
and colleagues were still neuron-specific although the difference between neuronal 
and nonneruonal cells was less extreme. Thus construct pX3CAT (identical to the 
pNSE300CAT construct generated during this project) was fortyfold and sevenfold 
more active, respectively, in neurons and PC12 cells, compared to HeLa cells. 
These data compare favourably with the results obtained in this project where 
pNSE300CAT was thrityfold and sixteenfold more active in P19 neurons and PC12 
cells, respectively, when compared to HeLa cells.
The main reason for concluding that elements responsible for neuron-specific 
expression must lie downstream from position -255 was the similar activity of 
pNSE300CAT and constructs containing more extensive tracts of upstream 
sequence. Sakimura and colleagues did not carry out extensive analysis of long 
constructs lacking intron 1, but construct pAlCAT/Sac, which contained 1.8 kbp of 
5' flanking sequence (equivalent to pNSE1800CAT) but also intron 1, was not 
significantly more active than a construct containing 255 bp of 5' flanking sequence 
and intron 1. A construct containing 2.7 kbp of 5' flanking sequence but no intron 
was slightly less active (in neurons) compared to pX3CAT. These data therefore 
support the conclusion made from the present study, which was that most of the 
onus for the control of gene regulation lay downstream from position -255.
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9.3.2 Further analysis of NSE  gene regulation in neuronal lines
Truncation of the NSE 5' flanking region beyond position -255 resulted in varying 
effects in different neuronal cell lines. In Neuro-2A cells, truncation from position 
-255 to position -120 caused a doubling of reporter activity suggesting that a silencer 
of some description had been removed. Conversely, in PC12 cells, the same 
deletion generated a five to sevenfold fall in CAT activity. And to box the compass, 
the same deletion in P19 neurons appeared to have no effect at all.
Generally, the analysis of neuronal cells failed to paint a clear picture of the 
mechanism used to regulate NSE. The neuroblastoma transfections alone 
demonstrated that neuronal cell lines vary considerably in the expression of 
transfected reporter constructs. There were really no common trends shared by both 
neuroblastoma lines except the shutdown of gene expression following truncation to 
position -65. NB4-1A3 cells generally demonstrated lower mean Relative CAT 
Activities than Neuro-2A cells, which was somewhat surprising considering that 
their morphology is rather more neuronal than the other cells. It is possible that this 
discrepancy reflected the ability of Neuro-2A cells to become confluent following 
transfection, whilst NB4-1A3 cells tended to become quiescent when 50-70% 
confluent. It is possible that such differences in growth properties could influence 
the regulation of NSE, although this has not been investigated. Studies of 
endogenous NSE gene expression in neuroblastoma lines have indicated considerable 
heterogeneity between lines (reviewed by Zomzely-Neurath, 1983) although this 
may reflect differing culture conditions when measurements were taken (Matranga et 
al., 1992). To establish the nature of NSE gene regulation in neuroblastoma lines, 
an extensive study would be required using a large panel of different neuroblastoma 
lines grown and transfected under standardised conditions. Only limited data was 
presented by Sakimura and colleagues concerning neuroblastoma cells and generally, 
these behaved as nonneuronal cells (although the first intron did cause some 
stimulation of reporter activity over that observed in HeLa cells). Unfortunately, 
there was no discussion of neuroblastoma culture conditions and it is likely that the 
cells were harvested when still proliferating and thus expressing relatively low levels
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of NSE. It would be useful to collect neuroblastoma cells at various confluences 
following transfection and assay for CAT activity. This would show the density 
dependent induction of NSE in more detail and might reveal the presence of cis- 
acting elements responsible for this effect.
PC 12 cells can be regarded as better candidates for the study of NSE gene regulation 
because both the undifferentiated and differentiated cells have been shown to express 
NSE mRNA and NSE protein at high levels (Vinores et al. , 1981; Sakimura et al. , 
1995; this project). As with the Neuro-2A and U-138 MG cells, PC12 cell cultures 
transfected with pNSE1800CAT demonstrated Relative CAT Activities of 
approximately 100%. Reduction of the 5' flanking region to 1000 bp and then to 
255 bp produced a 50% drop in reporter expression in undifferentiated cells, 
although cells differentiated with NGF and transfected with these two constructs 
maintained Relative CAT Activities in the order of 100%. These data suggested that 
positive modulators active in the undifferentiated cells lay in the unsequenced region 
and/or the distal 200 bp of the sequenced region of the NSE promoter. Further 
reduction to 120 bp generated a 5-10-fold reduction in both differentiated and 
undifferentiated cells, indicating that strong positive modulators were positioned 
between -255 and -120 bp upstream of the transcriptional start site. Reduction of 
the 5' flanking region to 65 bp reduced reporter expression to background levels.
Sakimura and colleagues did not present any data for undifferentiated PC12 cells, 
however, NGF-treated PC12 cells transfected with pX3CAT (equivalent to 
pNSE300CAT) showed a mean Relative CAT Activity of 144% compared to 80% in 
this study. It should be noted, however, that poor transfection efficiency for 
pNSE300CAT in the second transfection, and the high standard error of the mean 
resulting from this, somewhat reduced the overall mean value (Figure 6.39). In the 
first experiment, where transfection efficiency was greater and the error range 
smaller, the Relative CAT Activity was 138%, much closer to the value obtained by 
Sakimura and colleagues. Their construct pX3CAT/Bc (equivalent to 
pNSE120CAT) yielded a mean Relative CAT Activity of 27%, which is somewhat 
higher than the 11 % observed in this investigation, but indicative of a similar fall in
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reporter expression when this short region of the promoter was removed. However, 
further reduction of the 5' flanking region to 95 bp maintained reporter expression 
at low levels in this project (approximately 10% Relative CAT Activity) whilst the 
equivalent construct generated by Sakimura et al. - pX3CAT/Ba, yielded a Relative 
CAT Activity of 151%. Other direct comparisons between the present study and 
that of Sakimura et al. are difficult to make because the longest constructs generated 
by Sakimura and colleagues contained the first intron of the NSE gene, which was 
absent from those used in this project. However, a construct lacking the intron, but 
containing 2.7 kbp of upstream sequence was only 1.23-fold more active than 
pX3CAT (equivalent to pNSE300CAT) whilst in this project, the mean Relative 
CAT Activity of pNSE1800CAT was 1.5-fold greater than the (underestimated) 
mean Relative CAT Activity for pNSE300CAT.
In P19 neurons, pNSE1800CAT, pNSElOOOCAT, pNSE300CAT and 
pNSE120CAT constructs all showed similar Relative CAT Activities, in the range 
130-160%. Truncation to 95 bp of 5' flanking sequence resulted in a drop to 
approximately 90% Relative CAT Activity and truncation to 65 bp again reduced 
CAT activity to background levels. These results were subject to a greater degree 
of variability than other transfections, and the reasons for this were discussed in 
section 6.5.2.2. Sakimura and colleagues obtained data from primary cultures of rat 
cortical neurons transfected with NSE-driven CAT constructs. Generally, the levels 
of CAT activity obtained by Sakimura et al. were much greater than those observed 
here. For instance, rat neurons transfected with pX3CAT (equivalent to 
pNSE300CAT) demonstrated a mean Relative CAT Activity of 766%, compared to 
a maximum of 240% and a mean value of 155% obtained from P19 neurons. 
Furthermore, rat neurons transfected with pX3CAT/Bc (equivalent to 
pNSE120CAT) showed a mean Relative CAT Activity of 82%, compared to 130% 
for the P19 neurons in the present study and rat neurons transfected with 
pX3CAT/Ba (equivalent to pNSE95CAT) generated a mean Relative CAT Activity 
of 612%, compared to 90% for the P19 neurons. There appears to be no correlation 
between these results, either in absolute levels of CAT activity or in trend as the 5' 
flanking region of the gene is progressively truncated. However, this is not really
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surprising considering the differences in origin and relative differentiation of the two 
types of neuron. As discussed above, neurons studied in vivo vary considerably in 
their levels of endogenous NSE gene expression, depending upon their position in 
the central nervous system (Katagiri et a l., 1993; Frikke et al., 1987). It is 
therefore likely that different populations of neurons regulate the gene in diverse 
ways, and it has been suggested that the multiple transcriptional start sites attributed 
to the gene may also reflect this heterogeneity, as the RNA used for such analysis is 
always obtained from whole brain rather than isolated neuronal populations (Forss- 
Petter et al., 1986). Analysis of endogenous NSE gene expression in neurons 
isolated at different stages of development has also revealed extensive heterogeneity 
with respect to levels of expression and ex vivo ontogeny (Secchi et al., 1980; Bock 
et al., 1980; Schmechel et al., 1980; Ledig et al., 1982; Jirikowski et al., 1983; 
Weyhenmeyer and Bright, 1983; Di Liergo et al., 1991). This is thought to reflect 
different stages of maturation, starting with young postmitotic neurons equivalent to 
those deposited in the subventricular (inner mantle) layer of the neural tube at the 
beginning of neurogenesis and finishing with fully mature neurons such as those 
observed in the adult CNS. The neurons isolated by Sakimura and colleagues 
certainly differed from the P19 neurons in origin, and also probably in relative 
maturity, and this is another factor which could explain the differences in regulation. 
It is clear from the data presented in the report by Sakimura and colleagues that the 
neurons isolated from the rat neocortex expressed quantitatively greater amounts of 
NSE mRNA than did the P19 neurons considered here (Sakimura et al., 1995). It 
should also be borne inmindthat P19 neurons are generated by artificial mechanisms 
which may not apply in vivo and that the retinoic acid used in the differentiation 
process might also influence the expression of the reporter constructs. In the future, 
it would be advantageous to look at NSE gene regulation in different populations of 
cultured neurons and at neurons isolated from animals at different stages of 
development to determine the influence of such factors on the regulation of the gene. 
It would be necessary to correlate such studies carefully to investigations of 
endogenous gene expression in defined neuronal cell types to assess whether the 
observed differences were related to age and position of the cells.
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9.3.3 Further analysis of NSE gene regulation in nonneuronal cells
Truncation of the NSE 5' flanking region beyond position -255 generally had no 
effect in nonneuronal cells. In HeLa and P19 EC stem cells transfected with 
pNSE300CAT, mean relative CAT Activities were less than 10% and remained so 
when the flanking region was truncated further. Unfortunately, Sakimura and 
colleagues did not carry out extensive analysis of HeLa cells using the highly 
truncated constructs so it is difficult to compare the transfection data obtained here 
with their investigation. However, both studies strongly suggested that NSE gene 
expression is regulated by positive modulators or enhancers rather than negative 
modulators or silencers. Notwithstanding this conclusion, truncation of the NSE 5' 
flanking region from 255 bp to 120 bp in Ltk- cells resulted in a two to fourfold 
increase in Relative CAT Activity. This was greater than the twofold stimulation 
observed in Neuro-2A cells suggesting that between positions -255 and -120 lay a 
negative modulator which was more active in a nonneruonal cell line. Incidentally, 
similar results were obtained using neuroblastoma cell line NB35, which showed 
14% mean Relative CAT Activity when transfected with pX3CAT (equivalent to 
pNSE300CAT) compared to 29% when transfected with pX3CAT/Bc (equivalent to 
pNSE120CAT) (Sakimura et al., 1995).
9.3.4 N SE  gene regulation during neuronal differentiation and in the presence 
of Sox-2 and Sox-3 factors
As discussed in the final part of chapter 6, little conclusive data was obtained from 
experiments designed to investigate the mechanism of NSE gene regulation during 
neuronal differentiation. In the case of PC12 cells, this is perhaps not surprising 
because the preliminary experiments carried out and discussed in Chapter 5 
suggested that only a mild induction of NSE followed treatment with NGF. As 
discussed above, this probably reflected density-dependent induction of NSE in 
undifferentiated PC12 cells, a phenomenon which would certainly occur following
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transfection as the cells were allowed to become confluent prior to harvesting. The 
data from transfection experiments thus showed a similarly minor induction of 
reporter expression from construct pNSE1800CAT (90% mean Relative CAT 
Activity in untreated cells compared to 116% in NGF-treated cells). Truncation to 
1000 bp resulted in a significant (50%) fall in reporter activity in untreated cells but 
no significant effect in differentiated cells. In both cultures, truncation from -255 to 
-120 resulted in a striking drop in mean RCA (to approximately 10%). These 
results suggested that during NGF-induced differentiation of PC 12 cells, the control 
of neuron-specific gene expression was shifted from a system involving two positive 
modulators to one controlled by a single such modulator located between positions 
-255 and -120.
P19 stem cells expressed little CAT activity irrespective of which construct was 
introduced into them whilst high level reporter gene expression was demonstrated by 
all constructs transfected in P19 neurons, with the exception of the most truncated 
vector, pNSE65CAT. These results indicated that, once again, the activation of 
neuron-specific enhancers was central to the induction of NSE during neuronal 
differentiation, but suggested that such enhancers might lay downstream from 
position -95. As discussed above, Sakimura and colleagues also showed that a 
construct lacking the first intron and containing only 95 bp of 5' flanking material 
(termed pX3CAT/Ba) was capable of high level reporter expression in neurons. 
These results taken together suggest that sequences in the very proximal region of 
the 5' flanking sequence, perhaps overlapping the TATA-box or perhaps laying in 
the first exon, were activated during neuronal differentiation. The effects of these 
sequences, whilst appearing significant in the present study, are probably dwarfed 
by the gargantuan contribution of the first intron, as discussed below.
Coexpression of cSox2 or cSox3 appeared to upregulate A/5E-reporter constructs in 
NB4-1A3 cells, although careful analysis of the data revealed that this was more 
likely to represent an artefact of transfection. This series of experiments was carried 
out due to the availability of expression vectors containing the cSox2 and cSox3 
cDNAs and because of the exclusive and complementary expression domains of
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Sox2/3 and NSE in the CNS. As discussed above, most of the evidence presented in 
Chapter 6 argues against negative regulation of NSE, and this, together with the 
absence of consensus Sox binding sites in the sequenced portion of the NSE 5’ 
flanking region indicates that the Sox factors probably do not regulate neuron- 
specific enolase, at least not directly. There are several factors, however which may 
have prevented the identification of such an interaction. Firstly, the distal 800 bp of 
the NSE 5' flanking region has not been sequenced and may contain one or more 
Sox binding sites. Secondly, the mouse Sox clones were not available and the 
chicken ones, used in their place, might not function in the same manner across 
species as they would in a homologous environment. Thirdly, the Sox factors might 
influence NSE gene expression indirectly, or may act on a region outside that 
studied in this project. It is also acknowledged that no preliminary experiments 
were carried out to investigate the effects of Sox expression upon endogenous NSE. 
The seriousness of this omission is understood and should this avenue be pursued in 
the future, such an experiment would be vital. There are other proteins expressed in 
a similar pattern to Sox-2 and Sox-3, such as the NRSF (Schoenherr and Andersen, 
1995) and these are not thought to regulate NSE. The expression of Sox2/3 must 
therefore be regarded as purely circumstantial evidence for a role in NSE gene 
expression.
9.3.5 The role of distal regulatory elements and intron 1
One of the basic axioms upon which this project was founded was the competence of 
the 1.8 kbp 5' flanking sequence of the rat NSE gene to confer upon a heterologous 
gene the spatial, temporal and inducible specificity of endogenous NSE. The ability 
of this sequence to control the onset of reporter expression in parallel with the 
endogenous gene and to match its expression in the embryo was clearly shown in 
transgenic mice (Forss-Petter et al., 1990). Its competence to respond to several 
inducing agents, including retinoic acid and NGF, in the same manner as 
endogenous NSE, was shown in stably transfected ES cells (Alouani et al., 1993). 
However, whilst embryonic expression and inducible specificity were faithfully
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reproduced, the level of reporter gene expression in the adult brain failed to match 
that of endogenous NSE, indicating the absence of a strong, postnatally active 
enhancer element (Forss-Petter et al., 1990). The recent transient transfection study 
carried out by Sakimura and colleagues identified roles for more distal flanking 
sequence and the proximal half of intron 1 in neurons and PC 12 cells differentiated 
with NGF (Sakimura et al., 1995). A construct termed pEXCAT, containing 4.5 
kbp of 5’ flanking sequence and the proximal half of intron 1 (up to and including 
the Xba I site) generated a mean Relative CAT Activity of 5600% in neurons. 
Reduction of the 5' flanking sequence all the way down to 255 bp (the proximal Xho 
I site used herein to generate construct pNSE300CAT) resulted in only a 30% fall in 
reporter activity, suggesting, in excellent agreement with the data presented in this 
thesis, that most of the potential for controlling neuron-specific gene expression lay 
downstream from this position. However, removal of the first intron fragment 
resulted in a striking twenty fold reduction in CAT activity in neurons, and this 
effect was not ameliorated by replacing the intron upstream from the start of 
transcription, indicating that both the presence and position of the intron were 
critical factors for high level expression in neurons. Removing the intron had a 
negligible effect in nonneuronal cells such as primary cultured glial cells and HeLa 
cells but an approximately twentyfold reduction was also observed in PC 12 cells 
suggesting that the intron regulatory element was indeed a strong, neuron-specific 
enhancer. Unfortunately, Sakimura and colleagues did not present any intron data 
for neuroblastoma cells, however, because of the activity of this element in primary 
cultured neurons and differentiated PC12 cells, both ex vivo models of mature, 
postmitotic neurons, it is tempting to speculate that the intron represents the 
postnatally active enhancer missing from the NSE-lacZ transgenic mice (Forss-Petter 
el al., 1990). The region in question contains a number of interesting motifs, 
including a cAMP response element, which is a potential regulator of several 
neuronal genes including the rat dopamine (l-hydrogenase gene (Shaskus et a l.,
1992), and a neuronal consensus element (see Table 2.6). It is possible that the 5' 
flanking region contains elements responsible for spatial, temporal and inducible 
control which are active from onset, but that the dramatic postnatal increase in NSE 
gene activity is governed by this strong positive modulator which may itself be
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neuron-specific or may take its cue from its context within the gene. The 5' 
flanking sequence is obviously capable of neuronal gene regulation in the absence of 
the intron but to prove the reciprocal, one would require that the intron be placed 
downstream of a heterologous promoter, perhaps by replacing the first intron of an 
alternative, nonneuronal gene. Very recently, the first intron of the muscle-specific 
enolase gene has been shown to control its muscle-specific expression pattern and 
this gene is an excellent candidate for such an experiment. If the intron is neuron- 
specific in its own right, this would suggest two independent mechanisms o f 
neuronal gene regulation, perhaps reflecting the postnatal activation or synthesis of 
an intron binding neuron-specific transcription factor. This scenario would predict 
the existence of two independent or semi-independent mechanisms of neuron-specific 
gene expression governing the neuron-specific enolase gene.
Intron 1 was not considered in the transfection experiments presented herein and 
given its demonstrated importance, does this omission reduce the relevance of the 
data? Of course, the 5' flanking region of the NSE gene is still competent for 
neuron-specific regulation in the absence of intron 1 and this has been demonstrated 
not only in transgenic mice (Forss-Petter et al., 1990; Martinou el al., 1994) but 
also by herpesvirus-mediated transduction and by the transfection data obtained by 
Sakimura and coworkers. Thus, although the effect of the 5' flanking region has 
less impact than that of the intron, it is still worthy of investigation in its own right 
and may help to identify further control elements responsible for the regulation of 
the gene.
9.3.6 How useful are neuronal cell lines?
As discussed in section 9.2.1, transient transfection is a generally useful method for 
the study of gene regulation. However, the system has a number of disadvantages 
compared to in vivo analysis, reflecting the episomal nature of the foreign DNA and 
the transformed nature of the cells themselves. It is this second point which may be 
particularly relevant in the case of neuronal cell lines because, unlike the postmitotic
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cells from which they are derived, they have the ability to divide and proliferate in 
culture. It is therefore likely that the intracellular milieu of regulatory factors found 
in neurons in vivo is distinct from that found in neuronal cell lines and this may have 
unpredictable effects on the regulation of neuronal genes.
A second disadvantage of neuronal cell lines is that the vast majority are derived 
from the peripheral nervous system, e.g. PC12 cells (Green and Tischler, 1976) 
which are adrenal in origin. This means that most types of central neuron are not 
represented by cell lines and the value of peripheral lines in the study of 
panneuronal genes, such as NSE, is therefore questionable. Even if such lines were 
perfectly representative of the endogenous cells from which they were derived, 
studies involving them would still paint an incomplete picture of the mechanism of 
gene expression in the context of the whole nervous system. This is especially true 
of a gene such as NSE whose expression is characterised by different levels of 
mRNA and protein in different populations of neurons and neuroendocrine cells.
One of the most striking factors to emerge from the review of neuron-specific gene 
expression (see Chapter 2) was the level of conflict between transfection analyses 
using different cell lines and between ex vivo and in vivo studies. For example, the 
very proximal API and overlapping E box-containing dyad were shown to be both 
required and sufficient for cell type-specific expression of the tyrosine hydroxylase 
gene in PC8b cells (Yoon and Chickaraishi, 1992) but irrelevant in the closely 
related line PC12 (Wong et al., 1994). Further investigation in other cell lines 
highlighted the importance of a proximal octamer element (Dawson et al., 1994). 
Conversely, short regions of the tyrosine hydroxylase gene promoter were shown to 
be nonfunctional in transgenic mice (Banerjee et al., 1992) and more than 5 kbp of 
5' flanking material were in fact required for correct cell type-specific expression in 
vivo. Such reports for this and other neuronal genes may reflect genuinely different 
mechanisms active in distinct cell types, but nevertheless, they certainly emphasise 
the value of combined ex vivo and in vivo analysis of neuronal gene expression.
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9.4 Expression and regulation of NSE in vivo
9.4.1 Expression of endogenous NSE
An investigation of endogenous NSE expression in vivo was carried out so that 
patterns of transgene expression could be compared to that of endogenous NSE.
This has been a standard approach to the investigation of roles of specific regions of 
regulatory information in transgenic mice (for example, see Hoyle et al., 1994). 
Biochemical analysis was carried out first in order to confirm when the endogenous 
gene was expressed. However, northern and western analysis were insensitive to 
the low level expression of NSE occurring in young neurogenic structures, and 
neither mRNA not protein could be detected until E17.5. Similar studies carried out 
in the past a reached much the same conclusions. The earliest stage at which NSE 
protein could be detected was E15 (Fletcher et al., 1976) using a sensitive 
radioimmunoassay. E l5 embryos were not examined in this project but NSE 
protein could not be detected using western analysis at E14.5. NSE mRNA was also 
first detected at E15 by Zeitoun et al., based upon its ability to programme in vitro 
protein synthesis (Zeitoun et al., 1983) and Lucas et al., using northern analysis 
(Lucas etal., 1988).
in situ detection methods are more sensitive than northern and western blotting and 
have been used to detect gene products expressed at very low levels (Wilkinson, 
1992). Such studies have also revealed the expression of enolase genes much earlier 
than biochemical analyses have suggested. NSE protein was first detected at E10.5 
by in situ immunohistochemical analysis to cryostat sections (Forss-Petter et al., 
1990), and MSE mRNA was detected in cardiac tube at E7.25 by in situ 
hybridisation (Keller et al., 1992a), both several days earlier than previously 
reported by northern and western analysis (Lucas et al., 1988; Barbieri et al.,
1990). The expression of NSE protein was investigated by in situ 
immunohistochemical analysis between E9.5 and E14.5, NSE mRNA expression 
was investigated at E9.5 and E8.5 because of reports suggesting the accumulation of 
NSE transcripts prior to expression of the protein (Forss-Petter et al., 1986; Di
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Liergo et al., 1990). The purpose of these experiments was dual: firstly, they were 
necessary to provide a reference to which transgene expression patterns could be 
compared and secondly, they were necessary to identify an appropriate stage of 
development at which transgenic embryos could be studied. This was an important 
strategy in the project because, due to time constraints, the transient transgenic 
approach was favoured over the generation of trangenic lines. In the latter case, 
once a line is generated it can yield a limitless supply of experimental material for 
analysis. Conversely, it is the founder mice themselves which are sacrificed and 
used for analysis in the transient transgenic approach so only single embryos 
representing a given insertion event can be studied. It was therefore essential to 
determine the optimal stage of development before the embryos were isolated and 
this could only be done by looking at the endogenous gene.
The in situ hybridisation data indicated that the gene was first activated at E9.5, just 
following closure of the neural tube and at the time when the first neurons exit the 
cell cycle. Expression of the protein was first observed in ventral neurons of the 
rostral portion of the neural tube at E10.5, agreeing with previous observations 
(Forss-Petter et al., 1990), but judging by the dorsal extent of the expression 
domain in the transverse plane of the neural tube at this stage, it is likely that NSE 
protein expression begins at E10 or E10.25. This is because at a given level of the 
neural tube along the rostrocaudal axis, NSE protein expression was shown to begin 
in ventral (motor) neurons. As development proceeded, motor neurons in 
progressively more rostral and more caudal positions along this axis began to 
express NSE and, in a given transverse plane, expression spread progressively to 
interneurons in the lateral regions and eventually to sensory neurons in the dorsal 
neural tube. This spatiotemporal gradient along the rostrocaudal and dorsoventral 
axes gave the impression that more caudal segments were ‘regressed’ in comparison 
to more rostral segments. The expression of NSE in some lateral neurons at E10.5 
(Figure 7.8c(i)) suggested that analysis at marginally earlier stages would have 
caught the onset of expression in the first motor neurons to differentiate. These data 
suggested that NSE transcripts accumulated just prior to the protein, a factor which 
has been demonstrated by biochemical analysis in rats (Forss-Petter et al., 1986) but
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was not thought to occur in mice (Lucas et al., 1988). Analysis of NSE protein 
expression from El 1.5 to E l.5 revealed staining in neuronal structures as expected 
although both the neural and pigmented layers of the retina appeared NSE-positive 
(the pigmented retina is a nonneuronal structure, Browder et al., 1988).
Expression in the early brain was limited to the mantle layer (grey matter, mostly 
neurons) and peripheral marginal layer (rich in axon bundles) but absent from the 
ependymal layer (which contains proliferating cells). More intense staining was 
observed in midbrain and hindbrain structures (pons, medulla) compared to 
forebrain structures (hypothalamus, cerebral cortex) a phenomenon which has been 
observed previously and has been attributed to the relatively slow development of 
forebrain structures compared to other brain regions (Zomzely-Neurath and Walker, 
1980). The amount of NSE positive material appeared to increase throughout 
development, consistent with the continued deposition of postmitotic neurons. From 
these studies it was decided that E l3.5 would be a suitable stage at which to 
sacrifice transgenic embryos. This decision was taken on the basis that the pattern 
of NSE expression was characteristic and well-established at this stage throughout 
the brain and spinal cord, whilst the embryos were still a suitable and convenient 
size for wholemount staining.
9.4.2 Expression of (i-galactosidase under control of the NSE  promoter
From four embryo transfer procedures, nineteen embryos were isolated and seven 
were found to be transgenic based upon the results of PCR testing. Compared to 
previous such studies, this success rate (7/19 or 37%) was remarkably high. Forss- 
Petter and colleagues obtained eight founders from eighty transfers (10%) whilst 
Martinou and coworkers obtained six founders from the same number of transfers 
(7.5%) (Forss-Petter et al., 1990; Martinou et al., 1994). The proportion of 
transgenic embryos which expressed the transgene has also varied. In the present 
study, two embryos out of seven expressed detectable levels of (i-galactosidase, 
although the staining was weak and limited to certain neuronal populations. One 
embryo was shown to express lacZ in individual cells at the dorsal midline of the
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midbrain and hindbrain whilst both appeared to express lacZ in the neural 
component of the pituitary gland. However, most of the neuronal and nonneuronal 
cells in the embryo were p-galactosidase negative. In the study carried out by 
Forss-Petter et al., one of the eight transgenic lines was shown to contain a partial 
transgene and was not investigated further. Of the remaining seven, only four 
expressed detectable levels of P-galactosidase, and only two of these showed the 
high level, neuron-specific and panneuronal embryonic expression which was the 
major subject of the published article (Forss-Petter et al., 1990). Incidentally, the 
lines containing the lowest transgene copy number (3-5 copies, as determined by 
quantitative Southern analysis) were those that expressed the transgene most 
strongly. The two weakly-expressing lines had integrated approximately 10 copies 
of the transgene and the weak P-galactosidase activity could be detected only in a 
few discrete areas of the brain. lacZ mRNA and p-galactosidase activity could not 
be detected in a further line carrying more than 20 copies of the transgene. Of the 
six transgenic lines expressing human BCL-2 protein under the control of the NSE 
promoter (Martinou et al, 1994), five expressed high levels of the transgene product 
in neurons but in four lines this was restricted to the postnatal nervous system. The 
one line in which NSE-BCL-2 expression was detected in embryos was found to 
contain two insertions which segregated independently, suggesting integration into 
two different chromosomes (termed 'a' and 'b'). Embryonic expression of the 
transgene was associated with females displaying an imperforate vagina, and this 
was thought to reflect the effects of ectopic BCL-2 expression as the same effect was 
observed in transgenic mice in which BCL-2 was expressed under the control of the 
phosphoglycerate kinase promoter. Early expression was associated with one 
specific insertion only as this and the imperforate vagina phenotype were found only 
in progeny of the double-insert founder which themselves carried both insertions 
(NSEab), or the first insert only (NSEa). Progeny carrying the other insertion 
(NSEb) expressed BCL-2 in the postnatal nervous system, as did the other four 
lines, and did not display the vaginal phenotype. These results demonstrated that 
the expression of reporter genes under the control of the 1.8 kbp complete NSE 
regulatory sequence in transgenic mice was variable, probably reflecting the site of 
integration and probably also influenced by the transgene copy number. It is likely
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that neuron-specific elements are found in the 1.8 kbp sequence but that these are 
very sensitive to position effects. Thus, whilst Martinou et al. found that the 
neuronal specificity of this element was normally restricted to postnatal animals, 
Forss-Petter et al. found that levels of transgene expression in embryos and adults 
were approximately the same. Evidence from comparisons between endogenous 
gene and transgene expression (Forss-Petter et al., 1990) and from transfection 
experiments (Sakimura et al, 1995) have indicated that sequences outside the 1.8 
kbp 5' flanking element are also important for NSE gene regulation, at least 
postnatally. It would be interesting to look at the effect of intron 1 sequences in 
transgenic mice, perhaps by comparing mice containing and not containing the 
intron. A dominant negative FGF receptor has recently been expressed in 
transgenic mice under the control o f NSE 5' regulatory sequences plus the first 
intron and expression of the transgene was not detected until E l8 (F. Walsh, 
unpublished data). However, analysis was carried out by western blot, not by the 
more sensitive immunohistochemical staining, therefore the onset may well be 
earlier (pers. comm.).
Two conclusions can be drawn from these studies which may suggest routes for 
further investigation of NSE expression in transgenic mice. Firstly, the expression 
of a reporter gene under the control of the NSE promoter is generally restricted to 
neuronal structures, although the extent of that expression may vary from limited 
regions of the nervous system and peripheral neuroendocrine tissue (as found herein) 
to full panneuronal expression (Forss-Petter et al., 1990). The onset of expression 
is also variable and it is possible that analysis of the transgenic embryos obtained 
during this project at a later developmental stage would have been more rewarding. 
Secondly, and leading on from the first conclusion, it is probably nonproductive to 
conduct further experiments using the transient transgenic approach because of the 
limited analysis which can be carried out on single embryos. The variable 
expression of reporter genes driven by NSE flanking sequences is probably due to 
position effects but the competence of the 1.8 kbp regulatory sequence could be 
established in the absence of such effects, perhaps by flanking the transgene with 
boundary elements (Chada et al., 1985; Eissenberg and Elgin, 1991; Mlynarova et
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al., 1994). This competence should be firmly established before any conclusions 
can be drawn from the analysis of more truncated constructs.
9.4.3 How reliable are transgenic mice for the study of neuronal gene 
expression?
The advent of transgenic mouse technology has allowed reporter genes to be 
introduced directly into the nucleus of a mouse oocyte wherein they often integrate 
into the host DNA and become stably inherited and propagated in the mouse 
germline (Palmiter and Brinster, 1986). The expression of a transgene can then be 
observed in the context of the entire organism, which is a great advantage over cell 
line studies, and lines of transgenic animals yield a potentially limitless supply of 
experimental material (Twyman and Jones, 1995b). At present, the major 
disadvantage of transgenic analysis is that the site of transgene integration is random 
(unless specific allele replacement/gene knockout techniques are applied). The 
results of such random integration are position effects, whereby integrated genes 
come under the control of nearby endogenous regulatory elements, resulting in 
ectopic expression or inappropriate silencing which is not regulated by the integrated 
DNA. Position effects can lead to the misinterpretation of transgenic data and can 
generate contradictory results from independent studies using the same transgene. 
Many neuronal genes have been analysed in transgenic mice (Twyman and Jones, 
1995b) and, at present, the only way around the problem of position effects is to 
generate a number of transgenic lines so that one-off misexpression phenomena can 
be identified as such. Other strategies for studying gene regulation in vivo have 
been developed recently and these may contribute to the study of neuronal gene 
expression in the future. Such tactics include the transfection of brain sections using 
a particle mediated or 'gene gun’ approach (Lo et al., 1994), the transduction of 
reporter genes into neurons using recombinant neurotrophic viruses (Crystal, 1995; 
for examples of in vivo transduction using NSE reporter sequences, see Andersen et 
al., 1992 and 1993) and the transfection of living embryos in ulero by injecting 
pregnant mice with DNAiliposome complexes (Tsukamoto et al., 1995). These
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approaches combine the convenience of transfection with the ’whole organism' 
context of transgenic analysis and may well feature strongly in future analysis of 
neuronal genes.
9.5 Protein-DNA interactions in the NSE  5' flanking region
The results from transfection experiments were summarised at the beginning of 
Chapter 8 and from this summary, a number of regions of the proximal 5’ flanking 
sequence were identified as candidates for in vitro analysis. Region A, the fragment 
spanning between positions -255 and -120 which had been shown in this project to 
be active as a silencer in Ltk- and Neuro-2A cells, and similarly in NB35 
neuroblastoma cells (Sakimura et al., 1995), but as an enhancer in PC12 cells, was 
subjected to gel retardation analysis. This failed to identify consistent binding 
activity in extracts of PC12 cells or Neuro-2A cells, but a full range of experiments 
to optimise binding conditions was not attempted in the limited time remaining. A 
number of specific binding complexes was observed in extracts of Ltk- and HeLa 
cells but there was not time to pursue this discovery further. Future work could 
involve characterisation of the protein-DNA complexes by footprinting or 
methylation interference strategies. It might also be possible to identify the binding 
factor(s) by attempting to supershift the protein-DNA complexes with antibodies 
chosen on the basis of the consensus sites within this region. One putative target 
would be AP-2 (Imagawa et al., 1987). There are also several interesting motifs 
which may well bind novel factors - these include two AC-rich sequence elements, 
CCCCCACCC at position -180 and CCCCACCACCACCC at position -160. It is 
noteworthy that these sequences are similar to the PER2 element 
(CCCCCCACCCCCC) which was found to be essential for the expression of 
another neuronal gene, peripherin (Desmaris et al., 1992).
The most proximal 95 bp of 5' flanking region is still capable of neuron specific 
expression in P19 neurons and similar results were obtained using primary cultured 
neurons (Sakimura et al., 1995). To facilitate future analysis of this region, the
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most proximal 120 bp of 5' flanking material plus exon 1 was subcloned into 
pBluescriptIIKS + . This region contains consensus motifs for AP-1 (Lee et al., 
1987), AP-2 (Imagawa et al., 1987), Sp-1 (Briggs et al., 1986) and a putative 
TATA-like box. This region also contains several AC-rich elements similar to 
those described in the previous paragraph which may warrant further attention.
Sakimura an colleagues have reported the identification of brain-specific proteins 
binding to the intron and most proximal promoter region of the NSE gene, although 
further characterisation of these proteins has not been reported as yet (Katagiri et 
al., unpublished observations). Confirmation of protein binding activity in the 
proximal promoter is very encouraging, and Sakimura et al. report that both gel 
retardation and DNA footprinting are being used to characterise these interactions. 
Hopefully, the further study of these regions will eventually provide a full 
understanding of the mechanisms used to control NSE gene expression and this may 
contribute to our understanding of neuron-specific gene expression and the 
molecular biology of the enolase gene family.
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Figure 7.8: Following two pages
Figure 7.8: Expression of NSE protein in mouse embryos at E10.5. a) Size and appearance of 
mouse embryo at E10.5 showing the positions of sections to which the drawings and photographs in 
this figure refer, b) Schematic representation of the E10.5 mouse neural tube in transverse section 
(the position of each section is shown in (a)), showing anatomical differences along the rostrocaudal 
axis. The expression domain of NSE protein is shaded in and the photographic field of each 
photomicrograph (as shown in (c)) is marked with a dashed line, c) Photomicrographs of 
representative transverse sections, magnification x85, showing the diminishing extent of NSE 
expression along the rostrocaudal axis of the E10.5 mouse neural tube. NSE was detected using a 
polyclonal antiserum raised against human NSE and a secondary FITC-conjugated antiserum specific 
for rabbit IgG. Photographs were enlarged from original slides taken under epifluorescent 
microscopy using a x20 DIC objective lens.
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7.2.4.2 Expression of endogenous NSE protein at E10.5
Transverse 10pm sections were taken throughout E10.5 mouse embryos and NSE 
protein was detected as described in section 7.2.4. No NSE protein could be 
detected in the brain (data not shown) but expression was observed in the rostral 
part of the neural tube, specifically in cells believed to be motor neurons of the 
ventral horn (Figure 7.8). At the more rostral extremity of this domain of 
expression, NSE-positive neurons were visible in the mantle layer, which at this 
stage of development is restricted to bilateral crescents of tissue in the ventrolateral 
regions of the neural tube (Figure 7.8(i)). Sections taken progressively more 
caudally along the neural tube showed a regression of this domain, until at its 
caudal extremity, only a few individual NSE-positive cell bodies were detected 
(Figure 7.8(iv)).
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was carried out with automatic exposure. This is also reflected in the relatively 
high background signals observed in photographs from early developmental stages, 
where the expression of NSE was weak and localised.
2 5 1
Results: Chapter 7
7.2.4 Expression of endogenous NSE protein - in situ immunohistochemical 
analysis
The expression of NSE protein was investigated by cutting cryostat sections of 
mouse embryos freshly prepared as described in section 4.3.2. Embryos were 
studied between E9.5 and E14.5 for the reasons discussed above. NSE protein was 
detected with a polyclonal primary antiserum raised against human NSE and an 
FITC-conjugated secondary antiserum specific for rabbit IgG as described in section 
4.3.6. The suitability of the anti-human NSE antiserum for the detection of mouse 
antigen was established by immunoblot analysis (see Figure 5.2).
In this section, the expression of NSE protein is presented in the form of 
epifluorescent photomicrographs taken from cryostat sections subjected to treatment 
as described above and depicting various embryonic structures at various stages of 
development. Each set of photographs is accompanied by a drawing of an embryo, 
which shows the position of each cryostat section in relation to the whole organism, 
and a series of schematic sketches, showing the important anatomical landmarks 
within each cryostat section and the field of each photograph. Each figure is 
divided into three compartments, labelled (a), (b) and (c). Compartment (a) shows 
the size and appearance of the whole embryo, compartment (b) comprises the 
schematic sketches of the cryostat sections, and compartment (c) comprises the
photographs. Consecutive sections are identified by numbering i, ii, iii__etc. In
compartment (b), anatomical landmarks are labelled 1, 2, 3 ....etc., and are 
described in full under the sketches whilst dashed boxes, labelled A, B, C....etc., 
represent individual photographs and show the fields they cover.
For each cryostat section used to detect NSE, a serial section was used as a negative 
control. The negative controls were treated in the same manner as the experimental 
sections, but the primary antiserum was omitted from the first incubation. To 
conserve space, negative control photographs are not shown for each experiment 
described in this chapter, but an example is shown in Figure 7.6. It should be noted 
that the background signal is greater in the negative control because photography
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7.2.3.3 Wholemount in situ hybridisation to mouse embryos
In situ hybridisation to wholemount E8.5 and E9.5 mouse embryos was carried out 
as described in section 4.4. E8.5 mouse embryos treated with the antisense RNA 
probe showed no signal above the background observed in sense probe controls 
(Figure 7.5a). E9.5 mouse embryos demonstrated staining in the neuroepithelial 
lining of the forebrain, midbrain and hindbrain, but the signal was absent from the 
neural tube (Figure 7.5b). The brain-specific signal was not evident in control 
embryos treated with the sense probe.
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Figure 7.1. Biochemical analysis of NSE  gene expression during mouse development, a) Northern 
analysis, lanes loaded equally for total RNA (lOpg per lane) and probed with the Sma I - Nco I 
fragment o f the rat NSE  3' UTR: 1 - adult liver (negative control); 2 - adult brain (positive control);
3 - PO brain; 4 - E17.5; 5 - E 14.5; 6 - E12.5; 7 - E10.5. Lanes 4 -7  were extracts of whole embryos. 
Markers are Gibco BRL RNA ladder, b) Western analysis, lanes loaded equally for total protein 
(5pg per lane) and NSE detected with primary antiserum raised against human NSE and secondary, 
horseradish peroxidase-conugated secondary antiserum specific for rabbit IgG. Signal detected using 
diaminobenzidine tetrahydrochloride without metal ion enhancement: 1 - adult liver (negative control); 
2 - adult brain (positive control); 3 - PO brain; 4 - E17.5; 5 - E14.5; 6 - E12.5; 7 - E10.5. Lanes 4 -7  
were extracts of whole embryos. 45kDa marker is ovalbumin.
241
Results: Chapter 7
7.2.1 Biochemical analysis of endogenous N SE  gene expression during mouse 
development
The expression of NSE mRNA and NSE protein was investigated by northern and 
western analysis as described in sections 4.1.7.3 and 4.1.8. Total RNA and protein 
was isolated from E10.5, E12.5, E14.5 and E17.5 embryos, from the brains of 
neonatal cubs and from adult brain and liver. The last two extracts represented 
positive and negative controls, respectively. Lanes were loaded equally for total 
RNA (lOpg) or protein (5pg). NSE mRNA was detected using a probe 
corresponding to the rat NSE 3' untranslated region, as described in section 5.2.1, 
and NSE protein was detected using a primary antiserum raised against human NSE 
and a secondary, horseradish peroxidase-conjugated antiserum specific for rabbit 
IgG as described in section 5.2.1.
Similar studies in the past have shown that NSE protein can first be detected at E15 
(Fletcher et al. , 1976). Although the expression of mouse NSE mRNA does not 
appear to have been investigated by northern analysis, its presence has been 
demonstrated as early as E14, based upon its ability to programme in vitro protein 
synthesis (Zeitoun et al., 1983). In the present study, both mRNA and protein were 
first detected at E17.5. NSE mRNA was detected as a single hybridising band 
which comigrated with the 2.37 kb marker, corresponding to the expected size of 
the transcript (2233 b). NSE protein was detected as a single band which was 
slightly retarded with respect to the ovalbumin marker (45 kDa). Given that 
embryos from E15 and E16 were not considered, the first appearance of NSE 
protein broadly agreed with the previous studies of protein expression described 
above, however, the RNA analysis placed the onset of gene expression much later 
than previously reported. This discrepancy probably reflected differences in 
sensitivity between the two assays used. Both NSE protein and NSE mRNA were 
present at low levels in the embryo compared to adult brain. In each case, there 
was an approximate threefold increase in the level of gene product between E l7.5 
and PO, and a similar increase between PO and adulthood. These results, shown in 
Figure 7.1, underscore the biphasic increase in gene expression observed in
240
Results: Chapter 7
Chapter 7 - Analysis o f  the NSE promoter in vivo using transgenic mice
7.1 Chapter summary
As discussed in the experimental overview, studies of neuronal gene regulation 
based purely upon ex vivo promoter analysis are often inadequate, primarily because 
the investigator has no idea of the spatial and temporal effects of his deletions in the 
context of an entire organism. Furthermore, the highly artificial nature of the 
transfection assay can override some of the normal constraints which apply in vivo; 
these factors are summarised in Table 2.1. If possible, therefore, such constructs 
that are made should be tested in both environments so that the advantages of each 
system can be maximised. Indeed, this strategy was attempted in the project 
discussed in this thesis. This chapter considers the in vivo analysis of NSE gene 
regulation, firstly discussing the endogenous expression of NSE and then the 
expression of reporter transgenes driven by parts of the rat NSE 5' flanking 
sequence.
7.2 Expression of endogenous NSE  during mouse development
The importance of preliminary experiments to establish the endogenous expression 
of NSE in various cells lines was averred in Chapter 5. In a similar fashion, it was 
critical to characterise the endogenous expression of NSE during mouse 
development in order that patterns of reporter transgene expression could be 
compared and contrasted to those of the endogenous gene. In both cell lines and 
embryos, the expression of NSE mRNA and NSE protein was investigated using 
biochemical and in situ detection methods. In cell lines, the biochemical analysis 
was most important because the data from subsequent transfection experiments was 
largely quantitative. In embryos, however, the in situ analysis took on the more 
important role, as data concerning the spatial and temporal aspects of NSE gene 
regulation in mice were qualitative in nature.
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6.7 Conclusions from the Sox factor cotransfection experiments
The Sox-cotransfection experiments unexpectedly showed that in NB4-1A3 cells 
transfected with pNSE1800CAT, higher mean Relative CAT Activities were 
observed following cotransfection with either cSox2 or cSox3 expression vectors. 
This was the opposite effect to that expected from factors expressed in the 
ventricular regions of the nervous system, where NSE is absent, and whose 
expression is strongly downregulated in areas of the nervous system characterised 
by the presence of postmitotic neurons. Whist the apparent induction of NSE by 
cSox2 was minimal, cSox3 cotransfection appeared to sponsor a two to threefold 
upregulation of reporter activity. However, careful inspection of the transfection 
data revealed that the Actual CAT Activities of pCAT-Control cotransfected with 
cSox3 were twofold less than those arising from cotransfection with cSox2 or the 
negative control vector pBluescriptIIKS+. As discussed in Chapter 5, it is 
permissible to compare absolute CAT activités within an experiment involving one 
cell line because all conditions are standardised. Such a significant difference 
between control activities within the bounds of the same experiment must indicate 
an exogenous cause, and cSox3 might well be the culprit. If the effect of cSox3 on 
the SV40 promoter is considered, and the Actual CAT Activités for cells 
cotransfected with pCAT-Control and pcDSox3 are normalised for this, the 
observed increase in Relative CAT Actvitiy becomes insignificant. One must also 
bear in mind that the control for transfection efficiency, pSV-P-galactosidase, is 
driven by the same promoter as pCAT-Control. The effect of Sox cotransfection is 
clearly revealed by inspection of the soluble P-galactosidase assay readings. There 
is an approximate twofold reduction in apparent transfection efficiency between the 
Sox contransfected cells and the controls. This phenomenon is observed for both 
cSox2 and cSox3, thus it is unclear why cSox2 appears not to influence pCAT- 
Control to the same extent as cSox3. These data suggest that the Sox factors do not 
influence the regulation of NSE and that careful controls must be carried out in 
future experiments to ensure that any observed effects of the Sox factors are true 
and not artefactual.
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Activity of 120-140%. In the presence of cSox2 and cSox3 expression vectors, 
transfection efficiency was reduced approximately twofold. As the same mass of 
pSV-[l-galactosidase DNA was transfected in each case, the transfection efficiencies 
for the Sox cotransfections should have been similar to those for the control 
experiment. The different efficiencies observed therefore suggested that there was 
either an effect brought about by the Sox-cDNA-containing plasmids, or that the 
Sox factors were influencing the control plasmid promoters. Normalised CAT 
activities unexpectedly showed that both cSox2 and cSox3 caused a rise in NSE- 
driven reporter activity, and in the case of cSox3, a two- to threefold upregulation 
was observed. It was apparent, however, that the actual source levels of CAT 
activity from the control vector pCAT-Control were modulated by cotransfection, 
suggesting that the control vectors were indeed influenced by Sox expression. This 
point is expanded in the conclusion (section 6.7) and discussed in Chapter 9.
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6.6 Cotransfection of NSE-cat constructs with cSox2 and cSox3 expression 
vectors
The Sry-box containing transcription factors (Sox factors) were discussed in section
2.7.4 as potential regulators of neuronal gene expression and Sox-2 and Sox-3 were 
considered potential candidates for the regulation of NSE for several reasons. 
Expression of Sox-2 and Sox-3 factors in the developing chick and mouse nervous 
systems has been shown to be complementary to the expression of NSE  (Uwanogho 
et al., 1995; R. Lovell-Badge, unpublished data). Specifically, expression is 
observed in the proliferative zones, which are devoid of NSE protein (see Chapter 
7). A similar pattern of expression has been shown for NRSF mRNA (Schoenherr 
and Anderson, 1995) and the NRSF protein is a candidate negative regulator of at 
least 18 neuronal genes, but not of NSE. It is possible, therefore, that the Sox 
factors could fulfil an equivalent role in the regulation of NSE. Although the 
sequenced portion of the NSE 5’ flanking sequence appears to lack consensus 
binding sites for the Sox factors, there are several homologous elements and it 
should be borne in mind that the distal 800 bp of the complete NSE regulatory 
element has not been sequenced. In the first instance, therefore, transfections were 
carried out using pCAT-Control, pCAT-Basic and pNSE1800CAT in combination 
with expression vectors pcDSox2 and pcDSox3, which express the cSox2 and cSox3 
factors, respectively. Control transfections were carried out with pBluescriptUKS+ 
in place of the expression vectors. These experiments were designed to show 
whether the longest construct was modulated by the Sox factors. It was unfortunate 
that the mouse Sox-2 and Sox-3 expression vectors were unavailable, however, the 
chicken proteins display very similar patterns of expression and are 81% and 70% 
identical to the mouse proteins, respectively (Uwanogho et al., 1995).
Transfections were carried out in NB4-1A3 neuroblastoma cells because they 
represent a stage between nonneuronal proliferative cells and neurons, which could 
be sensitive to modulation by transcriptional regulators such as the Sox-2 and Sox-3 
factors. Furthermore, the slowing down of growth, which accompanies increasing 
cell confluence and the induction of NSE in neuroblastoma cells, might mimic the 
deposition of postmitotic neurons in the mantle layer, concomitant with the 
downregulation of cSox2 and cSox3, and the upregulation of cSoxl 1 (Uwanogho et 
al., 1995) and NSE (Zomzelly-Neurath, 1983). Thus, if these regulators were to be 
responsible for NSE gene regulation, one might expect to see repression of the NSE- 
driven construct compared to cells transfected with the control plasmid. The results 
showed that in the absence of Sox factors, the full length construct pNSE1800CAT 
was expressed at a greater level than pCAT-Control, with a mean Relative CAT
232
Results: Chapter 6
reduction following truncation from 120 bp to 95 bp, however, it is clear that the 
minimal 95 bp of 5 ’ flanking sequence is quite capable, in the presence of the 
TATA-like box required for basal transcriptional initiation, of sponsoring high level 
neuronal gene expression. These data suggest that sequences downstream of the 
transcriptional start site may be required for specific enhancement of NSE gene 
expression whilst elements in the 5’ flanking region control the temporal and spatial 
aspects of gene regulation. These factors are explored more thoroughly in Chapter 
9 in the light of recent evidence from further analysis of the NSE gene.
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